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INTRODUCTION 
The application of laser in the treatment of open-angle glaucoma dates 
back from the early Seventies. Krasnov (1973) and Hager (1973) in particular 
attempted to create a direct link between the anterior chamber of the eye 
and Schlemm's canal (trabeculopuncture). The success rate of this treatment 
was low and its complications were serious. 
When Gaasterland & Kupfer (1974) and subsequently Wickham et al. (1977) 
demonstrated that glaucoma could be induced in monkey eyes after laser mani-
pulation of the trabecular meshwork, the interest in clinical application of 
this therapy waned. 
We owe it to the perseverance of James B. Wise that today we can success-
fully use laser therapy of open-angle glaucoma. Wise proceeded from a patho-
genetic glaucoma model in which collapse of the trabecular sheets was regar-
ded as the cause of the outflow blockage. Shrinking and cicatrization caused 
by multiple laser coagulates distributed over 360° of the trabecular mesh-
work (Argon Laser Trabeculoplasty, ALT) will cause an increase in intertra-
becular spaces and therefore diminished outflow resistance. The preliminary 
results of this therapy showed a high success rate (Wise and Witter 1979). 
Numerous publications have confirmed these good results of ALT since its 
introduction, and ALT has assumed a prominent position in the treatment of 
glaucoma. Not all aspects have been elucidated, however, and some questions 
remain. What is the exact mechanism of action? Which are the optimal treat-
ment parameters? What are the short-term and long-term complications of this 
therapy? 
The most dangerous complication is the occurrence of postoperative in-
creases in intraocular pressure, which may aggravate visual field defects 
and may even lead to loss of central vision (Thomas et al. 1982; Weinreb et 
al. 1983). These increases in intraocular pressure cannot always be preven-
ted, despite modification of the ALT parameters. 
Encouraged by the good results, we have performed ALT at the Department of 
Ophthalmology of the St. Radboud Hospital, University of Nijmegen, since 
1982. A preliminary analysis of a small series of eyes thus treated showed 
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good results (Hendrikse 1984). Now, six years after introduction of ALT at 
our Department, the number of patients treated is sufficiently large for a 
more extensive study. 
The results of this study are presented in this thesis. The success rate 
and the pressure-reducing effects of ALT were studied in retrospect in a 
group of patients treated prior to 30th June 1986. Patients treated by ALT 
after this date were included in a prospective study and examined for in­
creases in intraocular pressure during the period immediately after ALT. 
This thesis comprises two parts. The first part discusses some aspects of 
open-angle glaucoma of relevance to ALT or to the study in general, with 
special reference to functional anatomy, physiology and pathology of the 
anterior chamber, the iridocorneal angle and the trabecular meshwork. In ad­
dition, ophthaHnological findings obtained in glaucoma patients are analys­
ed. 
The pathogenetic mechanisms possibly underlying the glaucomatous damage to 
the optic nerve are described because the optic nerve plays an essential 
role in the glaucoma concept. Prior to this, the first chapter outlines how 
current understanding of glaucoma can be explained from a historical per­
spective. 
The second part describes the results of the retrospective and prospective 
study. This part starts with a review of the literature on ALT. 
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PART I 

CHAPTER 1 
THE HISTORY OF GLAUCOMA 
The answer to the question of what our ancestors knew of glaucoma is not 
merely of importance to the ophthalmological historian but also contributes 
to our current view of this disorder. It seems not until recently that glau-
coma as such began to be studied seriously by ophthalmologists looking into 
its natural history, symptoms and cure. The clinical history, however, fa-
vours the belief that glaucoma is a disease of great antiquity. Predisposing 
factors such as old age, racial influences, climatic conditions, inflamma-
tory diseases of the eye and errors of refraction must always have been 
present. One may therefore conclude that glaucoma has always existed, al-
though our ancestors recognized it only in its final stage as a special form 
of amaurosis. 
Some contemplation of the history of glaucoma is required in order to gain 
insight into our current knowledge of this disease. 
The Old Testament mentions several cases of amaurosis, some of which were 
undoubtedly caused by glaucoma (Isaac, Genesis 27:1; Israel, Genesis 48:10; 
Eli, I Samuel 4:15; Ahijah, I Kings 14:4). Old age is given as the main 
cause of blindness in these cases, and different terms are used to describe 
visual impairment and amaurosis: the Hebrew word 'wattikhena', which means 
extinguished, 'kabad', meaning heavy or hard, and 'kamu·, which literally 
means that the eyes stood still. These terms refer to the chronicity of the 
disorder, the hardness of the eyeball, and the peculiar stare which charac-
terizes amaurosis following glaucoma (Gordon 1938). 
The ancient Greek physicians stressed the colour of the pupil as being of 
great diagnostic value. In the Hippocratic Aphorisms, 'glaucosis' is a dis-
order of the eyes becoming manifest in old age and causing blindness. "If 
the pupil becomes sea-coloured, sight is destroyed and amaurosis of the 
other eye often follows" (Gordon 1938; Sugar 1957). 
The term »green stare' may be derived from the word 'glaucos' which in Old 
Greek refers to 'blueish' or 'glossy' and in New Greek to 'sea-coloured' or 
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'greenish' (leydhecker I960). 
The Greek furthermore distinguished between a silver-grey and an greenish-
blue pupil, which were referred to as cataract and glaucosis respectively. 
The earliest Roman ophthalmologists regarded glaucosis and hypochyma (cat-
aract) as identical terms. According to Ephesus Rufus (about 50 A.D.) later 
writers did differentiate between the two disorders, ascribing glaucosis to 
a watery crystalline lens and cataract to a turbid fluid which settled be-
tween the iris and the lens (Chance 1962). 
In the year 395 A.D. emperor Theodosius split the Roman Empire. The East 
Roman Empire, unlike the western part, was well-organized, and Constanti-
nople was its centre for trade, industry and finance. The material circum-
stances were optimal for a revival of the old cultures, and medical writers 
depended entirely on the traditional works of Hippocrates, Galen and Celsus. 
Paulus Aegineta (629-690) followed the Greek dictum and differentiated be-
tween amaurosis arising from glaucoma and that caused by other conditions 
(Graefe-Saemisch 1908). 
Evidently, no new ideas were formulated in the ophthalmological field 
during this Byzantine period of reluctance to change. It was not until half-
way the 14th century that Sams-ad-din, an Arab ophthalmologist (1348) des-
cribed a characteristic picture of glaucoma as 'migraine of the eye'. In its 
acute stage the condition was characterized by hemicrania, deep-seated in-
flammation of the eye, turbidity of the humours, followed occasionally by 
cataract and permanent dilatation of the pupil. If chronic, it was associa-
ted with tenseness of the eyeball and loss of vision (Gordon 1938; Sugar 
1957). 
In 1622 Richard Banister edited 'A Worthy Treatise of the Eyes' - a trip-
let of ophthalmological handbooks. In the first - 'A Breviary of the Eye'-
he described an incurable form of cataract - gutta serena - which in its 
symptoms was analogous to absolute glaucoma. However, Banister's observa-
tions like those of his Arab predecessor were lost from sight until more 
than 125 years after Banister's first description (Koelbing 1967). 
In the first decade of the 18th century Michael Brisseau (1709) stated 
that glaucoma was a disease of the vitreous and not, like cataract, of the 
lens. His conclusions were based on his own observations and those of his 
colleague Maréchal. The latter dissected the eyes of Bourdelet, physician to 
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Louis XIV, and found by coincidence the vitreous to be somewhat opaque 
(Draeger 1961). Although Brisseau's concept was accepted by the German oph-
thalmologist Lorenz Heister (1683-1756), the general opinion prevailed that 
glaucoma was a disease of the lens. 
Johann Zacharias Platner (1745) rediscovered the signs of absolute glau-
coma previously described by Sams-ad-din and Banister, but still thought the 
lens to be the organ affected. 
Ophthalmological history provides us with numerous theories on the origin 
of glaucoma advanced between 1750 and 1850. Demours (1762-1836) was the 
first to describe "colours of the rainbow (halo vision) around a light", and 
ascribed the disease to gout and rheumatism. Beer (1763-1821) of Vienna and 
the Englishman William Lawrence (1783-1867) believed that glaucoma was 
caused by a chronic and malignant form of iritis, which affected the poste-
rior coats of the eye (Leydhecker 1960). 
Antonio Scarpa (1752-1832) as well as Weiler (1826) gave excellent des-
criptions of absolute glaucoma, both referring to the 'painful tension in 
the eyeball'. Fabini (1831) of the university of Pest mentioned eyeballs 'as 
hard as stones·, due to changes in the elasticity of the tunics of the eye-
ball. 
William Mackenzie (1830) ascribed the increased tension to inflammation, 
leading to overproduction of fluid in the eyeball; in 1854 he advocated 
paracentesis of the cornea for prevention and treatment of glaucoma. 
The invention of the ophthalmoscope by Hermann von Helmholtz (1850) in-
augurated a new era in ophthalmological research. The ophthalmoscope enabled 
investigators to study pathological changes in the retina and optic disk 
(Von Helmholtz 1851). 
In view of his great works and because he is generally regarded as the 
founder of modern ophthalmology, Albrecht von Graefe merits some special at-
tention. He was bom in Berlin on 2Bth May 1828. His father was Karl Ferdi-
nand von Graefe (1787-1870) - a renowned teacher, general in the Prussian 
army and court physician who came to be regarded as the founder of modern 
plastic surgery. Albrecht von Graefe was a bom scholar who at the age of 16 
went to the university of Berlin to be taught by famous medical leaders such 
as Virchow, Dieffenbach, Traube, Schlemm, Romberg and Schoenlein. In 1847 he 
wrote his thesis on bromide and graduated from the university. 
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During his 'Wanderjähre' his interest in ophthalmology deepened. He per-
formed ophthalmological research together with Arlt (Prague), Bernard 
(Paris), Jaeger (Vienna), Bowman (London), Mackenzie (Glasgow) and Donders 
(Utrecht), and finally returned to Berlin. 
By the time Von Helmholtz invented the ophthalmoscope, Von Graefe had a 
practice at 46 Karlstrasse in Berlin. The story goes that as soon as he laid 
hands on an ophthalmoscope, he knew by instinct how to use it (Ullman 1954). 
Several months before this happened the first description of the changes 
in the glaucomatous optic disk was published by Alfred Jaeger (1784-1871); 
he erroneously described these changes as 'globular swelling', and Von 
Graefe at first made the same mistake. In 1855 Weber was the first to demon-
strate cupping of the disk, and Muller (1858) observed cupping of the disk 
in enucleated glaucomatous eyes (Sugar 1957). 
Von Graefe demonstrated by close ophthalmoscopic examination that arterial 
pulsations, as he had described in glaucoma, could be elicited by pressure 
on the eyeball even in normal eyes. Further studies on the fundus preceding 
the final stage of glaucoma convinced Von Graefe that the increased pressure 
was not a complication but the cause of all the symptoms. He performed the 
first iridectomy ever in 1856 (Gordon 1938). 
It was Franciscus Cornells Donders (1818-1889), a close friend of Von 
Graefe and co-editor of "Archiv für Ophthalmologie", who proclaimed glaucoma 
simplex to be the basic form of glaucoma. 
With the works of Von Graefe, Donders and all others mentioned in this re-
view, we entered the modern era of glaucomology. The relation between intra-
ocular pressure and glaucomatous damage to the optic disk was more evident 
then ever before. More advanced techniques were developed to measure intra-
ocular pressure (Von Graefe 1862; Weber, Fick 1888, Schiötz 1905; Goldmann 
1954). and visual field defects (Von Graefe 1855; Bjerrum 1867; Foerster 
1882; Goldmann 1945). New pharmacological and surgical techniques were in-
troduced to prevent or arrest glaucoma. It would be entirely beyond the 
scope of this review to mention all the other clinicians and researchers who 
have contributed to our current glaucoma concept. Some relevant historical 
aspects of the modem period, however, may be mentioned in subsequent chap-
ters of this thesis. 
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CHAPTER 2 
FUNCTIONAL ANATOMY, PHYSIOLOGY AND PATHOLOGY 
mBODUCTICN 
The interaction between clinical medicine on the one hand and its basic 
disciplines of anatomy, physiology and pathology on the other has led to a 
comprehensive scientific glaucoma concept. An understanding of anatomical 
relations, pathophysiological processes and pathological changes in glauco-
matous eyes is not only of descriptive value to the clinician but also con-
tributes to diagnosis and therapy. 
This chapter discusses glaucoma in terms of these basic disciplines, and 
reduces glaucomatous changes to their morphological, physiological and path-
ological substrates. 
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2.1 EMBRYONIC DEVELOPMENT OF THE IRIDOCORNEAL ANGLE AND TRABECULAR MESHWORK 
The first signs of the primordium of the eye are already visible in the 
22-day embryo (maximum length 2 mm). The neural tube is still open and the 
prosencephalon forms the optic grooves on either side (fig.2.1A). As the an­
terior neuropore closes on about the 25th day the optic vesicles develop 
from these grooves (fig.2.IB). With the growth of the central nervous system 
these neural ectodermal vesicles are pushed away laterally in the direction 
of the surface ectoderm (Langman 1976). 
Induction from the neural ectoderm results in the primordium of the lens 
placode in the surface ectoderm (Smelser 1965). Differentiated growth causes 
an invagination in the optic vesicle which leads to the formation of the op­
tic cup, while the invaginating lens placode remains in touch with the neu­
ral ectoderm (fig.2.1С). Invagination is not limited to the central part of 
the optic cup but also occurs on the ventral side. In this process the cho­
roid fissure becomes manifest: a groove along which the hyaloid artery will 
be incorporated (fig.2.2A). 
The lens placode gives rise to the lens vesicle which loses its contact 
with the surface ectoderm (33 days). This is the time at which the surface 
ectoderm closes and the space between lens vesicle and ectoderm fills with 
mesoderm (fig.2.2B) (Barber 1955). 
From these basic embryonic structures further growth and differentiation 
taXe place until an integrated and functional organ has formed at birth. 
Table 2.1 presents a survey of the embryonic origins of the various intraoc­
ular structures. 
Figure 2.1. A. Cross-section through the prosencephalon of a 22-day embryo 
(about 14 somites) with visible optic grooves. The neural groove 
is wide open (after Heuser), в. Cross-section through the pros-
26 
encephalon of an embryo in week 4. The optic vesicles are in 
touch with the surface ectoderm, which in this area shows some 
thickening (lens placode), c. cross-section through the prosen-
cephalon of a 5 mm embryo; the optic vesicles show indentation 
and the lens placode has formed (after Mann). 
bitraretlnal space 
dieceptalon 
liyHoid artery linen of 
optic Etait 
Figure 2.2. A. Ventrolateral view of the optic cup and optic stalk in a 6-
week embryo. The choroid fissure is situated at the underside of 
the optic stalk and gradually narrows. B. Section through the 
lens vesicle, optic cup and optic stalk at the level of the 
choroid fissure (after Mann). 
Table 2.1. Origin of ocular tissues 
Neural ectoderm 
Surface ectoderm 
Neural crest 
Mesoderm 
Retinal pigment epithelium 
Iris sphincter muscle 
Iris dilator muscle 
Posterior iris neuroepithelium 
Pigmented and non-pigmented ciliary epithelium 
Optic nerve fibres and glia 
Lens 
Corneal epithelium 
Lacrimal gland 
Surface epidermis of the lids 
Epithelium of the adnexal glands 
Epithelium of the conjunctiva 
Corneal keratocytes 
Endothelium of the cornea 
Endothelium of the trabecular meshwork 
Iris and choroid stroma 
Ciliary smooth muscle 
Fibromasts of the sclera 
Optic nerve meninges 
Striated extraocular muscles 
Vascular endothelia 
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The pathophysiological substrate of glaucoma is nearly always to be found 
in a disturbed outflow of aqueous humour at the level of the anterior irido-
corneal angle and/or the trabecular meshworJc. Although the development of 
these regions is a controversial subject in the embryology of the eye 
(O'Rahilly 1975), a further discussion of this development is essential. 
At the time when the surface ectoderm closes over the separated lens ves-
icle (week 5) the formation of the cornea has started. At that time it con-
sists of two layers of ectoderm resting on a basement membrane. The area be-
tween the surface ectoderm and the neural ectoderm is filled with mesenchyma 
(omnipotent embryonic supportive tissue). Because the mesodermal somites are 
lacking in the cranial part of the embryo, much of this mesenchyma is made 
up of cells originating from the neural crest. This supportive tissue ex-
pands in several phases and in different directions. In the initial phase 
this mesenchyma grows between lens and corneal epithelium in order subse-
quently to form the corneal endothelium. In the second phase this growth is 
bidirectional: on the one hand the mesenchyma grows between corneal endothe-
lium and corneal epithelium to form the substantia propria corneae, while on 
the other hand it grows between corneal endothelium and lens epithelium to 
form the iridopupillary layer (O'Rahilly 1975). 
The future ciliary body has its embryonic origin both in the neural ecto-
derm and in the mesenchyma. At about week 12 the outer pigmented neural ec-
todermal leaf starts to show indentations which fuse with the inner non-pig-
mented leaf. These indentations are the precursors of' the ciliary processes. 
The core of these processes consists of mesenchyma, with evidence of early 
embryonic vascularization (Ozanics & Jacobiec 1982). 
The iridopupillary layer is vascularized from capillaries in the deep-
seated mesenchyma. Branches of the long posterior ciliary arteries anasto-
mose with the peripheral vessels of the iridopupillary layer and thus form 
the circulus arteriosus iridis major. The anterior part of this iridopupil-
lary layer is replaced by the iridopupillary membrane, which is supplied 
with blood from the posterior ciliary arteries and the greater arterial cir-
cle of the iris. The pupillary part of this membrane is incorporated in the 
membranous part of the iris through remodelling. The posterior pigment leaf 
of the iris develops from the non-pigmented epithelium of the ciliary body. 
The process of pigmentation starts at about halfway gestation at the pupil-
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lary border of the iris (Ozanics ь Jacobiec 1982). 
The stormy development and differentiated growth of cornea, iris and cili­
ary body have consequences for the primordial development of the anterior 
chamber, iridocorneal angle and trabecular meshwork. 
The bidirectional growth of mesenchyma (towards cornea and iridopupillary 
layer) provides the primordium of the iridocorneal angle (Tripathi & Tripa-
thi 1982). The anterior chamber develops through differentiated growth of 
originally mesenchymal structures. There is no consensus about the further 
development of the iridocorneal angle. The oldest theory maintains that the 
iridocorneal angle forms because the local mesenchyma becomes atrophic (Mann 
1949; Barber 1955). Another theory postulates a cleavage process in the me­
senchyma due to differences in growth rate between the component parts of 
the anterior segment of the eye (Allen et al. 1955; Burian et al. 1955). 
Neither theory is based on unequivocal evidence. 
At about month 4 the trabecular meshwork consists of undifferentiated me­
senchyma, linked apically to the corneal stroma and lined with corneal endo­
thelium (Smelser & Ozanics 1971). This endothelial lining is a continuous 
monocellular layer (Hansson & Jerndal 1971). 
Studies of foetal facility of outflow have demonstrated that this in­
creases from month 5 on and correlates with foetal age, length and corneal 
diameter (Kupfer & Ross 1971; Pandolfi & Astedt 1971). Further differenti­
ation within the trabecular meshwork seems to make this drainage possible. 
Between the fourth and fifth foetal month the cells off the uveal trabecu-
lae start to detach themselves (Wulle 1972) and the initially closed endo­
thelial lining loses its continuity (Kupfer & Ross 1971; Smelser & Ozanics 
1971; Hansson & Jerndal 1971). A persistent continuous endothelial lining 
could be the precursor of Barkan's membrane (Worst 1968). 
The corneal trabeculae show a similar process of discontinuation, and the 
intercellular spaces fill with longitudinal and transverse collagenous fi­
bres. 
Between month 4 and month 8 the cribriform trabeculae show major changes 
at the cellular level. In early foetal stages this part of the trabecular 
meshwork consists of round cells with large nuclei, sparse cytoplasm and few 
organellae. The cells are firmly linked together by tight junctions. In 
later foetal stages one finds flat cells with long cytoplasmic processes and 
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abundant organellae. The intercellular spaces are filled with fibrous mate-
rial except near Schlemm's canal. The transition from the cribriform tra-
beculae to Schlemm's canal is characterized by empty intercellular spaces 
(Wulle 1972). 
The differentiation of the trabecular meshwork fulfils the primary re-
quirement for a functional drainage system. A second requirement to be ful-
filled is the development of Schlemm's canal. At about month 4 the deepest 
part of the mesenchyma, posterior to the iridocorneal angle, already shows a 
venous plexus from which schlemm's canal is to develop (Barber 1955; Duke-
Elder 1963). Between month 4 and month 9, radical changes occur in the posi-
tion and structure of Schlemm's canal. Due to differentiated growth of the 
anterior segment the canal gradually shifts anteriorly from its initial 
scleral position, to attain its definitive position - the apical side of the 
iridocorneal angle - in month 9 (Smelser & Ozanics 1971). 
The wall of the venous plexus initially consists of cells with ample cyto-
plasm, and parts of the wall may encompass several layers of cells. From 
month 6 on these cells begin to flatten, and by about month 8 one finds a 
monolayer of extremely flat cells. Intracytoplasmic vacuoles become larger 
and establish contact with the cell membrane. Fusion of the cell membrane 
with the vacuoles largely occurs on the basal side of the cells. In this way 
a connection is established between Schlemm's canal and trabeculae (Wulle 
1972). 
The functional drainage system in the iridocorneal angle is complete imme-
diately before birth. The iridocorneal angle has opened through atrophy and/ 
or cleavage, the trabecular meshwork has differentiated and Schlemm's canal 
is in its proper position. 
The anatomy, physiology and pathology of these structures will be discus-
sed in the course of this chapter. 
2.2 ANTERIOR CHAMBER, IRIDOCORNEAL ANGLE AND TRABECULAR MESHWORK 
2.2.1 Macroscopic anatomy 
The anterior chamber of the eye is bounded by the corneal endothelium on 
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the anterior and by the iris or pupillary part of the lens on the posterior 
side. The anterior peripheral part of the anterior chamber is bounded by the 
trabecular meshwork and the posterior peripheral part by the ciliary body or 
the insertion of the iridai root. 
The anterior chamber is shaped like an ellipse with a flattened posterior 
aspect. This shape is determined by the fact that the plane of the iridai 
root is localized about 4.2 mm behind the corneal apex, while the pupillary 
rim lies only about 3.6 mm behind this apex. This difference of 0.6 mm is 
due to the anterior displacement of the iris caused by the lens (Hogan et 
al. 1971). However, the absolute value of this difference is less in myopic 
than in hypermétrope eyes (Tripathi & Tripathi 1982). 
With the aid of advanced techniques the depth of the anterior chamber can 
be measured objectively and accurately. Table 2.2 presents the values for 
the depth of the anterior chamber, corneal radius and corneal diameter re-
spectively as measured by Weekers et al. (1961). The table shows that the 
depth of the anterior chamber decreases significantly with increasing age. 
These findings are in agreement with data reported by other authors (Rosen-
gren 1950; Caprioli et al. 1986). This decrease in anterior chamber depth 
does not seem to correlate directly with the changed corneal radius or dia-
meter, but rather with the increased size of the lens (Weekers et al. 1961). 
Table 2.2. Dimension of human chamber and corneal curvature. (Weekers, R., 
Grieten, J., and Lavergne, G.: Ophthalmologica 142: 650, 1961). 
Under 15 yr 15-35 yr 35-55 yr Over 55 yr 
ÄC depüi 3.61 + 0.040 3.60 + 0.039 3.27 + 0.054 3.18 + 0.054 
Corneal radius Of 7.87 + 0.062 7.96 + 0.036 7.82 + 0.046 7.79 + 0.035 
diameter 
Corneal diameter 11.71 + 0.079 11.81 + 0.056 11.76 + 0.044 11.75 + 0.057 
Not only the depth of the anterior chamber but also the width of the iri-
docorneal angle correlates with age. Table 2.3 presents the results of a 
study of correlation between age and width of iridocorneal angle by Van 
Herick et al. in 1969 (for grading of angle width, see Chapter 3 ) . The angle 
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Table 2.3. Slitlamp grading of angles in unselected group of 2185 patients. 
(Van Herick, w., Shaffer, R., and Schwartz, Α.: American Journal 
of Ophthalmology 68:626, 1969). 
Age 
0-19 
20-39 
40-59 
60 plus 
Total 
Percent 
Grade 
1 
0 
3 
7 
4 
14 
0.64 
Grade 
2 
0 
1 
6 
16 
23 
1 
Grade 
3 
82 
303 
523 
413 
1321 
60 
Grade 
4 
511 
172 
109 
35 
827 
38.36 
Percent 
Grade 1 
0 
0.63 
1 
0.85 
Percent Total 
Grade l 4 2 
0 
0.84 
2 
4.2 
Total NuBfcer 
of Patients 
593 
479 
645 
468 
2185 
Table 2.4. Slitlamp grading of angles in group of 2185 patients classified 
according to refractive error. (Van Herick, W., Shaffer, R., and 
Schwartz, Α.: American Journal of Ophthalmology 68:626, 1969). 
Hyperopia 
Greater than +1.0 D 
Myopia 
Greater tlan -1.0 D 
Group Between 
-1.0 D i+l.OD 
Age Grades 1 & 2 Grades 3 & 4 Grades 1 & 2 Grades 3 & 4 Grades 1 & 2 Grades 3 & 4 
0-19 
29-39 
40-59 
60 plus 
0 
0 
4 [2%) 
14 (3.51) 
199 (100».) 
82 (lOOt) 
213 (981) 
389 (96.5>.) 
0 
1 (0.21) 
1 (0.34) 
0 
445 < 1 № ) 
429 (99.8t) 
315 (99.7*) 
159 (lOOt) 
0 
3 (0.П) 
8 (U) 
6 (21) 
524 (100t) 
429 (99.3*) 
743 (99t) 
350 (98*) 
width was estimated on the basis of slit-lamp findings because Van Herick et 
al. believed that these correlated well with gonioscopic estimates. The ta­
ble shows that the incidence of narrow iridocorneal angles increases with 
increasing age but that the absolute value of this incidence is low. In ad­
dition, these investigators demonstrated that the distribution of narrow 
iridocorneal angles correlates with errors of refraction (table 2.4). 
In normal physiological conditions the depth of the anterior chamber of 
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the eye varies with - among other things - accommodation. The maximally ac­
commodated eye shows a less deep anterior chamber than the relaxed eye 
(Brown 1973). During accommodation, however, the facility of outflow in­
creases significantly (Armaly ь Burian 1958; Armaly & Jepson 1962), and the 
decrease in chamber depth may be compensated by an increase in angle width 
(Tripathi & Tripathi 1982). 
The macroscopic anatomy of the iridocorneal angle is best described on the 
basis of the features revealed by direct or indirect gonioscopy (for de-
taiIs, see Chapter 3). 
In principle, four structures can be identified in the iridocorneal angle 
(Rohen 1978): 
1. The most anterior boundary is demarcated by Schwalbe's line. This struc­
ture is gonioscopically identifiable as a light-coloured zone between 
Descemet's membrane and the trabecular meshwork. At a more advanced age 
pigment deposits are often found around Schwalbe's line, particularly in 
the two lower quadrants of the iridocorneal angle (Shaffer 1962; Hoskins 
1972). Differentiation from the trabecular meshwork may be difficult. 
In some cases Schwalbe's line protrudes like a ring into the anterior 
chamber. Burian et al. (1955) observed this in 72 out of a total of 600 
eyes examined. This protrusion is probably explained by an excessive de­
position of mesenchymal material during embryonic development. 
2. Immediately behind Schwalbe's line the trabecular meshwork is found. The 
origin of this tissue lies on the scleral spur and ciliary body; the in­
sertion is on Schwalbe's line. At an early age it is often difficult to 
identify the trabecular meshwork. It presents as a semitransparent, blue-
ish-grey zone between the scleral spur and Schwalbe's line. Due to its 
microscopic structure it gives the iridocorneal angle an irregular sur­
face. A blood-filled canal of Schlemm may occasionally serve as demarca­
tion. Increased episcleral pressure in the eyeball due to compression of 
a contact glass or occlusion of the homolateral jugular vein may cause 
artificial reflux of blood into Schlemm's canal (Hoskins 1972). 
Even at an early age the trabecular meshwork may be readily identifiable 
on the basis of a pronounced degree of pigmentation. Such marked pigmen­
tation is found in conditions like the pigment dispersion syndrome (Ro-
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binson et al. 1981; Scheie ь Cameron 1981; Speakman 1981; Sugar 1984; 
Richter et al. 1986). 
An increase in pigmentation is also observed with increasing age (Hoskins 
1972; Mandell 1978). The lower two quadrants are more pigmented than the 
upper two, and the pigment is usually deposited on that part of the tra­
becular meshwork that lies above Schlemm's canal (Shaffer 1962). 
3. The third structure identifiable in open iridocorneal angles is the 
scleral spur, which presents as a light-coloured white band between tra­
becular meshwork and ciliary band. 
In various conditions it may be difficult to locate the scleral spur. 
When the iridocorneal angle is very narrow, the scleral spur is covered 
by the peripheral iris. Strongly pigmented uveal trabeculae may mask the 
scleral spur. Parts of the scleral spur may be concealed by peripheral 
anterior synechiae. Finally, there may be an abundance of iris processes: 
strands of tissue extending from the iris to the scleral spur. They occa­
sionally insert on the trabecular meshwork or even on Schwalbe's line. 
Morphologically they have the same structure as iridai tissue, and their 
morphology therefore differs from eye to eye (Hogan et al. 1971). They 
are probably remnants of an incomplete embryonic cleavage process (Shaf­
fer 1962). Their contribution of glaucoma is obscure. Abnormal numbers of 
iris processes may be found in normotensive eyes as well as in hyperten­
sive eyes and glaucomatous eyes (Lichter s, Shaffer 1970). 
4. Finally, the ciliary band is the most posterior structure of the irido­
corneal angle. This ciliary band is localized between the scleral spur 
and the insertion of the iridai root. The colour of this anterior surface 
of the ciliary body varies from greyish-white to brown, dependent on the 
degree of ocular pigmentation. Like the scleral spur, this ciliary band 
is often masked by iridai tissue, uveal trabeculae and iris processes. 
2.2.2 Microscopic anatomy 
Attempts to gain insight into the microscopic anatomy of the trabecular 
meshwork and Schlemm's canal date back more than a century. Despite sophis­
ticated techniques such as transmission electron microscopy and scanning 
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electron microscopy, fixation techniques and immunohistochemical staining, 
not all questions can be answered. One of the principal problems is the 
question whether in-vitro phenomena may be extrapolated to in-vivo situa-
tions. Nevertheless it is worthwhile to discuss the various findings and the 
theories arising from them. 
The outflow of aqueous humour from the anterior segment of the eye takes 
place along two important pathways (Fine 1964; Hogan et al. 1971; Tripathi & 
Tripathi 1982): 
1. The conventional outflow apparatus (trabecular meshwork and Schlemm's 
canal). 
2. Accessory outflow tracts: 
a) Posterior outflow to the vitreous body. 
b) Diffusion to iridai blood vessels and ciliary body. 
c) Transcorneal outflow. 
d) Uveoscleral and uveocortical outflow. 
The accessory outflow tracts are probably responsible for a small but sig-
nificant percentage of the total outflow of aqueous humour (Tripathi & Tri-
pathi 1982). 
Because most of the aqueous humour leaves the eye via the conventional 
outflow apparatus and because the major site of resistance to outflow is lo-
calized in this apparatus (Grant 1958), attention must focus on this appara-
tus. 
The following structures have of old been distinguished in the convention-
al outflow apparatus: 
1. The uveal trabeculae. 
2. The corneoscleral trabeculae. 
3. The trabecular wall of Schlemm's canal. 
4. The corneoscleral wall of Schlemm's canal. 
5. The collector channels and episcleral outflow tract. 
These structures will be discussed in the following subsections. 
2.2.2.1 Uveal trabeculae 
That part of the trabecular meshwork that constitutes the boundary between 
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the conventional outflow apparatus and the anterior chamber is referred to 
as uveal trabeculae. The classic microscopic features of this structure show 
a network of mostly radially arranged tissue strands extending between iris 
and ciliary body on the one hand, and cornea on the other (Ashton et al. 
1956; Flocks 1956; Speakman 1959; Ashton 1960). Tangential sections through 
the trabecular meshwork reveal that these tissue strands have a four-layer 
structure. There is a central collagenous core (first layer), embedded in 
elastic fibrillae (second layer). The third layer is formed by a glass mem­
brane - probably an equivalent of Descemet's membrane in the cornea. The 
fourth layer consists of endothelial cells (Ashton et al. 1956; Flocks 
1956). The mean diameter of these trabeculae is 4 \m, and they are so ar­
ranged as to form large (25-75 μη) diamond-shaped orifices (Ashton et al. 
1956). The dimensions of these orifices are such that they offer no resist­
ance to the outflow of aqueous humour to schlemm's canal (Speakman 1959). 
The introduction of transmission electron microscopy cast a new light on 
the structure of these trabeculae. Garron et al. (1958) were the first to 
employ this technique in studying the trabecular meshwork. They were unable 
to trace the classic four-layer structure (Garrón et al. 1958; Garron í. Fee-
ney 1959). The central collagenous core proved to consist of fibrillae with 
a periodicity of 64 nM, embedded in a homogenous matrix with an approximate 
thickness of 80-130 nM. This matrix comprises fibrillae with a periodicity 
of 100 nM and fibrillae showing no periodicity. The investigators were un-
able to trace a typical glass membrane. They concluded that the histologic-
ally identifiable elastic material probably consists of collagen aggregates 
with a periodicity of 100 nM, and that the glass membrane is identical to 
the ground substance. They believed this ground substance to consist mainly 
of mucopolysaccharides (Garrón & Feeney 1959). 
Application of new fixation and staining techniques by Spelsberg & Chapman 
in 1962 revealed that the homogenous matrix in actual fact is a thick base-
ment membrane on which the endothelial cells rest. They also were able to 
trace the fibrillae with a periodicity of 64 nM and 100 nM respectively, and 
in addition they reported that the endothelial cells have abundant organel-
lae and that consequently synthetic activity may be involved. 
The discussion about the presence or absence of elastic material in the 
trabeculae continues. Some authors maintain that the presence of this mate-
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rial in the trabeculae is beyond doubt (Tripathi & Tripathi 1982); others 
take a more moderate view and refer to an elastic-like material (rink et al. 
1978; Lütjen-Drecoll et al. 1981). 
Scanning electron microscopy makes it possible to obtain three-dimensional 
images of the trabecular meshwork. The uveal trabeculae present themselves 
as an irregular low-density network of tissue strands (Spencer et al. 1968). 
The orifices in this network are polygonal (Anderson 1971) and exceed a dia-
meter of 20 \m (Bill & Svedbergh 1972). 
The endothelial cells lining the trabeculae are mostly elongated flat 
cells. Their cytoplasm comprises the usual organellae such as central nucle-
us, agranular endoplasmic reticulum, granular endoplasmic reticulum, Golgi 
complex, lysosomes, vesicles and multivesicular bodies (Tripathi & Tripathi 
1982). These cells have long cytoplasmic processes that extend to contact 
adjacent cells (Inomata et al. 1972) via maculae occludentes and desmosomes; 
these processes often span an intertrabecular space (Tripathi 1977). The 
morphological features of these organellae suggests synthetic activity (Tri-
pathi s, Tripathi 1982). This synthetic activity receives attention in sub-
section 2.2.2.5. 
2.2.2.2 Corneoscleral trabeculae 
The tissue strands of the corneoscleral trabeculae consist of parallel 
sheets and microscopically show the same four-layer structure as those of 
the uveal trabeculae (Flocks 1956; Ashton 1960). The longitudinal axis of 
these sheets parallels that of the scleral spur and that of Schlemm's canal 
(Flocks 1956; Speakman 1959). The sheets are most numerous (8-15 on average) 
near the scleral spur (Flocks 1956). At that site the total thickness of 
these sheets is 120-150 \m, each individual sheet measuring 5-12 μπι (Tripa­
thi 6, Tripathi 1982). The intertrabecular spaces are narrower than those of 
the uveal trabeculae, measuring about 5-20 \m. These spaces gradually oblit­
erate near the transition of the trabecular meshwork to the corneal stroma 
(Tripathi 6 Tripathi 1982). 
The aqueous humour can reach Schlemm's canal because the sheets are perfo­
rated. These perforations are oval-shaped and smaller than those in the 
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uveal trabeculae (Bill & Svedbergh 1972). Again one finds the cytoplasmic 
processes spanning the inter- and intratrabecular spaces (Anderson 1971). 
The intratrabecular spaces seem to be tunnels extending through an endothe-
lial cell or localized at the boundary between two cells (Spencer et al. 
1968). The tunnels become narrower as they are closer to Schlemm's canal. 
The generally seem to be randomly distributed over the trabeculae, but they 
are rarely if ever juxtaposed (Fine et al. 1981). 
The electron microscopic anatomy of the sheets show the following struc-
tures from the inside out: a collagenous core, a layer of amorphous ground 
substance, a basement membrane and an endothelial lining (Tripathi & Tripa-
thi 1982). The thickness of the collagenous core diminishes as Schlemm's ca-
nal is approached (Flocks 1956; Speakman 1959; Bill s. Svedbergh 1972). Ac-
cording to Tripathi elastic fibrillae are present in the amorphous ground 
substance and in the basement membrane (Tripathi & Tripathi 1982). Ultrahis-
tochemical studies have shown, however, that by no means all fibrillae in 
these areas consist of elastic material (Liitjen-Drecoll et al. 1981). 
Attention should be paid to the presence of collagen with an electron mi-
croscopic periodicity of 95-125 nM in the collagenous core and basement mem-
brane; this collagen has been described as curly collagen (Garrón & Feeney 
1959) or lattice collagen (Rohen 1963). Curly collagen is seen more fre-
quently with increasing age (Rohen 1978) and is probably responsible for the 
thickening of the trabeculae at a more advanced age (McMenamin et al. 1986). 
The lining of the sheets consists of endothelial cells whose longitudinal 
axes parallel those of the trabeculae. They are in touch with each other via 
maculae adhérentes and gap junctions (Tripathi & Tripathi 1982). Their com-
position hardly differs from that of the cells in the uveal trabeculae. 
2.2.2.3 Trabecular wall of Schlenn's canal 
The trabecular wall of Schlemm's canal is the area of transition between 
the most peripheral corneoscleral sheets and the lumen of Schlemm's canal. 
This area generally encompasses three components: 
1. The endothelial lining of Schiomi's canal. 
2. Ά basaient membrane. 
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3. A connective tissue zone. The literature shows no consensus about the 
nomenclature of this zone, which on the basis of its specific microscop­
ic features is given various names: 
- pore tissue (Flocks 1956), 
- endothelial meshwork (Speakman 1960), 
- juxtacanalicular connective tissue (Fine 1964), 
- cribriform meshwork (Rohen 1969), 
- juxtacanalicular layer (Fink et al. 1972). 
I prefer the designation 'endothelial meshwork' because this indicates 
the localization and emphasizes the cellular component. 
The luminal side of the inner wall of Schlemm's canal proves to show ir­
regular features with many outpouchings into the lumen and deep grooves in 
the wall (Flocks 1956; Speakman 1959; Unger & Rohen 1959; Rohen 1960; Kayes 
1967; Tripathi 1968; Bill & Svedbergh 1972; Fink et al. 1978). The trabec­
ular side proves to give rise to septa which link the corneoscleral and tra­
becular walls of Schlemm's canal (Tripathi 1969). Taking the trabecular wall 
of Schlemm's canal as a flat region, the surface area is about 11 mm2. 
Taking the irregularity of its structure into account, however, Cole b Tri­
pathi (1971) estimate the total surface area to be 40 mm". 
The wall is lined by a continuous monolayer of endothelial cells (Tripathi 
1969). The diameter of these cells is about 4-8 \m (Bill & Svedbergh 1972), 
sometimes up to 12 \m (Tripathi 1977), and their length often exceeds 100 
щп (Bill s, Svedbergh 1972). At their most peripheral ends these cells often 
have diameters of only 0.1-0.3 \m (Kayes 1967; Fink et al. 1972). 
The cells are in contact via end-to-end touches, tongue-in-groove junc­
tions, zonulae adhérentes and zonulae occludentes (Kayes 1967; Tripathi 
1968; Fink et al. 1972). Although Spencer et al. (1968) were unable to iden-
tify tight junctions, their presence was confirmed with the scanning elec-
tron microscope (Inomata et al. 1972). 
These endothelial cells contain a nucleus, Golgi complex, mitochondriae, 
agranular endoplasmic reticulum, granular endoplasmic reticulum, multivesi-
cular bodies, glycogen, free ribonucleic acid granules and lysosomes. 
Fibrillar elements are found in addition. The cell surface often shows in-
vaginations on the basal side (Tripathi 1969) and is covered with micropino-
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cytosis vesicles (Tripathi 1969; Fink et al. 1972). The large nucleus is re­
sponsible for the previously mentioned outpouchings into the lumen of 
Schlemm's canal (Kayes 1967; Tripathi 1968; Fink et al. 1972; Bill & 
Svedbergh 1972). 
These endothelial cells differ from other endothelial cells in that they 
have large intracytoplasmic vacuoles (Fink et al. 1972). ЗреаЗопап (1959) was 
the first investigator to describe these vacuoles, which he believed to be 
postmortem artefacts. The first transmission electron microscopic studies of 
the trabecular meshwork likewise revealed these vacuoles (Garron et al. 
1958; Garron s. Feeney 1959), and in 1960 Speakman acknowledged that they 
were not post-mortem artefacts. 
Since these first descriptions many publications have confirmed the exist­
ence of these vacuoles (Holmberg 1959; Rohen 1960, 1969; Kayes 1967; Tripa­
thi 1968, 1969, 1971; Inomata et al. 1972; Fink et al. 1978; McMenamin & Lee 
1980; Tripathi & Tripathi 1982; McMenamin et al. 1986). Although a few 
authors still expressed doubt about the existence of these intracytoplasmic 
vacuoles (Fink et al. 1972; Shabo et al. 1973), it is now assumed that they 
are present in vivo as well. 
The incidence of these vacuoles differs markedly from eye to eye, but also 
within the same eye. Although most of the vacuoles seem optically empty, 
some flocculent material may occasionally be encountered (Tripathi 1969). 
Their diameter averages 5 \m (Speakman 1959; Tripathi 1968; Inomata et al. 
1972), with a maximum of 15 \m (Tripathi 1969). Four different types can be 
distinguished: 
1. Vacuoles opening up only on the basal side, i.e. towards the endothelial 
meshwork. 
2. Vacuoles opening up only on the apical side, i.e. towards the lumen of 
Schlemm's canal. 
3. Vacuoles opening up both on the basal and on the apical side. 
4. Entirely intracytoplasmic vacuoles. 
Excluding the entirely intracytoplasmic vacuoles, the above order of se­
quence also indicates the incidence of these types of vacuole. Only 1-2% of 
them are believed to open up on both sides (Kayes 1967; Tripathi 1968). The 
transcellular channel thus formed often shows a tortuous course, the apical 
aperture virtually never being localized above the basal one (Tripathi & 
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Tripathi 1982). Another finding is that the basal aperture is always larger 
than the apical one, and averages 1-3 \m (Inomata et al. 1972). 
Studies of the behaviour of the endothelial cells and vacuoles under 
standardized intraocular pressure revealed that, at pressures within physio-
logical limits (15 mm Hg), an increase in pressure causes an increase in 
both the incidence and size of the vacuoles. The size of the basal and api-
cal apertures also increases in that case. Vacuoles are no longer visible 
when the pressure is reduced to 0 mm Hg. High intraocular pressures (>50 mm 
Hg) are associated with lower incidences than physiological pressures (John-
stone & Grant 1973; Grierson & Lee 1975b). 
On the basis of the above data Tripathi developed a model in which these 
vacuoles are the regulators of intraocular pressure and responsible for 
transporting aqueous humour to Schlemm's canal (Tripathi 1968, 1969, 1971, 
1977, Tripathi & Tripathi 1982). The sequence of events in this process is 
schematically represented in figure 2.3. 
Figure 2.3. Diagrammatic representation of the cyclical sequence of events 
in the formation of vacuolar transcellular channels in the endo-
thelial lining of Schlemm's canal. From left to right: basal in-
vagination, intracytoplasmic vacuole, transcellular channel, fu-
sion of cell membranes. N: nucleus, (after Tripathi, R.C.: The 
Functional Morphology of the Outflow Systems of Ocular and Cer-
ebrospinal Fluids. Exp. Eye Res. Suppl.:65, 1977). 
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Hydrostatic pressure gives rise to an invagination on the basal side of 
the endothelial cell. This invagination becomes larger and forms a vacuole 
which contacts the apical side of the cell. The membrane of the vacuole fu­
ses with the apical cell membrane and a temporary transcellular channel is 
formed. Finally the cytoplasm rearranges itself on the basal side ала a fi­
nal/initial situation is attained/restored. According to Tripathi mainte­
nance of the steady state in intraocular pressure is achieved by this system 
of dynamic vacuolation (see also 2.2.2.5). 
The endothelium rests on a discontinuous, irregular basement membrane. In 
actual fact this is not a basement membrane but a layer of homogenous, amor­
phous ground substance in which fibrillar elements are embedded. The thick­
ness of these elements averages 8 nM (range 9-12 nM). The 'basement mem­
brane' is not continuous, of irregular morphology and varying in thickness 
(Garrón & reeney 1959; Tripathi 1968; Hogan et al. 1971; Inomata et al. 
1972; Fink et al. 1978; McMenamin & Lee 1980). 
The term endothelial meshwork refers to the area between the endothelial 
lining of Schlemm's canal and the most peripheral trabecular sheets. This 
area mainly encompasses three components: 
1. An amorphous-granular ground substance with fibrillar elements. 
2. Electron-dense material. 
3. A cellular component. 
Some authors maintain that the abovementioned basement membrane should 
also be included in this area (McMenamin & Lee 1980). 
Depending on age, the ground substance constitutes 10-40% of the surface 
area of the endothelial meshwork, the electron-dense material 5-25%, and the 
cellular component 25-45% (McMenamin & Lee 1980). 
The cellular component comprises endothelial cells as well as non-endothe-
lial cells such as plasma cells, macrophages, neutrophilic and eosinophilic 
granulocytes and mast cells (Tripathi & Tripathi 1982). 
The structure of the endothelial cell differs from that of the cell of 
Schlemm's canal and is more similar to that of the trabecular cells. They 
contain a nucleus, Golgi complex, mitochondriae, cytoplasmic filaments, 
phagocytes and a granular endoplasmic reticulum which differs markedly in 
structure from that of the other endothelium (Inomata et al. 1972; Tripathi 
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6 Tripathi 1982). These cells have long cytoplasmic processes in touch with 
each other and also with the endothelial cells of Schlemm's canal. They thus 
form a network of extracellular spaces in which the ground substance and 
fibrillar elements are embedded (Inomata et al. 1972). 
The fibrillar elements in these extracellular spaces are of varying ori­
gin: collagen, basement membrane material, microfibrillae, curly collagen 
and elastic-like fibres. The latter are arranged in a regular, equatorial 
pattern and link up with the endothelial lining of Schlemm's canal on the 
one hand, and the anterior fibres of the ciliary muscle on the other (Rohen 
19β1). 
A conspicuous feature of this endothelial meshwork is the presence of op­
tically empty spaces. These were described by Garrón as early as 1959, and 
particularly Rohen devoted considerable research to these empty spaces or 
cribriform pathways. They are delimited by the cells and ground substance, 
and according to Rohen are the principal localization of resistance to out-
flow (see also 2.2.2.5). 
2.2.2.4 "Rie outer wall of Schism's canal and collector channels 
Like the trabecular wall, the outer wall of Schlemm's canal is lined with 
a continuous monolayer of endothelial cells. These cells are longer and 
smoother than those of the trabecular wall and their nuclei are oval-shaped, 
as a result of which the outpouchings into the lumen are far less prominent 
(Tripathi 1968). 
They contain the usual organellae and their morphology resembles that of 
the endothelial cells of the trabeculae much more closely than that of the 
cells of the inner wall of Schlemm's canal (Fink et al. 1972). 
They differ from the endothelial cells of the trabecular wall of Schlemm's 
canal in two essential features: 
1. They show no vacuolation (Garrón & Feeney 1959; Fine 1964; Tripathi 
1968; Inomata et al. 1972; Bill i Svedbergh 1972). 
2. They rest on a distinctly structured basement membrane (Tripathi 1968; 
Inomata et al. 1972). 
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The area between this basement membrane and the scleral collagen essen­
tially resembles the endothelial meshwork (Fink et al. 1978), but the fi­
brillar component unmistakably dominates the cellular one (Tripathi ь Tri-
pathi 1982). This cellular component shows far more features of fibrocytes 
than of endothelial cells. Morphologically this area shows a much more rigid 
structure than the endothelial meshwork (Tripathi s, Tripathi 1982). 
The intraluminal septa in Schlemm's canal show a structure similar to that 
of the corneoscleral and trabecular wall respectively, which is to say that 
an endothelial layer and a basement membrane rest on a layer of fibrillar-
cellular tissue. The features of these components correspond with the char­
acteristics of the inner wall of Schlemm's canal on the trabecular side of 
the septa and those of the outer wall near the scleral side. There is a 
gradual transition from vacuolated to non-vacuolated cells as the scleral 
wall is approached (Tripathi 1968). 
In the outer wall there are apertures which are the start of collector 
channels. These apertures range in diameter from 20 μιη to 70 \m (Bill & 
Svedbergh 1972). Some 20-35 of these collector channels arise from Schlemm's 
canal, the number on the nasal side exceeding that on the temporal side. The 
endothelial lining is continuous with that of Schlemm's canal (Hogan et al. 
1971). 
The drainage of aqueous humour to the venous vascular system takes two 
principal routes (Tripathi s, Tripathi 1982): 
1. Drainage via collector channels to the deep scleral venous plexus. This 
deep plexus drains into the mid-scleral venous plexus, which is drained 
also from the venous ciliary plexus. From the mid-scleral plexus there 
is drainage to the episcleral plexus. 
2. Direct drainage via 'aqueous veins' formed by collector channels which 
drain directly into the episcleral vascular system. 
2.2.2.5 Resistance to outflow of aqueous humour 
Maintenance of intraocular pressure requires a resistance to the outflow 
of aqueous humour. On theoretical grounds, this resistance to outflow may be 
localized virtually throughout the conventional drainage system. 
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The principal barriers which the aqueous humour must overcome on its way 
to the episcleral vascular system are, successively: 
1. The uveal trabeculae. 
2. The corneoscleral trabeculae. 
3. The endothelial meshwork. 
4. The endothelial lining of Schlemm's canal. 
5. The collector channels and aqueous veins. 
Grant (1958) calculated that at least 75% of the resistance to outflow 
must be localized in the trabecular meshwork. Our insight into the localiza-
tion of the major site of resistance to outflow has been enhanced by perfu-
sion studies. In-vitro and in-vivo perfusions with latex particles, iron and 
gold particles, peroxidase, thorium dioxide and erythrocytes have contrib-
uted to the possible answers to two questions, which are still of current 
interest. What is the localization of the major site of resistance to out-
flow within the conventional drainage system? By which route(s) does the 
aqueous leave this drainage system? On the basis of possibilities suggested 
in the literature, four approaches to the latter question can be distin-
guished: 
1. Aqueous drainage via direct channels between the intertrabecular spaces 
and the lumen of Schlam's canal. 
The existence of direct channels of this kind has long been postulated. 
Dvorak-Theobald (1955) described these channels as 'Sondermann's chan-
nels', after the first investigator to describe them. Sondermann's chan-
nels were believed to be direct channels between the intertrabecular 
spaces and Schlemm's canal, with an average diameter of 25-30 \m. The ex-
istence of such channels has meanwhile been confirmed by such authors as 
Unger & Rohen (1959) and Ashton (i960), and denied by Flocks (1956), 
Speakman (1959) and Inomata et al. (1972). Perfusion studies have shown 
that these channels in the trabecular wall of Schlemm's canal do not com-
municate directly with the intertrabecular spaces (Inomata et al. 1972). 
Sondermann's channels are grooves in the wall ending blindly and provided 
with a continuous endothelial lining (Rohen 1969). They enlarge the sur-
face area of the trabecular wall (Cole & Tripathi 1971). Histological 
findings, electron-microscopic studies and calculations indicate that 
45 
Sondermann's channels, if they did communicate directly with the inter-
trabecular spaces, could not offer adequate resistance to outflow (McEwen 
1958; Tripathi i Tripathi 1982). 
2. Aqueous drainage via an active transport system. 
An active micropinocytosis process might play a role in transporting 
aqueous humour. Tracer studies have shown that this process does take 
place in the endothelial lining of Schlemm's canal, but that its contri-
bution to total drainage is minimal (MacRae & Sears 1970). Moreover, the 
filling of the pinocytosis vesicles proves to be highly dependent on the 
size of the particles used in perfusion (Inomata et al. 1972). 
3. Aqueous drainage via an intercellular transport system. 
It has already been mentioned that the intercellular communications in 
the endothelial lining of Schlemm's canal are of the zonula occludens 
type. Tracer studies in fact rarely show any passage of particles along 
the intercellular route (MacRae & Sears 1970; Inomata et al. 1972). 
Some investigators hold that the intercellular links are not zonulae 
occludentes but maculae occludentes with intercellular clefts of 5 nM 
(Shabo et al. 1973). This would imply the possibility of passage. Even if 
these apertures would measure 8 nM, however, it can be calculated that 
they drain only 1% of the total amount of aqueous humour (Bill 1975). 
It has recently been demonstrated that the intercellular communications 
are indeed of the zonula occludens type but locally occur in a specific 
configuration so that limited passage is possible (Raviola s, Raviola 
1981); the contribution to the total drainage, however, is small. 
4. Aqueous drainage via the dynamic system of vacuolar transcellular chan-
nels. 
The results of perfusion and tracer studies seem to warrant the conclu-
sion that most of the aqueous humour reaches the lumen of Schlemme canal 
via the previously described vacuoles (Inomata et al. 1972). These vacuo-
les prove to fill with tracer particles, which can be found also in the 
lumen of Schlemm's canal (Rohen 1963; MacRae s. Sears 1970; Inomata et al. 
1972; Tripathi (. Tripathi 1982). Owing to their malleability, erythro-
cytes and leucocytes can also reach Schlemm's canal via this transcellu-
lar route (Tripathi 1977). 
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The intertrabecular spaces show a gradual decrease in diameter from the 
uveal trabeculae towards Schlemm's canal. 
It may be stated in summary that the apertures in uveal trabeculae measure 
25-75 цт, those in the corneoscleral trabeculae 5-20 цт, and those in the 
endothelium 1-3 pm. This 'cribrate' aspect is also demonstrable by tracer 
studies. These show that small particles (<1.0 \m) can reach Schlemm's canal 
without difficulty. As the particle size increases, the tracer substance 
amount reaching the canal diminishes, because this substance is caught in 
the spaces of the endothelial meshwork (Karg et al. 1958; MacRae & Sears 
1970; Inomata et al. 1972). 
Tripathi & Tripathi (1982) postulate that " the endothelial lining of 
Schlemm's canal is an important factor in determining the outflow of aqueous 
humour and consequently in regulating the steady state of intraocular pres­
sure" . 
Rohen (1983), however, believes that the major resistance to outflow oc­
curs before the endothelium is reached and suggests that the empty spaces in 
the endothelial meshwork "....represent those parts of aqueous outflow path­
ways that determine the actual outflow resistance of the trabecular mesh-
work". The previously mentioned plexus of elastic-like material in the endo­
thelial meshwork will dilate these empty spaces as the ciliary muscle con­
tracts, thus reducing the resistance to outflow, inversely, relaxation of 
the ciliary muscle will lead to constriction of these spaces and thus in­
crease the resistance to outflow (Rohen 1983). 
Recent morphometric studies have demonstrated that the major resistance to 
outflow probably lies in the endothelial meshwork (Seiler & Wollensak 1985; 
Ethier et al. 1986). 
Apart from this physical-mechanical approach to resistance to outflow, 
more dynamic systems also seem to play a role. As already mentioned, the 
composition of the organellae of the various endothelial cells indicates 
synthetic activity. At least two groups of substances are formed which in­
terfere with intraocular pressure and possibly with the outflow of aqueous 
humour. These are prostaglandins and proteoglycans. 
Prostaglandins 
Prostaglandins are produced by cyclization and oxidation from unsaturated 
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essential fatty acids. In this way linoleic acid gives rise to arachidonic 
acid, which is the precursor of prostaglandin E
z
. The prostaglandins fre­
quently studied in connection with the eye are prostaglandin E 2 (PGE2) and 
prostaglandin F2= (PGF2°:). 
Experiments on rabbits, cats and monkeys have shown that intraocular or 
topical application of arachidonic acid or prostaglandin leads to a signifi­
cant rise in intraocular pressure (Eakins 1970; Podos et al. 1973; Conquet 
et al. 1975). An explanation of this phenomenon might be found in a disturb­
ance of the blood-aqueous barrier, expressed among other things in an in­
creased protein concentration of the aqueous humour (EaJcins 1970). 
Fatless parenteral nutrition leads to a reduction in prostaglandin synthe­
sis with decreased plasma PGE2 levels. Parallel to this a significant de­
crease in intraocular pressure is observed (Naveh-Floman & Belkin 1987). 
Apart from this ocular hypertensive effect of PGE 2 and PGFz", small doses 
of these substances have proved to produce an ocular hypotensive effect 
(Camras et al. 1977; Stem & Bito 1982; Bito et al. 1983). This ocular hypo­
tensive effect is not associated with a disturbance of the blood-aqueous 
barrier (Stern к Bito 1982). Dependent on the dose given, this hypotensive 
effect is preceded by a transient increase in pressure (Bito et al. 1983). 
Camras et al. (1977) suggest that this hypotensive effect of the prostaglan­
dins is caused by a reduced resistance to outflow. 
In 1983 Weinreb et al. demonstrated that human trabecular cells are capa­
ble of producing PGE2, PGF2œ and бКГд. in vitro. Weinreb et al. assumed that 
these prostaglandins function as local regulators and influence the resist­
ance to outflow. 
The results of these studies (often animal experiments) of course do not 
warrant far-reaching conclusions; many authors, however, are convinced that 
prostaglandin studies will contribute to clarification of the pathogenesis 
of glaucoma and may also contribute to the therapeutic repertory (Camras et 
al. 1977; stern s, Bito 1982; Bito 1983; Weinreb et al. 1983; Yousufzai s. 
Abdel-Latif 1983). 
Proteoglycans 
Proteoglycans are protein-polysaccharide complexes which in many tissues 
form the mucosubstances. Histochemically, they are divided into: 
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1. Acid mucosubstances, e.g. the mucopolysaccharides. These are produced 
from linear, acid heteropolysaccharides (glycosaminoglycans) in a complex 
with protein. The polysaccharide component amounts to 80%. The most com-
mon mucopolysaccharides are hyaluronic acid, chondroitin sulphate, derma-
tan sulphate, keratan sulphate and heparan sulphate. 
2. Neutral mucosubstances, e.g. the glycoproteins. These are produced from 
ramified neutral heteropolysaccharides in a complex with protein. The 
polysaccharide component amounts to 15-40%. 
Zimmerman demonstrated in 1957 that the trabecular meshwork contains muco-
polysaccharides, the highest concentration of which is found in the endothe-
lial meshwork. The localization of mucopolysaccharides was determined more 
accurately in the mid-Seventies. in the conventional drainage system they 
proved to be present at the following sites (Grierson & Lee 1975a; Armaly & 
Wang 1975): 
1. The trabeculae (apical side endothelial cell, basal side endothelial 
cell, basement membrane, collagenous core, curly collagen, elastic-like 
material. 
2. The endothelial meshwork (apical side endothelial cell, basement mem-
brane, collagen, curly collagen, elastic-like material, empty spaces). 
3. The endothelial lining of Schlemm's canal (apical side endothelial cell, 
basal side endothelial cell, vacuoles). 
4. The corneoscleral wall of Schlemm's canal and the collector channels. 
Armaly & Wang (1975) assume that these mucopolysaccharides are produced by 
the endothelial cells themselves and do not originate from the aqueous 
humour (mucopolysaccharides in the collagenous core, for example, cannot 
originate from the aqueous). 
François (1975) suggested the correlation between mucopolysaccharides and 
resistance to outflow to be as follows. A decrease in intraocular pressure 
leads to a higher degree of polymerization of mucopolysaccharides. This im-
plies an increase in hydration capacity and a constriction of the trabecular 
spaces, causing an increase in resistance to outflow. Inversely, an increase 
in intraocular pressure causes release of depolymerizing enzymes, leading to 
dehydration and reduced resistance to outflow. 
The study of cell cultures from trabecular material has also contributed 
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to research into resistance to outflow. Cells obtained in this way closely 
resemble the in-vivo cells as to cell surface, cell junctions, organellae 
and nuclear chromatin (Alvarado et al. 1982). On the basis of these in-
vitro findings the endothelial cells of the trabecular meshwork can be di-
vided into three groups as to location and function (Rohen et al. 1982; 
Polansky et al. 1984): 
1. Endothelial cells. These grow in cell cultures as a single layer and show 
a non-thrombogenic surface. Under thrombinogen stimulation they prove 
capable of producing plasminogen activator which, if necessary, keeps the 
outflow channels free from obstructing material via fibrinolysis. 
2. Phagocytic cells. In-vitro cells may show phagocytic activity. 
3. Connective tissue cells. In-vitro cells can produce various substances 
including glycosaminoglycans (Alvarado & Polansky 1979; Polansky et al. 
1984), glycoproteins (Alvarado & Polansky 1979; Worthen & Cleveland 1982) 
and collagen (Polansky et al. 1984). 
Glycoproteins (fibronectin and laminin) and glycosaminoglycans have also 
been demonstrated in the conventional drainage system by immunoassays and 
immunohistochemical techniques (Rodrigues et al. 1980; Radda et al. 1983; 
Acott et al. 1985). 
On the basis of the properties of these mucosubstances and their distribu-
tion in the drainage system they are assigned a role in resistance to out-
flow and possibly in the pathogenesis of glaucoma (Radda et al. 1983; Floyd 
et al. 1985; Acott et al. 1985; Ethier et al. 1986; Gard et al. 1987). 
2.2.2.6 Changes in the outflow apparatus with ageing 
The incidences of increased intraocular pressure and glaucoma increase 
with increasing age (Graham 1978). The morphological changes in the drainage 
system observed at an advanced age are often not readily distinguishable 
from those of glaucoma (Fine 1964; Nesterov & Batmanov 1974; Fine et al. 
1981; Tripathi & Tripathi 1982); it is conceivable that only a quantitative 
difference separates ageing phenomena from glaucoma (Rohen 1969). 
The changes in the trabecular sheets with increasing age are the following 
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(Rohen 1969; Hogan et al. 1971; Rohen 1978; McMenamin fr Lee 1980; Tripathi & 
Tripathi 1982; McMenamin et al. 1986). The total thickness of each sheet in-
creases, mainly through deposition of homogenous and fibrillar material ir 
the cortical zone of the sheet. There is an increase in collagen, elastic-
like material and basement membrane material, and a striking increase in 
curly collagen. The collagenous core shows sign of degeneration such as 
fragmentation, variation in diameter and a change from regular to curly col-
lagen. This ageing process is described as hyalinization by Rohen (1968). 
Hyalinized sheets are described as tending to adhere to each other (Rohen 
1969; Lütjen-Drecoll 1973). Because the inter- and intratrabecular aqueous 
pathways are quite wide, however, this hyalinization process does not affect 
resistance to outflow (McMenamin et al. 1986). 
The cellular component of the trabecular sheets likewise shows changes. 
The most conspicuous change is a decrease in the number of cells with in-
creasing age (Tripathi & Tripathi 1982; McMenamin et al. 1986; Grierson & 
Howes 1987). This is an absolute decrease rather than a relative diminution 
as compared with the increased homogenous and fibrillar material (Alvarado 
et al. 1981). During the foetal period and the first years of life there is 
a very rapid non-linear decrease, but subsequently the relationship between 
cell diminution and age becomes linear (Alvarado et al. 1984). 
The endothelium also shows changes in terms of intracellular organization. 
There is an increase in the total number of cell organellae, pigment gran-
ules and lysosomes. This could indicate increased phagocytic activity, which 
parallels the atrophy of the tissues in the anterior segment of the eye (Mc-
Menamin et al. 1986). 
On the whole, the changes in the endothelial meshwork resemble those in 
the remainder of the trabecular meshwork. Again one observes a decrease in 
cellularity (Alvarado et al. 1981; Tripathi & Tripathi 1982; Alvarado et al. 
1984) as well as in homogenous ground substance (McMenamin et al. 1986). 
There is a significant increase in electron-dense material (collagen, elas-
tic-like fibres, curly collagen and intermediate fibres) (Tripathi & Tripa-
thi 1982; McMenamin et al. 1986). This electron-dense material is not de-
posited at random in the endothelial meshwork but in the form of plaques. 
Rohen distinguishes three plaque types (Rohen 1970, 1978, 1983; Rohen et al. 
1981): 
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"Type I : This first form has a fairly homogenous appearance, less electron-
dense than the elastic fibres but easily distinguishable from deposits of 
precipitated protein or fibrin. The plaque size varies considerably. 
Type II : These are considerably more electron-dense than the Type I 
plaques and resemble the central core or elastic fibres. They are not usual-
ly as extensive and large as the Type I plaques. 
Type III: The third form is comprised of band-like plaques with a regular 
periodicity of dark nodules or strips embedded in an electron-dense homoge-
neous material. Occasionally these striated bands resemble the sheath mate-
rial of the elastic fibres within the hyalinized trabeculae." 
These three types occur in primary open-angle glaucoma but may also be 
found in non-glaucomatous eyes in comparable age groups. There is an impor-
tant quantitative difference, particularly in the incidences of Types II and 
III (Rohen 1983). Type III plaques are rarely observed in normotensive eyes 
(Rohen 1978) (see also 2.2.2.7). 
Rohen (1981, 1983) postulates that local synthesis of extracellular mate-
rial leads to thickening of pre-existent elastic-like fibres. McMenamin et 
al. (1980, 1986), however, postulate that debris from the uveal and corneo-
scleral trabeculae is caught in the endothelial meshwork. 
With increasing age, Schlemm's canal shows an increasing incidence of lo-
cal occlusion and obliteration of the lumen due to fibrosis and secondary 
vascularization. However, even eyes of aged persons with extensive degenera-
tive changes still show many areas of normal morphology (Nesterov & Batmanov 
1974; McMenamin et al. 1986). The endothelium of Schlemm's canal shows dimi-
nution of cellularity and a significant decrease in the number of vacuoles 
(McMenamin et al. 1986). 
2.2.2.7 Morphological changes in the trabecular meshwork in primary 
open-angle glaucoma 
The changes in the trabecular meshwork in primary open-angle glaucoma 
(POAG) can be summarized as follows (Rohen 1978; Tripathi & Tripathi 1982): 
1. Hyalinization of the uveal and corneoscleral trabeculae (see subsection 
2.2.2.6). 
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2. Plaque formation in the endothelial meshwork (see subsection 2.2.2.6). 
3. Decreasing cellularity of the trabecular meshwork. Alvarado et al. (1984) 
demonstrated that the cell diminution-age curves of eyes with POAG paral-
lel those of normotensive eyes. However, the glaucomatous eyes do show an 
absolutely greater decrease. 
4. A decreased incidence and size of the vacuoles of the endothelial lining 
of Schlemm's canal. 
5. Stenosis and obliteration of the lumen of Schlemm's canal. 
Various authors have pointed out that these changes are not specific of 
POAG but are observed also in pseudo-exfoliation glaucoma, secondary glau-
coma and senescence (Nesterov & Batmanov 1974; Rohen 1978; Fine et al. 1981; 
Tripathi & Tripathi 1982). The morphological substrate of POAG should there-
fore pose not so much a qualitative as a quantitative problem (Rohen 1970; 
Rodrigues et al. 1976; Tripathi & Tripathi 1982; Rohen 1983). 
Recent studies, however, have produced new evidence which reduces this 
'quantity emphasis'. Three of these studies may be discussed here. 
1. Plaques in the endothelial meshwork. 
Studies of the morphology of the endothelial meshwork in tangential sec-
tions have revealed a network of elastic-like fibres which links up both 
with the endothelial lining of Schlemm's canal and with the ciliary mus-
cle. They also showed that some of the Type II and III plaques are not 
true plaques at all but merely components of the abovementioned network 
of elastic-like fibres (Rohen et al. 1981). 
Ultrahistochemical studies, including enzymatic digestion methods, have 
shown that Type I plaques occur in two varieties. The composition of one 
of these varieties seems specific of POAG and cannot be traced in non-
glaucomatous eyes (Rohen et al. 1981; Lütjen-Drecoll et al. 1981). In ad-
dition to a quantitative difference, a qualitative difference seems to 
exist as well. 
2. Morphometric estimation of the concentration of electron-dense material 
in the endothelial meshwork. 
Alvarado et al. (1986) demonstrated that the concentration of electron-
dense material (the totality of Type I, II and III plaques) in the endo-
thelial meshwork of glaucomatous eyes significantly exceeds that in a 
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non-glaucomatous control group. 
Computer models imitating and calculating the permeability of the endo-
thelial meshwork and the changes in resistance to outflow have shown that 
this significant difference is not sufficient to explain the difference 
in facility of outflow between non-glaucomatous eyes and eyes with POAG. 
A solely quantitative difference between glaucomatous and non-glaucoma-
tous eyes is therefore unlikely (Alvarado et al. 1986). 
3. Glycosaminoglycans and glycoproteins. 
in-vitro studies have shown that trabecular cells are capable of produc-
ing glycosaminoglycans and glycoproteins, and immunoassays show that 
these can also be found in vivo (see 2.2.2.5). Computer simulation pro-
grammes show that the presence of a glycosaminoglycan gel in the empty 
spaces of the endothelial meshwork might very well regulate resistance to 
outflow (Ethier et al. 1986). Recent research has revealed that the con-
centration of certain glycosaminoglycans resistent to enzymes, is higher 
in glaucomatous eyes (Collins et al. 1987; Samuelson et al. 1987). 
To summarize: beside a quantitative difference in morphological changes of 
the trabecular meshwork there is undoubtedly a qualitative difference too. 
In addition, the function and localization of products such as prostaglan-
dins, glycosaminoglycans and glycoproteins may cast a fresh light on the 
pathogenesis of glaucoma. 
2.3 AQUEOUS HUMOUR FORMATION AND DYNAMICS 
Normally, no blood vessels are found in the cornea, lens, vitreous body 
and trabecular meshwork. For continuation of their metabolic status these 
avascular structures are dependent on aqueous humour, among other things. 
Another major function of aqueous humour is maintenance of intraocular pres-
sure. The homoeostasis between the production on the one hand and the out-
flow of aqueous humour on the other, ensures a steady state in intraocular 
pressure. 
Aqueous humour is produced in the ciliary body. A cross-section through 
this ciliary body shows a distinct triangular shape, of which the short an-
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terior side is virtually at right angles to the sclera. The iris arises on 
this anterior side, which also links up with the scleral spur and the tra-
becular meshwork (Streeten 1982). 
The ciliary body can be divided into two parts: the pars plana (ciliary 
orbiculus) and the pars plicata (ciliary crown). The pars plicata owes its 
name to the presence of some 70-80 prominent folds: the ciliary processes, 
which are symmetrically distributed over the ciliary body. The pars plana 
constitutes the posterior part of the ciliary body, bounded by the ciliary 
processes on the one hand, and the ora serrata on the other (Hogan et al. 
1971). 
The ciliary body is supplied with blood from the long posterior ciliary 
arteries and the anterior ciliary arteries, which form collateral anastomo-
ses at three different sites: 
1. In the episclera they form the episcleral circle. 
2. In the ciliary muscle they form the intramuscular circle. 
3. In the iridai root they form the greater arterial circle. 
The greater arterial circle gives rise to anterior and posterior arterio-
les which supply blood to the ciliary processes. In these processes they 
form a complex anastomotic vasculature (Morrison & Van Buskirk 1986). 
The innervation originates from both the parasympathetic and the sympa-
thetic nervous system. The parasympathetic nerve fibres arise from the 
Edinger-Westphall nucleus and accompany the oculomotor nerve. In the ciliary 
ganglion they synapse, to enter the eye via the short ciliary nerves. They 
form an extensive plexus around the ciliary muscle. 
The sympathetic neurons form an extensive plexus in the ciliary processes 
and arise from nerve fibres accompanying the ciliary arteries. Some of the 
sympathetic innervation is established via the ciliary ganglion and the long 
ciliary nerves (Streeten 1982). 
The ciliary body comprises four layers. From the sclera these layers are 
known in succession as ciliary muscle, stroma, pigmented epithelium and non-
pigmented epithelium. Because the ciliary muscle plays no essential role in 
aqueous humour formation, it will not be discussed in detail. 
The stroma consists of low-density tissue composed of collagenous fibril-
lae with a periodicity of 50-58 nM and microfibrillae which contain some 
elastin. The interstitial cells are uveal fibroblasts, melanocytes and mast 
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cells, along with a large number of myelinated and unmyelinated nerve fi-
bres. This area is abundantly vascularized, mainly by veins and capillaries; 
the latter are of the fenestrated type (Hogan et al. 1971; Streeten 1982; 
Morrison & Van BusJcirk 1986). 
The cells of the pigmented layer form a single layer extending from the 
ora serrata to the iris. They are cuboid cells and their basement membrane 
shows numerous invaginations. The lateral cell walls are straight and linked 
up by gap junctions, desmosomes and puncta adhérentes (Raviola ь Raviola 
1978). Zonulae occludentes are not seen, and these cells therefore have no 
barrier function (Streeten 1982). Intracytoplasmic organellae such as mito-
chondriae, granular endoplasmic reticulum and Golgi complex are evidently 
less numerous than in non-pigmented epithelium. Many large, round and oval-
shaped melanin pigment granules complete the cell contents (Streeten 1982). 
The cells of the non-pigmented epithelium are in apex-to-apex contact with 
those of the pigmented epithelium. This can be explained from the invagina­
tion of the optic cup during embryonic development. The basal cell wall, 
which, together with the basement membrane constitutes the boundary of the 
posterior chamber of the eye, shows numerous invaginations. Unlike the pig­
mented epithelium, the lateral cell walls in the non-pigmented epithelium 
also show extensive invaginations. Another difference lies in the fact that 
the apical intercellular links are made up of zonulae occludentes, zonulae 
adhérentes and gap junctions (Raviola & Raviola 1978). That this difference 
is essential is apparent from tracer studies showing that the tracer sub-
stance could not pass the zonulae occludentes (Smith 1973). Raviola & Ravi-
ola (1978) nevertheless conclude that this is not an absolute barrier but 
one that allows some leakage of ions and small molecules. The cytoplasm of 
these cells contains more organellae than that of the cells of the pigmented 
epithelium (Streeten 1982). 
The fact that the protein concentration of the blood is many times as high 
as that of the aqueous humour warrants the conclusion that there must be a 
barrier between blood and aqueous humour (Cole 1978). Another argument in 
favour of this is provided by tracer studies (Smith 1973; Hirsch et al. 
1980). 
The blood-aqueous barrier can be divided into an anterior and a posterior 
part (Bill 1986). In order to reach the posterior chamber of the eye, an in-
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travaisal substance will have to pass in succession the endothelium of the 
vascular wall, the stroma, the pigmented and the non-pigmented epithelium of 
the ciliary body (the posterior blood-aqueous barrier). In order to pass 
from the iris to the posterior chamber the substance must pass the vascular 
wall, stroma, iridai musculature and iridai epithelium (the anterior blood-
aqueous barrier). Because the anterior surface of the iris comprises no com­
plete layers of cells, passage to the anterior chamber will occur (Hogan et 
al. 1971). 
The vascular component of the posterior blood-aqueous barrier, i.e. the 
blood vessels of the ciliary processes, consist of thin-walled fenestrated 
capillaries which constitute no barrier to ions and small molecules. Nor 
does the stroma constitute an obstruction. From an anatomical point of view 
the barrier should be localized in the epithelium of the ciliary body (Bill 
Ш 6 ) . 
Tracer studies with relatively small molecules (horse-radish peroxidase, 
Smith 1973) and large molecules (autologous antiperoxidase antibodies, 
Hirsch et al. 1980) have shown that the major barrier consists of the inter­
cellular junctions of the cells of the non-pigmented epithelium. 
The vascular component of the anterior blood-aqueous barrier consists of 
relatively thick-walled capillaries (Bill 1986). The endothelial cells of 
these capillaries are linked via zonulae occludentes (Freddo & Raviola 
1982). 
It may be stated in summary that the posterior component of the blood-
aqueous barrier is largely of an epithelial nature, while its anterior com­
ponent is largely endothelial. 
The first step in the production of aqueous humour consists of the forma­
tion of a plasma filtrate in the ciliary stroma. Because the capillaries 
have fenestrated walls, plasma proteins may be expected to be present in 
this filtrate. From this plasma filtrate water and other substances are 
transported to the posterior chamber of the eye, often against a concentra­
tion gradient (Sears 1975; Sears & Kondo 1986). Table 2.5 lists the concen­
trations of several substances in aqueous humour an plasma respectively 
(Cole 1978). 
Aqueous humour formation exclusively by ultrafiltration seems unlikely for 
several reasons. Bill (1973) calculated that the transepithelial hydrostatic 
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Table 2.5. Concentration of the major elements of aqueous humour as compared 
to the normal plasma values (after Cole). 
Aqueous Humour Plasma 
Sodium 
Chloride 
Bicarbonate 
Ascorbate 
Glucose 
Protein 
153 
134 
19.6 
1.06 
3.7-4.8 
0.3-1.0 
143 
106 
25.0 
0.04 
4.7-6.5 
70 
((iM/ml) 
(μΜ/ml) 
(цМ/ml) 
(μΜ/ml) 
(μΜ/ml) 
(mg /ml) 
pressure in monkey eyes can never be sufficiently high to overcome the sum 
of the osmotic pressure in the ciliary stroma and the intraocular pressure. 
In addition he demonstrated that diminution of the arterial pressure hardly 
affects aqueous humour formation. Finally he demonstrated that aqueous hu­
mour formation is independent of the increase in blood flow through the 
ciliary body. 
The exceptionally high ascorbate concentration in aqueous humour is based 
on a carrier-mediated process. The maximum is attained at a plasma concen­
tration of 3 mg/lOO ml, beyond which a further increase in plasma concentra­
tion causes no further increase in aqueous concentration (Krupin et al. 
1986). The results of this and other studies indicate that aqueous humour 
formation is very likely based on cell-mediated processes. 
That the active transport is based on the metabolic activity of the cili­
ary epithelium can be demonstrated with the aid of metabolic inhibitors such 
as dinitrophenol, styrylquinoline and fluoroacetate. Therapeutic agents ac­
ting through enzyme inhibition are likewise used in research of this type 
(Sears & Kondo 1986). 
Current attention in the literature focuses on three enzyme systems: 
1. Carbonic anhydrase. 
2. Na-K-ATPase. 
3. Adenylate cyclase. 
The first two in particular play a role in theories on aqueous humour forma­
tion. 
Cole (1978) assumes that the following intracytoplasmic processes in the 
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non-pigmented epithelium are of importance (figure 2.4). Sodium ions play an 
essential role in aqueous humour formation. Sodium influx arises from dif-
ferences in concentration between intra- and extracellular milieus. Conse-
quently sodium ions pass through the apical cell wall of the non-pigmented 
epithelium by diffusion. In addition, exchange against hydrogen ions proba-
bly contributes to this. As in most other epithelial structures, active out-
flow of sodium ions depends on the presence of Na-K-ATPase. This enzyme is 
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Figure 2.4. Intracytoplasmic processes in the non-pigmented epithelium in­
volved in the production of aqueous humour (after Cole). 
present in the cell membrane and can transport sodium ions to the extracel­
lular milieu against a concentration gradient. The active transport of so­
dium ions along the lateral cell wall of the non-pigmented epithelium leads 
to the development of a hyperosmolar milieu in the intercellular spaces. In 
order to abolish this concentration gradient, water is attracted from the 
adjacent tissues (osmotic water flux). Because the lateral intercellular 
space is open on only one side (the apical side containing a tight junction 
complex), a flow in the direction of the posterior chamber of the eye re­
sults. 
Carbonic anhydrase facilitates dissociation of carbon dioxide and water 
into hydrogen ions and bicarbonate. The hydrogen ions are probably exchanged 
against sodium ions on the apical cell wall. The bicarbonate probably plays 
a role in anion homoeostasis, the anion deficit being compensated by bicar-
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bonate. 
Inhibition of Na-K-ATPase, e.g. with ouabain, leads to reduced outflow of 
aqueous humour (Simon et al. 1962). Carbonic anhydrase inhibitors cause re­
duction of the inflow of sodium ions and bicarbonate, with a parallel de­
crease in the inflow of aqueous humour (Sears ь Rondo 1986). 
The following shows that the question of aqueous humour formation has cer­
tainly not yet been fully answered. Physiological and biochemical research 
has revealed that p-adrenergic substances play a role in regulating intra­
ocular pressure. These substances act via adenylate cyclase. The ciliary 
processes prove to contain mainly 32-adrenergic receptors (Nathanson 1981). 
Blockage of the ß-receptors by a non-selective p-blocker proves to reduce 
intraocular pressure (Zimmerman & Kaufman 1977). Blockage of the p-receptors 
is believed to reduce aqueous humour formation (Weinreb 1987). However, 
Betaxolol - a Pi-selective p-blocker - also causes an adequate decrease in 
intraocular pressure (Stewart et al. 1986). The question thus arises wether 
it is the Pi- or the p2-blocking effect that causes intraocular pressure to 
decrease? Does the ciliary epithelium contain pi-receptors? Answers to these 
and other questions will contribute to clarification of the problem of 
aqueous humour formation. 
2.4 OPTIC NERVE 
2.4.1 Macroscopic anatomy 
The optic cup is initially connected to the brain via the optic stalk. 
With the constant increase in the number of nerve fibres growing in the di-
rection of the brain, the inner wall of the optic stalk increases in size 
and inner and outer leaf fuse. The cells of the inner layer then form a net-
work of neuroglia cells. The optic stalk becomes the optic nerve (fasciculus 
opticus ), i.e. essentially an extension of the white matter of the brain. 
The length of the optic nerve from the lamina cribrosa to the optic chiasm 
ranges from 35 to 55 mm. The site of entry into the eye is 3 mm medial to 
the posterior pole. 
In the orbit and the optic canal the optic nerve is enveloped by the dura 
60 
mater, arachnoid and pia mater. These membranes are continuous with those of 
the brain and have the same structure. 
The following parts of the optic nerve may be distinguished (Hayreh 
1978a): 
1. An intracranial part. 
2. An intracanalicular part. 
3. An intraorbital part, with: 
a) An anterior orbital segment (the anterior part of this segment is 
known as retrolaminar region of the optic nerve). 
b) A posterior orbital segment. 
4. An intraocular part (optic nerve head), with: 
a) A surface nerve fibre layer. 
b) A prelaminar region. 
c) A lamina cribrosa region. 
The intraorbital and the intraocular part of this optic nerve are subject to 
pathological changes in glaucoma. 
2.4.2 Microscopic anatomy 
The surface nerve fibre layer comprises the optic nerve fibres as they 
converge from the retina to the optic nerve head. This layer is separated 
from the vitreous body by the inner limiting membrane of Elschnig, which 
consists entirely of astrocytes (Anderson 1970). At the site of the physio-
logical cup this layer may be thickened, in which case it is called the cen-
tral meniscus of Kuhnt. 
In the prelaminar region the nerve fibres extend in bundles enveloped by 
tube-like glial channels which consist of specialized astrocytes known as 
spider cells (Anderson 1969). This glial tissue forms trabeculae within 
which capillaries extend (Hayreh 1978a). 
In the central part one finds a depression which corresponds with the 
physiological cup. The depth of this cup can vary considerably and extend as 
far as the lamina cribrosa (Hayreh & Vrabec 1966). 
At the edges the intermediary glial tissue of Kuhnt demarcates the bound-
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ary from the retina, and Jacoby's layer that from the choroid. Both tissues 
consists of astrocytes arranged in columns around the optic nerve (Hogan et 
al. 1971). 
The lamina cribrosa consists of a network of compact connective tissue, of 
largely transverse arrangement. Thick columns link it peripherally to the 
retina and centrally to the vessels (Hayreh 1978a). The extracellular matrix 
comprises collagen types I, II and IV as well as laminin (Hernandez et al. 
1986, 1987). The amount of elastic material may vary (Anderson 1969). 
The lamina cribrosa constitutes a sieve with numerous perforations through 
which the nerve fibre bundles pass. The perforations are circular and oval-
shaped and vary in size. The nerve fibre bundles are enveloped by a continu-
ous glial membrane which separates nerve tissue from connective tissue (Hay-
reh 1978a). 
The function of the lamina cribrosa is to reinforce the site of entry of 
the optic nerve and to provide support to the nerve fibre bundles (Hogan et 
al. 1971). 
As a result of myelination the retrolaminar, intraorbital part of the op-
tic nerve is twice as thick as its intraocular part. The membranes envelop-
ing the optic nerve at this level are pia mater, arachnoid and dura mater. 
Here, too, the nerve fibre bundles extend in a network of connective tissue 
which is peripherally linked to the pia mater, centrally with the blood ves-
sels and anteriorly with the lamina cribrosa. The nerve fibre bundles pass 
through polygonal perforations and are separated from the connective tissue 
by astroglia cells. 
2.4.3 Arterial vascularization of the anterior part of the optic nerve 
The vascularization of the anterior part of the optic nerve has been des-
cribed in detail by Hayreh (1962, 1963, 1966, 1969, 1970, 1975a, 1975b, 
1978a, 1980, 1985). Despite considerable interindividual variation the fol-
lowing basic pattern seems to be present in the majority of cases. 
The lamina cribrosa region is supplied with blood from centripetal 
branches of the short posterior ciliary arteries; occasionally, blood is 
supplied from the arterial circle of Zinn and Haller. The central retinal 
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artery has no ramifications in this region. 
The prelaminar region is vascularized by centripetal branches from the 
peripapillary choroid. The choroid is supplied from the posterior ciliary 
arteries, and in some cases branches from the lamina cribrosa contribute to 
the vascularization of this region. 
As a rule there are two or three posterior ciliary arteries which arise 
from the ophthalmic artery. Dependent on their position in relation to the 
optic nerve, they are called medial and lateral posterior ciliary artery. 
Each supplies half the choroid and optic nerve head, the distribution usual-
ly being vertical. The vascularization in the prelaminar part, like that in 
the laminar part, is segmental; in this region, too, the central retinal ar-
tery does not ramify. 
The surface nerve fibre layer receives blood from the retinal arterioles 
- usually branches from the peripapillary region. In addition, the temporal 
sector of the optic nerve head may be supplied from the prelaminar region. 
The capillaries of the optic nerve head anastomose posteriorly with those 
of the prelaminar part and anteriorly with those of the peripapillary reti-
na, but not with those of the choriocapillaris. 
The anterior segment of the intraorbital part of the optic nerve is sup-
plied from two vascular systems: 
1. The axial centrifugal vascular system. In 75% of optic nerves studied the 
intraneural part of the central retinal artery ramifies in this region 
(Hayreh 1978a). 
2. The peripheral centripetal vascular system. These vessels are found in 
100% of cases and are made up of: 
a) Recurrent pial branches from the peripapillary choroid. 
b) Pial branches from the central retinal artery. 
c) Pial branches from the collateral branches of the ophthalmic artery. 
2.4.4 Autoregulation of the retinal and optic nerve circulation 
The presence or absence of autoregulation in the vasculature of the retina 
and optic nerve is of relevance in theories on the pathogenesis of glaucoma-
tous damage. 
63 
Autoregulation may be regarded as the ability of blood vessels to maintain 
the blood flow at decreasing perfusion pressure. The rule of thumb is that 
perfusion pressure equals the difference between mean arterial pressure and 
intraocular pressure. Indications of the existence of autoregulation can be 
obtained by measuring the blood flow at diminishing perfusion pressure. This 
diminution is achieved by reducing arterial pressure, increasing intraocular 
pressure, or a combination of these. 
That the retinal circulation has adequate autoregulation may be concluded 
from the following studies, using different parameters of blood flow: 
1. Hadioactively labelled microspheres. The distribution of the microspheres 
as a function of intraocular pressure shows that the retinal blood flow 
is independent of intraocular pressure (Aim & Bill 1973). 
2. Onlabelled microspheres. The blood flow in the retinal circulation re­
mains constant until the perfusion pressure has decreased to about 28 mm 
Hg (Geijer & Bill 1979). Dependent on the position of the body, the nor­
mal perfusion pressure value is 55-70 mm Hg (Bill 1978). 
3. Піе luminal diameter of retinal arteries as a function of intraocular 
pressure. The luminal diameter of retinal arteries increases as intraocu­
lar pressure increases, in normal eyes as well after sympathetic denerva­
tion. This is suggestive of local autoregulation independent of innerva­
tion (Rüssel 1973; Wilson et al. 1981). 
4. Blue-field entoptic phenoaenon. A test subject is enabled to observe the 
motion of leucocytes in the macular capillaries. The speed at which the 
leucocytes move provides as measure for blood flow. These studies have 
shown that retinal blood vessels are capable of maintaining a totally un-
disturbed blood flow at intraocular pressures of about 6-30 mm Hg (Riva 
et al. 1981; Grunwald et al. 1982, 1984). 
The question whether such autoregulation exists in the optic nerve cannot 
be unequivocally answered. One of the problems that confront investigators 
is the fact that the circulation in the optic nerve originates from at least 
two systems (2.4.3). Aim s, Bill (1973) studied blood flow using labelled 
microspheres and found that an increase in intraocular pressure gave rise to 
a significant decrease in the blood flow in the choroid and prelaminar re-
gion. They concluded from this finding that this part of the optic nerve has 
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no autoregulation. On the other hand, Geijer s. Bill (1979) demonstrated with 
the aid of unlabelled microspheres that the blood flow in the prelaminar 
part of the optic nerve does have autoregulation. 
The oxygen tension in the anterior part of the optic nerve as a function 
of perfusion pressure in Rhesus monkeys show that a decrease in the latter 
pressure leads to rapid stabilization of the former, on the basis of a mech-
anism of autoregulation (Ernest 1974, 1975, 1976). 
Recent research into the relationship between the amplitude of the visual 
evoked response and intraocular pressure revealed the following. Proceeding 
from an intraocular pressure within physiological limits, an increase in 
this pressure causes a decrease in the VER amplitude. From an intraocular 
pressure of about 30 mm Hg on, however, a plateau phase ensues during which 
the amplitude remains constant or even increases again. Intraocular pres-
sures of 60 mm Hg or over consistently cause decreased VER amplitudes. These 
findings might suggest the presence of autoregulation in the anterior part 
of the optic nerve (Pillunat et al. 1985a, 1985b, 1986, 1987) (see also 
'Electrodiagnostical tools' (3.7)). 
2.4.5 Pathogenesis of optic nerve damage 
Generally speaking there are two concepts of explaining the pathogenesis 
of glaucomatous changes in the optic nerve: 
1. The vasogenic concept. 
2. The mechanical concept. 
2.4.5.1 Vasogenic concept 
This concept proceeds from the postulate that the changes in the optic 
nerve result from decreased arterial circulation, i.e. from ischaemia. This 
ischaemia is caused by a decrease in perfusion pressure, due either to an 
increased intraocular pressure or decreased blood pressure, or a combination 
of these (Hayreh 1980). Some indications in support of this concept may be 
listed: 
1. Fluorescein fundus angiography. Talusan & Schwartz (1977) demonstrated 
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that in the heterogenous patient population they studied, only patients 
with chronic open-angle glaucoma and those with sectoral anterior 
ischaemic opticoneuropathy showed absolute filling defects in the optic 
disk. Loebl & Schwartz (1977) demonstrated that patients with ocular hy-
pertension showed a higher incidence of filling defects in the optic disk 
than did non-glaucomatous normotensive patients. The incidence of filling 
defects in glaucomatous eyes was found to exceed that in eyes with ocular 
hypertension (Schwartz et al. 1977). 
These authors conclude that the blood supply to the optic nerve is dis-
turbed in open-angle glaucoma and ocular hypertension. 
2. Peripapillary choroidal changes. The incidence of peripapillary atrophy 
is higher in open-angle glaucoma and ocular hypertension than in non-
glaucomatous normotensive eyes (AiraXsinen et al. 1987). Because the 
blood supply to the pre- and retrolaminar parts of the optic nerve partly 
originates from the peripapillary choroid, atrophy in this region must 
affect the circulation in the optic nerve. 
3. Splinter hemorrhages. The literature contains varying reports on the pre-
valence of splinter hemorrhages on the optic disk. Susanna et al. (1979) 
reported a prevalence of 36.9% in primary open-angle glaucoma, and of 8% 
in ocular hypertension. Kitazawa et al. (1986) found a prevalence of 4.2% 
in primary open-angle glaucoma, 20.2% in low-tension glaucoma, 0.5% in 
ocular hypertension, 0.4% in non-glaucomatous normotensive eyes and 0% in 
primary angle closure glaucoma. The incidence of these splinter hemor-
rhages was determined by Gloster (1981) and found to be 30% in primary 
open-angle glaucoma. Susanna et al. (1979) as well as Hayreh (1985) be-
lieve that these splinter hemorrhages are caused by small local microin-
farcts. Spaeth (1986) maintains that they may also be explained mechani-
cally. 
4. Uw-tension glaucoma. Although low-tension glaucoma is regarded as a sep-
arate entity and shows subtle differences in optic nerve morphology from 
primary open-angle glaucoma (Caprioli & Spaeth 1985), a common pathogene-
tic basis may probably be assumed to exist (Lewis et al. 1983; Hayreh 
1987). High incidences of cardiovascular diseases (Hayreh 1987), peri-
papillary choroidal and optic disk filling defects (Geijssen et al. 1985) 
and splinter hemorrhages (Gloster 1981; Kitazawa et al. 1986) in low-ten-
sion glaucoma indicate the likelihood of a vascular pathogenesis. It is 
virtually impossible to explain low-tension glaucoma in mechanical terms. 
5. Systemic blood pressure. It is an established fact that an acute decrease 
in blood pressure may lead to (further) glaucomatous dysfunction. This 
seems even more evident in glaucoma patients with arterial hypertension 
(Kolker 1978; Hayreh 1985). The extent to which non-glaucomatous normo-
tensive eyes are likewise susceptible to this acute decrease in blood 
pressure remains obscure. Drance (1966) reported that haemodynamic crises 
as a result of acute blood loss can lead to ischaemia of the optic nerve. 
This was not confirmed in a prospective study by Jampol et al. (1978). 
The importance of systemic blood pressure seems more pronounced in low-
tension glaucoma. Drance et al. (1973) and Goldberg et al. (1981) found a 
higher incidence of low arterial pressure in patients with low-tension 
glaucoma than in those with primary open-angle glaucoma. 
6. Optic disk cupping in anterior iscbaemic opticoneuropathy (ΆΙΟΝ). Hayreh 
(1975b, 1980, 1985) reported that the majority of patients with an AION 
resulting from temporal arteritis develop an optic disk cupping indistin­
guishable from glaucomatous disk cupping. Others, however, report that 
they have never seen optic disk cupping after AION (Maumenee 1977). 
7. Cavernous atrophy. Histological examination of monkey eyes with induced 
glaucoma reveals cavernous or lacunar atrophy in the retrolaminar part of 
the optic nerve (Kalvin et al. 1966). The cavernous spaces are filled 
with a hyaluronidase-sensitive acid mucopolysaccharide (Zimmerman et al. 
1967). Hayreh (1969) postulated that this cavernous atrophy results from 
ischaemia caused by increased intraocular pressure. This is further em­
phasized by the histological findings in AION, which show changes consis­
tent with cavernous atrophy in the retrolaminar part as well (Hayreh 
1975b). He therefore maintains that, analogous to cavernous degeneration 
of the brain in chronic ischaemia, the circulatory disturbances in the 
peripapillary choroid lead to ischaemia and hence to retrolaminar cavern­
ous atrophy (Hayreh 1980). 
8. Autoregulation of the optic nerve vasculature. As described in subsection 
2.4.4, the correlation between the amplitude of visual evoked responses 
and intraocular pressure warrants the conclusion that the anterior part 
of the optic nerve also has autoregulation. Studies by Pillunat et al. 
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(1985a, 1985b, 1986, 1987) have shown that the typical amplitude curve is 
not found in glaucoma patients. The autoregulation pathway is lacking 
both in primary open-angle glaucoma and in low-tension glaucoma. Perhaps 
glaucoma patients lack the autoregulation mechanism of the anterior part 
of the optic nerve. 
2.4.5.2 Mechanical concept 
Since the intraocular pressure plays a key-role in the definition of glau-
coma, a mechanical concept of the pathogenesis of optic nerve damage seems 
to present itself as well. Indications in support of this arise from the 
following studies: 
1. Histology of the lamina cribrosa. Histological examination has revealed 
that damage to the optic fibres occurs at the level of the scleral lamina 
cribrosa. The earliest lesion consists of disappearance of neural tissue 
with intact astrocytes and capillaries. As the disease progresses, the 
lamina cribrosa shows backward and lateral bowing. An increasing cupping 
is not caused by degeneration of astrocytes, nor by enlargement of the 
scleral canal (Quigley & Green 1979; Quigley et al. 1981). 
2. Morphology of translaminar channels. The organization of ganglion cell 
axons in the retina and the anterior part of the optic nerve shows that 
paracentral scotomata and Bjerrum's scotomata are explained by dysfunc-
tion of the superior and inferior quadrants of the optic nerve (Radius & 
Anderson 1979, 1981). Consistent with this are findings in the lamina 
cribrosa, showing that the translaminar channels are largest in these 
quadrants and that the laminar sheets are very thin. Consequently these 
two quadrants are most susceptible to mechanical pressure (Quigley & 
Addicks 1981; Quigley et al. 1981, 1982). 
3. Early histological findings. The earliest histological findings in the 
lamina cribrosa proper is compression of the sheets, resulting in a de-
crease in total thickness. This occurs even before any visual field de-
fect develops. The abovementioned backward and lateral bowing occurs in a 
later phase. 
Parallel with this the number of neurons diminishes, the decrease being 
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most marked in the superior and inferior quadrant. A loss up to 50% of 
the neurons is believed not necessarily to lead to clinically detectable 
visual field defects (Quigley et al. 1983). It is in particular the large 
optic nerve fibres that are lost first (Quigley et al. 1987). 
4. Loss of blood vessels. Although the above findings strongly accentuate 
compression of tissues, it is not clear wether the damage to the nerve 
fibres occurs directly or via interference with the blood supply. Induced 
glaucoma in primate eyes and also findings in human eyes reveal that 
there is no disproportionate loss of blood vessels in the anterior part 
of the optic nerve with the progression of glaucomatous damage (Quigley 
et al. 1984). 
5. Blood flow. Measurement of blood flow in the optic nerve with labelled 
tritium iodoantipyrine gives a true reflection of the flow without direct 
interference with it. Such flow measurements were carried out in simian 
eyes with induced chronic open-angle glaucoma and revealed no change in 
flow with the increase in intraocular pressure. Only when the pressure 
exceeded 75 mm Hg did a progressive decrease in flow occur (Quigley et 
al. 1985). 
6. Axoplasmic transport. Because axons lack synthetic activity, they are de-
pendent on axoplasmic transport for suppletion of proteins and other mol-
ecules as well as for maintenance of their axoplasm, axolemma and synap-
ses. This transport takes place in two directions: orthograde axoplasmic 
transport from cell body to synapse, and retrograde axoplasmic transport 
towards the cell body. Orthograde axoplasmic transport comprises a rapid 
(100-500 mm/day), an intermediate (5-50 mm/day) an a slow (0.4-5 mm/day) 
component. The rate of retrograde axoplasmic transport is 50-260 mm/day 
(Bunt & Minckler 1982). 
Orthograde axoplasmic transport may be studied with the aid of labelled 
amino acids; retrograde axoplasmic transport with the aid of horseradish 
peroxidase. 
The relationship between increased intraocular pressure and axoplasmic 
transport has been studied in detail in simian eyes in which acute or 
chronic glaucoma had been induced. The following findings were obtained: 
a. Both the rapid and slow component of the orthograde axoplasmic trans-
port show a block at the level of the lamina cribrosa. This block is 
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partial at moderately and complete at markedly increased pressures 
(Anderson & Hendrickson 1974; Levy 1974; Minckler et al. 1976; Gaas-
ter land et al. 1978). 
b. Retrograde axoplasmic transport likewise shows a block, the intensity 
of which also depends on the degree and duration of increased intraoc-
ular pressure (Minckler et al. 1977). 
c. This axoplasmic transport block is reversible and disappears after re-
duction of pressure (Levy 1974; Quigley & Anderson 1976). 
d. The block is not evenly distributed over the optic nerve but is more 
pronounced on the temporal (Minckler et al. 1977) and on the polar 
side (Quigley s, Anderson 1977). 
e. A simultaneous study of the behaviour of capillaries and axoplasmic 
flow reveals that the collapse of capillaries and the axoplasmic block 
are localized at different sites in the lamina cribrosa. This argues 
against a vascular cause of the axoplasmic transport block (Minckler 
et al. 1977). 
f. In particular the retrograde axoplasmic transport block is most pro-
nounced in the peripheral axons of an axon bundle, i.e. axons loca-
lized in the immediate vicinity of capillaries and therefore in a vas-
cular safe zone. The fact that precisely these axons are involved, ar-
gues against a vascular cause. 
g. Studies of this axoplasmic transport block under hyperbaric oxygen 
conditions reveal no difference from the block in eyes dissected under 
physiological oxygen conditions (Quigley et al. 1980). 
h. An increase in intraocular pressure causes indentation of the axon by 
glial tissue and collagen. An axoplasmic transport block is observed 
at the site of this indentation - a finding arguing strongly in favour 
of a mechanical origin of the block (Minckler & Ogden 1987). 
To summarize: axoplasmic transport studies indicate the likelihood of a 
mechanical pathogenesis of damage to the optic nerve. 
2.4.5.3 Conclusion 
The pathogenesis of damage to the optic nerve may be explained in vascular 
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as well as in mechanical terms. There is sufficient evidence in favour of 
both concepts, and arguments in favour of one concept often do not exclude 
those in favour of the other. Analogous with other chronic diseases, primary 
open-angle glaucoma may also be regarded as a condition of multifactorial 
origin (Graham 1978), in which both mechanical and vascular factors play a 
role. Bill ь Sperber (1987) assume that glaucoma with a relatively low in­
traocular pressure (<25-30 mm Hg) is probably due mainly to a vascular in­
sufficiency, in some cases perhaps combined with a week lamina cribrosa. In­
traocular pressures between 30 and 40 mm Hg will in particular cause mechan­
ical damage, and even higher pressures will add ischaemia as complicating 
factor. 
Further research will have to disclose the extent to which each of the 
concepts contributes to the pathogenesis, and whether a complete synthesis 
may be found. 
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CHAPTER 3 
METHODS OF EXAMINATION AND DIAGNOSTIC FEATURES 
IN GLAUCOMA 
шпювдспда 
This chapter describes findings at ophthalmological examination which 
point in the direction of glaucoma, with special reference to open-angle 
glaucoma. 
The various diagnostic aids are discussed in separate sections, always 
bearing in mind that the diagnosis 'glaucoma' cannot be made until after in­
tegration of all findings. 
The discussion of patient characteristics in Chapters 5 and 6 will regu­
larly refer back to this chapter. 
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3.1 BASIC ЕХЙМШАТІШ 
This section discusses some findings obtained in routine ophthalmological 
examination and possibly suggestive of glaucoma. Routine diagnostic work al­
so includes taking the history, determination of optimal visual acuity and 
slit-lamp examination. 
It is an established fact that patients with open-angle glaucoma may be 
free from symptoms for considerable time. Yet it is of great importance to 
take the history if there is a suspicion of glaucoma, because there may be 
anamnestic indications of the type of glaucoma involved as well as of the 
presence/absence of detectable causes. If the intraocular pressure (IOP) 
rises rather abruptly to 40-50 mm Hg, the patient may experience this as 
painful. The localization of the pain is indicated in the eye or the superi­
or part of the orbit. Unilateral headaches, too, may point in the direction 
of increased IOP. 
Complaints about visual acuity as rule occur as a late symptom of glauco­
ma. In cases of this kind extensive damage to the nerve fibre layer already 
exists. Occasionally the presence of a Bjerrum scotoma may cause complaints 
about visual acuity. The most common cause of such complaints, however, is 
the corneal oedema resulting from a fairly acute increase in IOP. 
Although a halo may be observed in association with several ophthalmologi­
cal diseases - e.g. uncorrected errors of refraction and nuclear lens scle­
rosis - this phenomenon may also indicate glaucoma. Particularly in subacute 
chronic angle-closure glaucoma and in glaucomatocyclitic crises, this is 
frequently observed; but also in young patients with open-angle glaucoma 
whose IOP may initially be very high. 
Black outs have been described in patients with glaucoma and homolateral 
carotid artery insufficiency, in whom the diminished circulation in the op­
tic nerve may reduce visual acuity. 
Apart from these more or less specific complaints, questions are always to 
be asked concerning other ophthalmological lesions and eye operations, trau­
mata and inflammations. The history is completed by questions about other 
diseases or complaints, use of medication, and family history. 
Slit-lamp examination may contribute to differentiation between various 
types of glaucoma. For example a shallow anterior chamber and narrow irido-
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corneal angle suggest angle-closure glaucoma, and KruXenberg's spindles on 
the corneal endothelium indicate the possibility of pigmentary glaucoma. 
However, slit-lamp examination as a rule reveals no abnormalities in primary 
open-angle glaucoma. 
3.2 TONOMETRY 
3.2.1 Biophysical aspects 
An increased IOP as such is not conclusive of glaucoma. The same applies 
to other diagnostic aids, however, and it is evident that the diagnosis 
'glaucoma' cannot be made until the findings of various examinations are in-
tegrated. Nevertheless, tonometry (rightly) has a central position in the 
diagnosis of glaucoma. It is a simple, rapid, inexpensive test and it may be 
maintained in general that glaucomatous damage correlates with the degree 
and duration of increased IOP (Krieglstein 1980). 
The only totally reliable method of measuring IOP would be open manometry 
- a technique which of course cannot be clinically applied. Efforts have 
been made to find indirect ways of estimating IOP, and the current tonome-
ters are all based on the closed manometry principle. It should be borne in 
mind, however, that the contact of the tonometer with the eyeball causes 
volume displacement and therefore a change in pressure. The IOP measured is 
therefore always higher than the true IOP. 
The principle on which most tonometers are based is application of a force 
to the eye and measurement of the resulting deformation of the eyeball. This 
is done in two different ways: 
1. A constant force is applied to the eye and the deformation is measured 
(indentation tonometry). 
2. A standard deformation of the cornea is effected and the force required 
for this is measured (applanation tonometry). 
The most commonly used indentation tonometers are based on the Schiötz 
principle. Because the indentation depends directly on the rigidity of the 
eyeball (which is not clinically measurable), this type of tonometry yields 
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too high or too low values in the case of abnormal rigidity. 
Goldmann's applanation tonometry was an important advance in the develop­
ment of tonometry. Again one is confronted with the elasticity of the cor­
nea, which counteracts applanation. In addition, however, the capillary ac­
tivity of the tear film applies suction to the tonometer, which promotes ap­
planation. These antagonistic forces cancel each other at a tonometer diame­
ter of about 3 mm. In that case the total intraocular volume displacement 
amounts less than 1 μΐ, whereas in indentation tonometry the volume dis­
placement may be 10-60 μΐ. The true I0P is about 0.98 times the IOP measured 
by applanation tonometry (Draeger & Jessen 1978; Chandler & Grant 1979a,· 
Krieglstein 1980). 
3.2.2 Clinical aspects 
The course of IOP is characterized by fluctuations in height, the time 
factor of which can range from less than a second to several hours. Rapid 
pulsatory changes occur synchronously with the heartbeat, and the amplitude 
of the IOP then varies from 0.5 to 7 mm Hg (Leydhecker 1976). Perkins ь 
Phelps (1984) found no significant difference in the mean height of this am­
plitude between non-glaucomatous normotensive eyes and eyes with primary 
open-angle glaucoma (POAG) or low-tension glaucoma. Slower oscillations (4-
20 sec) are caused by respiration and vasomotor waves (Krieglstein 1980). 
The diurnal rhythm is superposed on these rapid changes. This diurnal 
rhythm is of clinical importance for several reasons. Drance (1960) found 
that the peak pressure in normotensive non-glaucomatous eyes as well as in 
eyes with POAG occurred in 60% of cases at a time outside the regular work­
ing hours of an ophthalmologist. Measurement of a statistically normal IOP, 
therefore, by no means excludes the possibility of periods of increased IOP. 
The reverse may likewise occur. Kitazawa & Horie (1975) reported the occur­
rence of decreases in IOP during the night and early morning hours, 12 of 27 
eyes with POAG they examined having an IOP below 20 mm Hg. 
Another important clinical fact is that the difference between peak pres­
sure and through pressure is much larger in glaucomatous eyes than in non-
glaucomatous eyes (Drance 1960). Kitazawa ь Horie (1975) found that in nor-
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mal eyes this difference averaged 6.5 + 0.28 mm Hg, with a maximum of 11 mm 
Hg. In a group of eyes with POAG, however, this difference averaged 15.6 + 
1.7 mm Hg, with a maximum of 34 mm Hg. Of course the peale pressure in eyes 
with POAG (37.6 + 4.28 mm Hg) was much higher than that in normal eyes (17.0 
+ 0.8 mm Hg). Precisely in cases of glaucoma, therefore, one should be pre-
pared for peak pressures with sometimes very high values. 
Finally it should be borne in mind that the difference in I0P between the 
two eyes of the same individual may be substantial, and that this difference 
is larger in glaucomatous eyes (Davanger 1965). Nevertheless the diurnal 
rhythm in both eyes is highly symmetrical and the effect of any therapy can 
be assessed only if this is applied unilaterally, the contralateral eye be-
ing used as control (Kitazawa & Horie 1975). 
Apart from these more or less intrinsic fluctuations there are also ex-
trinsic factors determining the variations in I0P. 
Tarkkanen & Leikola (1967) demonstrated that the height of I0P depends on 
the position of the body. Proceeding from a sitting position the IOP will 
rise when the patient reclines. A Trendelenburg position of 30-75° causes a 
further increase in IOP, caused by increased venous pressure. 
Using a scleral contact lens connected with a pressure transducer, Miller 
(1967) demonstrated that the lid pressure during normal periodic blinking 
amounts to about 10 mm Hg. Keeping the eyes closed with the eyelids firmly 
compressed can cause a lid pressure of 51 mm Hg. 
Repeated measurements of IOP within a brief space of time (once per minute 
during 5 minutes) leads to a significant decrease in IOP. A prolonged tono-
meter/cornea contact time likewise causes a decrease in IOP (Wilke 1972). 
Exhausting exercise has an ocular hypotensive effect (Lempert et al. 1967; 
Passo et al. 1987). This occurs during the exercise and continues for some 
time after its completion. The degree and the duration of the decrease in 
IOP are more pronounced in glaucomatous than in non-glaucomatous eyes (Lem-
pert et al. 1967). 
Condition training causes a significant decrease in baseline IOP but does 
result in a lower (exercise) decrease in pressure (Passo et al. 1987). 
Cigarette smoking increases IOP. Proceeding from the assumption that an 
increase by 5 mm Hg within 5 minutes of the last puff is significant, this 
response is found in 11.4% of a group of non-glaucomatous eyes and in 37.1% 
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of glaucomatous eyes. This difference is significant (Mehra et al. 1976). 
Of several climatological parameters (atmospheric pressure, clouding, rel-
ative humidity of the air, mean temperature, maximum temperature, minimum 
temperature, rain, hours of sunshine, wind velocity), only atmospheric pres-
sure and relative humidity prove to exert a significant effect on IOP. The 
IOP decreases with increasing atmospheric pressure and increases with in-
creasing relative humidity. Multiple regression analysis has shown, however, 
that the influence of these factors on individual IOP variations is only 
minimal (Jonas et al. 1986). 
3.3 GONIOSCOPY 
Gonioscopy is the principal aid in differentiating between different forms 
of glaucoma. Both in primary and in secondary glaucoma gonioscopy yields 
highly relevant information on the configuration of the iridocorneal angle 
and possible details of the component parts. 
In principle, there are two types of gonioscopy: 
1. Direct gonioscopy with the aid of, say, a Koeppe gonio-lens. 
2. Indirect gonioscopy with the aid of a mirror contact glass. 
Both methods give a good picture of the angle of the anterior chamber, and 
the choice of technique depends on the preference and experience of the in-
vestigator. 
The following is a step-by-step description of a systematic examination of 
the angle of the anterior chamber. 
1. Evaluation of angle width. 
Since on the basis of pathophysiology, aetiology and therapeutic implica-
tions open-angle and closed-angle forms of glaucoma are distinguished, 
estimation of the width of the iridocorneal angle is an essential feature 
in gonioscopy. The distinction between open-angle and closed-angle as 
such is inadequate, because there are many transitional forms. A clini-
cally adequate grading system was evolved by Shaffer (1962) and is shown 
in table 3.1. 
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Table 3 . 1 . Shaffer grading system of angle width, ( a f t e r : Shaffer, R.N.: 
Gonioscopic Anatomy of t h e Anter ior Chamber of t h e Eye. I n : 
Stereoscopic Manual of Gonioscopy by Shaffer, R.N. The C.V. 
Mosby Company, Saint Louis, 1962.) . 
Angle Grade Angle Width Numerical Grade Clinical Interpretation 
Wide open angle І5°-ІЬ° Grade 4 Angle closure is not possible 
35°-20° Grade 3 Angle closure is not possible 
Narrow angle 20' Grade 2 Angle closure is possible 
Narrow angle, extreme 10° or less Grade 1 Angle closure is probable 
Narrow angle, slit The angle is critically narrowed, quite 
possibly against the trabecular raeshwork 
beyond Schwalbe's line 
Narrow angle, in part 0° Grade 0 Angle is partial or complete 
or totally closed. closed 
In association with the width of the angle the shape of the i r i s at the 
s i t e of i t s insertion on the c i l iary band should always be described as 
well. A s l ight ly convex shape i s characterist ic of the normal physiologi­
cal s i tuat ion. Pronounced convexity i s usually observed in hypermetropic 
eyes, and in a number of these cases the i r i s may occlude the angle of 
the chamber. In myopic and aphakic eyes, however, the i r ida i root is 
f lat . A concave shape of the i r i s can be found after posterior uveitis 
and after a vitrectomy via the pars plana; i t is caused by contraction of 
c i c a t r i c i a l t i ssue behind the i r i s (Chandler ь Grant 1979b). 
2. structures in the angle. 
Four essential structures can be distinguished in the angle: Schwalbe's 
l ine, trabecular meshwork, scleral spur and c i l iary band. The normal fea­
tures of these structures have been described in subsection 2.2.1. Gonio­
scopy should be used to look for glaucoma-specific features of these 
structures. 
Prominence of Schwalbe's line as such is not generally related to glauco­
ma. This mildest form of iridocorneal dysgenesis without concomitant le­
sions i s observed in adults as well as in children with and without glau­
coma. Only if th i s prominence is associated with adhesions between the 
peripheral i r i s and cornea, alone or in combination with pupillary abnor-
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malities, should one be mindful of the possibility of glaucoma (Chandler 
Ь Grant 1979b). 
The most conspicuous aspect of the trabecular meshwork is its degree of 
pigmentation. Scheie (1957) assigned to this degree of pigmentation val­
ues ranging from score 0 (total absence of pigment) to score +4 (maximum 
pigmentation). The latter is observed in the pigment dispersion syndrome, 
although in cases of pseudo-exfoliation glaucoma the trabecular meshwork 
may also be markedly pigmented (Hoskins 1980). 
When the scleral spur is clearly visible allround in a patient with glau­
coma, the diagnosis 'open-angle glaucoma' is very plausible. A very pro­
minent scleral spur, however, may indicate a posttraumatic condition. 
3. Iridai structures in the angle. 
The distinction between iris processes and peripheral anterior synechiae 
is very important. As already mentioned, iris processes have the same 
structure as the iris and their frequency and form vary from eye to eye. 
They occur in normal non-glaucomatous as well as in glaucomatous eyes 
(Lichter & Shaffer 1970). 
Peripheral anterior synechiae on the other hand show a more solid struc­
ture and often present as non-perforated structures covering the trabecu­
lar meshwork. They are always acquired and their possible causes include 
traumata, inflammations, rubeosis, chronic angle-closure glaucoma, essen­
tial iridai atrophy and mesodermal dysgenesis (Mandell 1978). These peri­
pheral anterior synechiae may also be observed after operations (Chandler 
i Grant 1979b) and following argon laser trabeculoplasty (Traverso et al. 
1984). 
4. Blood vessels in the angle. 
The presence of blood vessels in the angle does not as such indicate a 
pathological situation. Normal blood vessels include the circumferential 
arterial circle in the iridai root, and the radial vessels in the iridai 
stroma (Hoskins 1980). If there is neovascularization, this often takes 
the form of vessels arising from the ciliary body and covering iridai and 
angle structures. They form an irregular network (not arranged strictly 
radially or circumferentially) and are not covered by iridai stroma. 
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3.4 OPHIHALMDSCOPY 
It is evident that assessment of the optic disk is among the most valuable 
methods in the clinical evaluation of glaucoma or glaucoma suspect. The pre-
dictive value of a 'glaucomatous' disk for occurrence of visual field de-
fects, however, is neither 100% specific nor 100% sensitive (Sommer et al. 
1979b). In all cases the diagnosis is clinched by a combination of more or 
less specific characteristics of the disk, in combination with the results 
of other diagnostic tests/examinations. Some of the specific glaucoma char-
acteristics are discussed in the following subsections. 
3.4.1 Cup/disk ratio 
There are two ways of quantifying the cupping of the optic disk. One may 
proceed from the colour of the cup, i.e. the central pallor of the disk 
(colour cup), or alternatively one may proceed from the boundaries of the 
cup as indicated by the kinking of the blood vessels (contour cup). For sev-
eral reasons the use of the contour cup is preferable to the use of the col-
our cup. The contour cup reflects the true size of the cupping, whereas the 
colour cup is only a colorimetrie indication of it. Colour cup and contour 
cup are virtually equal in size in normal non-glaucomatous eyes, whereas in 
glaucomatous eyes the contour cup is larger than the colour cup (Schwartz 
1973). The colour cup underestimates the true size of the cupping because 
even in advanced cases of glaucoma the disk often retains a proper colour, 
particularly on the nasal side (Schwartz 1973). Estimation of the size of 
the cupping on the basis of colour can be impeded if there is concomitant 
peripapillary atrophy. The size of the colour cup is age-dependent, showing 
an increase with increasing age (Schwartz et al. 1973). 
The progression of the cup/disk ratio is estimated better from the contour 
cup than from the colour cup (Yablonski et al. 1980). 
It can be stated in general that the colour cup underestimates the true 
cupping, and therefore the severity of the glaucomatous damage. 
The cup disk/ratio in a glaucoma patient should be related to the distri-
bution of cup/disk ratios in a population. Aoialy (1969) demonstrated that, 
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in a group of 1444 non-glaucomatous persons, the cup/disk ratio distribution 
showed a skewing towards low values. Some 82% of his study population showed 
a cup/disk ratio of 0.3 or less (horizontal cup/disk ratio). The cup/disk 
ratio increases with increasing age, but this effect can be ascribed largely 
to an increase in high intraocular pressures with increasing age. In the va­
rious age groups the cup/disk ratio proves to be dependent on the height of 
IOP (Armaly 1969). 
It may be concluded from the above that a cup/disk ratio of 0.4 or more 
may be indicative of glaucoma, but does not prove its presence. Progression 
in the cup/disk ratio, however, is a much more reliable characteristic of 
the glaucomatous optic disk. 
In a group of patients with ocular hypertension Motolko & Drance (1981) 
found that 31% of the subpopulation that ultimately developed visual field 
defects showed a progressive increase in cup/disk ratio as well (versus only 
8% of the subpopulation without visual field defect). Sommer et al. (1979a) 
found progressive increase of the cup/disk ratio in 10 of 12 eyes with ocu­
lar hypertension, and in only 11% of a control group. Yablonski et al. 
(1980) found no difference in absolute progression of cup/disk ratio between 
patients who developed visual field defects, and patients who did not. The 
relative progression (as percentage of the initial value), however, did show 
a statistically significant difference. This is compatible with the findings 
of Motolko & Drance (1981) and Sommer et al. {1979a), who demonstrated that 
patients who develop visual field defects show not only progression of the 
cup/disk ratio but also a higher cup/disk ratio. 
Beside the absolute value and progression of the cup/disk ratio, asynmetry 
in a patient also seems an important indication of the presence of glaucoma. 
Motolko ь Drance (1981) found a cup/disk ratio asymmetry of at least 0.2 in 
44% of eyes with ocular hypertension and visual field defect; this was found 
in only 24% of the eyes without field defects. The difference was not sta­
tistically significant, but indicative. 
Yablonski et al. (1980) found a statistically significant difference in 
the incidence of cup/disk ratio asymmetry between eyes with ocular hyperten­
sion that did, and those that did not developed visual field defects. This 
difference was significant both for the horizontal and for the vertical cup/ 
disk ratio, and for colour cup and contour cup. Inversely they found that a 
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cup/disk ratio difference of at least 0.2 is associated in 91% of cases with 
a visual field defect in the eye with the higher cup/disk ratio. 
Kirsch ь Anderson (1973) reported that asymmetry frequently occurs in 
glaucomatous eyes and is rarely seen in normal, normotensive eyes. Otherwise 
they denied the importance of this asymmetry by concluding that n in all 
our cases with definite asymmetry the glaucomatous cupping could have been 
recognised by examination of the affected disc without comparison to the 
fellow disc". This can be explained from the patient selection in their 
study, which involved only "definitely glaucomatous eyes". 
3.4.2 Localized notching of the neural rim 
A localized narrowing of the neural rim is called a notch. A notch is usu­
ally localized on the superotemporal or inferotemporal side of the neural 
rim. If there is only narrowing of the neural tissue, the notch is described 
as incomplete; if no neural tissue is left, the term complete notch applies. 
Hitchings ί Spaeth (1976) described a subpopulation of glaucomatous eyes 
showing only focal notching of the neural rim, without distinct cupping of 
the remainder of the disk. In most cases the notch was localized in the in­
ferotemporal quadrant. In this group of 23 eyes, 19 showed a nerve fibre 
bundle defect. In 1977 they published a continuation of this study, report­
ing that at that time all 23 eyes showed a nerve fibre bundle defect. In 
five classified subpopulations (cupping with or without neuroretinal rim 
pallor, overpass cupping, beanpot cupping and focal notching of the neuro­
retinal rim) the presence of a notch proved correctly to predict the pres­
ence of a nerve fibre bundle defect in 100% of cases. 
Motolko s. Drance (1981) found notching of the neural rim in 62% of hyper­
tensive eyes with subsequent visual field defect, versus 16% of a control 
group. This difference was statistically significant. 
3.4.3 Vertical ovality of cupping 
In non-glaucomatous eyes the physiological cup is usually round and some-
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times shows horizontally ovality (Kirsch & Anderson 1973). In a population 
studied by Weisman et al. (1973), 4% of the normal and 33% of the glaucoma-
tous eyes proved to show vertical ovality of the cup (i.e. a difference of 
at least 0.2 between the vertical and the horizontal cup/disk ratio); a dif-
ference of 0.1 was found in as many as 60% of the glaucomatous eyes. In the 
case of unilateral visual field defect 21% of the unaffected eyes were found 
to show vertical ovality of the cup; this percentage is significantly larger 
than that in non-glaucomatous eyes. The incidence of vertical ovality de-
pends on the cup/disk ratio: it is 25% with a ratio of 0.3-0.4 and 57% with 
a ratio of 0.5-0.6 (Weisman et al. 1973). 
Gloster (1975) calculated an ovality ratio on the basis of the cup diame-
ters. A value below 1.0 implies horizontal ovality, and one in excess of 1.0 
indicates vertical ovality. In various series he found the following values: 
0.96 for normal eyes, 1.06 for eyes with ocular hypertension, 1.05 for con-
tralateral eyes of patients with unilateral POAG and 1.20 for eyes with 
POAG. These values indicate that early glaucomatous damage is associated 
with vertical cup elongation. A striking finding in this study was that the 
optic disk as such, too, is more oval-shaped in glaucomatous eyes (although 
the vertical elongation of the cup exceeds this value). Why the optic disk 
also becomes more oval-shaped remains obscure. 
3.4.4 Optic disk haemorrhages 
As already mentioned in subsection 2.4.5.1, the prevalence of optic disk 
haemorrhages reported in the literature is rather variable, ranging from 
4.2% (Kitazawa et al. 1986) to 36.9% (Susanna et al. 1979). The incidence is 
about 30% (Gloster 1981). 
The extent and intensity of haemorrhage varies from patient to patient and 
depends partly on the interval between onset of haemorrhage and its ophthal-
moscopic detection. The majority of these haemorrhages are linear in shape 
and radially orientated, although occasionally they may be circular. They 
are usually localized on the neural rim between the boundaries of the optic 
cup and the optic disk. Sometimes they extend as far as the peripapillary 
tissue, but they always remain in touch with the disk. They are most fre-
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quently found in the inferotemporal quadrant of the disk (Gloster 1981). 
The occurrence of an optic disk haemorrhage seems related to the value of 
the vertical cup/disk ratio, a high cup/disk ratio giving a higher incidence 
of haemorrhages (Gloster 1981). 
Motolko ь Drance (1981) found an optic disk haemorrhage in 44% of 16 hy­
pertensive eyes which subsequently developed a visual field defect, but in 
only 2.6% of a control group without visual field defect. 
Drance et al. (1977) reported that the incidence of progressive visual 
field defects in eyes with POAG is significantly higher in the presence of 
an optic disk hemorrhage. 
Tuulonen et al. (1987) compared a group of glaucomatous eyes with optic 
disk haemorrhage, with a group without haemorrhage but matched for diagno­
sis, disk appearance and visual fields. Their principal finding was that the 
two groups did not differ significantly in the rate of progression of glau­
comatous damage to disk and visual field. This difference from earlier 
studies may be explained from the fairly unique way in which the control 
group was formed. Despite these findings, however, occurrence of an optic 
disk haemorrhage should be regarded as a risk factor (Tuulonen et al. 1987). 
3.4.5 Pallor of the optic disk 
Two forms of pallor of the optic disk should be distinguished. The first 
is the central pallor corresponding with the colour cup (see 3.6.1). The 
second is a more or less localized pallor of the neural rim. 
Hitchings ь Spaeth (1976, 1977) established that pallor of the neural rim 
has a high predictive value regarding visual field defects. Visual field de­
fects were found in 60 out of 68 eyes showing this phenomenon. Proceeding 
from the ophthalmoscopic features the visual field defect was correctly 
predicted in 58 eyes. 
An explanation of this pallor of the neural rim is to be found in a re­
duced blood supply to the optic disk. Yet the blood supply is not the only 
factor determining its colour. This is apparent from the fact that the tem­
poral edge of the disk is usually slightly paler than the nasal edge, even 
though this area is well vascularized both from the retinal arterioles and 
99 
from the prelaminar region. Fluorescein fundus angiography sometimes re­
veals a quite adequate vascularization despite clinically evident pallor of 
the neural rim (Spaeth 1978). 
It may be concluded that localized pallor of the neuroretinal rim is fre­
quently associated with nerve fibre bundle defects and constitutes a relia­
ble predictor of visual field defects. 
3.4.6 Peripapillary atrophy 
Peripapillary atrophy is a common finding in glaucomatous eyes, but little 
is known about its role in the progression of glaucoma. Yet both in clinical 
and in pathogenetic terms improved insight into the relationship between 
peripapillary atrophy and glaucoma is very important. 
Kirsch & Anderson (1973) found that most glaucomatous eyes with advanced 
cupping show a peripapillary halo; on the other hand, normal eyes often show 
peripapillary atrophy or congenital crescents and rings which are not read­
ily distinguishable from the glaucomatous halo. 
Motolko к Drance (1981) found no statistical significant difference in in­
cidence of peripapillary atrophy between hypertensive eyes which developed 
visual field defects, and eyes which did not. 
Airaksinen et al. (1987), however, demonstrated that the incidence of 
peripapillary atrophy in eyes with POAG and ocular hypertension (39% and 37% 
respectively) significantly exceeds that in normal eyes (18%). They also 
demonstrated that the development of visual field defects is not dependent 
on the presence of peripapillary atrophy, and that the neural rim loss is 
not related to concomitant peripapillary atrophy. 
It may be concluded that the presence of peripapillary atrophy constitutes 
no 'hard' evidence of glaucoma, although high myopia with the corresponding 
lesions in the posterior pole of course entails an increased risk for pa­
tients with glaucoma (Krupin & Podos 1978). 
3.4.7 Overpass cupping 
Overpass cupping is the term applied to that form of glaucomatous cupping 
100 
in which retinal vessels span the cup in the manner of a suspension bridge. 
As a result, the cup/disk ratio may well be underestimated (Hitchings s, 
Spaeth 1976). 
Overpass cupping is not pathognomonic of early glaucoma. The phenomenon 
can also be observed in optic atrophy due to neurological causes. However, 
it is more frequently observed in contralateral eyes of patients with uni-
lateral POAG than in non-glaucomatous eyes (Spaeth 1978). 
The explanation of this phenomenon is to be sought in the blood supply to 
the anterior part of the optic nerve. The surface nerve fibre layer is vas-
cularized by retinal arterioles, while the prelaminar region receives blood 
from the posterior ciliary arteries. Proceeding from the assumption that in-
creased IOP exerts a greater influence on the blood supply to the prelaminar 
region (autoregulation not yet demonstrated) than on the retina (autoregula-
tion demonstrated), loss of prelaminar tissue can give rise to cupping, 
while the tissue bridge at the level of the surface nerve fibre layer re-
mains intact (Spaeth 1978). 
3.4.8 Previously described criteria 
Two more or less classic characteristics of glaucoma - nasal displacement 
of the vascular tree and undermined disk margins - are also encountered in 
physiological situations and therefore do not constitute 'hard' evidence of 
the presence of glaucoma (Kirsch & Anderson 1973). 
However, this applies solely to the isolated occurrence of these features. 
Spaeth (1978) also regards them as so-called 'soft' signs, but observes very 
rightly that they are very valuable if found in combination with other glau-
comatous features. 
3.5 PERIMETRT 
Perimetry is of essential importance in glaucoma, both diagnostically and 
therapeutically. After all, visual field defect have of old been included in 
the glaucoma definition; and to the patient they are often the only subjec-
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tive complaint. 
The purpose of this section is not to present a complete review of perime-
try but rather elucidate some aspects of perimetry of relevance to this the-
sis. 
3.5.1 Procedure of examination 
A distinction is made between kinetic and static perimetry. In the former 
the stimulus moves from the periphery towards the centre. Per measurement, 
the size and intensity of the object are constant and the stimulus position 
is variable. The advantage of kinetic perimetry is its swiftness; the disad-
vantages are largely determined by the variability of the speed and direc-
tion of object movements, which may cause a considerable standard deviation 
of results. The detection capacity of kinetic perimetry is lower than that 
of static perimetry (Aulhorn & Harms 1967; Greve 1978). 
Static perimetry entails a constant stimulus position with variable lumi-
nance. This causes less standard deviation of results and higher sensitivity 
in detecting early visual field defects (Greve 1978). The examination may be 
made as single stimulus perimetry or as multiple stimulus perimetry. The 
latter technique saves considerable time, which is important particularly in 
the detection phase. Another way of saving time is by suprathreshold perime-
try, using a stimulus luminance above the threshold value. In order to avoid 
false-positive and false-negative results it is important to ensure that the 
luminance throughout the field has an equal value above the threshold (Greve 
& Verduin 1977). 
The instruments used to perform perimetry may be divided into manual, 
semi-automatic and automatic perimeters. In the past decade computerized 
perimetry in particular has come to the fore. 
3.5.2 Detection and assessment 
With regard to the position of perimetry in glaucoma mentioned in the in-
troduction, a distinction can be made between a detection phase and an as-
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sessment phase (Greve & Verduin 1977; Greve 1978, 1980a). In both phases 
perimetry has to fulfil certain criteria. 
In the detection phase it is important to use a rapid, reliable technique 
that demonstrates even small glaucomatous visual field defects. The initial 
defects often consist of spot-like paracentral scotomas (Aulhorn & Harms 
1967) and wedge-shaped defects (Greve & Verduin 1977). Kinetic perimetry is 
less suitable for their detection; the value of this type of perimetry in 
the detection phase lies in determining the shape and size of the blind spot 
and the peripheral visual field. Static perimetry, on the other hand, is far 
more suitable to detect these small defects. Greve (1980c) demonstrated that 
120-150 stimuli within the 30° visual field are sufficient to detect defects 
of 3-5°. An additional number of stimuli is required to examine the nasal 
visual field. 
An instrument very suitable for this detection phase is the Peritesi 
(Greve 1980b). Using a multiple-stimulus, threshold-related suprathreshold 
technique, 157 stimuli are offered within the 25° visual field. The stimuli 
are 0.4 log in excess of the threshold value, which reduces the risk of 
false-positive and false-negative results. This technique is suitable for 
detection of defects measuring 3° or more. The Friedmann Visual Field Ana-
lyzer is an example of a manual multiple-stimulus static perimeter. The 
original version with 46 stimuli has been modified in several other ver-
sions, e.g. the 100-hole front plate (Friedmann 1977) and the Amsterdam 
front plate with 150 positions (Greve 1978). 
When a glaucomatous defect is detected in the detection phase, the general 
implication is that the patient must remain under supervision for the rest 
of his life. Perimetry has become the pivot of investigation, and a stabi-
lized visual field indicates that therapy is adequate. This assessment phase 
serves a dual purpose. To begin with, an attempt is made to describe the de-
fect accurately; secondly follow-ups will have to show wether glaucomatous 
defect shows any progression. Kinetic perimetry is a suitable technique to 
establish the shape and size of the defect, but its standard deviation ren-
ders it less suitable for follow-ups. Unlike the detection phase, the as-
sessment phase calls for single stimulus and threshold luminance perimetry 
(Greve 1980a). 
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3.5.3 Glaucomatous visual field defects 
3.5.3.1 Early defects 
It is of paramount importance to detect the earliest glaucomatous defects. 
As long as there are no defects, after all, one is more reluctant to start 
pressure-reducing therapy than in the presence of a defect. It should be 
borne in mind, however, that there may be non-glaucomatous visual field 
changes which require no therapy (3.5.4). The following will show that de­
tection of these early changes largely depends on the definition of a visual 
field defect and the technique used. 
Greve ь Verduin (1977) demonstrated that isolated kinetic perimetry failed 
to reveal early glaucomatous visual field defects (defined as wedge-shaped 
defects) as well as more advanced defects in 68% of cases. In this phase, 
kinetic perimetry is in fact subordinate to static perimetry. 
Aulhorn ь Harms (1967) and Drance (1969), using combined static and kine­
tic perimetry, established that the earliest defects are spot-like absolute 
scotomas in the Bjerrum area. The baring of the blind spot that was pre­
viously interpreted as characteristic, turned out to be detectable in virtu­
ally all persons (Drance 1969), and enlargement of the blind spot and con­
traction of the visual field, too, are neither early nor specific glaucoma 
features (Aulhorn & Harms 1967). 
The question wether the nasal step is among the earliest glaucomatous de­
fects and wether it is pathognomonic of glaucoma, receives no unequivocal 
answer in the literature. Aulhorn & Harms (1967) found a nasal step as first 
defect in only 0.5% of cases, but its frequency rose with increasing glauco­
matous defects. Zingirian et al. (1979) used a modification of kinetic peri­
metry to demonstrate that 13 out of 20 eyes with ocular hypertension showed 
a nasal step, whereas routine perimetry revealed no defects. However, they 
regularly found an isolated nasal step also in normotensive eyes. Drance et 
al. (1979) found an isolated nasal step as first defect in 20% of cases; Le­
blanc (. Becker (1971) reported the same in 11% of cases. According to Drance 
(1979) the earliest glaucomatous defects consists of a combination of isola­
ted paracentral scotomata and a nasal step. 
Using multiple-stimulus static perimetry, Greve et al. (1979) found that 
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the earliest defect often is a reversible wedge-shaped defect. An absolute 
scotoma may later develop at the site of this earliest defect. 
Lichter & Standard! (1979) maintain that marked asymmetry between two eyes 
may be indicative of an early glaucomatous defect, even though this asym-
metry as such need not be immediately regarded as pathological. A unilater-
ally enlarged blind spot in combination with isopter contraction could be 
regarded as such. 
It may be concluded that the chance of early detection of visual field de-
fects depends on the methods and definitions used; that in the detection 
phase static perimetry is preferable to kinetic perimetry; and that early 
visual field defects may include marked asynmetry, spot-like paracentral 
scotomata, wedge-shaped defects and nasal steps, per se or in combination 
with absolute scotennata. 
3.S.3.2 Stages of visual field defect 
On the basis of many static and kinetic perimetric studies, Aulhorn (1980) 
divided glaucomatous visual field defects into five stages. An advantage of 
this system is that it gives a good impression of the sequence of events and 
the rate of progression. The system is of course a simplification of reality 
but does not violate it. 
Figure 3.1 presents the five stages described by Aulhorn and shows the 
course of an initial relative defect which ultimately results in a collapse 
of the central visual field. On the basis of these stages the sequence of 
events will be discussed step by step. 
Stage 1. 
The initial stage is characterized by a relative visual field defect, 
which is usually larger than the absolute defects in more advanced cases. 
Its localization is often near the centre, more often in the superior than 
in the inferior part of the visual field. Its shape is usually arcuate, and 
one should be aware of the possibility of a smaller absolute defect local-
ized within the relative one. 
In some cases a relative defect disappears and an absolute scotoma subse-
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Figure 3.1. The five stages of development of glaucomatous visual field de-
fect as described by Aulhorn (1980). As an example of the se-
quence of events, a beginning defect in the lower half of the 
visual field is shown. Stage 2 and 3 represent two possibilities 
for each stage (after: Aulhorn, E.: Comparative visual field 
study in patients with primary open angle glaucoma and anterior 
ischaemic optic neuropathy. In Greve, E.L. (ed.): Glaucoma Sym-
posium. Diagnosis and Therapy. Amsterdam 1979. Doc. Ophthalmolo-
gica Proc. Series 22:3, 1980). 
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quently develops at this site (Greve et al. 1979). Aulhom (1978) believes 
that only these small relative defects are reversible, but Iwata (1979) 
found that small spot-like scotomata and nasal steps may likewise disappear, 
if only transient. 
Stage 2. 
The first absolute defects may be small and round. Larger defects show a 
more arcuate shape. This stage is characterized by the fact that the scoto-
mata are not linked to the blind spot. In some instances a larger relative 
defect may extend between the blind spot and absolute scotoma, but on the 
other hand the absolute scotoma may well be localized in an otherwise en-
tirely normal visual field. Many patients show several small scotomata whose 
relative positions correspond with the course of the pericentral nerve fibre 
pathway. 
These scotomata are characterized by the fact that they are localized rel-
atively far from the blind spot, and move in its direction only as the de-
fect progresses. This confirms the contention that enlargement of the blind 
spot cannot be regarded as conclusive of early glaucomatous visual field de-
fect. 
Aulhom (1978) studied the positions of the scotomata in the visual field 
and found that the frequency distribution is virtually the same in the supe-
rior as in the inferior part of the field. He also found that the scotomata 
in the superior part show a more arcuate pericentral localization, that in 
the inferior part more scotomata are found in the nasal quadrant, and that 
the scotomata in the superior part are closer to the centre than those in 
the inferior part. 
Kosaki (1979) studied the topography of scotomata in all glaucoma stages 
and established an overall predilection for the superior visual field, and 
especially the nasal quadrant. The inferotemporal quadrant often remains in-
tact until the very last. A study involving a long-term follow-up of visual 
fields by computerized perimetry likewise revealed a predilection for the 
superonasal quadrant (Gloor et al. 1987). The even distribution reported by 
Aulhom is probably due to the fact that only stage 2 patients participated 
in this part of his study. 
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Stage 3. 
This stage is characterized by a classic Bjerrum scotoma. The small abso-
lute scotomata of stage 2 have fused and are linJced to the blind spot. 
Bjerrum's scotoma is usually observed in the 10-20° visual field and has a 
narrow base near the blind spot, fanning out towards the centre. 
Aulhorn maintains that this is the first phase in which a nasal step may 
be observed but, as previously noted, not all investigators agree with this. 
A progressive increase in disappearance of nerve fibre bundles is clinically 
characterized by defects in the nasal visual field - a phenomenon known as 
nasal breakthrough. 
Stage 4. 
There is a gradual transition from stage 3 to stage 4, and it may be main-
tained that stage 4 begins when a scotoma loses its arcuate shape. The supe-
rior and the inferior visual field are usually both affected, and visual 
complaints may develop. Central vision is not affected and visual acuity 
therefore remains unchanged. 
Stage 5. 
This ultimate stage is characterized by collapse of the central visual 
field. 
The above division is base on perimetric findings obtained in over 18,000 
persons, including at least 6000 glaucoma patients or glaucoma suspects. 
This is by no means the only conceivable classification, but it is one that, 
because of its relative simplicity and especially because of its sequential 
character, enhances our insight into glaucomatous visual field defects. 
3.5.4 General considerations on the glaucomatous visual field 
3.5.4.1 Age-related changes of the normal visual field 
Using kinetic perimetry, Drance et al. (1967) demonstrated that both the 
central and the peripheral visual field show a linear surface area diminu-
ios 
tion with increasing age. This effect is measurable from the age of 10-20 
years on. The blind spot shows significant enlargement, with increasing age. 
Since these findings were obtained in mydriasis, the effect cannot be as-
cribed to miosis. 
More advanced techniques of examination revealed the following: using au-
tomated static perimetry, Haas et al. (1986) found a significant decrease in 
mean sensitivity with a linear course of about 0.58 dB loss per decade. This 
decrease begins at an early age. There are topographic differences, the cen-
tre and the periphery showing a greater decrease than the pericentral re-
gion. Haas et al. ascribed these findings to increasing turbidity of the me-
dia as well as changes in the sensory system. 
In addition to this linear decrease in mean sensitivity Jaffe et al. 
(1986) also found a linear loss of surface area as well as volume of the 
visual field with increasing age. Unlike Haas et al., Jaffe et al. found a 
linear decline in topographic terms, with a mean loss of 0.0015 dB per year 
per degree of excentricity. A possible explanation might be that the rate of 
ganglion cell loss is the same throughout but is less quickly noticed at the 
centre due to the one-to-one linking of ganglion cells and photoreceptors. 
Haas et al. as well as Jaffe et al. demonstrated that the superior visual 
field shows a more marked decline in sensitivity than the inferior field. 
3.5.4.2 Visual fields, glaucoma and cataract 
Niesel et al. (1978) demonstrated that cataract formation in non-glaucoma-
tous patients can lead to visual field changes, more specifically isopter 
contraction and loss of central isopters. 
Greve (1980c) showed that the static sensitivity curve is not only lowered 
but also flattened. At kinetic perimetry this flattening may lead to pseudo-
defects. In cases of glaucoma with concomitant cataract, therefore, static 
perimetry (more especially large-stimulus static perimetry) is to be prefer-
red. 
A general decline of sensitivity and loss of central isopters is to be as-
cribed more to the cataract than to the glaucoma in concomitant cases. A lo-
cal decrease in sensitivity should be ascribed to the glaucoma. In terms of 
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technique of examination, i t should be ensured that the pupil has a minimum 
diameter of 2.5 mm (Greve 1980c). 
3.5.4.3 Rate of progression of glaucomatous field defects 
I t i s an established fact that normalization of I0P in cases of POAG does 
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Figure 3.2. Progression in four representative patients illustrated in 
graphs of scotoma mass over time. A. Linear progression. B.Cur­
vilinear progression. С Episodic progression. D. No significant 
progression, (after Mikelberg, F.S., Schulzer, M., Drance, S.M., 
and Lau, W. : The rate of progression of scotomas in glaucoma. 
Am. J. Ophthalmol. 101:1, 1986). 
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not guarantee prevention of further visual field defects (see later). The 
rate of progression of visual field defects can vary considerably from pa-
tient to patient. Mikelberg et al. (1986) found four different forms in 
which this progression manifests itself (figure 3.2A through D). In a series 
of 45 eyes with POAG they observed linear progression in 49% after a mean 
follow-up of 91.2 months (fig. 3.2A), curvilinear progression in 20% (fig. 
3.2B), episodic progression in 7% (fig. 3.2C) and no significant progression 
in 24% (fig.3.2D). The mean scotoma mass was significantly lower in the cur-
vilinear than in the linear group. There was a highly significant correla-
tion between the mean scotoma mass and the rate of progression, implying 
that eyes with larger scotomata show a higher rate of progression. 
Granström (1985) demonstrated that progression of visual field defects is 
significantly more frequent as the defect at initial examination is larger. 
Wilson et al. (1982) had previously shown that the rate of progression of 
visual field defects to a pre-determined ultimate stage indeed depends on 
the initial situation. In addition they found that the rate of progression 
is higher in males, higher if there is a positive glaucoma family history, 
and higher as the initial IOP is higher. There was no demonstrable correla-
tion between the rate of progression of visual field defects on the one 
hand, and age and systolic blood pressure on the other. 
To sunmarize: the rate of progression of visual field defects is dependent 
on the degree already developed, and possibly related to age, family history 
and IOP. 
3.5.4.4 Glaucomatous visual field defects an intraocular pressure 
The risk of development of visual field defects is small at a moderately 
increased IOP (Annaly & Sayegh 1969; Kitazawa et al. 1977), but increases as 
the IOP increases (Odberg & Riise 1987). 
There is no unequivocal answer to the question of what happens with the 
visual field after pressure-reducing therapy in the case of manifest glauco-
ma. In an exhaustive review of the literature, Pohjanpelto (1985) found that 
progression of visual field defects occurs in an average of 50% of glaucoma 
patients after surgery and/or medication. His own study revealed progression 
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in 70-80% of eyes with POAG or pseudo-exfoliation glaucoma after a mean fol­
low-up of 9 years. An interesting finding was that there was no significant 
difference in mean IOP between the group that did and the group that did not 
show progression. 
Multiple correlation analysis applied to 81 eyes revealed no significant 
correlation between mean IOP and progression of visual field defects; how­
ever, this correlation became unmistakably significant when the standard de­
viation of IOP was included in the results (Niesel ь Flairaner 1980). This 
might warrant the conclusion that the peak pressures which occur exert more 
influence than the mean IOP. 
The lastmentioned finding appears to be contradicted by the results re­
ported by Radius & Maumenee (1977) in 16 eyes with angle-closure glaucoma 
and temporarily very high IOP, in whom they were unable to detect glaucoma­
tous visual field defects. However, since IOP is totally normal between at­
tacks (unlike the pressure in POAG), the results of this study must not be 
compared with those of the abovementioned studies. 
The fact that the result of a pressure-reducing intervention in visual 
field terms depends on the damage already inflicted, needs no further argu­
mentation. It is clearly illustrated by the study of Aggerwal s. Hendeles 
(1986), who found that normalization of IOP after trabeculectomy performed 
on eyes with marked glaucomatous lesions does not guarantee that the central 
visual field is spared. 
3.6 ΤΟΝΟΟΗΑΙΉΥ AND PHOVOCATIVE TESTS 
3.6.1 Tonography 
In 1950 Grant introduced tonography as a method of measuring aqueous hu­
mour dynamics. Using a continuous electronic Schiötz tonometer, Grant was 
able to estimate the facility of outflow and the rate of aqueous flow. 
In 1951 Grant published a monumental study comprising over 1000 tonograph-
ic findings obtained in normal eyes and in various forms of glaucoma. He 
demonstrated the clinical applicability of his method and contributed to the 
clarification of the pathophysiology of various forms of glaucoma and the 
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mechanism of action of various surgical and pharmacological therapies. He 
demonstrated, for instance, that resistance to outflow rather than aqueous 
humour formation is increased in virtually all forms of glaucoma. The de-
crease in facility of outflow in POAG was so consistent a finding that Grant 
believed it possible to discriminate between glaucomatous and normal eyes 
solely on this basis. He showed that the facility of outflow decreased very 
markedly during an attack of angle-closure glaucoma, and returned to normal 
after the attack. He demonstrated that the effects of various operations and 
miotic medications are based on an increased facility of outflow. 
It is quite evident that this study and subsequent studies have greatly 
contributed to our current glaucoma concept. 
What is the position of tonography in the current approach to glaucoma? 
Apart from critical remarks on the technical aspects of tonography (Fisher 
et al. 1970; Fisher 1972; Dueker 1978; Armaly 1984), objections may be 
raised concerning the validity of its results. If a patient shows an in-
creased IOP in combination with glaucomatous cupping and visual field de-
fects, is it really necessary to demonstrate that this is caused by a de-
creased facility of outflow? And is it necessary to demonstrate that the de-
crease in IOP upon miotic medication results from an increased facility of 
outflow? 
The severity of glaucoma cannot be assessed from the value of the facility 
of outflow. Fisher et al. (1970) demonstrated that facility of outflow cor-
relates less with visual field defects than tonometry. Tonography does not 
seem to supply any additional information. 
Does tonography have predictive value regarding future increases in IOP or 
visual field defects? Graham (1978) found no correlation between the initial 
facility of outflow value and the behaviour of IOP over a follow-up period 
of 2-3 years. Wilensky et al. (1974) performed a prospective study of the 
values of various methods of examination used in cases of ocular hyperten-
sion, and their correlation with visual field defects. They demonstrated 
that a facility of outflow lower than 0.15, although reasonably sensitive, 
has a low specificity; in other words: the risk that an eye with a facility 
of outflow below 0.15 and ocular hypertension will subsequently develop 
glaucoma is small. 
The result of the water drinking test - increased IOP - is reasonably 
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sensitive but has a low specificity (Odberg ь Riise 1987). Determining the 
facility of outflow after the water drinking test adds nothing to the test 
result (Kronfeld 1975). 
It may be concluded that, although tonography has enhanced our under­
standing of glaucoma, its current clinical value for the individual patient 
is only relative (with a few exceptions). However, tonography can be an im­
portant aid in the evaluation of new therapeutic techniques. 
3.6.2 Provocative tests 
The purpose of using provocative tests in glaucoma research should be to 
discriminate between patients who do and those who do not develop visual 
field defects. This should apply in particular to patients with increased 
IOP without other evident glaucomatous damage (ocular hypertensives or glau­
coma suspects). 
The battery of such provocative tests so far developed encompasses the 
water drinking test, the pilocarpine test, the epinephrine test, the fluor­
escein angiography provocative test, the elevation of venous pressure test, 
the phenylthiocarbamide taster test and the corticosteroid provocative test 
The value of the corticosteroid provocative test will be discussed in some 
detail because this test is regarded as the one most widely used. 
After topical application of corticosteroids during a certain time (gen­
erally 4-6 weeks), the following effects can be measured: 
1. Non-glaucomatous normotensive eyes show an increase in IOP above the 
group median (Armaly 1963a; Becker & Mills 1963). There seem to be two 
subgroups: responders and non-responders. Responders (IOP 21 mm Hg and 
over) account for 30% of the entire group. The responder/non-responder 
ratio is age-related, the proportion of responders increasing with in­
creasing age. Above the age of 40 the responder rate is 44% (Becker t> 
Mills 1963). 
The increase in IOP is parallelled by a decrease in facility of outflow 
(Armaly 1963a; Becker s. Mills 1963). 
Perimetry in this group shows that no changes are generally observed be-
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fore the age of 40; above this age, however, the size of the blind spot 
increases and there is constriction of the 1/2 isopter (Armaly 1964). 
2. Patients with ocular hypertension or glaucoma suspects likewise show the 
abovementioned changes in I0P and facility of outflow. In this group, 
however, these changes are more pronounced (Becker & Mills 1963). Again 
there are responders and non-responders, some 25% of the patients respon-
ding with an increase in I0P by at least 5 mm Hg (Dean et al. 1975). As 
the I0P increases typical glaucomatous visual field defects may develop 
(Kolker et al. 1964). 
3. Glaucomatous eyes nearly always show a marked increase in I0P and a de-
crease in facility of outflow after corticosteroid provocation (Armaly 
1963b; Becker & Mills 1963). Perimetry often shows increased scotomata 
(Armaly 1964; Kolker et al. 1964), although this is not an obligatory 
finding (Kolker et al. 1964). 
4. The hypertensive effect of corticosteroids is reversible and generally 
measurable after a short time (Armaly 1963a; Leblanc et al. 1970). The 
visual field defects are likewise reversible, but the recovery period may 
be as long as 4 months. The increase in I0P should at least be 8 mm Hg 
before a defect occurs (Hart s- Becker 1977). 
5. On the basis of the diversity in I0P responses Becker et al. (1964, 1965, 
1970) believed that a recessively transmitted corticosteroid response 
could be described. This would mean that three subgroups might be distin-
guished: non-responders (nn), moderate responders (ng) and responders 
(gg). Glaucoma patients would be mainly responders,and glaucoma suspects 
for the most part moderate responders. 
Despite the above described differences between normal eyes, eyes of glau-
coma patients and eyes of glaucoma suspects, one continues to be confronted 
with the individual patient. In other words: what is the predictive value of 
the corticosteroid response? Investigations into this question are impeded 
by the fact that only a minority of patients with ocular hypertension ulti-
mately develop glaucoma, and often not until after a long period of time. A 
prospective study by Odberg & Riise (1987) revealed that the steroid provo-
cative test is of hardly any importance as predictor of early glaucoma (i.e. 
increased cup/disk ratio and/or visual field defect). A response of, say, 
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+10 mm Hg after steroid provocation was seen no more frequently in the group 
subsequently developing glaucoma. The same applies to the pilocarpine test. 
It can be stated that the sensitivity of most provocative test is reason-
able, but their specificity is low. Consequently their predictive value is 
low. Kitazawa et al. (1977) found 100% sensitivity for the corticosteroid 
provocative test, at a specificity of only 40%. Should all responders be 
treated as future glaucoma patients, therefore, then a large group would in-
deed be given unnecessary therapy. 
3.7 ELEXTTRDDDUaaOSTICM. TOOLS 
Application of electrophysiological tests in clinical diagnosis and evalu-
ation of therapy of glaucoma has so far been limited, but in terms of scien-
tific experiments the findings are undoubtedly of importance (see 2.4.4). 
3.7.1 Pattern reversal evoked responses (PVER) 
Pillunat et al. (1985a, 1985b, 1986, 1987) studied the correlation between 
perfusion pressure and amplitude of PVER. The perfusion pressure was reduced 
by step-wise raising of IOP using a suction cup. Since there is considerable 
interindividual variation in the absolute value of the amplitude, this is 
expressed in percents, proceeding from an initial amplitude of 100%. Accord-
ing to Pillunat et al. the correlation between IOP and PVER amplitude can be 
used to differentiate between non-glaucomatous eyes (fig 3.3A), eyes with 
POAG (fig. 3.3B) and eyes with low-tension glaucoma (fig. 3.4). 
As IOP increases, non-glaucomatous eyes initially show a rapid decrease in 
PVER amplitude to 50% of the initial value at an IOP of about 30 mm Hg. The 
amplitude then stabilizes or even shows some increase, until the IOP attains 
about 60 mm Hg. At the moment the noise level is attained, the IOP amounts 
to 80-90 mm Hg. 
Eyes with POAG initially show a less rapid decrease in PVER amplitude, 
which is still about 90% at an IOP of 50 mm Hg. Next comes a rapid decrease 
which ends at a noise level when the IOP is about 80 mm Hg. There is no pla-
teau fílase. 
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Figure 3.3. Visual evoked response amplitude plotted against intraocular 
pressure for A. a healthy eye and B. an eye with POAG. (after 
Pillunat et al. 1985a, 1985b, 1986, 1987). 
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Figure 3.4. Visual evoked response amplitude plotted against intraocular 
pressure for an eye with low-tension glaucoma (after Pillunat et 
al. 1985a, 1985b, 1986, 1987). 
In low-tension glaucoma the initial decrease more or less parallels that 
in non-glaucomatous eyes. Again there is no plateau phase, and the noise 
level is attained at an TOP of about 70 mm Hg. 
Pillunat et al. derived two conclusions from these results. To begin with, 
the plateau phase which characterizes normal eyes may indicate the presence 
of an autoregulation mechanism in the anterior part of the optic nerve. This 
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mechanism is believed to be lacking in patients with POAG and low-tension 
glaucoma. Secondly, low-tension eyes could have a lower pressure tolerance 
at the level of the optic nerve than normal eyes with POAG. 
3.7.2 Pattern reversal electroretinogram (PERG) 
Van lith et al. (1984) found that the PERG of glaucomatous eyes had a sig-
nificant lower amplitude and longer latency than that of normal eyes. A 
striking finding was that these results did not correlate with visual field 
defects, nor with IOP. However, a lower coefficient of correlation (0.28) 
was found for the correlation between PERG and cup/disk ratio. This is pos-
sibly explained by the fact that only cases of not very advanced glaucoma 
were included in this study. 
Papst et al. (1984) believed they could describe a correlation between 
PERG amplitude and IOP. IOP values in excess of 30 mm Hg were always related 
to low amplitudes. Artificial reduction of IOP caused an increase in poten-
tial into the normal region. In the case of unilateral ocular hypertension, 
reduction of IOP did cause an increase in PERG amplitude but still below 
that in the unaffected eye. These PERG changes may indicate diminished auto-
regulation in the retina. 
Recent reports (Wanger & Persson 1987; Korth et al. 1987) mention a de-
creased PERG amplitude and increased latency (Korth et al. 1987) with in-
creasing age. 
After correction of PERG results for age, glaucomatous eyes, and possibly 
also eyes with ocular hypertension, showed a significantly lower PERG ampli-
tude than normal, non-glaucomatous eyes (Wanger & Persson 1987; Korth et al. 
1987). 
Moreover, Korth et al. (1987) found a correlation between the decrease in 
amplitude on the one hand, and on the other hand an increase in cup/disk ra-
tio, increased visual field defects and a decreased temporal neuroretinal 
rim in glaucomatous eyes. However, the sensitivity of the PERG in detecting 
glaucomatous damage is low (50%). 
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PART I I 

CHAPTER 4 
ARGON LASER TRABECULOPLASTY 
A REVIEW 
пгиюотепш 
In 1979 Wise i Witter published their first, preliminary results obtained 
by Argon Laser Trabeculoplasty (ALT) used as a pressure-reducing therapy in 
glaucoma. Their publication prompted application of this technique on a 
larger scale. 
The current position of ALT in the treatment of glaucoma largely depends 
on the objective one seeks to achieve. ALT is being applied as an alterna­
tive to surgical intervention, as initial therapy, as an alternative to med­
ication, and as adjuvant to medication. It is beyond argument that highly 
adequate medical and surgical techniques are available to reduce intraocular 
pressure (IOP). A review of these techniques would be beyond the scope of 
this thesis, but in the following chapters references will be made to pros­
pective, randomized studies comparing ALT with medical and surgical tech­
niques of treating glaucoma. 
The advantages of ALT are simplicity of procedure - permitting its use in 
an out-patient setting - and the fact that it hardly interferes with the pa­
tient's general daily activities. In addition, ALT is relatively inexpensive 
and, if correctly indicate and performed, effective. It will be subsequently 
shown that ALT is not without side effects and complications, and cannot al­
ways obviate surgical intervention. 
On the basis of data from the literature this chapter presents an up-to-
date outline of ALT. The tables referred to are presented in an appendix to 
this chapter. 
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4.1 HISTORICAL REVIEW 
Table 4.1 presents a survey of the studies discussed in the following re-
view. 
In 1973 Krasnov reported some results of laser therapy in primary open-
angle glaucoma (POAG). He made use of the laser property of producing not 
only a coagulating but also a perforating effect (micropuncture). Because 
coagulation causes cicatrization and (according to Krasnov) reduces outflow 
if applied to the trabecular meshwork, he started looking for a laser which 
combined a maximal perforating and a minimal coagulating effect. This he 
found in the Q-switched ruby laser with an ultra-short pulse time of 1Q-9 
sec. With this laser he attempted to create a direct link between the ante-
rior chamber and Schlemm's canal (Laser Trabeculopuncture). Nine of the ten 
patients this treated showed a significant fall in IOP (averaging 6.3 mm 
Hg). This decrease became manifest 1-4 days after treatment and persisted 
from 1 week to 6 months. Retreatment again produced a transient decrease in 
IOP. The use of the argon laser produced a less marked decrease in IOP which 
lasted less long, caused more inflammatory symptoms and required retrobulbar 
anaesthesia. Krasnov concluded from these results that it would be premature 
to start using the laser clinically on a larger scale. 
Likewise in 1973 Hager published his results, but unlike Krasnov he did 
make use of the coagulating effect of laser. He performed trabeculopunctures 
with the aid of a continuous wave argon laser, using a power of about 1000 
mW and an exposure time of 1-3 sec. In this way he attempted to create 1-3 
trabeculopunctures. Of 28 eyes thus treated, 13 (46.4%) proved to show ade-
quate regulation of IOP after a follow-up of at least 4 months. Hager con-
cluded that it should be possible on a limited scale to ensure adequate IOP 
regulation by means of these trabeculopunctures, but that on the other hand 
damage might be inflicted on tissues due to the long exposure time involved. 
Gaasterland & Kupfer (1974) demonstrated the possibility of inducing glau-
coma in normal Rhesus monkey eyes by intensive coagulation of the trabecular 
meshwork. They used numerous bums in a procedure in which the total energy 
invested could be as high as 80 Joules. 
Wickham et al. (1977) likewise observed diminished outflow after argon la-
ser manipulation of the trabecular meshwork. In addition, however, they dis-
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covered that the effect produced depends largely on the energy level in­
volved (total energy = number of bums χ exposure time χ power). Exposing 
the trabecular meshwork in simian eyes to the total energy of 1.5 J resulted 
in an increase in outflow, while a total energy of 41 J caused a decrease in 
outflow. 
Using a continuous wave argon laser, Ticho (1977) applied about 50 burns 
to 60° of the trabecular meshwork (spot size 50 μιη, exposure time 0.1 sec, 
power 1000-3000 mW). Some of the eyes thus treated showed an initial de­
crease in IOP, but generally this persisted only a short while. 
Stiegler (1979) used a pulsed argon laser and punctured the trabecular 
meshwork about 40 times in one quadrant. He reported a success rate of 81% 
in patients with POAG. 
De Heer & Peperkamp (1979) obtained good results using a variable exposure 
time. They found that results in patients treated with short exposure times 
and high intensity (0.05 sec, 2000 mW) were better than those obtained with 
long exposure times at low intensity (0.1 sec, 700 mW). 
The above studies would seem to indicate that results obtained by a number 
of techniques were promising but that optimal treatment parameters were 
still to be established unequivocally. The minimum requirements to be met by 
laser therapy were: a short exposure time, treatment of a larger part of the 
trabecular meshwork, and investment of a relatively low level of total ener­
gy in the trabecular meshwork. The question arises wether the parameters 
used by such investigators as De Heer s, Peperkamp (1979) could in fact lead 
to perforation of the trabecular meshwork; in other words: was trabeculo-
puncture really involved? 
wise & Witter (1979) selected their parameters on the basis of a pathophy­
siological glaucoma model. They postulated that in the case of glaucoma the 
trabecular meshwork has collapsed, causing an increased resistance to out­
flow and therefore an increased IOP. Making superficial burns in the trabec­
ular meshwork will cause shrinkage of the collagenous core of the laminae, 
and secondary retraction due to cicatrization. The intertrabecular space 
will be enlarged, and resistance to outflow decreases. This effect was des­
cribed as tightening effect, and this form of treatment was initially known 
as Laser Trabeculo Tightening (Wise 1981). Later, the designation Argon La­
ser Trabeculoplasty (ALT) was generally accepted. 
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The technique applied by Wise & Witter might be described as the Standard 
Wise ALT. After local anaesthesia, 100 burns were applied to or immediately 
posterior to the pigmented trabecular meshwork, using a 50 \m beam diameter, 
0.1 sec exposure time and a power setting of 1000-1500 mW. Pigment disper­
sion and gas bubble formation were chosen as criteria for a good burn. Af­
ter-treatment consisted of application of eyedrops containing antibiotics. 
The results of this therapy were promising. Of 41 phakic eyes with POAG, 
38 (92.7%) proved to have an IOP of 20 mm Hg or lower after 3-6 months. The 
mean decrease in IOP was 10.29 mm Hg at an initial IOP of 26.46 mm Hg. Only 
one eye subsequently required pressure-reducing surgery. 
After a period of 12 months, 21 of the 23 eyes followed up (91.3%) still 
had a regulated IOP with an unchanged decrease in IOP (mean decrease 10.64 
non Hg). 
Results were decidedly less good in a smaller group of aphakic eyes, but 
nevertheless 8 of the 15 eyes treated were spared pressure-reducing surgery 
after a follow-up of at least 6 months. 
Wise 5, Witter concluded that the results of this pilot study were promis­
ing but that further, more detailed investigations were required to estab­
lish whether this technique would be eligible for general practical use. 
After this publication research into various aspects of ALT has taken a 
much wider scope. Several of these aspects will be discussed systematically 
in the following sections. 
4.2 RESULTS OF ALT Ш PHAKIC OPEN-ANGLE GIADC0MA 
4.2.1 Standard Wise ALT as secondary therapy 
Table 4.2 presents a compilation of the studies to be discussed in this 
section. 
The results to be discussed were obtained in studies using the Standard 
Wise ALT, i.e. 100 burns applied to the pigmented part of the trabecular 
meshwork or immediately posterior to it over a distance of 360° in one ses­
sion, with a 50 urn beam diameter, 0.1 sec exposure time and a power setting 
of about 1000 mW. 
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For several reasons (some of which are mentioned in the table), comparison 
of the results of the various studies requires great prudence: 
1. Although most of the results were obtained in prospective studies, some 
retrospective studies were included as well (Horns et al. 1983; Lieberman 
et al. 1983; Tuulonen & Airaksinen 1983a). This methodologically differ-
ent basis is of course important in interpreting, in particular, the fol-
low-up results. 
2. The type of glaucoma may also vary. Some studies are limited to POAG, 
whereas others also describe other forms of open angle glaucoma (OAG). 
3. The number of eyes treated ranges from 19 (Schultz et al. 1987) to 237 
(Thomas et al. 1982) and this affects statistical analysis. Moreover, the 
number of patients included in a study is often smaller because ALT was 
applied bilaterally. This is a possible source of distortion of the re-
sults, particularly because the exact sequence of bilateral treatment is 
not always described. One may expect that the worst eye is treated first, 
and that the indication for treatment of the other eye depends on the re-
sults obtained in the first. This may imply a form of selection in that 
bilateral treatment is confined to cases in which the first treatment was 
successful. It would be better to randomize patients with bilateral glau-
coma for ALT of only one eye. An alternative is to include only the eye 
treated first in the presentation of results, and to discuss the bilater-
ally treated patients separately. 
4. Comparison of the absolute and relative decreases in IOP should always be 
correlated with the initial IOP because these are not independent varia-
bles (see later). 
5. The criteria for success may differ in different studies. Because the in-
dication for ALT was made in all cases as an alternative to surgical in-
tervention, success may be defined as actual obviation of surgery (Wi-
lensky & Jampol 1981; Horns et al. 1983; Demailly et al. 1985). Other 
criteria may be added in that success is defined as an IOP which is 21 mm 
Hg or lower during at least one year, without additional medication and 
without further damage to the optic disk and visual field (Tuulonen & 
Airaksinen 1983a). The consequence is that success rates on the basis of 
different success criteria can hardly be compared and that the success 
133 
rates reported depend largely on the success criteria accepted. This is 
illustrated by the study of Wilensky & Jampol (1981), who reported that 
ALT obviated surgery in 100% of cases. Applying the additional criterion 
that the ultimate I0P should be 21 mm Hg or lower, however, one would 
find a success rate of only 54.5%. 
Bearing the above considerations in mind, we find that the IOP decrease 
that can be achieved by Standard Wise ALT ranges from 19.5% at an initial 
IOP of 21.7 mm Hg (Traverso et al. 1986) to 43.2% at an initial IOP of 28.4 
mm Hg (wise 1981). The success rate ranges from 65.4% on the basis of strict 
criteria (Tuulonen & AiraJcsinen 1983a) to 100% on the basis of milder crite-
ria (Wilensky & Jampol 1981). These results were recorded after a specified 
follow-up period and therefore warrant no conclusion on a possible reduction 
of the IOP decrease or the success rate in the subsequent course of time. 
The IOP decrease is already considerable 1 week after ALT, but seems com-
plete after 4-8 weeks (Schwartz & Kopelman 1983; Bergeâ 1984; Weinreb et al. 
1983b). Nevertheless individual patients who show no initial reaction may 
have a decrease in IOP after a few weeks (Wise 1981; Wilensky & Jampol 1981) 
4.2.2 Standard Wise ALT as primary therapy 
Table 4.3 presents the results of ALT applied as primary therapy in newly 
diagnosed glaucoma. The parameters of the Standard Wise ALT were fully adop-
ted by Thomas et al. (1984), Tuulonen (1984) and (except for a beam diameter 
of 100 pm) Rosenthal et al. (1984). The additional success criterion applied 
by these authors was that the IOP decrease after ALT should persist without 
further medication. 
The IOP decrease achieve in these cases slightly exceeds that achieved by 
ALT as secondary therapy. However, if we relate this decrease to the higher 
initial IOP in these patients, then the IOP decreases in both groups are of 
the same magnitude. This is illustrated by the IOP decrease in the study of 
Tuulonen (1984) - 30.1% at an initial IOP of 25.6 mm Hg - which corresponds 
entirely with the IOP decrease following secondary ALT given comparable ini-
tial lOPs (Homs et al. 1983; Lieberman et al. 1983; Schwartz & KopeUnan 
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1983; Bergeâ 1984). 
The reported success rates range from 65% (Rosenthal et al. 1984) to about 
80% (Thomas et al. 1984; Tuulonen 1984). The larger spot size in the study 
of Rosenthal et al. may have played a role in their lower success rate. 
Since the results in the different studies again may be compared only with 
reservations, the results reported by Tuulonen et al. (1985) can be used to 
compare primary ALT with secondary ALT: these results pertain to similar 
study populations with a similar possible bias. One of the findings in this 
study of factors influencing ALT results was that ALT as primary therapy 
- i.e. in patients not given previous local or systemic treatment for the 
increased IOP - yields significantly better results than ALT as secondary 
therapy. 
The following question now arises. What is the position of ALT in the 
treatment of glaucoma patients or glaucoma suspects? All patients in the 
abovementioned studies showed evident damage to the optic disk and glaucoma-
tous visual field defects. The position of ALT in the treatment of glaucoma 
seems to have changed as experience has increased in the course of the years 
and as ALT has proved to be a relatively safe intervention. After all, why 
should patients first be adjusted to maximum medication, with the known pos-
sibility of many side effects and untoward effects? This seems to apply in 
particular to the use of carbonic anhydrase inhibitors. 
One step further might be to resort to ALT for patients with a number of 
glaucoma-specific features but without visual field defect. Likewise, pa-
tients with an increased IOP without other glaucoma characteristics but at 
an increased risk (e.g. in view of a positive family history) might be eli-
gible for ALT. Because no pertinent data could be found in the literature, 
this subject will be given further consideration in the discussion of our 
own results. We have treated a number of patients with an increased IOP, 
with or without glaucomatous disk changes, but certainly without glaucoma-
tous visual field defects. 
4.2.3 Long-term results of Standard Wise ALT 
Tables 4.4 and 4.5 respectively present the extent of the IOP decrease and 
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the success rate in relation to the follow-up period. 
Interpretation of these tables should take into account that the patient 
population often diminishes as the follow-up period increases, and that the 
IOP decrease should always be related to the initial TOP in the subpopula-
tion examined after a certain time. 
Since for the results reported by Wise (1987) the initial IOP was not 
known for each subpopulation, the relative IOP decrease was determined pro-
ceeding from the initial IOP for the entire patient population (29.6 mm Hg). 
Tor the other studies, the relative IOP decrease was calculated on the basis 
of the initial IOP in the population involved. 
Both Tuulonen et al. (1985) and Schwartz et al. (1985) reported results 
indicating that the IOP decrease becomes somewhat less marked as the follow-
up period increases. That this phenomenon is not due to a lower initial IOP 
can be established by recalculation. In both studies, however, the patients 
with IOP decreases and the longest follow-up periods originated from subpop-
ulations significantly smaller than the original population. 
Pohjanpelto (1983) reported no diminishing tendency of the IOP decrease 
(either relative or absolute) with an increasing follow-up period. Wise 
(1987) found no diminishing tendency in the absolute decrease. 
An explanation of these differences poses problems. A striking difference 
between the population studied by Schwartz et al. (1985) and the other study 
populations lies in the fact that the majority of the glaucoma patients in 
the former study were of the negroid race. In this study a significant dif-
ference in success rate existed between the white and the negroid patients. 
The extent to which this applies also to the IOP decrease remains obscure. 
Another difference between the group who did and the group who did not 
show diminution of the IOP decrease is to be found in the initial IOP. The 
initial lOPs in populations with a diminishing tendency were 22.7 mm Hg 
(Tuulonen et al. 1985) and 24.8 mm Hg (Schwartz et al. 1985) respectively; 
those in the populations without a diminishing tendency were 27.6 mm Hg 
(Pohjanpelto 1983) and 29.6 mm Hg (Wise 1987) respectively. That a positive 
correlation exists between initial IOP and IOP decrease has already been 
noted and will be discussed in detail later. At odds with this is the fact 
that some authors report a lower success rate at higher initial lOPs 
(Schwartz & Kopelman 1983; Tuulonen et al. 1985; Moulin et al. 1987). 
136 
A third difference, finally, lies in inter-investigator differences in 
performing the Standard Wise ALT. 
The literature shows a fair consensus about the success rate (table 4.5). 
The success rate diminishes as the follow-up period lengthens. Schwartz et 
al. (1981, 1983, 1985) reported a success rate of 46.3% after a follow-up of 
5 years. It is to be noted that the white subpopulation had a success rate 
of 65%, while that of the negroid subpopulation was only 32% after 5 years. 
Using the Kaplan-Meier survival curve, Schwartz et al. calculated that the 
median time before an IOP exceeded 21 mm Hg was only 12 months in the ne-
groid, and 60 months in the white subpopulation. 
At odds with these findings are the results by Wise (1979, 1981, 1987), 
who found that the control rate (IOP less than 21 mm Hg) in negroid patients 
weis 75% after 6 years (9 out of 12 eyes), 87% after 7 years (7 out of 8 
eyes), 80% after 8 years (4 out of 5 eyes) and 100% (2 out of two eyes) af-
ter 9 and 10 years. However, Wise did confirm the diminishing tendency of 
the success rate. Nevertheless 7 out of 10 eyes treated are well-regulated 
after a follow-up of 10 years. 
An alternative way of defining the success rate of ALT is to look at the 
annual rate of filtering surgery within a department after introduction of 
ALT. Martenet & Schwarzenbach (1986) found that the rate of filtering sur-
gery during the first whole year after introduction of ALT diminished from 
96 to 59. Gilbert et al. (1986) found an annual rate of filtering surgery of 
16 before ALT was introduced; during the first year after introduction of 
ALT this rate was l, after 2 years it was 12 and after 3 years it was 18. 
The authors conclude from these findings that "...ALT may be effective in 
delaying the need for surgery, but in many cases it probably does not pre-
vent it...". Even though this conclusion may be quite correct in substance, 
two notes should be made: in this study the ALTs were performed by resi-
dents, which may have affected results (Khan et al. 1986), and the majority 
of patients treated were of the negroid race (75.0%). 
It may be mentioned in passing that the success rate of filtering surgery 
(91%, Schoenleber et al. 1987) is not unfavourable influenced by ALT. 
Several authors have compared ALT results with surgical results. In a ran-
domized prospective study Watson et al. (1984) compared the results of ALT 
with those of trabeculectcMy, using a modification of the Standard Wise ALT 
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by treating only one half of the trabecular meshwork, and the other half if 
necessary. Success was defined as a controlled IOP without further medica-
tion. After a follow-up of 6 months 10% of the ALT group required additional 
pressure-reducing surgery, while another 11.7% needed additional medication. 
In the trabeculectomy group only 6.3% required additional medication. In the 
ALT group the IOP decrease averaged 28.1% of an initial IOP of 28.8 mm Hg, 
while in the trabeculectomy group the IOP decrease averaged 51.3% of an ini-
tial IOP of 34.9 mm Hg. Watson et al. therefore concluded that, although ALT 
can effectively reduce the IOP, the IOP decrease is significantly less than 
that achieved by trabeculectomy. 
Grehn & Schildwächter (1987) performed a non-randomized prospective compar-
ative study of ALT and goniotrephination. They, too, used a modification of 
the standard Wise ALT by treating only one half of the trabecular meshwork 
in two sessions. The study was not randomized because the functionally most 
affected eye was operated on. After a follow-up of 3-29 months they found an 
IOP decrease of 18.9% of an initial IOP of 26.5 mm Hg in the ALT group, ver-
sus 46.1% of an initial IOP of 29.7 iran Hg in the goniotrephination group. 
The success rate in the ALT group was 51.3%, versus 90.9% in the goniotreph-
ination group. It should be pointed out that the ALT modification the used 
gives less good results - both in success rate and in IOP decrease - than 
the Standard Wise ALT (see 4.4). In the goniotrephination group cataracts 
developed in 4.5% of the patients and in 17.1% visual acuity was reduced by 
more than two lines; in the ALT group, no patient developed a cataract and 
visual acuity was reduced in only 6.9%. These authors concluded that gonio-
trephination is to be preferred if a marked IOP decrease is required (very 
high IOP or severe visual field defects) and that ALT is to be considered 
for eyes with still adequate vision. 
In a randomized prospective study Migdal & Hitchings (1984) compared the 
results of ALT, trabeculectomy and medication in newly diagnosed glaucoma. 
After a 6-month follow-up they found an IOP decrease of 44.0% in the ALT 
group and of 53.6% in the trabeculectomy group, given the same initial IOP 
(33.6 mm Hg). The success rates were 73.3% for the ALT and 100% for the tra-
beculectomy group. They concluded that ALT as well as trabeculectomy are el-
igible for primary therapy in glaucoma, but that the latter should be reser-
ved for the more advanced cases. 
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Wise (1987) rightly points out that ALT or trabeculectomy should be per-
formed before serious damage to the optic disk develops. He regards the two 
techniques as complementary, ALT being indicated in moderate glaucoma, es-
pecially in patients over 60, and trabeculectomy in advanced glaucoma with 
poor patient compliance and at an age under 60. 
To sumnarize: the results of the Standard Wise ALT (including the long-
term results) are fair, although the success rate tends to diminish somewhat 
with increasing time, and that the trend seons to be to carry out ALT in 
moderate glaucoma and resort to surgery in more advanced cases. 
4.3 COMPLICATIONS OF ALT 
Table 4.6 presents a survey of the most common complications of ALT. 
In virtually all cases mild anterior iritis characterized by a mild flare 
and cells occurs during the first week after ALT. This iritis generally dis-
appears within a week. Most patients thus treated are given corticosteroid 
eyedrops to use during the first week, but even without these the iritis 
disappears spontaneously (Thomas et al. 1982). 
Severe iritis develops only occasionally, the incidence generally being 
less than 1% (Wise 1981; Pohjanpelto 1983; Tuulonen & Airaksinen 1983a; Ber-
geâ 1984). In two out of 22 eyes treated (9%) Wilensky i Jampol (1981) ob-
served severe uveitis accompanied by an increased I0P and formation of peri-
pheral anterior synechiae. In both cases the uveitis disappeared only after 
months of local and/or systemic therapy. 
Haemorrhages occur in about 5% of cases; there is usually slight bleeding 
directly from the bum, but occasionally also from the area adjacent to the 
burn (Thomas et al. 1982). An additional burn at the site of the haemorrhage 
or slight pressure exerted with the contact glass generally stops bleeding 
(Wise 1981; Thomas et al. 1982; Schwartz & Kopelman 1983). The occurrence of 
haemorrhages is not related to the power setting nor to the presence or ab-
sence of blood in Schlemm's canal prior to treatment (Thomas et al. 1982). 
Reflux of blood from Schlemm's canal,'as postulated by Wise (1981) and Lich-
ter (1982), is therefore unlikely. Haemorrhages do not affect the I0P de-
crease or the success rate (Thomas et al. 1982; Schwartz s, Кореіліап 1983). 
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Some authors described the occurrence of epithelial corneal bums, which 
generally disappears within a few hours to days and have no apparent se-
quelae. Endothelial burns have not been observed. 
The incidence of formation of peripheral anterior synechiae (PAS) ranges 
from 0.7% to 47.1%. These PAS usually extend between iris and ciliary band 
and scleral spur but in a minority of cases may reach the trabecular mesh-
work. These are usually small, peak-shaped synechiae generally affecting 
less than 30e of the iridocorneal angle (Thomas et al. 1982; Lieberman et 
al. 1983). 
Several parameters have been tested with regard to the formation of PAS. 
Schwartz et al. (1981) found a correlation with a high ALT power setting, 
but others were unable to confirm this (Thomas et al. 1982; Traverso et al. 
1984a). There is no correlation between the formation of PAS and the degree 
of postoperative iritis (Thomas et al. 1982), width of chamber angle, number 
of burns, sex (Traverso et al. 1984a), age, type of glaucoma, preoperative 
medication, trabecular pigmentation and visible effect of burn (Rouhiainen 
et al. 1988a). 
Application of burns to the posterior part of the trabecular meshwork 
leads to a significantly higher PAS incidences (Hoskins et al. 1983; Kita-
zawa et al. 1984; Traverso et al. 1984a). Rouhiainen et al. (1988a) found 
PAS in 40.0% of cases combining posterior localization of bums with a high 
power setting (800 mW) and in 0% of the cases combining an anterior locali-
zation with a low power setting (500 mW). 
Rouhiainen et al. (1988a) found a less marked IOP decrease in eyes with 
PAS formation, but other authors failed to confirm this (Thomas et al. 1982; 
Moulin s. Haut 1983; Schwartz & Kopelman 1983; Traverso et al. 1984a). 
•me principal complication of ALT is the occurrence of an IOP increase af-
ter treatment. As table 4.6 shows, it was not until after some time that 
these IOP increases were identified as a complication of ALT. Wilensky s. 
Jampol (1981) and Thomas et al. (1982) were the first to point out these IOP 
increases and the risks entailed. Thomas et al. (1982) described in a case 
report how one of their patients with an IOP increase of 12 mm Hg developed 
a severe visual field defect with loss of central vision afterwards. 
The incidence of IOP increases depends on two essential parameters: the 
minimum IOP increase interpreted as significant, and the timing of the first 
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Ю Р check-up after ALT. The lower limit selected ranges from +1 mm Hg to +10 
mm Hg; the timing of the first check-up ranges from the first hour after ALT 
to a few days later. 
As experience with ALT increased and attention focused increasingly on the 
occurrence of IOP increases, more and more publications reported IOP in­
creases often occurring immediately after ALT. The table demonstrates that 
consistent early check-ups after ALT are imperative. After rearrangement of 
the IOP data it is evident that the high IOP increases occur immediately af­
ter ALT and that the first check-up after 1 day or later fails to detect 
many of these IOP increases: 
minimum IOP 
increase 
+1 mm Hg 
+1 mm Hg 
+5 to +10 
mm Hg 
time of first 
check-up 
1 hour 
1 day or later 
1 hour 
incidence 
70.0% 
56.1% 
42.1% 
25.3% 
24.0% 
14.8% 
9.2% 
33.0% 
26.2% 
21.1% 
3.8% 
(Weinreb et al. 1983a) 
(Krupin et al. 1984) 
(Frucht et al. 1985) 
(Thomas et al. 1982) 
(Lichter 1982) 
(Bergeá 1984) 
(Horns et al. 1983) 
(Lieberman et al. 1983) 
(Zborowski et al. 1984) 
(Frucht et al. 1985) 
(Firmström 1985) 
+5 to +10 1 day or later 16.0% (Smith 1984) 
mm Hg 14.4% (Pohjanpelto 1983) 
8.5% (Schwartz & Kopelman 1983) 
6.1% (Lieberman et al. 1983) 
Further analysis revealed that most IOP increases occurred within one hour 
of treatment, but that they also occur as late as 4-5 hours after ALT (Wein-
reb et al. 1983a; Krupin et al. 1984; Frucht et al. 1985). They may even oc-
cur much later (weeks) (Thomas et al. 1982; Schwartz & Kopelman 1983). 
Additional medical therapy, e.g. acetazolamide, mannitol intravenously or 
glycerol orally, is called for in view of an IOP increase in some 10-20% of 
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cases and generally produces an adequate decrease in IOP (Weinreb et al. 
1983a; Krupin et al. 1984; Frucht et al. 1985). 
The course of the IOP increase is generally mild, although very high IOP 
values have been reported. The majority of patients show a spontaneous de-
crease after some time (a few hours to about 3 weeks after ALT). 
It is difficult to establish how often permanent IOP increases occur. It 
is well known that IOP increases may occur which cause immediate danger and 
necessitate surgical intervention (Horns et al. 1983). The question whether 
after a certain interval a secondary IOP increase may occur as a result of 
ALT cannot be readily answered. The natural cause of glaucoma is gradual and 
an accelerated increase in visual field defects due to ALT can be measured 
only if the population treated is matched with a control group for glaucoma 
type, height of IOP, severity of optic disk damage, visual field defect, 
age, sex, medication used and duration of manifest glaucoma. Of course this 
poses difficulties in actual practice, quite apart from the fact that it 
would be unethical to deprive the control group of therapy, be it medica-
tion, surgery or ALT. The literature mentions an occasional instance in 
which an adequate IOP decrease was initially achieved but an IOP increase 
occurred after a certain interval (4 weeks; Tuulonen & Airaksinen 1983a). In 
these specific cases the IOP had increased to far above the initial IOP, and 
surgical intervention was necessary. The relatively brief interval between 
treatment and IOP increase indicates the possibility of a causal relation-
ship. 
None of the studies in which IOP was carefully registered (Lieberman et 
al. 1983; Weinreb et al. 1983; Krupin et al. 1984; Zborowski et al. 1984; 
Finnström 1985; Frucht et al. 1985) mentions resistant IOP increases. Per-
haps the early detection of these IOP increases and adequate therapy have 
played a role in this aspect. 
Thomas et al. (1982) and Weinreb et al. (1983a) each described a patient 
in whom severe progression of the visual field defect was believed to have 
followed an IOP increase. However Thomas et al. did not record this IOP in-
crease until after 3 days, and Weinreb et al. reported that the IOP " 
steadily increased to as high as 62 mm Hg ", but that the onset of the 
IOP increase was within one hour of completion. 
Hourly check-ups on the ICH» for a few hours after ALT sean to be ілц>ега-
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tive both for preventive and for therapeutic reasons. 
Some authors maintain that an IOP increase need not reduce the IOP reduc-
tion achieved nor the success rate (Thomas et al. 1982; Moulin s, Haut 1983; 
Bergeâ 1984; Krupin et al. 1984; Smith 1984; Tuulonen et al. 1985). Others, 
however, report a less marked IOP decrease and a lower success rate for eyes 
which showed an IOP increase in the immediate post-ALT phase (Weinreb et al. 
1983b; Zborowski et al. 1984). 
A number of factors have been tested for correlation with the occurrence 
of IOP increases. The literature is not always unequivocal in its conclu-
sions about each of these factors. Thus Krupin et al. (1984) found no sig-
nificant correlation between the power setting used and IOP increases, 
whereas Rouhiainen et al. (1987b) reported an increasing incidence with 
higher power settings (incidences 13%, 26% and 52% at power settings of 500, 
700 and 900 mW respectively). Rosenblatt ь Luntz (1987) demonstrated that 
the power setting used had been higher for the eyes showing IOP increases. 
Hoskins et al. (1983) found a lower incidence when fewer than 65 burns had 
been applied, but Krupin et al. (1984) found no correlation with the number 
of bums. 
A number of factors have been described as not being correlated with the 
occurrence of IOP increases: 'good' bum criterion (blanching, bubble, 
blanching and bubble; Rouhiainen et al. 1987b), age, iris colour, initial 
IOP, glaucoma type and number of agents used in preoperative medication 
(Robin et al. 1987). 
Other factors do seem to correlate with IOP increases. Keightly et al. 
(1987) reported a correlation between pre-ALT coefficient of facility of 
outflow, and the occurrence of post-ALT IOP increases. Specifically eyes 
with a coefficient of 0.20 μΐ/min/mm Hg or less were expected to show IOP 
increases. Eyes with higher coefficients, however, likewise showed IOP in­
creases. In other words, the sensitivity was reasonably high but specificity 
was low. 
Thomas et al. (1982) found that ALT of the trabecular meshwork in two 
sessions caused evidently fewer and less high IOP increases. Application of 
burns to the anterior part of the trabecular meshwork also led to fewer IOP 
increases (Kitazawa et al. 1984). Because these and other treatment varia­
bles have been tested for their effects on IOP decrease, success rate and 
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Ю Р increase, they will be discussed in a separate sections (4.4). 
Attempts to prevent occurrence of IOP increases with the aid of various 
eyedrops given as pre- and post-ALT medication, generally causes no decrease 
either of the incidence or of the height of IOP increases (tables 4.7 and 
4.8). Because there are often slight inflammatory reactions immediately af­
ter ALT, it seems logical to look for preventive agents in particular in the 
group of the antiphlogistics. 
Ruderman et al. (1983) found no significant difference in mean height and 
incidence of IOP increases between a group treated with corticosteroid eye­
drops and a group not so treated. 
Prostaglandins can cause a disturbance of the blood/aqueous barrier and an 
increase IOP (see 2.2.2.5). Laser applications in the eye disturb this bar­
rier (Schrems et al. 1983, 1985; Schrems 1985), and in theory a release of 
prostaglandins could be responsible for the IOP increase following ALT. Con­
sequently pre-ALT treatment with non-steroid anti-inflajranatory drugs, e.g. 
the prostaglandin synthetase inhibitors flurbiprofen and indomethacin, could 
influence the IOP increase; the more so because in animal experiments these 
agents have shown a barrier-stabilizing effect after laser therapy (Schrems 
1985). Unfortunately, neither flurbiprofen nor indomethacin proved to affect 
the incidence and height of post-ALT IOP increases in actual practice (Wein-
reb et al. 1984; Hotchkiss et al. 1984; Gelfand & Wolpert 1985; Pappas et 
al. 1985; Tuulonen 1985). These studies also show that IOP increases do not 
correlate with the severity of inflammatory symptoms (conjunctival redness, 
anterior chamber flare, anterior chamber cells) immediately after ALT. A 
striking finding was reported by Hotchkiss et al. (1984) and by Gelfand & 
Wolpert (1985); the group treated with the prostaglandin synthetase inhibi­
tors showed a significantly less marked IOP decrease than the group not so 
treated (significant after 1 month (Gelfand & Wolpert 1985) and after 1 day, 
1 week and 5 weeks (Hotchkiss et al. 1984)). Others were unable to confirm 
this difference (Pappas et al. 1985; Tuulonen 1985). 
Why do these agents have no reducing effect on the incidence and height of 
IOP increases? Several possible explanations present themselves (Hotchkiss 
et al. 1984; Pappas et al. 1985; Tuulonen 1985). To begin with there might 
have been a release of endogenous prostaglandins after all. Alternatively, 
after inhibition of prostaglandin synthetase another pathway of production 
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may be created and other prostaglandins released. Possibly, also, prosta­
glandins do not play a role in the pathogenesis of IOP increases, but debris 
causes a mechanical block at the level of the trabecular meshwork. Makabe 
(1988) found that the IOP increase is parallelled by a decrease in outflow 
of aqueous humour. Possibly, also, other substances may play a role, e.g. 
histamine, 5-hydroxytryptamine, norepinephrine, slow-reacting substance of 
anaphylaxis, substance Ρ or cyclic AMP. Finally, the fact that treatment 
with these substances sometimes causes a less marked IOP decrease might in­
dicate that the trabecular meshwork needs a certain amount of prostaglandins 
(Hotchkiss et al. 1984). This is consistent with what has been pointed out 
in 2.2.2.5: small doses of prostaglandins have an ocular hypotensive effect. 
It seems obvious that this could play a role in the early post-ALT phase, 
but how to explain the difference in IOP decrease after l month, when pros­
taglandin synthetase inhibitors are no longer used? 
Ofner et al. (1984) found an unmistakable decrease both in incidence and 
height of IOP increase after post-ALT administration of a 4% pilocarpine so­
lution. Nevertheless, an IOP increase also occurred in 36.3% of the pilocar­
pine treated cases. Use or non-use of miotics by the patients prior to ALT 
is not specified in this study. The reducing effect of pilocarpine may be 
suggestive of a mechanical basis of the IOP increase. 
Another agent with an unmistakable reducing effect is the Clonidine deri­
vative ALO 2145 [2-(4-amino-2,6-dichloro)-phenylimino-imidazolidine] - an ^ г 
agonist (Robin et al. 1987; Brown et al. 1988). Clonidine reduces the blood 
supply to the ciliary body, thus causing hyposecretion of aqueous humour. 
After a one-month follow-up Robin et al. (1987) found no difference between 
the treated and untreated group, and results may therefore be described as 
encouraging. Brown et al. (1988) on the other hand found a significantly 
lower IOP in the placebo treated group at one week, but ascribe this differ­
ence to the fact that additional therapy was often necessary in the placebo 
treated group. Wether other * 2 agonists have a function in this respect and 
wether ALO 2145 can assume a position among other hypotensive medications, 
are questions which may possibly be answered in the future. 
Apart from the above described ALT modifications and substances influen­
cing the IOP increase, and a few other factors, it seems impossible to pre­
dict which patient or eyes are at risk to develop an IOP increase. Our pros-
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pective study of ocular and extraocular factors which may play a role in 
this respect, may provide further information on this question. 
4.4 TREMMENT VARIABLES 
Application of technical ALT parameters other than those used by Wise 
serves a dual purpose. To begin with, it might be possible in this way to 
reduce both the incidence and height of the IOP increases. Moreover, other 
ALT techniques (ALT modifications) might lead to better results. 
On theoretical grounds, several ALT modifications are eligible. For the 
parameters directly related to ALT, the following alternatives may be con-
sidered: 
- bum localization: anterior, posterior, pigmented trabecular meshwork, 
scleral spur and ciliary band; 
- number of sessions in which ALT is craiçleted: one or two ; 
- part of the trabecular meshwork circumference treated: 90°, 180°, or 360°,· 
- bum diameter: 50 \m or otherwise; 
- exposure time: 0.1 sec or otherwise; 
- total number of bums: 25, 50 or 100; 
- power setting: 1000 mW or otherwise. 
Various combinations of these parameters afford a total of 720 different 
possibilities of performing ALT. Should we also include use or non-use of 
pre- or post-ALT medication, type of laser (Argon blue, Argon blue-green, 
Krypton, YAG), iris stretching and the contact glass used (Goldmann three 
mirror contact lens or Ritch ALT lens) then the total would increase to 
23,040. 
Of course not all combinations are sensible. It makes no sense, for in-
stance, to perform treatment of 90° of the trabecular meshwork circumference 
with 100 bums of 100 \m diameter at a power setting of 2000 mW and an expo-
sure time of 0.2 sec. 
Table 4.9 lists the most commonly used ALT modifications with the corre-
sponding IOP decreases and success rates. The trend of these ALT modifica-
tions as compared with the Standard Wise ALT is to treat a smaller part of 
the trabecular meshwork circumference or, if the entire circumference is 
146 
treated, to do this in two sessions. The total energy invested (number of 
burns χ exposure time χ power) virtually never exceeds 15 Joules. 
For the reasons presented in 4.2.1 and in view of the fact that several 
different ALT modifications are involved, it is difficult to compare these 
modifications. It is more sensible to establish how the results of the vari­
ous modifications compare with those of the Standard Wise ALT. 
In most cases the Standard Wise ALT gives an IOP decrease by at least 20% 
(see table 4.2). Also in view of the mean height of the initial IOP (about 
25 mm Hg), a decrease by 20% would seem to be the minimum which an ALT modi­
fication should produce. Other authors agree with us (Lichter 1982; Hoskins 
et al. 1983; Traverso et al. 1986). In addition, a minimum success rate of 
60% should be achieved. 
Table 4.9 shows that most ALT modifications fulfil these criteria, al­
though there are a few exceptions. One-session treatment of only 90° of the 
trabecular meshwork circumference leads to a small IOP decrease and a low 
success rate (Schwartz et al. 1983). Although Wilensky s, Weinreb (1983a) 
found an IOP decrease by 22.7%, this could be counted as success in only 
47.6% of the cases. The 22.7% IOP decrease was small if related to the ini­
tial IOP (29.9 mm Hg). Additional treatment of another 90° led to an addi­
tional IOP decrease (total IOP decrease 31.4%) and raised the success rate 
to 66.7% (Wilensky t, Weinreb 1983a). Nevertheless, ALT over only 90° is 
sometimes sufficient to control glaucoma (Lehmann s, Faggioni 1986). If com­
pared with one-session ALT over 180°, this two-session treatment possibly 
causes a somewhat smaller IOP decrease and lower success rate (Grehn ь 
Schildwächter 1987). 
A power setting of less than 500 mW gives a smaller IOP decrease and a 
lower success rate (Rouhiainen & Teräsvirta 1986; Rouhiainen et al. 1987a). 
A factor of importance in this respect is the exposure time and therefore 
(indirectly) the total energy invested in ALT. Whereas Rouhiainen et al. 
(1987a) achieved a maximum success rate of 50.0% with a power setting of 500 
mW, Blondeau et al. (1987) achieved a success rate of 100% with this set-
ting. However, the total energy invested by Rouhiainen et al. was 3 Joules 
at the maximum, versus a total of 10 Joules invested by Blondeau et al. If 
the power setting is at least 500 mW, however, than Rouhiainen et al. 
(1988b) found no differences in IOP decreases at 500, 600, 700 or 800 mW. 
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A spot size of only 25 цт gave an IOP decrease by only 18.5% (Schwartz et 
al. 1983). It should be borne in mind, however, that the initial IOP was low 
(21.3 mm Hg). The success rate (60.0%) was likewise rather low. 
Application of burns to the ciliary band generally gives good results, ex­
cept with the ALT modification used by Reibaldi et al. (1985); they applied 
more than 100 burns with a diameter of 200 \m and achieved a successful IOP 
decrease in only 26.7% of cases. This may have been due to the composition 
of the patient population (patients with wide peripheral and total iridec­
tomies, aniridia). 
The low success rates of the ALT modifications used by Kitazawa et al. 
(1984) were probably based on the fact that the success criteria were stabi­
lization of the visual field defect and an ultimate IOP below 20 mm Hg. 
Moreover, the total energy invested in the one-session treatment of the pos­
terior trabecular meshwork with 100 burns was rather high (20 Joules). 
TO sunmarize : most ALT modifications yield good results if: at least 180° 
of the trabecular meshwork circumference is treated, the power setting is at 
least 500 nW, and the total energy invested is at least 3 Joules (Rouhiainen 
i Teräsvirta 1986), but on the other hand should not exceed a maximum (prob-
ably 20 J). 
Two ALT parameters seem to exert a significant influence on the occurrence 
of post-ALT IOP increases: treatment of maximally 180° of the trabecular 
meshwork circumference in one session, and application of burns to the an-
terior part of the trabecular meshwork (table 4.10). 
Distribution of ALT over two sessions does not significantly affect the 
total incidence of IOP increases but does influence the mean height of these 
increases. Thomas et al. (1982), for instance, found a total incidence of 
25.2% for one-session ALT and 25.4% for two-session ALT. The distribution, 
however, was such that higher IOP increases (>5 or 10 mm Hg) occurred more 
frequently in the one-session group. Heijl (1984) reported that the height 
of the IOP increase exceeded 5 mm Hg in 4 out of 8 eyes in the one-session 
group, and in 3 out of 8 eyes even exceeded 15 mm Hg, whereas 6 eyes in the 
two-session group showed an IOP increase not exceeding 5 mm Hg. 
The time at which the maximal IOP increases occurs was distinctly earlier 
in the group treated over only 180° (mean interval after ALT 1.55 hr) than 
in the group treated over 360° (mean interval after ALT 3.5 hrs) (Weinreb et 
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al. 1983a). The proportion of eyes requiring additional medication in view 
of an IOP increase was also higher in the 360° group than in the 180° group 
(Weinreb et al. 1983a). 
Application of bums to the anterior part of the trabecular meshwork also 
reduces the height of the IOP increase, but on the other hand clearly influ-
ences the incidence of IOP increases (Schwartz et al. 1983; Kitazawa et al. 
1984). 
As already pointed out in 4.3, there is a correlation between the power 
setting used and the occurrence of IOP increases (Rouhiainen et al. 1987b). 
A lower power setting gives fewer IOP increases. On the other hand, however, 
it may also give a less marked IOP decrease and a lower success rate. 
It may be stated in sunmary that, in terms of incidence and height of any 
ICH» increases, ALT modifications treating the anterior trabecular meshwork 
in two sessions are to be preferred to the Standard Wise ALT. 
Table 4.11 lists the various lasers which have been tested for efficacy in 
laser trabeculoplasty. To summarize: the Argon green and Argon blue-green 
lasers give statistically significant better results than the Krypton laser 
(Makabe 1986) and also (but not significantly) better results than the YAG 
laser (Martenet & Schwarzenbach 1986). 
The Krypton laser initially causes an IOP decrease, but this effect is 
transient. After 3 months the IOP has returned to the initial value (Makabe 
1986). Spumy & Lederer (1984) found no difference in IOP decrease between 
the Krypton red/yellow and the Argon blue-green laser, but it should be 
noted that these results were recorded after a follow-up of 1-10 months and 
that the control group treated with the Argon laser was a selected popula-
tion (contralateral eyes of patients already treated unilaterally with the 
Krypton laser) and therefore a source of bias. According to these authors an 
advantage of using a Krypton laser lies in deeper penetration of the trabec-
ular meshwork as a result of less absorption in the pigmented endothelial 
cells of the trabeculae. However, if the tightening effect postulated by 
Wise does indeed play a role in the mechanism of action of ALT, then this 
should be a disadvantage rather than an advantage. 
In the case of a narrow iridocorneal angle (or beak-shaped angle) as a re-
sult of a 'plateau iris', ALT may be preceded by iris stretching (iridoplas-
ty or gonioplasty). For this purpose larger bums O100 \m) are applied to 
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the peripheral iris. The technical details of iris stretching given in vari-
ous studies vary somewhat: 6-12 spots, 50-100 (im, 0.1 sec, 750-1000 mW (Lie-
berman et al. 1983), 80-100 spots, 100 \m, 0.1 sec, 400-600 mW in several 
sessions (Reibaldi et al. 1985), or 50 spots, 200 \m, 0.2 sec, 700 mW in two 
sessions (Wishart et al. 1987). 
The majority of authors report that iris stretching preceding ALT has no 
untoward effect on the result (Thomas et al. 1982; Lieberman et al. 1983; 
Reibaldi et al. 1985; Traverso et al. 1986). Only Wishart et al. (1987) re-
ported very poor results in a prospective comparative study of the results 
obtained by various techniques to reduce IOP in narrow-angle glaucoma. Half 
the patients (N=8) treated by iris stretching preceding ALT developed syn-
echial closure of the anterior chamber angle. We believe that a possible 
cause of these disappointing results may be found in the patient selection 
in this study: just patients with narrow angle glaucoma and a axial anterior 
chamber depth of less than 2.5 mm were submitted to iris stretching, while 
iris stretching is indicated in eyes with a narrow angle due to a plateau 
iris and normal anterior chamber depth. Furthermore, their technique dif-
fered somewhat, because per session, 180° of the trabecular meshwork circum-
ference was treated (high maximum energy possible, because in half of the 
eyes treated a 0.2 sec exposure time and a spot size of 100-150 \m was used) 
and 180" of the iris (maximum energy 3.5 Joules). This means that the total 
energy invested after the first session could be high, while the second half 
was left untreated and thus leaving the angle narrow, other authors needed 
only 6 Joules (Reibaldi et al. 1985) or 12 Joules (Lieberman et al. 1983) 
for treatment of 360° of the trabecular meshwork and iris. 
Another treatment variable is the experience of the person performing the 
ALT. Using multiple step-wise logistic regression analysis, Tuulonen et al. 
(1985) found that one of the factors enhancing the chance of a successful 
ALT is its performance by a person experienced in this technique. Khan et 
al. (1986) found that the IOP decrease in eyes with POAG following ALT per-
formed by residents was 22.9% of an initial IOP of 24.0 mm Hg, which is a 
rather small decrease. Brodell et al. (1986) found an IOP decrease by 34.2% 
of an initial IOP of 29.8 mm Hg following ALT performed by residents. This 
result does not differ from the results obtained by more experienced inves-
tigators. It seems likely, however, that any n surgical procedure, es-
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pecially one as delicate and precise as ALT, has a learning curve. Eventual 
mastery of a procedure is always preceded by inexperience n (Khan et al. 
1986). 
In conclusion, an optimal ALT has the following characteristics: treatment 
of 360" of the anterior trabecular meshwork circumference in two sessions 
separated by an interval of about 4 weeks, using a total of 120 bums with a 
spot size of 50 pm, an exposure time of 0.1 sec and a power setting which, 
dependent on the degree of pigmentation among other things, causes blanching 
and/or bubble formation. The ALT should be performed with a Argon Continuous 
Wave Laser, and check-ups for IOP increases should be carried out throughout 
a few consecutive hours following ALT. After-treatment consists of cortico-
steroid eyedrops. The effect of ALT should be watched during about 4 weeks 
after intervention. 
The reason for adding a second session even though the first may have pro-
duced an IOP decrease is twofold. To begin with, a 360° ALT causes a more 
marked IOP decrease than a 180° ALT, although this difference is seldom sta-
tistically significant (Schwartz et al. 1983; Lustgarten et al. 1984). Elsâs 
(1987) found a significant difference in success rate between 180° ALT (15%) 
and 360° ALT (69%) as primary therapy. Secondly, Wise (1987) examined fol-
low-up on more than 1700 ALT patients and found the optimal number of spots 
to be about 120. Not everyone agrees with this. Rouhiainen & Teräsvirta 
(1988) belief that one should treat just 180° of the trabecular meshwork, 
and treat the other half if a late failure has occurred. 
Apart from the previously described empirical reasons for treating the an-
terior part of the trabecular meshwork, this localization is theoretically 
also preferable to a more posterior localization. As pointed out in 2.2.2.1, 
this part of the trabecular meshwork comprises only the uveal strands, which 
form large diamond-shaped meshes. This part does not really participate in 
the active drainage of aqueous humour to Schlemm's canal, and destruction of 
trabeculae (as a result of ALT) therefore does not interfere with a system 
of essential importance in the outflow of aqueous humour. 
Because a minimum energy level is required to achieve an adequate IOP de-
crease, the power setting should be sufficiently high. Good criteria for in-
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dividual titration of this power are blanching and bubble formation. That 
high energy investments correlate with more Ю Р increases has to be accepted 
for the sake of the result. 
Different values for the Standard Wise ALT parameters spot size and expo­
sure time do not contribute essentially either to the result or to the inci­
dence of IOP increases; these parameters therefore remain unchanged. 
That Argon Continuous Wave Laser is preferable to lasers with other wave­
lengths has already been discussed. 
It should be emphasized that a standard ALT protocol - regardless of the 
ALT modification used - should always include early and intensive IOP check­
ups. As pointed out, this is certainly of preventive and possibly also of 
therapeutic value. Corticosteroid eyedrops following ALT serve to prevent 
severe iritis and also contribute to the swift disappearance of the mild 
iritis observed in virtually 100% of cases. As already pointed out, there is 
no consensus on this subject and prescription of corticosteroids is not an 
obligatory feature of the standard protocol. 
In view of the fact that the prostaglandin synthetase inhibitors flurbi­
profen and indomethacin have unfavourably affected the IOP decrease in a 
number of reported cases, these should not be given after ALT. 
ALO 2145 (see 4.3) seems to have a reducing effect on the incidence and 
height of IOP increases, but requires further clinical investigation. 
4.5 PATIENT VARIABLES 
As tables 4.2 and 4.9 indicate, the IOP decreases and success rates repor­
ted in various studies vary considerably. This may in part be explained by 
differences in ALT modifications used, but on the other hand there should be 
factors explaining differences despite similar ALT modifications. Moreover, 
there must be variables which affect the ALT results, because a consistent 
100% success rate is never achieved. That these variables are often ocular 
and extraocular patient variables will be discussed in this section. 
Tables 4.12 and 4.13 indicate wether the authors listed discovered a cor­
relation between success rate and IOP decrease respectively, and some obvi­
ous patient variables. Again we must take the reservations mentioned in sub-
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section 4.2.1 regarding comparison of literature data. 
A superficial perusal of these tables reveals two striking aspects. To be-
gin with, there is no consensus in the literature regarding the majority of 
the variables. Secondly, by no means all investigators have tested the pa-
tient population treated for these variables, although most investigators 
studied their material intensively. 
The publications listed show that sex does not affect either IOP decrease 
or success rate and (although this is mentioned only once) that there seems 
no difference in success rate between right and left eyes. 
There is also consensus about the correlation between initial IOP and IOP 
decrease. Without exception it is observed that a higher initial IOP gives a 
more marked decrease in IOP. For some of the studies listed table 4.14 indi-
cates the correlation between IOP decrease and either mean initial IOP 
(MIIOP) or range of initial IOP values (RIIOP). The coefficients of correla-
tion found vary rather widely: 0.335 (Traverso et al. 1987), 0.363 (Traverso 
et al. 1986), 0.68 (Grinichi et al. 1987), 0.73 for white and 0.75 for ne-
groid patients (Krupin et al. 1986) and 0.848 (Bergeà 1984). The following 
question now arises in this context: is the IOP decrease achieved at a high 
initial IOP sufficient to describe an ALT as successful? Proceeding from the 
criterion that the ultimate IOP should be lower than, say, 22 mm Hg than an 
IOP decrease by 20 mm Hg from an initial IOP of 45 mm Hg would have to be 
described as a failure. If only the criterion of a certain IOP decrease is 
applied (e.g. a decrease by at least 20% of the initial value), than this 
should be described as exceedingly successful. 
We believe that the success and failure criteria should be adapted to the 
indication for ALT therapy. Then the IOP decrease in the above case would be 
insufficient in a patient with already advanced visual field loss, but cer-
tainly adequate if the ALT had been performed prior to a cataract extrac-
tion. Some flexibility in this context is required, not in order to enhance 
the success rate but in order to establish whether the desired post-ALT sit-
uation is in fact achieved. 
Safran et al. (1984) found that the initial IOP of the successfully 
treated eyes was significantly lower than that of failure eyes. Tuulonen et 
al. (1985) likewise found that the success rate was correlated with the ini-
tial IOP, but noted rightly that flexibility in this respect is recommenda-
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ble. Moulin et al. (1987) found a lower success rate for eyes with an ini-
tial IOP in excess of 28 mm Hg. 
Striking findings were reported by Schwartz s, Kopelman (1983) and Schwartz 
et al. (1985). After a maximum follow-up of 4 years they found an unequivo-
cal correlation between success rate and initial IOP, whereas after a 6-year 
follow-up this correlation was no longer significant. Because the study pop-
ulation diminished in size as the duration of follow-up increased, interpre-
tation of this finding is difficult. It may be that the range of initial 
lOPs is smaller as the follow-up advances because eyes with a high initial 
IOP are more likely to be deemed failures and eliminated from the further 
follow-up. This would mean that the mean initial IOP remains fairly constant 
but that eyes with truly high initial IOP select themselves out and cloud 
the correlation between initial IOP and success rate. 
Zborowski et al. (1984) found no correlation between initial IOP and suc-
cess rate at an initial IOP limit of 30 mm Hg; Bergeâ (1986a) found none at 
an initial IOP limit of 28 mm Hg, and Lehmann & Faggioni (1986) found none 
at an initial IOP limit of 25 mm Hg. 
The effect of the degree of pigmentation of the trabecular meshwork on IOP 
decrease and success rate is controversial. Tuulonen et al. (1985) found no 
correlation between success rate and degree of pigmentation. Bergeâ (1986a) 
found that complete absence of pigment in the chamber angle (TP 0 in the 
classification of Scheie (1957), see also 3.3) clearly reduced the success 
rate, but that the amount of pigment present (TP+1 to TP+3) did not signif-
icantly affect the success rate. The latter also applied to the IOP decrease 
(Bergeâ 1984). Traverso et al. (1986) on the other hand found a more marked 
IOP decrease in the eyes showing most pigmentation. Since only a few groups 
were involved here, no far-reaching conclusions should be drawn from these 
findings (Traverso et al. 1986). Grinichi et al. (1987) found no correlation 
between degree of pigmentation and IOP decrease, but this must have been due 
in part to the gross pigmentation classification (lightly pigmented versus 
more heavily pigmented). Rouhiainen et al. (1988b) found a statistically 
significant greater IOP decrease in eyes with a heavily pigmented trabecular 
meshwork, but these results are probably biased because a heavily pigmented 
trabecular meshwork occurred more frequently in eyes with pseudo-exfoliation 
glaucoma, whose IOP decrease was greater then that in eyes with POAG. 
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No difference in IOP decrease was found between hyperopic and щуоріс eyes 
(Traverso et al. 1986). High myopia (-6.25 diopters or more) gave a less 
marked IOP decrease, but the difference was not statistically significant 
(Traverso et al. 1987). 
Remarkably little is known about the correlation between IOP-reducing med­
ication and ALT results. Tuulonen et al. (1985) found that, in general, eyes 
given no medication respond better to ALT. This is also apparent from the 
fact that ALT as primary therapy gives very good results. More specifically, 
Tuulonen et al. found that pilocarpine unfavourably influenced ALT results. 
Timolol and carbonic anhydrase inhibitors had no significant effect on suc­
cess rate. Rouhiainen et al. (1988b) found on the other hand, that the pre-
ALT used glaucoma medication (i.e. pilocarpine, timolol, pilocarpine and ti­
molol, pilocarpine and timolol and acetazolamide, or other combinations) did 
not statistically significantly influence the amount of IOP reduction after 
ALT. since these correlations are reproducible, they will be given attention 
in the discussion of the results in our own patient population. 
Skin colour does not significantly affect either success rate or IOP de­
crease. The colour of the iris (a factor related to skin colour) likewise 
has no effect on these parameters. Schwartz & Kopelman (1983) and Schwartz 
et al. (1985) are an exception to this rule. After a maximum follow-up of 4 
years they found no significant difference in success rate between white and 
black patients, but after a follow-up of 6 years the negroid patients had a 
distinctly lower success rate than whites, and patients with blue irides had 
better results than those with brown irides. wise (1987), however, reported 
unmistakably better results for black patients, and in fact results slightly 
better than those for the entire population. 
One might suppose that the duration of follow-up is of influence. Schwartz 
et al. (1985) calculated a median time until the IOP returns back to 21 mm 
Hg or over, and found this to be 12 months for black and 60 months for 
whites. Wise (1987), however, reported much better results in his black pa­
tients after a follow-up of up to 10 years after ALT. How these differences 
should be explained remains obscure. 
In view of the data in the tables there seems to be no consensus about the 
correlation between age on the one hand, and success rate and IOP decrease 
on the other. There are two limitations, however, which play a role in des-
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cribing this correlation. Firstly, the numbers of eyes of patients below a 
certain age (e.g. under 40) are generally small. Leydhecker (1979) estimates 
that only one out of 500 adult glaucoma patients is under 30. These small 
numbers have repercussions on statistical analysis. Moreover, it should be 
realized that the age limit used in demonstrating a correlation is of impor-
tance, and that this is not a uniform parameter in the literature: 40 years 
(Thomas et al. 1982), 55 (Zborowski et al. 1984), 60 (Schwartz & Kopelman 
1983; Moulin & Haut 1983). Comparing mean ages of failure patients and suc-
cess patients (Rouhiainen et al. 1987a), large populations are needed to 
demonstrate a statistically significant difference. 
With the exception of the studies of Tuulonen et al. (1985) and Rouhiainen 
et al. (1987a), with insufficiently accurate documentation of these data, 
published reports indicate that the success rate increases with increasing 
age. The same applies to the IOP decrease. The above described limitations 
dictate that these correlations are not always statistically significant, 
but do always indicate a trend. 
The why of this correlation with age is not clear. Safran et al. (1984) 
suppose that glaucoma is the same disease entity at an early as at a more 
advanced age but that the pathogenetic mechanism may differ. In my opinion 
another aspect also plays a role: the ageing process of the trabecular mesh-
work (see 2.2.2.6). Apart from the changes in the glaucomatous trabeculae 
there is no reason to assume that this normal ageing process should not play 
a role. Since changes in POAG and ageing changes in the trabecular meshwork 
show marked similarities and the effect of ALT is certainly at least partly 
produced via the tightening process postulated by Wise, this aspect must 
play a role. 
Another factor undoubtedly involved is the severity of glaucomatous damage 
at the time of the ALT. Traverso et al. (1986) found that the progression of 
visual field defects was higher as more damage had already been inflicted, 
even though the IOP decrease in this group did not differ from that in the 
group with less glaucomatous damage. Wise (1987) found that the surgery rate 
was 51% for eyes with advanced cupping (cup/disk ratio = 0.9 or higher), 
versus 16% for eyes with cup/disk ratios of less than 0.9. The eyes with ad-
vanced cupping showed progressive visual field loss after ALT despite the 
fact that the IOP had been normalized. The implications have already been 
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discussed (see subsection 4.2.3). 
A final factor not included in the tables is the influence of glaucoma 
surgery on the ALT results. It may be assumed in general that a single pres-
sure-reducing operation has only a minimal effect on the ALT result (Thomas 
et al. 1982; Da3ce i Bos 1983; Elsas & Karstadt 1983; Lieberman et al. 1983; 
Schwartz & Kopelman 1983; Tuulonen & Airaksinen 1983b). Two or more opera-
tions have an unmistakable unfavourable effect on the success rate (Lieber-
man et al. 1983). 
Remarkably few data are available on the type of operation in relation to 
the ALT result. Only Thomas et al. (1982) adequately describe the type of 
pressure-reducing surgery performed prior to ALT. This, too, is one of the 
aspects considered in the discussion of our own results. 
Fellman et al. (1984) report that, after trabeculectomy failure, 67% of 30 
eyes (25 patients) subsequently treated by ALT showed no further visual 
field loss after an average follow-up of 14 months. A striking finding was 
that some patients (20%) showed no progression even though the IOP was un-
changed after ALT. A factor of possible influence in this respect is that 
ALT exerts a significant influence on various parameters of the diurnal 
rhythm, and reduces mean daily pressure, peak pressure, pressure range and 
minimal pressure (Greenidge et al. 1983). Inversely, progression has also 
been observed despite an IOP decrease after ALT. This is not so very unusu-
al, because it has also been described after pressure-reducing surgery and 
medication (see 3.5.4.4). 
4.6 ALT AND VISUAL FIELD 
The influence of ALT on two aspects of visual field loss has been studied. 
An IOP decrease following ALT does not lead to an improvement of the visual 
field defect (Heijl s. Bengtsson 1984; Holmin & Bauer 1984). Both studies 
used a so-called performance value, i.e. the sum of threshold values recor-
ded on 64 test points (Competer computerized perimetry). Although an ade-
quate IOP decrease was achieved, there was no significant change in perfor-
mance value after a follow-up of one month. The occurrence of IOP increases 
after ALT resulted in an increases or a decrease of this performance value, 
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but on average no changes occurred (Heijl ь Bengtsson 1984). 
Studies of this type give little information on the ALT results but much 
about the correlation between IOP and visual field defects. An TOP decrease 
causes no improvement in performance value. 
The long-term effect of ALT on visual field defects can be described as 
follows. After a 12-month follow-up Schultz et al. (1987) found that 5 out 
of 19 eyes (26.3%) showed exacerbation of the visual field defect (OCTOPUS 
computerized perimetry). significant differences in IOP parameters were 
found between eyes that did and those that did not show exacerbation of vis­
ual defects: mean pretreatment IOP 30.0 versus 24.3 mm Hg (p=0.033), mean 
highest recorded posttreatment IOP 28.0 versus 21.3 mm Hg (p=0.057), varian­
ce of posttreatment IOP reading 25.1 mm Hg versus 5.8 mm Hg (p=0.044). 
Traverso et al. (1986) likewise found increased visual field loss in 28.3% 
of cases (OCTOPUS computerized perimetry; 113 eyes; follow-up 3-22 months). 
Prost et al. (1987) found stabilization of visual field defects in 30% of 
the eyes and improvement in 55% (OCTOPUS 2000 automatic perimetry; 20 eyes; 
follow-up 12 months). 
To sunmarize: the risk of progression of visual field defects increases as 
the initial IOP is higher, a higher peak pressure occurs after ALT, and con­
siderable damage already exists. In addition it should be borne in mind that 
follow-up data on perimetry still cover only a limited period as compared 
with those on glaucoma treated by medication or surgery. 
4.7 RETREAIMENT 
Table 4.15 lists the results reported by various authors with regard to 
retreatment after failure of ALT. 
Most authors describe the results of retreatment in patients who showed a 
good initial response to ALT and developed an IOP increase only after a 
longer time (late failures). Bergeâ (1986b) also describes results of re-
treatment after early failure (within 2 months). 
The success rate of retreatment is lower than that of initial ALT. Depen-
dent on the success criteria applied, it ranges from 32.5% to 60.0%, but in 
the majority of cases it is about 35%. A more important finding than the 
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success rate, in my opinion, is the risk that a patient has to have pres-
sure-reducing surgery after retreatment. This risk is about 50%, which is 
fairly high (Messner et al. 1987; Richter et al. 1987). 
The chance that retreatment will successfully reduce TOP is smaller after 
early than after late failures. Retreatment proved successful in 11 out of 
16 late failures (68.8%), and in only 1 out of 4 early failure eyes (Bergeâ 
1986b). 
The median time to failure was calculated with the aid of Kaplan-Meier 
survival analysis and proved to be 9 months (Richter et al. 1987). Calcula-
ted with the aid of life-table analysis it was 12.3 months (Bergeâ 1986b). 
Both values are evidently below the 60 months calculated after an initial 
ALT (Schwartz et al. 1985). 
The ЮР decrease following successful retreatment is of the same order as 
that after an initial ALT: 10.4 mm Hg (Brown et al. 1985b), 7.1 mm Hg (Ber­
geâ 1986b), 8.1 mm Hg (Richter et al. 1987). Bergeâ (1986b) found no statis-
tically significant difference in IOP decrease between eyes given retreat-
ment over 360° (7.8 mm Hg) and those given retreatment over 180° (6.6 mm 
Hg). After recalculation in terms of relative IOP decrease this amounts to a 
decrease by 28.0% of an initial IOP of 27.9 mm Hg after retreatment over 
360°, and 22.4% of an initial IOP of 29.6 mm Hg after retreatment over 180°. 
Again the trend is evident: 360° ALT gives a more marked decrease. 
Richter et al. (1987) found that results tended to be better after re-
treatment of the nasal than after that of the inferior trabecular meshwork, 
better in phakic than in aphakic eyes, and better in eyes given the initial 
360° ALT in two sessions than in those initially treated by 360° ALT in one 
session. However, none of these differences was statistically significant. 
IOP increases are again the principal complication following retreatment. 
The incidence depends on the criteria applied to interpret an IOP increase 
as significant, and ranges from 0% (Messner et al. 1987; Richter et al. 
1987) to 38.5% (Brown et al. 1985b). Brown et al. (1985b) reported that 
38.5% of retreatjnent eyes showed an IOP increase by 1 mm Hg or more, while 
11.5% showed an increase by more than 10 mm Hg. Retreatment was by a two χ 
180° ALT modification. Eight of the 10 eyes with IOP increase involved show­
ed increased optic nerve damage and visual field loss and required surgery 
within a month of retreatment. It should be noted, however, that post-re-
159 
treatment Ю Р check-ups were not done until after one day, and that it could 
not be established whether the IOP increases occurred after the first or af­
ter the second retreatment session. Nevertheless this incidence of IOP in­
creases, and certainly that of pressure reducing surgery, is very high. 
Starita et al. (1984a) found an IOP increase by at least 10 mm Hg in 29.4% 
of cases, in the majority within one hour of retreatment (one-session ALT 
over 360* of the trabecular meshwork circumference). 
Richter et al. (1987) treated only 180° of the trabecular meshwork circum­
ference in one session and after this retreatment observed no IOP increases 
exceeding 6 mm Hg; they had no need for pressure-reducing surgery in view of 
an IOP increase. 
Messner et al. (1987) performed ALT over 360° in one session but applying 
only 50 burns, and found no IOP increases in excess of 10 mm Hg. 
Retreatment over only 180° of the trabecular meshwork circumference or 
with only 50 burns distributed over the entire circumference thus gives a 
lower incidence and height of any IOP increases. 
To sunmarize: the chance of success is significantly lower after retreat-
ment than after initial ALT; in the case of success the IOP decrease is not 
less marked; the ocular hypotensive effect after retreatment persists less 
longer than that after an initial ALT; some 50% of eyes require pressure-re­
ducing surgery after retreatment; limitation of the number of bums or of 
the distance over which the trabecular meshwork is treated entails only a 
small risk of severe IOP increases. 
4.8 ALT AND ITS EFFECT ON MEDICAL CCHTROL OF ШШСОМА 
Table 4.16 presents data on the possibility of reducing or discontinuing 
ocular hypotensive medication after successful ALT. 
The range of percentages reported for reduction or discontinuation of 
glaucoma medication is partly explained by the fact that most authors, es­
pecially in retrospective studies, use no standardized protocol in this re­
spect. Since the success criteria vary widely, the chance of reduced medica­
tion also varies in the various studies reported. 
In most of the prospective studies the investigators wants to measure the 
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true pressure-reducing effect of ALT, and this implies that as many varia-
bles as possible are left unchanged. Of course changed medication is a high-
ly disturbing variable in this context. 
However, some general conclusions seems justifiable. In a substantial per-
centage of cases it is possible to maintain proper IOP control after ALT 
with reduced medication. However, the chance that medication can be stopped 
entirely is small. A majority of the patients treated remains dependent on 
some form of ocular hypotensive medication after ALT. 
Pollack t, Robin (1982) specifically studied reduction of medication fol-
lowing ALT. They specified in their protocol that reduction of medication 
should not start until 3-6 months after an ALT, and that only one drug at a 
time should be discontinued until the IOP exceeded 21 mm Hg at two succes-
sive measurements. The sequence of stopping medication was: carbonic anhy-
drase inhibitor, miotic, adrenaline and timolol. They found that IOP control 
could be maintained with less medication in 38.9% of cases, and entirely 
without medication in 33.3%. More specifically, they reported that 6 out of 
9 patients no longer required carbonic anhydrase inhibitor, and 6 out of 8 
patients no longer needed a miotic. It was also established that the chance 
of maintaining a controlled IOP without medication diminishes with more pre-
ALT medication. Fink et al. (1982) likewise found that ALT is an adequate 
alternative to carbonic anhydrase inhibitors. 
Migdal s. Hitchings (1984) performed a prospective randomized study of the 
results of primary therapy of glaucoma, and found that the ALT group showed 
an IOP decrease of 44.0%, versus 32.9% of the group treated by medication at 
virtually identical initial IOP values (follow-up 6 months). 
Tuulonen et al. (1987) performed a retrospective study of 32 eyes treated 
by primary ALT, while a control group matched for diagnosis, optic disk ap-
pearance and visual field was treated by medication. After a 5-year follow-
up 50.0% of the ALT group showed a controlled IOP without additional thera-
py, versus 21.9% of the medication group (p<0.02). The intervention index 
(higher score with more adjustments or additions to the primary therapy) was 
9 for the ALT group and 25 for the medication group. The decrease in neuro-
retinal rim area was 0.06 for the ALT group and 0.15 for the medication 
group (p<0.017). The IOP decrease in the ALT group exceeded that in the med-
ication group (no exact values presented). Tuulonen et al. concluded that 
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ALT as primary therapy yields better results than medication. 
It may be stated in sunmary that in many cases medication can be reduced 
following ALT, that the percentage of eyes controlled without medication is 
distinctly smaller, and that the chance of discontinuing medication is smal­
ler as pre-ALT medication was more extensive. Hie chance of stopping miotics 
and carbonic anhydrase inhibitors is great. As primary therapy, ALT would 
sean to be preferable to medication. 
4.9 ALT AND CATARACT 
4.9.1 ALT after cataract extraction 
Table 4.17 presents results of ALT in aphakic eyes. Virtually all studies 
also presenting results in phakic eyes, show a lower success rate and less 
marked IOP decrease in aphakic than in phakic eyes (Wise & Witter 1981; Tho­
mas et al. 1982; Demailly et al. 1985; Hoskins 1987; Moulin et al. 1987). 
Lieberman et al. (1983) found a success rate not clearly different from that 
in phakic eyes, but the number of aphakic eyes in their series was small. 
Horns et al. (1983) found similar success rates and IOP decreases in phakic 
and aphakic eyes after a comparable follow-up period. Van Meter et al. 
(1988) reported an IOP decrease by more than 5 mm Hg in 8 out of 10 aphakic 
or Pseudophakie eyes with glaucoma after penetrating keratoplasty. The over­
all results seem less good in aphakic than in phakic eyes, but there is no 
consensus on this point. 
The data in the literature warrant no unequivocal answer to the question 
why aphakic eyes should respond less well than phakic eyes. Descriptions of 
the status of the iridocorneal angle after cataract extraction are often in­
complete, and important questions cannot be answered. Was there vitreous hu­
mour prolapse after the cataract extraction? Were extensive peripheral syn-
echiae observed after the cataract extraction? Had glaucoma been present 
even before the cataract extraction? 
Wise ь Witter (1979) reported that three eyes with vitreous in the anteri­
or chamber did not respond to ALT. Of 12 aphakic eyes without vitreous in 
the anterior chamber, 8 responded well to ALT. 
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Robin s. Pollack (1983) explicitly mentioned that glaucoma was not directly 
related to cataract extraction; their results were good. 
Moulin et al. (1987) had a success rate of 41.7% in aphakic eyes, but ex-
cluded cases of obstructive glaucoma from treatment. 
Thomas et al. (1982) had a distinctly less good success rate for aphakic 
eyes with open-angle glaucoma than for phakic eyes with this type of glauco-
ma. Efforts to correlate success and IOP decrease in aphakic eyes with other 
ocular variables may contribute to a consensus. 
Few results obtained in Pseudophakie eyes are reported in the literature, 
but it seems that results in Pseudophakie eyes are better than those in a-
phakic eyes (Hoskins 1987). 
In our opinion it is methodologically questionable to lump aphakic with 
Pseudophakie eyes (Schlosshardt 1986) in ALT evaluations. 
The above questions concerning ALT in aphakic and Pseudophakie eyes will 
be discussed along with our own results. 
4.9.2 Cataract extraction after ALT 
Because cataract extraction does not affect the ocular hypotensive effect 
of ALT, cases of glaucoma and co-existing cataract should preferably be 
treated first by ALT and then by cataract extraction (unless one opts in fa-
vour of pressure-reducing surgery) (Thomas et al. 1982; Brown et al. 1985b; 
Savage et al. 1985; Simmons 1987; Goldmann & Mellin 1988). This sequence is 
given extra emphasis in view of the fact that results of ALT in aphakic (and 
Pseudophakie?) eyes are less good than those in phakic eyes. 
If cataract extraction is performed after ALT, there is no difference in 
effect between ICCE and ECCE (Brown et al. 1985b; Goldmann & Mellin 1988). 
Savage et al. (1985) found no difference in early pressure elevations af-
ter cataract extraction in glaucomatous eyes controlled by ALT or by medica-
tion. However, the incidence of these pressure elevations was higher in 
glaucomatous (29%) than in non-glaucomatous eyes (3%); intensive postopera-
tive check-ups are therefore imperative. 
Galin et al. (1984) found that 3 months after ALT followed by cataract ex-
traction and implantation an IOP of less than 19 mm Hg could be maintained 
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with topical medication in only 25% of cases. After sclerectomy, cataract 
extraction and anterior chamber implantation this was achieved without topi­
cal medication in 40% of cases. They concluded that combined surgery with or 
without implantation effects better and more significant I0P control than 
ALT followed by cataract extraction and implantation. A conspicuous fact was 
that the original ALT group comprised 27 patients and that an I0P of less 
than 19 mm Hg was achieved in only 7. The ALT modification used did not dif­
fer markedly from other modifications, apart from a somewhat lower power 
setting (600-800 mW). An exact analysis of their results in relation to ALT 
is not feasible due to lack of relevant information. 
4.10 ALT Ш PSEUDO-EXFOLIATim GLAUCOMA 
The results of ALT in pseudo-exfoliation glaucoma are listed in table 
4.18. The studies quoted have been so chosen as to permit comparison with 
results in POAG. 
Without exception, the IOP decrease achieved in pseudo-exfoliation glau­
coma exceeds that in POAG. However, the initial IOP in pseudo-exfoliation is 
always higher than that in POAG, and a marked IOP decrease was therefore to 
be expected. Other studies not directly comparing results with those in POAG 
also mention marked IOP decreases: 39.7% of an initial IOP of 31.2 iran Hg 
(Lieberman et al. 1983); 31.0% of an initial IOP of 28.7 mm Hg (Logan et al. 
1983); 51.5% of an initial IOP of 33 mm Hg (Robin S. Pollack 1983); 24.9% of 
an initial IOP of 27.1 mm Hg (Xu et al. 1985). 
Does this marked IOP decrease result in a higher success rate? At first 
glance the success rate for pseudo-exfoliation glaucoma indeed seems higher 
than that for POAG, but this impression changes when the duration of follow-
up is considered. Virtually all quoted studies with a maximum follow-up of 
12 months show a higher success rate for pseudo-exfoliation glaucoma than 
for POAG, but from 12 months on there are some shifts in that the success 
rate for both becomes equal. In this respect the study of Rouhiainen (1987b) 
is not representative because low-energy ALT modifications were used, which 
exert an essential influence on the success rate. 
If the above suggested correlation between success rate and follow-up ap-
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plies, than pseudo-exfoliation glaucoma has a higher initial response but 
also a higher failure rate with an increasing follow-up period. Higginbotham 
& Richardson (1986) used the Kaplan-Meier curve data analysis and establish-
ed that pseudo-exfoliation glaucoma did show a faster rate of failure than 
POAG. Others, too, reported a faster diminution of the IOP decrease in pseu-
do-exfoliation glaucoma compared with POAG (Pohjanpelto 1983; Schwartz s. Ko-
pelman 1983; Moulin et al. 1987; Tenner & Keck 1987). 
These tendencies are well illustrated in studies by Tuulonen et al. (1985, 
1987) in which ALT was performed as primary therapy. The initial success 
rate in pseudo-exfoliation glaucoma was 94.3%, versus 72.2% in POAG. After a 
5-year follow-up, however, both groups showed a success rate of 50%. This 
demonstrates, firstly that the success rate diminishes as the follow-up pro-
gresses, and secondly that the failure rate in pseudo-exfoliation glaucoma 
takes a faster course. 
For the sake of completeness it is to be noted that in some studies pseu-
do-exfoliation glaucoma continued to show a higher success rate (Bergeâ 
1986a). 
To summarize: pseudo-exfoliation glaucoma shows a more marked initial de-
crease than POAG, which is explained by the higher initial IOP; the initial 
success rate is higher in pseudo-exfoliation, but the failure rate increases 
more rapidly. 
4.11 ALT IN PIGMEHT DISPERSION SYNDROME AND GLAUCOMA 
Table 4.19 lists the results of ALT in pigment dispersion syndrome with 
glaucoma. Because the number of eyes treated is usually small, direct com-
parison with POAG is as a rule impossible. 
The pigment dispersion syndrome generally seems to respond well to ALT, 
but the various studies report a wide range of success rates (43.8% to 
100%). This cannot be explained with the aid of the available literature 
data. Lunde (1983) found a correlation between age and ALT response in pa-
tients with the pigment dispersion syndrome. He found that the subgroup 
showing failure after a varying interval showed a higher average age than 
the success group (59 versus 31 year) and had a longer glaucoma history 
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(10.2 versus 2.5 years). Because the pigment dispersion syndrome usually be­
comes manifest in the fourth decade of life (Hoskins 1978), the duration of 
the glaucoma history must be determined largely by age. Discarding mean age 
in favour of proportions, we find that age was always under 40 in the suc­
cess group (4 patients, 6 eyes), whereas in the failure group (6 patients, 6 
eyes) only one patient was under 40, the others all being 58 years or older. 
Another remarkable fact was that the eyes in the failure group had a 
higher IOP at the time of failure than the initial I0P. Lunde concluded that 
in cases of this type it is quite possible to inflict further damage on the 
trabecular meshwork. 
Taking Lunde's data as representative, the range of success rates should 
in part be explicable from the age distribution. Unfortunately this age cor­
relation cannot be studied in detail because most studies give no (specific) 
age definition. 
Lieberman et al. (1983) found a mean age of 37.7 years in the success 
group and of 51 years in the failure group. Robin & Pollack found a 100% 
success rate at a mean age of 36 years. Traverso et al. (1986) found no dif­
ference in response between patients under and patients over 60. In view of 
Lunde's finding this age limit was too high. Lieberman et al. (1983), by the 
way, found no increase in excess of the initial IOP in failure cases. 
In sumnary it may be stated that ALT in the pigment dispersion syndrome 
gives a good response provided the patient is not older than 40-50 years and 
has no excessively long glaucoma history. One should be alert to the possi­
bility of an IOP increase folioving ALT in the somewhat older patient. 
4.12 ALT Ш LOW-TENSION GIAUCOMA 
Because the IOP decrease largely depends on the initial IOP, one may won­
der whether ALT can be successful in low-tension glaucoma. 
In 8 patients with low-tension glaucoma and a maximal initial IOP of 21 mm 
Hg, Strasser & stelzer (1983) found a mean IOP decrease of 4.13 mm Hg. The 
contralateral eyes served as control eyes and showed an IOP increase by 0.16 
mm Hg. The IOP decrease in the treated eyes therefore was an ALT effect. Un­
fortunately these IOP changes were recorded after a very brief follow-up pe-
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riod (2 weeks) and consequently are of no value in assessing the success 
rate of ALT in low-tension glaucoma. 
Schwartz et al. (1984) reported a success rate of 72.7% after a mean fol-
low-up of 21.6 months. They deemed an ALT successful if there was no further 
progression of optic disk damage and visual field loss and if the IOP de-
crease amounted to at least 2 mm Hg. After 12 months 16 out of 22 eyes were 
found to fulfil these criteria. The IOP decrease in this group was 5.8 mm Hg 
after 2 months, 4.9 mm Hg after 12 months, and 3.3 mm Hg after 24 months. 
Again we observe a diminishing IOP decrease with an increasing follow-up pe-
riod. In 7 eyes of this group a diurnal IOP curve was determined before and 
after ALT. The mean pre-ALT IOP was 16.27 mm Hg, and the mean peak IOP was 
19.43 mm Hg. After ALT, both had decreased by 6.2 mm Hg - a finding corre-
sponding with that reported by Greenidge et al. (1983). In 18% of the eyes 
an IOP increase occurred after 1-21 days. Schwartz et al. concluded that ALT 
results in low-tension glaucoma are encouraging even though the effect di-
minish with increasing time. 
Thomas et al. (1982) treated 65 eyes with an initial IOP of 10-19 mm Hg. 
After a mean follow-up of 4.7 months the IOP decrease was 4.2 mm Hg (28.0%). 
A subpopulation of these eyes had an initial IOP of 10-14 mm Hg and in this 
group the IOP decrease was 2.6 mm Hg; despite this limited IOP decrease 
Thomas et al. stated that eyes with an initial IOP of 13-14 mm Hg occasion-
ally do show an IOP of 8-9 mm Hg after ALT. 
Sharpe & Simmons (1985) performed ALT on 85 eyes of 67 patients with a 
maximum initial IOP of 19 mm Hg. Because bilateral treatment is a source of 
bias, only the eyes treated first were included in this study. After a mean 
follow-up of 30 (12-50) months a success rate of 46.3% was measured (31 
eyes), the criteria applied being an IOP decrease of at least 20% and a sta-
ble visual field and optic disk. Of the 36 failure eyes, 25 showed no 20% 
IOP decrease but did have a stable visual field and optic disk. Only 11 eyes 
(16.4%) showed further glaucomatous progression or needed pressure-reducing 
surgery. A striking finding was that a number of eyes had an IOP between 0 
and 5 mm Hg after ALT, although no eye showed this very low IOP after 30 
months. 
TO sunnarize: fairly good results can be obtained also in low-tension 
glaucoma; in this category, too, the IOP decrease diminishes with increasing 
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time; in same cases, however, very low IOP values are achieved. 
4.13 ALT IN SECONDARY GLAUCOMA 
The following survey presents ALT results in various secondary types of 
glaucoma; most of the studies listed involve small number of eyes and direct 
comparison with POAG is therefore impossible. 
Type of glaucoma Number Success Authors 
Angle-recession 
Traumatic 
Uveitic 
Juvenile 
Congenital 
Sturge-Weber syndrome 
4 3 Thomas et al. (1982) 
4 0 Robin i. Pollack (1983) 
4 1 Tuulonen & Airaksinen (1983b) 
4 0 Goldmann S, Meilin (1987) 
4 3 Thomas et al. (1982) 
6 2 Horns et al. (1983) 
8 3 Robin i Pollack (1983) 
5 1 Tuulonen ь Airaksinen (1983b) 
11 3 Goldmann & Meilin (1987) 
10 4 Horns et al. (1983) 
3 0 Schlosshardt (1986) 
4 2 Robin Ь Pollack (1983) 
2 2 Robin Ь Pollack (1983) 
The fact that in secondary glaucoma types ALT produces an adequate IOP de­
crease and success rate in few if any cases is explained by the cause of the 
IOP increase. The possible effect of ALT is based on a collapsed trabecular 
meshwork which after ALT shows an increase in intertrabecular space. In most 
cases of secondary glaucoma the trabeculae are not collapsed and consequent­
ly ALT cannot be effective. Another reason is that many eyes with secondary 
glaucoma are also aphakic, which as such may explain a less good response 
(Tuulonen & Airaksinen 1983b). 
4.14 IODE OF ACTIGN 
Because ALT is applied to the trabecular meshwork, it seems obvious that 
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the pressure-reducing effect should result from local changes. Ocular 
changes following ALT will now be discussed from various points of view. 
That the mode of action of ALT probably involves the trabecular meshwork 
seems plausible on the basis of conclusions from: 
Clinical findings: 
ALT is an effective therapy for POAG (4.2) and particle block glaucomas 
such as pseudo-exfoliation glaucoma (4.10) and pigment dispersion syndrome 
(4.11). Secondary forms of glaucoma in which trabecular changes often play 
no major role, will generally benefit little from ALT (4.13). 
Pathogenetic findings: 
That pathological changes in the trabecular meshwork play a role has been 
discussed in 2.2.2.7; these changes can be summarized as follows: 
1. Hyalinization of the uveal and corneoscleral trabeculae. 
2. Plaque formation in the endothelial meshwork. 
3. Decreased cellular density of the trabecular meshwork. 
4. Decreased frequency and size of the vacuoles in the endothelial lining of 
Schlemm·s canal. 
5. Stenosis and obliteration of Schlemm's canal. 
6. Increasing concentration of electron-dense material in the endothelial 
meshwork. 
7. Increased concentration of glycosaminoglycans in the empty spaces. 
That ALT causes changes in this system will be discussed below. 
Tonographic findings: 
Table 4.20 presents tonographic findings following ALT. Both after a very 
brief follow-up (1 day, Merté et al. 1985) and after a longer period (24 
months, Schwartz & Kopelman 1985) the facility of outflow is significantly 
increased. Bischoff & Speiser (1985) also found an increased facility of 
outflow but this was evident only in eyes with low pre-ALT value. Although 
the above findings are consistent throughout the literature, Makabe (1988) 
found that the I0P decrease in the first days following ALT was attributed 
mainly to a reduction in aqueous humour formation, while the late IOP reduc-
tion resulted from an increase in facility of outflow. 
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BrubaJcer ь Liesegang (1983) reported increased facility of outflow and di­
minished resistance to outflow but no changes in rate of flow of aqueous, 
permeability of blood-aqueous barrier, permeability of corneal endothelium, 
volume of anterior chamber, mean endothelial cell size and corneal thick­
ness. Traverso et al. (1984b) found no statistically significant difference 
between pre-ALT and post-ALT corneal endothelial cell density. An even more 
impressive sign that ALT acts via this increased outflow is the fact that no 
increased values are found in failure eyes (BrubaJcer & Liesegang 1983). 
Fluorophotcmetric findings: 
Feller & Weinreb (1984) found a significantly increased fluorescein leak­
age 1 day and 1 week after ALT - a finding suggestive of a disturbance of 
the blood-aqueous barrier. One month after ALT there was no longer any dif­
ference from the pre-ALT value or from control eyes. The increased leakage 
in the immediate post-ALT phase may indicate a disturbance of the blood-aq­
ueous barrier and may explain the IOP increase. However, the ocular hypoten­
sive effect of ALT cannot be attributed to a lasting change in this barrier. 
Findings of Wise ь Witter (1979) and Wise (1981, 1984, 1987): 
Wise suggested as hypothetical mode of action that ALT reduces the circum­
ference of the trabecular ring by causing shrinkage of the collagen of the 
trabecular beams and, secondly, by retraction following cicatrization. As a 
result, the trabecular ring is displaced towards the centre of the anterior 
chamber, and the intertrabecular space increases. This is described as 
'tightening effect*. 
Low-dose ALT: 
That the ocular hypotensive effect of ALT is not based solely on mechani­
cal factors is evident from the results obtained by ALT applied to only a 
very limited part of the trabecular meshwork. Although the IOP decrease 
achieved in most of these cases is insufficient, a few successes are on rec­
ord. Drance et al. (1987) achieved adequate IOP control in 2 out of 12 eyes 
treated by application of only 10 bums to 30° of the trabecular meshwork 
circumference. 
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Histopathological findings: 
Post-ALT histopathological findings are only of relative value, on the one 
hand because no trabeculectomy material can be obtained from successfully 
treated patients, and on the other hand because eyes obtained postmortem af­
ter a successful ALT are hardly available. Trabeculectomy material from pa­
tients with an insufficient response to or an IOP increase after ALT does 
provide some information, but this findings must not be simply extrapolated 
to eyes successfully treated by ALT. The same applies to eyes submitted to 
ALT while a trabeculectomy had already been planned (Rodrigues et al. 1982). 
Animal experiments, more specifically in simian eyes, provide no real so­
lution to the problem because the anatomy of the iridocorneal angle and tra­
becular meshwork in simian eyes clearly differs from that in human eyes (Van 
der Zypen & Fankhauser 1984). Even if one accepts this, the fact remains 
that one must make do with non-glaucomatous eyes because induction of chron­
ic glaucoma without interference with the trabecular meshwork is impossible. 
Nevertheless, continued histopathological research is certainly to be re­
commended because results, in combination with other findings, may lead to 
plausible hypothesis concerning the ocular hypotensive effect of ALT. 
Histopathological findings as to localization of laser bums: 
By means of histopathological verification Starita et al. (1984b) demon­
strated that it is possible to localize laser bums exactly on the desired 
part of the trabecular meshwork during ALT. 
Histopathological measurements of the size of laser burns at a spot size 
of 50 цт produces surprising results. Melamed t> Epstein (1987a) found that 
this spot size could lead to a burn with an average diameter of 218 \m. Sev­
eral possible explanations present themselves. Wise (1984) established that 
only 4 of the 27 lasers he examined actually gave a spot size of 50-60 pm 
after setting the value at 50 цт. The others gave spot sizes with a diameter 
of 70 цт (twice the surface area) to 160 цт (ten times the surface area). 
The size of the bum proves to depend on the power setting, higher setting 
giving larger bums (Starita et al. 1984b,· Melamed ь Epstein 1987a). The de­
gree of pigmentation likewise correlates with burn size: larger bums are 
seen with increasing pigmentation (starita et al. 1984b; Zink et al. 1984). 
A striking fact in this context is that both the power and the degree of 
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pigmentation have to meet minimum requirements if a successful IOP decrease 
is to be achieved. 
Histopathological findings after ALT in human eyes: 
In human eye-bank eyes submitted to ALT at an IOP of 20-40 mm Hg, Van Bus-
kirk et al. (1984) found distention of Schlemm's canal after ALT at an IOP 
of 40 mm Hg; trabecular cell density in the treated eyes was 39% lower than 
in the treated eyes, and the distribution of incorporated "S-sulphate in 
the treated eyes was evidently different. The latter finding is a reflection 
of the production of glycosaminoglycans and therefore of the extracellular 
matrix. These authors hypothesized that, apart from a mechanical effect, ALT 
also interferes with cellularity and with synthesis of glycosaminoglycans in 
the remaining cells. Bylsma et al. (1988) found that the decreased cellular­
ity is preceded by an increase in DNA replication (1-2 days after ALT). 
In trabecular material obtained shortly after ALT, Rodrigues et al. (1982) 
found disruption of trabecular beams, clusters of melanin pigment granules, 
macrophages and oedema of endothelial cells at the site of laser burn. Adja­
cent areas were relatively intact. 
Greenidge et al. (1984) found similar changes in trabeculectomy material 
obtained during an IOP increase after ALT. Excessive presence of intertra-
becular material after ALT may offer a mechanical explanation of the occur­
rence of IOP increases. 
Trabeculectomy material obtained after a longer interval showed fibrosis 
at the site of the laser burn, this area being covered by a layer of abnor­
mal corneal endothelial cells with migratory features. These cells obliter­
ated the intertrabecular spaces. The chance that cells of this type migrate 
increases as the b u m localization is more anterior; however, abnormal (tra­
becular endothelial?) cells have also been observed after posterior burn lo­
calization (Rodrigues et al. 1982). 
These findings are compatible with the tightening effect postulated by 
Wise. 
Histopathological findings in simian eyes: 
Melamed et al. (1985, 1986, 19в7а) also found disruption of trabecular 
beams, debris in the intertrabecular spaces, inflammatory cells and phago-
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cytic activity of the endothelial cells in the immediate post-ALT phase. The 
endothelial meshwork was intact. After 4 weeks the laser burns had turned 
into organized scars with adherence and collapse of trabecular beams. In 
these studies, too, mention is made of the cellular layer continuous with 
the corneal endothelium. 
The area without lesions showed wide open intertrabecular spaces free from 
debris. The undamaged parts of the inner wall of Schlemm's canal showed sig­
nificantly more herniations than the damaged areas. These herniations com­
prised significantly more vacuoles, as confirmed by tracer studies (Melamed 
ь Epstein 1987b). This may be explained by a shift of aqueous humour to the 
undamaged areas. 
In the acute post-ALT phase Van der Zypen i FanWiauser (1984, 1987) like­
wise found the above described changes, with in addition dissolution of col­
lagenous components in the trabecular meshwork. This collagen degradation 
increases, while at the same time the cells of the endothelial meshwork show 
a lytic degenerative process. The monolayer of endothelial cells forms sim­
ultaneously. After considerable time the laser burns no longer contain 
cells, and but little collagen. Besides these degenerative processes, regen­
erative processes are seen with cells seeming to produce collagen or to pro­
duce phagocytic action. The amount of collagen has diminished, both in the 
trabeculae and intertrabecularly. 
CGNCLUSIGNS 
At least three factors would seem to play a role in the ocular hypotensive 
effect of ALT: 
1. A mechanical factor. Histopathological findings are consistent with the 
tightening effect postulated by Wise. Another mechanical factor may be a 
shift of aqueous humour to undamaged areas of the trabecular meshwork. 
2. A cellular factor. A decrease in the cellular density of the trabecular 
meshwork may stimulate the other cells to develop activity. Manifesta­
tions of this activity may be increased phagocytic activity, migration of 
cells, degeneration and regeneration of cells. 
3. A biocheeical factor. After ALT, trabecular endothelial cells show a 
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changed production of glycosaminoglycans, leading to a change in the com-
position of the extracellular matrix. The collagen turnover likewise 
changes with, as a result, a decrease in the amount of intertrabecular 
collagen. 
Two theories are currently being entertained with regard to IOP increases 
following ALT: 
1. Disturbance of the blood-aqueous barrier as manifested by increased flu-
orescein leakage in the immediate post-ALT phase. A fact compatible with 
this is that prostaglandins can induce IOP increases. A fact incompatible 
with this is that prostaglandin synthetase inhibitors exert no influence 
on the IOP increases. 
2. A second explanation is mechanical blockage of intertrabecular spaces af-
ter ALT. Compatible with this are the histopathological findings, the 
fact that pilocarpine partly prevents IOP increases, and the limited du-
ration of the IOP increases, which corresponds with the time required by 
cells to develop phagocytic activity. 
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APPENDIX 
TO 
CHAPTER 4 
Table 4 .1 . Results of laser treatment of the iridocorneal angle in the early 
and la te Seventies. 
Laser Spot Exp. (limber Power Total Circum- Results 
Type Size Time bans Energy ference 
Krasnov (1973) Q-Switched 250-500 
ruby 
10-20 2-4 <180e initial Hypotensive 
Hager (1973) cont. wave 50 1-3 1-3 1000 1-9 «SO' initial Hypotensive 
argen 
Gaasterland i cont. wave 50 0.2-0.5 200 400-800 16-80 360' induced glaucoma 
Kiçfer (1974) argon 
Ticho (1977) cont. wave 50 0.1 50 1000-3000 5-15 60° initial hypotensive 
argon 
HicUiam cont. wave 50 0.2 150 50 
et al. (1977) argem 0.2 170 1200 
1.5 360° outflow increase 
41 360° outflow decrease 
De Heer & cont. wave 50 0.02-0.1 30-120 500-2500 2.1-8.4 360* favourable 
РереПилр (1979) argon 
Stiegler (1979) pulsed 50 1-1.5 40 
argon 
90,, β Η success rate 
Wise & cont. wave 50 0.1 100 1000-1500 10-15 360' m success rate 
Witter (1979) argon 
Spot Size in μη. 
Exposure Time in seconds. 
Power in ufi. 
Total Energy in Joules. 
Circumferaice : Total amount of trabecular meshwork circumference treated. 
Cont. wave argon: Continuous wave argon laser. 
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Table 4 . 2 . Resu l t s of standard Wise ALT as secondary therapy in phakic, 
(primary) open-angle glaucoma. 
Year Design Ind Type N FU ют + SD lOPD lOPDtt) SC SR 
Wise 
Hilensky i Janpol 
Thomas et al. 
Horns et al. 
Lieberman et al. 
Pohjanpelto 
Schwartz i Kopelnan 
1981 
1981 
1982 
1983 
1983 
1983 
1983 
Tuulonen & AiraJtsinen 1983a 
Bergea 
Denailly et al. 
Traverso et al. 
Schultz et al. 
1984 
1985 
1986 
1987 
pro 
pro 
pro 
retro 
retro 
pro 
pro 
retro 
pro 
pro 
pro 
pro 
OAG 
OAG 
POftG 
PCftG 
PCftG 
POAG 
OAG 
PCftG 
PQAG 
PQAG 
POAG 
OAG 
150 
22 
237 
174 
74 
59 
82 
52 
50 
104 
186 
19 
6 
11.3 
5 
10 
11-26 
6 
24 
12 
6 
12 
3-22 
>12 
28.37 
27.5 + 3.2 
23.0 
25.4 + 4.9 
25.2 
25.2 
25.8 + 6.1 
21.2 + 0.7 
25.9 + 4.0 
21.7 + 7.5 
25.8 + 5.2 
12.3 
7.2 
7.0 
7.8 
7.8 
9.2 
7.3 
4.6 
7.2 
4.2 
6.7 
43.2 
26.2 
30,4 
30.6 
30.9 
36.5 
29.7 
21.7 
27.8 
19.5 
26.0 
2 
6 
3,4,6 
6 
1,4,6 
1,2,5 
1,3,4 
2,3,4 
2 
6 
4 
1,2 
85. П 
100 % 
85.2», 
82.3% 
79.7* 
76.3>„ 
77 \ 
65.4». 
90.0% 
93.3* 
72.0* 
68.41 
Design : Design of study (pro: prospect ive; retro: re t rospect i ve ) . 
Ind : Indicat ion t o t r e a t pat ients ( 1 : presurgical p a t i a i t s ; 2: ALT as primary therapy included). 
Type : Glaucoma type treated KPlfflG: (primary) open-angle glaucoma). 
N : Numtoer of eyes. 
FU : Follow-up (nonths). 
HOP + SD : I n i t i a l I0P + standard deviat ion in m Hg. 
lOPD : ЮР decrease in ил Hg. 
K M (*) : Relat ive ЮР decrease as a function of HOP. 
SC : Success c r i t e r i a ( 1 : ninimal I0PD included; 2: f inal maximm ЮР included; 3: opt ic disk s t a b l e ; 
4: v isual f i e l d defect s t a b l e ; 5: stop glaucoma medication / no s t a r t of glaucoma medication; 6: 
avoid surgery). 
SR : Success rate. 
Table 4 . 3 . Resu l t s of Standard Wise ALT as primary therapy i n phakic, (pr i­
mary) open-angle glaucoma. 
Year Design Ind Type N FU HOP + SD lOPD ІОРОШ SC SR 
Rosenthal e t a l . 1984 pro i OAG 43 6-18.5 30 13-14 43-46 2,5 65.1». 
Thomas e t a l . 1984 pro i OAG 26 7.5 30.2 9.9 32.8 5,6 83.3». 
Tuulonen 1984 retro i POAG 21 12 25.6 + 0.9 7.7 30.1 2,3,4,5 81.0Î 
Ind: ALT as i n i t i a l therapy. Каиіл ілд abbreviat iois as i n tab le 4.2. 
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Table 4.4. Results of standard Wise ALT in phakic, (primary) open-angle 
glaucoma. IOP decrease as a function of follow-up (months). 
Moulin i Haut 
Pohjanpelto 
Tuulonen et al. 
Schwartz et al. 
Wise 
Year 
1983 
1983 
1985 
1985 
1987 
FU: 
im Hg 
m Ης 
om Hg 
m Hg 
nu Hg 
( 
9.0 
37.0 
11.0 
39.8 
8.9 
35.3 
12 
9.9 
36.9 
11.0 
39.8 
6.6 
29.1 
7.8 
31.0 
11.8 
40.2 
18 
11.5 
41.7 
5.3 
24.5 
7.7 
31.3 
24 
11.1 
40.2 
7.0 
31.3 
7.3 
29.8 
11.2 
37.8 
30 
11.1 
40.2 
3.9 
18.0 
6.9 
27.5 
36 
11.8 
42.8 
7.0 
28.1 
13.0 
43.9 
48 
6.8 
28.8 
11.6 
39.2 
60 
4.9 
19.7 
12.3 
41.6 
72 
12.4 
41.9 
84 9« 108 120 
12.5 12.6 13.4 12.5 
42.2 42.6 45.3 42.2 
FU : Follow-up in months. 
m Hg: IOP decrease in m Hg. 
\ : Relative IOP decrease as a funrtion of initial IOP. 
Table 4.5. Results of Standard Wise ALT in phakic, (primary) open-angle 
glaucoma. Success rate as a function of follow-up (months). 
Tear(s) FU: 12 24 36 48 60 72 
Moulin et al. 
Schwartz et al. 
Wise 
1987 
1981, 1983, 1985 
1979, 1981, 1987 
89.01 
96.3». 
91.81 
71.6t 
76.8t 
89 .It 
64.4t 59.1t 
84.5t 77.3t 
46.3t 
71. et 70.0t 63.2t 
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Table 4.6. Incidence of side effects and complications after ALT. 
MPS 
Year I r i t i s Нааюгг Opacit WS Incid Hin Time 
Schwartz et al. 
Wilensky i Jaiiçol 
Wise 
Lichter 
Thomas et al. 
Homs et al. 
Liebeman et al. 
Moulin i Haut 
Pohjanpelto 
Schwartz ( Кореіші 
Tuulonen i Airate inai 
Heinreb et al. 
Bergeá 
Krupin et al. 
Smith 
Zborovski et al. 
Finnstri» 
Frucht et al. 
1981 
1981 
1981 
1982 
1982 
1983 
1983 
1983 
1983 
1983 
1983a 
1983a 
1984 
1984 
1984 
1984 
1985 
1985 
100* 
100* 
CGBOOn 
CGODIOn 
canon 
camon 
100* 
canon 
camon 
camon 
59* 
100* 
5.7* 
5.0* 
2.0* 
2.3* 
0.3* 
8.0* 
5.0* 
3.8* 
1.9* 
frequent 
25* 
frequent 
occasionally 
sonetimes 
80.0* 
28.6* 
rare 
0.7* 
2.0* 
47.1* 
15.0* 
42.0* 
19.4* 
32.0* 
3.8* 
23.0* 
24.0* 
25.3* 
9.2* 
33.0* 
22.0* 
6.1* 
19.0* 
14.4* 
8.5* 
11.1* 
70.0* 
14.8* 
56.1* 
16.0* 
26.2* 
3.8* 
42.1* 
21,1* 
10 
10 
10 
10 
day 1 
day 1 
day 1 
1-6 h 
1-6 h 
day 1 
day 1 
day l 
day 1 
1-8 h 
day 1 
1-7 h 
day 1 
1-2 h 
2-3 h 
1-4 h 
1-4 h 
Haenorr: Haenorrhages during ALT. 
Opacit : Corneal opacit ies . 
PAS : Peripheral anterior synechiae. 
I0PS : I0P spike. 
Incid : Incidence. 
Hin : Mininal I0P change indicating an I0PS in m Hg. 
Tine : First checX-up at which I0P was neasured (h: hours). 
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Table 4.7. Incidence of ЮР spikes with different 
t ion. 
pre- and post-ALT medica-
Ш е п т а л et al. 
Ofner et al. 
Robin et al. 
Brown et al. 
Weinreb et al. 
Hotchkiss et al. 
Tuulonen 
Panas et al. 
Year 
1983 
1984 
1987 
1988 
1984 
1984 
1985 
1985 
Gelfand ι Holpert 1985 
Medication 
prednisolone 
pilocarpine 4% 
ALO 2145 
ALO 2145 
flurbiprofen 
flurbiprofen 
iixtanethacine 
indomethacine 
indonethacine 
Minimal positive 
change (mn 
1 
1 
1 
10 
5 
10 
1 
10 
1 
10 
3 
9 
1 
Hg) 
Incidence of I0PS 
Treated 
77.81 
36.3% 
20.5% 
4.0% 
9.8% 
4.9% 
58.7% 
5.6% 
41.6% 
4.2% 
60.0% 
8.0% 
56.5% 
Untreated 
70.0% 
72.7% 
58.8% 
17.6% 
23.8% 
19.0% 
56.4% 
20.6% 
32.0% 
16.0% 
40.0% 
12.0% 
59.1% 
p-value 
NS 
p< 0.05 
p< 0.001 
p< 0.005 
p= 0.095 
p= 0.062 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS : (lot significant. 
Treated : Pre- or Post-ALT treatment with the respective medication. 
Untreated: Control (placebo) group. 
Table 4 .8 . Mean maximum 
ication. 
change in IOP with different pre- and post-ALT med-
R u d e n m et al. 
Ofner et al. 
Robúi et al. 
Brown et al. 
Weinreb et al. 
HotcWtiss et al. 
Tuulonen 
Pappas et al. 
Year 
1983 
1984 
1987 
1988 
1984 
1984 
1985 
1985 
Gelfand & Holpert 1985 
Medication 
prednisolone 
pilocarpine 4% 
ALO 2145 
ALO 2145 
flurbiprofai 
flurbiprofen 
indonethacine 
indomethacine 
indonethacine 
Mean Махіпш IOP Change (m Hg) 
Treated 
+ 7.72 + 8.62 
no mean change 
< initial IOP 
< initial IOP 
+ 0.9 
+ 0.7 
+ 1.7 + 3.9 
+ 2.2 + 3.8 
+ 1.39 + 4.18 
Untreated 
+ 7.35 + 9.28 
+ 3.1 
> initial IOP 
> initial IOP 
+ 0.4 
- 1.6 
+ 2.9 + 7.0 
+ 2.9 + 5.1 
+ 1.63 + 5.80 
p-value 
NS 
p< 0.05 
p< 0.001 
p< 0.05 
NS 
NS 
NS 
NS 
NS 
Abbreviations as in table 4.7. 
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Table 4.9. Results of modifications on Standard Wise ALT. 
Heiji 
Schwartz et al. 
Finnstroœ 
Weinreb et al. 
Lustgarten et al. 
Schwartz et al. 
Lustgarten et al. 
Heijl 
Singh i Kaur 
Blondeau et al. 
Year 
1984 
1983 
1985 
Loc Cir Ses 
AN 
AN 
AN 
1983b M 
1984 
1983 
1984 
1984 
1987 
1987 
Martenet i Schwarzenb.1986 
Kitazawa et al. 
Weinreb et al. 
Jager et al. 
Lustgarten et al. 
Storpile et al. 
Schwartz et al. 
Kitazawa et al. 
Thomas et al. 
Reibaldi et al. 
Kitazawa et al. 
Schwartz et al. 
Thomas et al. 
Schwartz et al. 
Sherwood et al. 
Raitta ι Letho 
Klein et al. 
Lehmann & Faggioni 
Rouhiainen et al. 
1984 
AN 
AN 
AN 
AN 
AN 
AN 
AN 
AN 
1983b AN 
1987 
1984 
1986 
1983 
1984 
1982 
1985 
1984 
1983 
1982 
1983 
1987 
1983 
1985 
1986 
AN 
AN 
AN 
AN 
PO 
PO 
PO 
PO 
PO 
PO 
PO 
PI 
PI 
PI 
PI 
1987a PI 
Grehn ь Schildwachter 1987 
Lehmann i Faggioni 
Hiloisty i Weinreb 
Date i Bos 
Elsàs i Harstad 
Payer 
Bechetoille et al. 
Reibaldi et al. 
1986 
PI 
PI 
1983a PI 
1983 
1983 
1985 
1985 
1985 
SP 
SP 
CB 
CB 
CB 
360 
360 
360 
360 
360 
360 
360 
360 
360 
360 
180 
180 
180 
180 
180 
180 
90 
360 
360 
360 
180 
180 
180 
360 
360 
360 
360 
360 
180 
180 
90 
90 
360 
180 
360 
360 
360 
Nunber Exp 
80-115 0.1 
100 0.1 
80-100 0.1 
100 
100 
50 
50 
0.1 
var 
0.1 
var 
78-121 0.1 
100 
100 
50 
50 
50 
50 
50 
1+ 100 
1 
1+ 
1+ 
25 
100 
100 
100 
50 
50 
50 
100 
100 
107 
60-80 
0.1 
0.2 
0.1 
0.1 
0.1 
0.1 
var 
0.1 
0.1 
0.2 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.2 
0.1 
80-119 0.1 
40-60 
50 
12-35 
25 
100 
100 
100 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
50-100 0.2 
>100 0.1 
Spot 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
25 
С Power 
1 
ti 
700-1000 
800 
var 
it 
var 
* 
800-1200 
500 
600-1300 
i** 
800 
var 
1 1000 
1 
1 
1 
1 
1 
1 
1 
150-350 1 
** 
ti* 
1090 
1000 
*** 
It« 
ti 
500-1000 
50-100 1 1000-2000 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
200 
1 
1 
1 
1 
1 
2 
800-1200 
490-910 
100-500 
300-1500 
420-560 
900 
600-1500 
500-800 
1000-1200 
400-600 
Gl E 
3 ï 
2 ï 
2 ï 
3 ï 
2 Y 
1 Y 
1 Y 
N 
21 
16 
52 
20 
16 
31 
14 
16 
22 
14 
104 
18 
20 
52 
15 
47 
11 
35 
102 
196 
54 
30 
40 
20 
24 
81 
62 
32 
67 
3 Y 115 
3 
3 
3 Y 
3 
30 
21 
10 
54 
Y 101 
3 
3 
44 
15 
ГО 
1 я 
6 m 
12 m 
2m 
4 ν 
6 w 
4 w 
1m 
11 m 
24 m 
l-12m 
2m 
6 m 
4w 
3 m 
5 m 
>6 m 
б-ЗОлі 
>6 m 
4m 
3m 
7.8m 
ПОР 
25.7 
21.0 
26.6 
28.0 
27.2 
24.6 
26.5 
25.4 
26.0 
22.7 
25.9 
24.5 
28.0 
29.8 
25.8 
23.0 
24.0 
24.0 
24.7 
22.7 
25.1 
21.3 
3O-40m 23.8 
1 m 
4 m 
3-12m 
3-29m 
4 m 
12 m 
30.8 
27.1 
25.1 
23.0 
26.5 
24.0 
29.9 
25.5 
0.5-101« 26.2 
4 w 
18m 
7-24m 
25.9 
IOPD 
30.9 
28.0 
28.0 
24.8 
35.3 
21.0 
34.3 
25.9 
27.7 
29.1 
29.4 
32.9 
27.7 
27.1 
25.6 
10.4 
22.9 
32.7 
18.5 
30 
28.2 
28.4 
39.0 
7-18 
18.9 
26.7 
22.7 
33.3 
30.2 
20.7 
SR 
64.0* 
80.8». 
93.8». 
83.9% 
100 % 
77.3% 
100 % 
86.5». 
54.6». 
88.7». 
100 % 
83.0». 
59 1 
37.15 
86.3». 
84.5*. 
70. η 
86. П 
95.0* 
60.0». 
79.2* 
77.8». 
21-50 
50.4* 
47.6* 
90.0* 
92.6* 
94.1». 
88.1* 
26.7* 
Loc : Localization of laser burns (AN: anterior trabecular meshwort; PO: posterior trabecular meshwork; PI: 
pigmented trabecular meshwork; SP: scleral spur; CB: ciliary band). 
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Cir : Total awNint of trabecular meshwrX circumferaice treated (expressed in degrees). 
Ses : Number of sessicms used to treat Uie trabecular mestiworX (1+: second session performed if necessary). 
Number: Total number of bums applied to the trabecular meshwork. 
Exp : Exposure time in seconds (var: variable). 
С : Criterion for burn (1: buttle formation and/or blanching; 2: just blanching). 
Power : Power in M (var: variable; *: 800-1650 n«, not specified for modification; **: 750-1300 M, not 
specified for modification; ***: 700-1000 π«, not specified for modification). 
Gl : Glaucoma type(s) treated (1: primary open-angle glaucoma; 2: primary open-angle glaucoma and pseudo-
exfoliation glaucoma; 3: open-angle glaucoma; 4: heterogeneous group of glaucomas). 
E : Exclusion rules in selecting patients (Y: yes). 
N : Number of eyes. 
FU : Follow-up (m: months; w:wee)ts). 
H O P : Initial I0P in m Hg. 
lOPD : Relative I0P decrease in ». as a function of initial I0P. 
SR : Success rate. 
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Table 4.10. Incidence and height of I0P spikes as a function of: 
a. Amount of trabecular meshwork circumference treated in one 
session (upper part). 
b. Localization of laser bum (lower part). 
Year Circumference Incidence Height 
Themas et al. 
Weinreb et al. 
Heijl 
Kitazawa et al. 
1982 
1983a 
1984 
1984 
360° vs 
360° vs 
360° vs 
360' vs 
ЗбО" vs 
180 
180 
180 
180 
180 
14.4* 
9.4* 
70.0». 
29.5* 
82.» 
vs 
vs 
vs 
vs 
vs 
8.81 
2.9* 
55.0* 
17.1* 
58.4* 
>5 m H g 
>10 mn Hg 
+12.1 vs +5.0imHg 
+10.9 vs +3.4 m Hg 
+61.0* vs +22.6* 
Year Anterior /Posterior Incidence Height 
Schwartz et al. 1983 
Kitazawa et al. 1984 
ant. vs post. 
ant. vs post. 
6.3* 
22.2* 
32.0* 
58.4* 
-0.4 vs 
+11.2* vs 
+3.2 mHg 
+22.6* 
Table 4.11. IOP decrease with different lasers of varying wavelengths. 
Greenidge et al. 
Smith 
Spumy i Lederer 
ИакаЬе 
Year 
1983 
1984 
1984 
1986 
Martenet 4 Schwarzenbach 1986 
Schreas et al. 1988 
lOPD : IOP decrease. 
[¿ser 
Pulsed Argon 
Argon BG 
Krypton R/Y 
Krypton R 
Krypton R 
Argon К 
Krypton R 
Krypton R 
Argon BG 
Krypton R 
Krypton R 
Argon BG 
YAG free run 
YAG free run 
FU : Follow-up (h: hours; w: weeks; a: 
Argon : Argon laser (cont 
Krypton : Krypton laser (R: 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
Cont. Argon 
Argon G 
Argon BG 
Argon BG 
Argon G 
Argon G 
Argon BG 
Argon G 
Argon G 
Argon BG 
Argon G 
Argon G 
Argon BG 
Argon В 
nonths). 
continuous wave; BG: blue-green; 
red; R/Y: red/yellow). 
I0PD (mi 
3.9 
7.1 
7.2 
4.8 
4.8 
7.0 
2.3 
2.3 
7.1 
0.2 
0.2 
7.9 
3.9 
10.4 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
vs 
G : greai). 
Hg) 
3.6 
8.0 
6.9 
7.0 
7.6 
7.6 
7.1 
7.3 
7.3 
7.9 
8.2 
8.2 
6.6 
9.6 
FU 
8w 
10 m 
5 m 
24 h 
24 h 
24 h 
4 w 
4 w 
4 w 
3m 
3m 
3m 
8 w 
11 m 
p-value 
not significant 
not significant 
p< 0.01 
p< 0.01 
p> 0.5 
p< 0.001 
p< 0.001 
p> 0.8 
not significant 
not significant 
YAG free run: YAG laser, free-running mode. 
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Table 4.12. Correlation between success rate and patient variables . 
Year OD/OS P i p Med HOP Color Age Sex Race Glauc 
NO NO 
NO NO 
NO NO 
YES 
NO 
NO 
YES 
NO YES 
Thomas et al. 
Moulin t. Haut 
Schwartz i Kopelman 
Safran et al. 
ZborowsXi et al. 
Danailly et al. 
Schwartz et al. 
Tuulonen et al. 
Bergeà 
Khan et al. 
Krupin et al. 
Lehmann & Faggioni 
Traverso et al. 
Rouhiainen et al. 
Wise 
1982 
1983 
1983 N0 
1984 
1984 
1985 
1985 
1985 
1986a 
1986 
1986 
1986 
1986 
1987a 
1987 
N0 : tío correlation found. 
YES : Correlation found. 
P i p : Trabecular pigmentation. 
Med : Pre-ALT medication. 
HOP : Initial I0P. 
NO 
YES 
YES 
YES 
NO 
NO 
YES YES 
NO 
NO 
NO 
YES 
YES 
N0 
YES 
YES 
YES 
NO 
NO 
NO 
NO 
NO 
Glauc: Glaucomatous danage. 
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Table 4.13. Correlation between IOP decrease and patient variables. 
Year Refr P i p HOP age Sex Pace Med 
Thomas et al. 
Horns et al. 
Lieberaan et al. 
Moulin i Haut 
Safran et al. 
Bergeà 
Ztttrovski et al. 
Klein et al. 
Xu et al. 
Brodell et al. 
Krupin et al. 
Leimnn i Faggioni 
Traverso et al. 
Grinichi et al. 
Jäger et al. 
Rouhiainen et al. 
Traverso et al. 
Rouhiainen et al. 
1982 
1983 
1983 
1983 
1984 
1984 
1984 
1985 
1985 
1986 
1986 
1986 
1986 
1987 
1987 
1987a 
1987 
19B8b 
YES 
NO YES 
NO 
ND 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
YES 
N0 
YES 
YES 
N0 
YES 
N0 
N0 
N0 
N0 
N0 
N0 ND 
Refr.: Refractive error. 
Remaining abbreviations as in table 4.12. 
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Table 4.14. Correlation between initial Ю Р and relative IOP decrease for: 
a. Mean initial IOP (upper part). 
b. Range of initial IOP (lower p a r t ) . 
Year ШІ0Р I0PD Ш О Р I0PD ΜΠΟΡ I0PD MIIOP І(М ШІОР I0PD 
Elsâs 4 Harstai 1983 17.4 20.1 22.9 27.5 26.6 32.7 32.2 45.6 
Кіеіл et al. 1985 19.4 12.9 24.0 27.9 29.4 32.0 36.9 36.6 
B r o d e l l e t a l . 1986 22.8 28.9 28.4 28.8 33.3 37.5 36.7 51.7 
Tear RIIOP lOPD ШОР lOPD RIOT KFD ШОР lOPD ШОР lOPD RIIOP НИ) 
Thomas et al. 1982 10-19 28.0 20-29 30.4 
Schwartz i Kopelman 1983 19-25 34 26-30 37 
Lehmann i Faggioni 1986 15-19 19 20-24 24 25-29 42 
30-39 39.7 40-49 47.3 >50 50 
>30 39 
30-34 39 
HII0P: Mean initial IOP (nn Hg). 
RIIOP: Range of initial IOP (un Hg). 
lOPD : Relative IOP decrease in % as a function of initial IOP. 
Tab le 4 . 1 5 . S u c c e s s r a t e and IOP s p i k e s f o l l o w i n g r e t r e a t m e n t . 
Starita et al. 
Brown et al. 
Bergeà 
Messner et al. 
Richter et al. 
Year 
1984a 
19851) 
1986b 
1987 
1987 
ALT 
Initial 
Cire Ses 
360' 
360' 
360' 
360' 
360' 
1/2 
1/2 
1 
1/2 
1/2 
Retreatment 
Cire Ses 
360° 
360' 
360° 
360' 
180° 
1 
2 
1/2 
1 
1 
N 
17 
26 
20 
14 
40 
Failures 
L 
L 
E,L 
L 
L 
se 
1,4 
1,6 
1,2 
1 
1,3,4,6 
SR 
35.04 
38.54 
60.04 
35.74 
32.54 
Min 
10 
10 
10 
6 
I0PS 
Incid 
29.44 
11.54 
0 4 
0 4 
Cire 
Ses 
N 
Failures: 
SC 
im 
Total part of trabecular meshwort circumference treated. 
Nimber of sessions (1/2: one or two sessions). 
Nimber of eyes. 
Failures following init ial ALT (E: early failures (<2 months); L: late failures 0 2 months)). 
Success criteria (1: minimal IOP decrease included; 2: maximm final IOP included; 3: optic disk 
stable; 4: visual field loss stable; 5: stop glaucoma medication/no start of glaucoma medication; 
6: avoid surgery). 
IK" spike (min: ш л ш т change in IOP indicating an I0PS (nn Hg) ; Incid: incidence). 
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Table 4.16. ALT and i t s e f f e c t on medical control . 
Hedication 
Tear Glaucona FU Less stopped Total 
Thonas et al. 
Homs et al. 
Liebennan et al. 
Pohjarpelto 
1982 
1983 
1983 
1983 
Tuulonen к AiraXsinei 1983a 
Zink et al. 
Danailly et al. 
Finnströn 
Xu et al. 
Sherwood et al. 
1984 
1985 
1985 
1985 
1987 
ИМ 
PCM 
GAG 
PQAG 
PtRG 
GAG 
P(M 
CftG 
CM* 
CM" 
PCM 
5.2 
10 
16 
12 
>12 
1.5 
3 
12 
12 
3 
3 
>12 
26. a 
52.5* 
19.0* 
17.6* 
64.9* 
58.9* 
70.4* 
55.6* 
35.8* 
35.0* 
45.8* 
0 * 
5.1* 
27.6* 
35.3* 
17.5* 
5.7* 
10.1* 
4.0* 
3.8* 
10.0* 
12.5* 
26.1* 
27.9* 
57.6* 
46.6* 
52.9* 
82.4* 
64.4* 
80.5* 
59.6* 
39.6* 
45.0* 
58,3* 
Medication: Percentages o f e y e s with l e s s or no medication fol lowing ALT. 
Glaucoma : Glaucasa t y p e ( s ) t r e a t e d (PCM: primary open-angle glaucoma; CM: open-angle glaucoma). 
FU : Follow-up (months). 
* : Half c ircuuference ALT. 
** : Ful l circumference ALT. 
Table 4.17. Resul ts of ALT in aphakic glaucoma. 
Year N FU ПОР on Hg lOPD * SR 
Hise i Witter 
Thomas et al. 
1979 
1982 
Bellows & Johnstone 1983 
Horns et al. 
Lieberaan et al. 
Robin i Pollack 
Danailly et al. 
Hoskins 
Moulin et al. 
1983 
1983 
1983 
1985 
1987 
1987 
15 
29 
15 
34 
7 
6 
6 
68 
12 
6 
2.7 
8.2 
10 
11.3 
7 
12 
12 
24 
27.06 
21.7 
25.3 
24.7 
22.7 
34 
29.0 
9.7 
32.4 
27.9 
26.4 
50.0 
6.4» 
5.9* 
53.3* 
58.6* 
80.0* 
83.3* 
85.7* 
100 * 
50.0* 
70 * 
41.7* 
N : thnber of e y e s . 
FU : Follov-up (nontl is). 
ПОР : Initial K P (ив Hg). 
lOPD : Relative Ю Р decrease in * as a function of initial I0P (*: m Hg). 
SR : Success rate. 
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Table 4.18. Initial Ю Р , relative IOP decrease and success rate in pseudo-
exfoliation glaucoma as compared with TOAG. 
Thorns et al. 
Elsas i Harstad 
Horns et al. 
Pohjanpelto 
Raitta i Lehto 
Tuulonen & Airateinen 
Bergeà 
Danailly et al. 
Schwartz et al. 
Tuulonen et al. 
Bergeà 
Year 
1982 
1983 
1983 
1983 
1983 
1983a 
1984 
1985 
1985 
1985 
1986a 
Higginbothan ь Richardson 1986 
Traverso et al. 
Grinichi et al. 
Rouhiainen et al. 
Moulin et al. 
1986 
1987 
1987a 
1987 
FU 
5 ni 
0.5-lOm 
1.0- 4.511 
8в 
бш 
6 η 
Um 
12ι 
6 m 
12 m 
2 m 
6 η 
18 η 
36 m 
24 в 
24 m 
4-б 
7-8W 
9m 
12 η 
24» 
36 B 
12 m " 
12 в"* 
24 η 
ПОР 
POM 
23.0 
23.4 
25.5 
25.2 
26.4 
21.2 
25.9 
24.4 
22.4 
21.7 
27.1 
23.1 
22.3 
•mHq 
PEG 
28.5 
27.4 
30.2 
26.8 
32.9 
24.1 
29.9 
28.8 
25.5 
22.0 
29.9 
22.5 
23.5 
I0PD* 
POAG 
22.3 
21.0 
30.6 
36.5 
35.7 
35.3 
18.2 
17.4 
21.7 
27.8 
9.7* 
8.9* 
7.7" 
7.8* 
31.3 
22.8 
26.3 
14.5 
31.3 
9.1 
6.7 
PEG 
43.5 
33.6 
42.4 
40.3 
36.9 
36.2 
27.6 
30.7 
36.5 
43.8 
12.0' 
11.8" 
9.8' 
7.6' 
32.4 
25.1 
38.0 
33.5 
37.1 
17.8 
11.9 
SR 
POftG 
82.5* 
93.7». 
82.3% 
77.6% 
65.4І 
90.01 
93.31 
44.9* 
79* 
79* 
59». 
35* 
21* 
73.5* 
PEG 
97.1* 
94.1* 
87.5* 
95.9* 
68.4* 
97.6* 
94.1* 
75.9* 
73* 
54* 
54* 
50* 
35* 
60.0* 
HOP: Initial I0P (впНд). 
I0PD: Relative I0P decrease in * as a function of initial ОТ. 
Ж : Success rate. 
FU : Follow-up (n: months; v: weeks). 
POM: Priaary open-angle glaucona. 
PEG : Pseudo-exfoliation glaucona. 
* : m Hg. 
" : Power > 350 M. 
" » : Power < 350 »H. 
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Table 4.19. Success rate and relative IOP decrease following ALT in pigment 
dispersion syndrome. 
Year FU ПОР on Hg lOPD t SR 
Thomas et al. 1982 
Horns et al. 1983 
Liebeman et al. 1983 
Lunde 1983 
Robin & Pollack 1983 
Strasser (, Häuf 1984 
Denailly et al. 1985 
Schlosshardt 1986 
Traverso et al. 1986 
Moulin et al. 1987 
Ν : Number of eyes. 
FU : Follow-up (arnüis). 
HOP: Initial IOP ( m H g ) . 
I0PD: Relative IOP decrease 
SR : Success rate. 
6 
6 
16 
13 
11 
9 
17 
8 
20 
12 
ini 
13.5 
7 
18 
7 
3.7 
12 
10.5 
24 
25.0 
23.3 
27.8 
32.0 
22.0 
as a function of follow-ip. 
40.0 
36.5 
11.5 
31.5 
30.9 
100 i 
100 \ 
43.81 
61.51 
72.71 
77.81 
70.51 
75.0% 
81 1 
83.31 
Table 4.20. Changes in faci l i ty of outflow following ALT. 
Year 
Hilensky t Janpol 1981 
Ttonias et al. 1982 
Brubaker ь Liesegang 1983 
Schwartz i Kopelaan 1983 
Bischoff i Speiser 1985 
Merté et al. 1985 
ΠΙ 
1 Й 
5 m 
3 ι 
3 η 
3 w 
6 в 
24 в 
1-2 ш 
1 d 
1.5а 
12 • 
total 
success 
responders 
non-responders 
N 
13 
173 
163 
9 
8 
36 
43 
18 
36 
71 
44 
35 
Facility of outflow (iil/mn/nmHq) 
Pre-Μ,Τ 
0.105 + 0.016 
0.14 
0.10 
0.09 
0.14 
0.08 
0.10 0.06 
Post-ALT 
0.168 + 0.31 
0.23 
0.23 
0.21 
0.14 
0.19 
0.16 
0.15 
0.09 
Change 
+0.063 
+0.09 
+0.13 
+0.12 
0 
+0.11 
-0.01 
+66Î* 
+74*' 
+77Î* 
FU: Follow-up (d: day; w: weeks; в: goiUis). 
Ν : Ninber of eyes. 
* : No absolute values available. 
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CHAPTER 5 
RETROSPECTIVE STUDY 
5.1 AIM OF THIS STUDY 
The principal aim of this retrospective study was the evaluation of 
changes in IOP following Argon Laser Trabeculoplasty (ALT). Success or fail-
ure were determined by changes in IOP. The second focus of this study was on 
the influence of ocular variables, patient variables and ALT variables on 
the changes in IOP. 
in the event of bilateral ALT the results in the eye treated first were 
primarily considered (contrary to what has so far been usual in most of the 
literature studied). A study of results in unilaterally and bilaterally 
treated patients as one large group of eyes for various reasons entails a 
risk of distortion. To begin with, the ALT indication for the second eye of 
a patient already treated unilaterally may depend on the favourable response 
of the first eye. Secondly, it is improbable that the ALT responses in both 
eyes of a given individual would not correlate. Finally, patient variables 
can only be tested for the response in one eye in order to exclude the per-
centage of bilaterally treated patients to lead to systematic distortion, 
precluding comparisons between different studies. 
However, primary evaluation of the eyes treated first also encompasses a 
selection (favouring functionally less good eyes) because in patients with 
bilateral glaucoma the eyes with the most advanced loss of function (or the 
highest IOP) will be treated first. Nevertheless this method merits prefer-
ence, particularly if the results obtained in bilaterally treated patients 
are studied separately. 
In studies in which patients with excessive values are selected on the ba-
sis of a given variable (e.g. IOP), repeated measurements in the course of 
time involves a so-called regression to the mean effect. The intensity of 
this effect depends on physiological variation and measuring error. Since in 
the study under discussion a patient was selected on the basis of repeatedly 
measured excessive IOP combined with 'circumstantial evidence' (optic disk 
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damage and visual field defect), this effect on the ALT result is bound to 
be very small. 
A number of variables so far given insufficient attention in the litera­
ture were documented to permit evaluation of their influence on the ALT re­
sult. These variables include: 
- The extent of optic disk damage and visual field loss and, inversely, the 
response to ALT of eyes with increased IOP, with or without glaucomatous 
optic disk damage but without visual field defect (suspected glaucoma). 
- Already instituted medication and surgical therapy. 
- Findings in aphakic eyes other than those of aphakia. 
- Gonioscopic findings and their effect on ALT. 
- The influence of cataract extraction in secondary glaucoma. 
The influence of non-ocular features such as age and sex on ALT results 
will be considered as well. 
The most relevant ALT features which may affect results are: 
- The various ALT modifications. 
- The quality of the ALT performed. 
- Iris stretching and combination of ALT with iridotomy. 
- The experience of the person performing the ALT. 
- The ALT modification as related to the chance that repeated ALT will be 
successful. 
Apart from these specific questions, more general aspects of ALT will re­
ceive attention. 
Since the abovementioned variables can often be categorized only specific­
ally, patient descriptions are largely devoted to this. 
5.2 DESIOI OF THE НЕИЮЗРЕСП Е STUDY 
During the period 15th June 1982 through Z4th June 1986, unilateral or bi­
lateral ALT was performed on 351 patients in the Ophthalmological Department 
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of the Nijmegen University Hospital. Patients treated after 24th June 1986 
were included in the prospective study to be presented in Chapter 6. 
The only exclusion rule concerns exclusion of patients with a follow-up 
shorter than 6 weeks. On the basis of th i s reason, and for other reasons 
l i s ted in table 5.1, 39 patients were excluded from this study. 
Table 5.1. Reasons for non-participation of 39 patients in the retrospective 
study. 
ALT not possible (no ALT after iris stretching (4); no visualization (1); 6 
ALT not possible because of other reasons (11). 
Insufficient data on patient or treatnent. 7 
Planned trabeculectomy within 2 weeks post-ALT. 1 
No follow-up because of: death of patient (colon carcinoma (1); myocardial 13 
infarctim (1); CVA (1); unknown (1)); patient records no 
longer available (9). 
No follow-up because of patient поп-соярііапсе. 5 
Incomplete or less than 6 weeks follow-up. 7 
Total 39 
The data of 312 patients who in the end participated were collected from 
the patient records and recorded on the basis of a code book (Addendum 1). 
For patients referred back to their own ophthalmologists, follow-up data on 
IOP, medication and secondary interventions (if any) were requested from 
these colleagues (26.6% of the total group). 
On the basis of glaucoma type and/or specific ocular status at the time of 
ALT, the patients were included in one of the nine following subgroups: 
1. Phakic primary open-angle glaucoma (phakic POAG). 
2. Aphakic primary open-angle glaucoma (aphakic POAG). 
3. Pseudophakie primary open-angle glaucoma (Pseudophakie POAG). 
4. Pigment dispersion syndrome. 
5. Low-tension glaucoma. 
6. Neovascular glaucoma due to diabetes mellitus. 
7. Secondary glaucoma. 
8. Glaucoma suspect without glaucomatous optic disk damage (disk-). 
9. Glaucoma suspect with glaucomatous optic disk damage (disk-·-). 
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Phakic PQAG and glaucoma suspect: 
Eyes with increased Ю Р , glaucomatous optic disk features and glaucomatous 
visual defects, without other demonstrable glaucoma causes and without ocu­
lar data justifying inclusion in one of the other subgroups, were included 
in the subgroup phakic POAG. 
If a patient showed only bilateral increased IOP, or unilateral increased 
IOP and normal contralateral IOP without glaucomatous optic disk damage and 
without visual field defect, then the treated eye was included in the sub­
group glaucoma suspect without glaucomatous optic disk damage (disk-). If 
glaucomatous optic disk damage was present but no visual field defect, then 
the treated eye was included in the subgroup glaucoma suspect with optic 
disk damage (disk+). 
Enlargement of the blind spot, total or central loss of sensitivity or a 
combination of the two at perimetry was not classified as a glaucomatous de­
fect (see 3.5.3.1). 
If on the basis of the criteria one eye would have to be included in one 
of the two glaucoma suspect subgroups while the contralateral eye showed ev­
ident POAG , then the first eye too was classified in one of the subgroups 
phakic, aphakic or Pseudophakie POAG. 
Of 59 glaucoma suspects, 52 had a symmetrical classification (26 bilateral 
glaucoma suspect without and 26 with glaucomatous optic disk damage), 5 were 
unilateral glaucoma suspects, 1 was a unilateral glaucoma suspect with con­
tralateral traumatic glaucoma, and only 1 was a glaucoma suspect with optic 
disk damage in one eye and without damage in the other. This patient was 
treated by unilateral ALT (on the side with optic disk damage) and was clas­
sified in the corresponding subgroup. 
Within the glaucoma suspect subgroups, no further distinction was made be­
tween phakic, aphakic and Pseudophakie eyes (5 aphakic/pseudophakic eyes in 
59 glaucoma suspects). 
Aphakic and Pseudophakie glaucoaa: 
Included in these two subgroups were eyes with evident glaucoma or in­
creased IOP prior to cataract extraction (not resulting from cataract ex­
traction) . 
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Pigment dispersion syndrome: 
Eyes with pigment dispersion syndrome and increased IOP, with or without 
glaucomatous optic disk changes and/or visual field defects, were included 
in this subgroup. Of 10 eyes treated, 1 showed only increased IOP while the 
remaining 9 showed glaucomatous features as well. 
Low-tension glaucoma: 
This subgroup included eyes in which glaucoma had developed while the IOP 
remained normal {< 21 mm Hg). 
Neovascular glaucoma: 
This smallest subgroup included 4 eyes with rubeosis irides and increased 
IOP resulting from diabetes mellitus. Two eyes in addition showed glaucoma-
tous optic disk features and/or visual field defects. 
Secondary glaucoma: 
Various types of secondary glaucoma were lumped in this group to begin 
with. At evaluation of results, however, each of these types will receive 
attention on a limited scale. Secondary glaucoma types in this subgroup in-
cluded (number of eyes specified): 
- Corticosteroid glaucoma (systemic corticosteroids used in the treatment of 
sarcoidosis (1) and uveitis (1)). 
- Uveitic glaucoma (common uveitis (11) and acute exudative syphilitic uve-
itis (D). 
- Traumatic glaucoma (blunt trauma (6) and sharp trauma (2)). 
- Glaucoma following cataract extraction (l). 
- Glaucoma/IOP increase following surgery for detached retina (5). 
- Miscellaneous (condition following untreated central vein occlusion (1), 
condition following treated central vein occlusion (1) and tapetoretinal 
degeneration (1)). 
Seven of these eyes were submitted to ALT in view of increased IOP without 
glaucomatous optic disk changes or visual field defect but giving the clini-
cal impression that IOP reduction was required for preventive reasons. 
In the discussion of results, 7 eyes will be added (with congenital glau-
207 
coma (4), juvenile glaucoma (1), congenital cataract and glaucoma (1) and 
hyperthyroidism (1)). 
5.3 DEMOGRAPHIC DATA 
Table 5.2 presents a survey of some demographic data, specifying in addi-
tion the rate of bilateral treatment per subgroup. The percentage of pa-
tients treated bilaterally depends on the type of glaucoma and ranges from 
0% (within secondary glaucoma) to 63.2% (low-tension glaucoma). The total of 
eyes treated was 443 (in 312 patients) but 7 eyes of 7 patients are not in-
cluded in the tables. They will be considered in the discussion of results 
obtained in secondary glaucoma types. The response of the contralateral eye 
was not evaluated in 3 patients because the diagnosis of this eye differed 
from that of the first eye. 
Table 5.2. Demographic characteristics distributed per subgroup (Disk -/+: 
without/with glaucomatous optic disk damage; Bilat: percentage 
patients with bilateral ALT). 
Number Age 
Glaicma type Fat Eyes Bilat Mean + SD Min - Max Male:resale CD : OS 
Phatíc PCM 
Aphakic PCM 
Pseudophalcic POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Corticosteroid 
Uveitic 
Traunatic 
Post Cataract Extr. 
Post Retinal Detaclm. 
Miscellaneous 
Glauccna Suspect, Disk-
Glaucoma Suspect, Disk* 
Total 
153 
19 
10 
10 
19 
4 
31 
2 
12 
8 
1 
5 
3 
28 
31 
305 
219 
25 
14 
16 
31 
5 
35 
3 
14 
9 
1 
5 
3 
44 
44 
433 
43.« 
31.6* 
4/10 
6/10 
63. г% 
1/4 
12.91 
1/2 
16.7* 
1/8 
57.lt 
41.91 
42.0» 
67.6 + 11.4 
68.8 + 11.3 
73.3+ 6.6 
41.6 + 11.1 
68.5 + 8.1 
67.3+ 7.9 
50.2 + 16.4 
40.5 + 16.3 
52.8 + 15.7 
40.5 + 16.5 
72 
57.2 + 12.3 
52.7 + 20.6 
60.4 + 15.0 
64.2 + 14.9 
29-
37-
63-
27-
56 -
59-
20-
29-
23-
20-
36-
29-
14-
17-
88 
84 
- 83 
- 65 
 81 
- 75 
78 
52 
78 
64 
66 
- 66 
- 88 
81 
64.3 + 14.1 14 - 88 
92 
6 
5 
7 
6 
2 
18 
8 
7 · 
1 
2 
14 
16 
61 
13 
5 
3 
13 
2 
13 
2 
4 
1 
1 
4 
1 
14 
15 
166 : 139 172 : 133 
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The mean age was calculated on the basis of the age at the time of (the 
f i r s t session) of ALT. The mean age of a l l patients in th i s study was some 
64 years. In the pigment dispersion syndrome and secondary glaucoma the mean 
age was below t h i s . 
Glaucoma suspects without disk damage averaged younger than those with 
disk damage. The l a t t e r averaged younger than patients with phakic POAG. 
The sex dis tr ibut ion revealed a female predominance in the low-tension 
glaucoma subgroup (predominance in the aphakic POAG group is less pronounced 
if a l l eyes with cataract extraction are included), and a male predominance 
in the pigment dispersion syndrome and traumatic glaucoma subgroups. 
5 . 4 EXTRAOCULAR FEATURES 
Table 5.3 shows the frequencies of extraocular diseases as noted in the 
patient records. 
Table 5.3. Frequencies of extraocular diseases. 
№) Known Concomitant Diseases 53.31 
Arterial Hypertension 14.H 
Cardiovascular Diseases 13.4% 
Pulmonary Diseases 9.5% 
Diabetes Mellitus 7.2% 
Neoplasia 2.0% 
Neurological Diseases 1.6% 
Disorders of Uie Joints and Connective Tissue 1.6% 
Thyroid Diseases 1.3% 
Diseases of Uie Kidney an Urinary Tract <1.0% 
Diffuse Systadc Diseases <1.0% 
Psychiatric Diseases <l.0% 
This table shows that v i r tual ly one out of every two glaucoma pat ients has 
one or more concomitant pathological conditions. These figures probably un­
derestimate the true s i tuat ion because i t could not be established with cer­
tainty that a complete history was taken in a l l cases. 
A number of factors have been identified as high-risk factors regarding 
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glaucoma (arterial hypertension, diabetes mellitus and cardiovascular condi­
tions such as cardiac decompensation, angina pectoris, arrhythmias and myo­
cardial infarction). At least one of these high-risk factors was evident in 
34.1% of the POAG cases (phakic, aphakic and Pseudophakie), 47.2% of low-
tension glaucoma cases, 10.7% of the glaucoma suspects without and 29.0% of 
those with optic disk damage. The frequency in glaucoma suspects without 
disk damage was significantly lower than that in POAG (p<0.02) and that in 
low-tension glaucoma (p<0.001). There was an indication of a difference be­
tween the glaucoma suspect subgroups (p<0.10). 
5.5 GENERAL· OCULAR Е Х А М Ш А Т І Ш 
The mean preoperative visual acuity per subgroup is mentioned in table 
5.4. As compared with phakic POAG, eyes with POAG and cataract extraction, 
eyes with neovascular glaucoma and eyes with secondary glaucoma had slightly 
lower visual acuity. Good visual acuity values were found, on the other hand 
in the pigment dispersion syndrome and in glaucoma suspects. 
Table 5.4. Mean visual acuity before ALT, per subgroup. 
Phakic И М 0.55 + 0.32 
Aphakic POAG 0.34 + 0.29 
Pseudophakie POAG 0.35 + 0.31 
Piquait Dispersion S. 0.75 + 0.34 
Low-tension Glaucoma 0.46 + 0.30 
Neovascular Glamm 0.34 + 0.38 
Secondary Glaucoma 0.42 + 0.31 
Glaucoma Suspect, Disk- 0.79 + 0.27 
Glaucoma Suspect, Disk* 0.68 + 0.29 
Apart from factors associated with glaucoma or its therapy there were in 
the patient population studied some concomitant ophthalmological changes 
which partly explained the abnormal visual acuity in some cases. Of 258 
phakic eyes, 117 (45.3%) showed a more or less interfering cataract. In ad­
dition there were other findings which in some cases may have unfavourably 
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affected vision (table 5.5). 
Table 5.5. Findings at preoperative ophthalmological examination. 
Eyes 
Cornea Cornea Edema 3 
Cornea Opacities 3 
Comea Scar 1 
Bullous Keratopathy 1 
Cornea Neovascularization 1 
Miscellaneous 1 
Iris Iritis 9 
Rubeosis Irides 3 
Iris Transillumination 4 
Iris Atrophy 1 
Iridodonesis 1 
Iris Scar 1 
Pupil Posterior Synechiae 5 
Irregular Pupil 1 
Lais Traumatic Lensluxation 1 
Retina Central Retinal Vein Occlusion 7 
Diabetic Retinopathy 4 
Hypertaisive Retinopathy 2 
Snailtrack 1 
Tapetoretinal Degeneration 1 
Macula Pigment Alterations 20 
Senile Macular Degeneration 4 
Drusen 2 
Cystoid Macular Mena l 
Strabisms 1 
Disturbed Eye Movenents 1 
Congested Episcleral Veins 1 
Proptosis 1 
5.6 SPECIFIC GLAUCCMA FEATURES 
5.6.1 Scales for nedication, optic disk and visual field function 
For three glaucoma features scales were developed, or existing scales a-
dapted. 
If for example several medications are included in a scale, then the sum 
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of the scores determines the total score for the eye. 
Table 5.6 presents a scale for topical glaucoma drugs. The number of 
points assigned to a particular type of eyedrop was based, on the one hand 
on its position in the treatment of glaucoma and on the other hand on the 
frequency and severity of its side effects. The scores go from 0 (no topical 
medication) to 3 (irreversible Cholinesterase inhibitors). The use of car-
bonic anhydrase inhibitors was not included in this score but coded separa-
tely. 
Table 5.6. Scale for topical glaucoma drugs. 
Score 
Miotics: 
Pilxarpine 1-24, Isoptocarpine 1-2% 1 
Pilocarpine 44, Isoptocarpine 44 2 
Äcididine (Glaucostat"), Carbachol (Isopto Carbachol") 2 
Fluostigmine (Diflupyl"), Fysostigmine, Echothiophaat 3 
(Rraspholine Iodide") 
Beta-Adrenerg Blocking Agents: 
Timolol (Tiroptol" 0.25-0.504), Hetipranolol (Beta-Ophtiole") 1 
Betaxolol (Betoptic") 
Sympathomimetic Agents: 
Adrenaline (Isopto Efcinal", Егру") 1 
Dipevrefine (Diopine") 1 
Sympatholytic Agents: 
Guanethidine (Ismelin") 2 
Combined Agents: 
Aciclidine/Epinephrine (Glaucadrine") 2 
Metipranolol/Pilocarpine (Nonnoglaucon") 2 
Guanethidine/Mrenaline (Suprexon") 2 
Another scale was developed for the degree of glaucomatous optic disk dam­
age (table 5.7). Proceeding on the basis of the cup/disk rat io points were 
assigned in numbers increasing by steps of two. Given explicit ly mentioned 
ver t ica l ovality, nasal displacement of blood vessels or peripapillary atro-
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phy, the score was increased by one point. If there was no glaucomatous cup­
ping or if a physiological or central cupping was described, the score was 
set at 0. 
Table 5.7. Scale for the degree of glaucomatous damage to the optic disk. 
Score 
No glaucomatous cupping, physiological or central cupping 0 
Beginning glaucomatous cupping, cup/disk ratio 0.4-0.5 2 
Moderate glaucomatous cupping, cup/disX ratio 0.6-0.7 4 
Severe glaucomatous cupping, cup/disk ratio >0.7 6 
Total cupping 8 
Vertical ovality score +1 
Nasal displacment of blood vessels score +1 
Peripapillary atrophy score +1 
Finally, visual field loss was used in a classi f ication (table 5.8) based 
on stages of visual field defect as described by Aulhorn (3.5.3.2). 
The principal modification in relation to the existing scale was addition 
of categories А, В and C: enlargement and/or baring of the blind spot, a de­
crease in t o t a l or central sensit iv i ty, and a combination of these respect-
Table 5.8. Classification of findings at perimetric examination. 
Stage 
No visual field defect; no visual field changes 0 
Relative visual field defect 1 
Absolute defects іл Uie Bjerrm area not linied to the blind spot, unless by a 2 
relative defect; absolute nerve fiber bundle defect 
Bjerrm scotola; isolated nasal step 3 
(Half)-ring shaped absolute paracentral defect 4 
Caitral island, with or without te^nral rest 5a 
Central island collapsed 5b 
Enlargement and/or baring of the blind spot Ά 
Decrease in total or central sensitivity В 
Ai В С 
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ively. As already pointed out in 3.5.3.1, these are neither early nor spe-
cific glaucoma features; they were separately coded, however, because they 
cannot be included in the stage 'no visual field changes'. 
5.6.2 Findings 
5.6.2.1 Glaucoma medication and previous glaucoma surgery 
Table 5.9 shows the distribution of various types of glaucoma drugs per 
subgroup. 
Table 5.9. Distribution of topical glaucoma drugs and carbonic anhydrase in-
hibitor use before ALT, per subgroup (Beta-block: Beta-adrenerg 
blocking agents; CAI: Carbonic anhydrase inhibitors). 
Phakic POAG 
AphaXic POAG 
PseuuophaJcic POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoœa 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
None 
5.η 
10.5». 
2/10 
10.5t 
21.4t 
12.9t 
8.2t 
Beta-block 
83.0t 
84.2t 
9/10 
7/10 
78.9t 
4/4 
90.3t 
57.1t 
64.5t 
79.3t 
Miotics 
51.0t 
26.3t 
3/10 
2/10 
21.1t 
19.4t 
35.7t 
54.8t 
41.0t 
Synçatlmiietics 
13.lt 
36. St 
4/10 
1/10 
5.3t 
29.0t 
14.3t 
19.4t 
17.0t 
Combined Agents 
7.8t 
10.5t 
5.3t 
9.7t 
3.2t 
6.2t 
CM 
19.6t 
26.3t 
3/10 
1/10 
10.5t 
2/4 
45.2t 
14.3t 
9.7t 
21.0t 
In about 1 out of 12 eyes in this study no topical glaucoma drugs were 
prescribed. This concerned 15 eyes (4.9%) which had shown an allergic reac-
tion to one or several eyedrops, and 10 eyes (3.3%) of patients who could 
not or would not apply eyedrops. 
A majority of the patients used a ß-blocker, and some 50% a miotic. Only a 
very small number used an irreversible Cholinesterase inhibitor (2.6%). Be-
cause eyedrops were sometimes used in combination, the total percentage in a 
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subgroup often exceeds 100%. 
Carbonic anhydrase inhibitors were used by 21.0% of the patients. As com­
pared with phakic POAG, we find a low frequency in low-tension glaucoma, 
pigment dispersion syndrome and glaucoma suspects. A high frequency is ob­
served in eyes with neovascular glaucoma and secondary glaucoma. 
Table 5.10 presents the medication scores and the mean score per subgroup 
and in addition shows the distribution of carbonic anhydrase inhibitor in 
relation to the medication score. 
Table 5.10. Distribution of medication scores and mean medication scores, 
before ALT, per subgroup (SD: standard deviation). 
PhaJdc F0AG 
AphaJtic PORG 
Pseiriophaiic POAG 
Pigment Dispersion S. 
Lew-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Dis)c+ 
Total 
0 
5.« 
10.5* 
2/10 
10.54 
21.« 
12. η 
8.2* 
Carbonic AniiyiJrase Inhibitor 4.0І 
1 
32.71 
26.1% 
4/10 
5/10 
63.2% 
4/4 
51.6* 
42. η 
35,5* 
39.0». 
15.1», 
2 
39.2!; 
42. It 
6/10 
3/10 
21. Π 
35.5* 
25.0* 
32.3* 
35.7* 
23.9* 
3 
15.0* 
15.8* 
5.3* 
9.7* 
7.1* 
9.7* 
11.7* 
37.1* 
4 
2.6* 
5.3* 
3.2* 
3.6* 
3.2* 
2.6* 
3/8 
5 
3.9* 
6.5* 
2.6* 
3/8 
6 
0.7* 
0.3* 
Mean + SD 
1.9 + 1.1 
1.8 + 1.0 
1.6 + 0.5 
1.1 + 0.7 
1.2 + 0.7 
1.0 
1.7 + Ο.β 
1.3 + 1.0 
1.7 + 1.3 
1.7 + 1.1 
The mean medication score was highest for eyes with phakic POAG. Most eyes 
showed a total score of 1 or 2 points, as could have been expected on the 
basis of the distribution of the types of drugs. 
The use of carbonic anhydrase inhibitors increased with increasing medica­
tion score, which is consistent with the strategy that maximum topical medi­
cation was usually tried first. One patient used no topical medication but 
did receive a carbonic anhydrase inhibitor (4% of all eyes with score 0). 
Apart from medication, a number of eyes had also been submitted to glau­
coma surgery. Table 5.11 presents the distribution and type of glaucoma sur­
gery performed. 
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Table 5.11. Frequency distribution and type of pre-ALT glaucoma surgery per 
subgroup (Others: iridencleisis, Scheie procedure, subscleral 
trepanation, Elliot procedure; Comb: combination of trabeculec­
tomy with other filtering procedure). 
PtaXic POAG 
Aphakic POftG 
PseudophaXic POAG 
Pigment Dispersion S. 
Low-tension Glaucona 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma suspect, Disk+ 
Total 
Not Operated 
86.9% 
42.П 
3/10 
10/10 
89.5». 
4/4 
54.8І 
92.9% 
90.3». 
79.3* 
Filtering 
Trabeculectomy 
1 
9.2% 
31.6% 
3/10 
10.5% 
19.4% 
3.2% 
10.5% 
>1 
0.7% 
19.4% 
2.3% 
Procedures 
Others 
5.3% 
2/10 
7.1% 
1.6% 
Comb 
0.7% 
5.3% 
1/10 
3.2% 
3.2% 
1.6% 
Iridec­
tomy 
2.6% 
3.2% 
1.6% 
Cyclo-
cryo 
5.3% 
3.2% 
0.7% 
Unknown 
10.5% 
1/10 
1.0% 
About 1 out of 5 eyes had already been submitted to one or more opera­
tions. As compared with phakic POAG, eyes with aphakic or Pseudophakie POAG 
and those with secondary glaucoma showed a high frequency. 
Most of the eyes operated on had been submitted to a single trabeculecto­
my; 7 eyes had been submitted to at least 2 trabeculectomies (including 2 
eyes submitted to 4 trabeculectomies each). 
A different filtering procedure (iridencleisis, Scheie procedure, subscle­
ral trepanation, Elliot procedure) had been performed on 5 eyes, and 5 eyes 
had been submitted both to trabeculectomy and to another filtering proce­
dure. 
A peripheral iridectomy or laser iridectomy/iridotomy had been performed 
on 5 eyes. One aphakic eye had been treated by cyclodialysis following tra­
beculectomy and trabeculotomy, and one eye with traumatic glaucoma had been 
submitted to cyclocryocoagulation. 
The exact glaucoma operation performed on 3 eyes could not be traced. One 
aphakic eye was believed to have been submitted to a total of 9 operations. 
Four eyes (3 phakic POAG eyes and l glaucoma suspect with optic disk dam-
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age) had already undergone ALT elsewhere. 
5.6.2.2 Optic disk 
Table 5.12 presents the distribution of optic disk scores and the mean 
disk score per subgroup. 
Table 5.12. Distribution of disk scores and mean disk scores before ALT, per 
subgroup (SD: standard deviation). 
0-1 2-3 4-5 6-7 8 Mean + Я) 
PhaXicPOM 
Aphakic PQAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension GLaucara 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
9.3* 
6.3». 
3/10 
2/4 
25.01 
100% 
12. П 
19.74 
14.7* 
25.0t 
3/10 
5.3% 
1/4 
10.7». 
45.6* 
16.3». 
18.6». 
6.3* 
1/10 
1/10 
36.8* 
7.2* 
19.4* 
15.6* 
45.3* 
37.5* 
7/10 
3/10 
52.6* 
1/4 
46.4* 
19.4* 
38.6* 
12.0* 
25.0* 
2/10 
5.3». 
10.7* 
3.2* 
9.8* 
4.8 + 2.3 
5.1 + 2.5 
6.2 + 1.1 
2.8 + 2.5 
5.3+ 1.5 
2.0 + 2.8 
4.1 + 2.9 
3.1 + 2.6 
4.1 + 2.6 
For 10 eyes (3.3%) no recent disk score was traceable (3 eyes with phakic 
POAG, 3 with aphakic POAG, 3 with secondary glaucoma and 1 glaucoma suspect 
without glaucomatous optic disk damage). These eyes were classified on the 
basis of optic disk descriptions recorded some considerable time prior to 
ALT; this may have had consequences only for the glaucoma susjject without 
optic disk damage if during the interval between documentation and ALT optic 
disk damage had occurred. 
Leaving aside the subgroup of glaucoma suspects without optic disk damage 
(these eyes have score 0 per definition), 53.4% of the eyes had a score of 
at least 6 points, which reflects a minimum cup/disk ratio of 0.8. 
A disk score of 0-1 was found in 58 eyes, including 28 glaucoma suspects 
without optic disk damage. Four eyes in the subgroup glaucoma suspect with 
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optic disk damage had a score of 0-1 but were nevertheless classified in 
this subgroup on the basis of clinical impression mentioned in the patient 
records. 
It has already been pointed out in section 5.2 that 7 eyes with secondary 
glaucoma and 1 eye with pigment dispersion syndrome showed no glaucoma fea­
tures other than increased Ю Р . Two eyes with pigment dispersion syndrome 
showed no evidently glaucomatous cupping but did have visual field defects. 
A total of 15 eyes with POAG (14 phakic and 1 aphakic) showed no glaucoma­
tous optic disk features, but were nevertheless classified in the relevant 
subgroups in view of findings in the contralateral eye or because there were 
glaucomatous visual field defects. 
A high mean disk score was found in eyes with POAG and cataract extraction 
and in low-tension glaucoma. 
The frequency of eyes with a disk score of 6 and higher was 57.3% for pha-
kic POAG and 22.6% for glaucoma suspects with glaucomatous optic disk damage 
(p<0.001). 
5.6.2.3 Visual field stages 
The findings obtained at perimetry are subject to several limitations. To 
begin with, a visual field stage could be assigned to only 224 eyes (73.4%) 
because the interval between perimetry and ALT must not exceed 6 months 
(this in order to prevent any increase in visual field defect due to glau­
coma progression from being ascribed to insufficient response to ALT). This 
approach implies a selection on the basis of the frequency of perimetry in 
an eye. In actual fact this may mean that eyes with a high perimetry fre­
quency on the basis of glaucoma severity and/or progression of visual field 
defect, had a better chance of being assigned a score. 
Other factors playing a role in not assigning a visual field stage were: 
ocular factors (conditions after detachment of the retina, with or without 
surgical therapy, panretinal laser coagulation for diabetic retinopathy, 
pronounced miosis and the presence of a marked cataract), patient-related 
factors (insufficient cooperation) and logistic reasons. In regard to the 
lastmentioned reasons it should be borne in mind that a number of patients 
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were referred in whom a previously diagnosed visual field defect would not 
always be confirmed. 
When a visual field stage was assigned to an eye, this was not always done 
on the basis of the same perimetric technique. In our department we use 
Goldmann kinetic perimetry, static perimetry (Friedman Visual Field Analy-
ser /Peritest) or a combination of these. 
Table 5.13 presents the distributions of visual field stages found in the 
subgroups. 
Table 5.13. Distribution of preoperative visual field stages per subgroup 
(Scored: percentage of eyes in which perimetric findings fulfil-
led the criteria accepted so that a value could be assigned). 
PhaXic POM 
AphaJcic POAG 
PseudopfiaJcic POflG 
Pigment Dispersion S. 
Low-taisicm Glaucana 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk* 
Total 
scored 
71.« 
68. « 
5/10 
7/10 
94.7t 
1/4 
67.71 
71.« 
90. ì\ 
П.і% 
0 
2.7t 
7.7t 
1/7 
4.8t 
60.0t 
42.9t 
13.4t 
1 
12.6t 
3/7 
4. Bt 
8.0t 
2 
25.2t 
7.7t 
1/7 
11.1t 
23.et 
16.5t 
3 
20.7t 
23.1t 
1/7 
33.3t 
14.3t 
16.1t 
4 
8.1t 
15.4t 
16.7t 
6.3t 
5a 
8.1t 
15.4t 
2/5 
22.2t 
9.5t 
e.5t 
5b 
0.9t 
1/5 
0.9t 
Ά 
0.9t 
7.7t 
4.8t 
5.0t 
1.8t 
В 
13.5t 
15.4t 
2/5 
1/1 
28.6t 
25.0t 
46.4t 
19.6t 
С 
7.2t 
7.7t 
1/7 
16.7t 
9.5t 
10.0t 
10.7t 
8.9t 
A number of eyes with pigment dispersion syndrome, neovascular glaucoma or 
secondary glaucoma showed no evident visual field defects (see 5.2/5.6.2.2). 
The subgroups phakic, aphakic and Pseudophakie POAG included eyes without 
evident glaucomatous visual field defects (stages 0, A, B, and C). This was 
a result of the way in which the eyes were classified: partly on the basis 
of the findings in the contralateral eye. Another reason is that eyes were 
included in these groups when past perimetry had revealed glaucomatous vis­
ual field loss which, however, was absent at the time of staging. 
Stages 4 and 5 are more often encountered in low-tension glaucoma and in 
eyes with POAG and cataract extraction than in phakic POAG. 
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5.6.2.4 Gonioscopy 
The gonioscopic findings are listed in table 5.14. 
Table 5.14. Pre-ALT gonioscopic findings per subgroup (PAS: peripheral ante-
rior synechiae; TP +3/+4: trabecular pigmentation +3/+4; Miscel-
laneous: (local) angle obliteration, shallow anterior chamber, 
abnormal blood vessels in the chamber angle, trabecular meshwork 
not/hardly pigmented, angle recession and altered anatomy of the 
angle). 
Phakic POAG 
Aphakic POAG 
Pseudophakie POSG 
Pigment Dispersion s. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disfr 
Total 
None 
60.« 
31.64 
6/10 
78.94 
1/4 
45.24 
64.34 
Í1.34 
56.14 
Harrow Angle 
19.64 
10.54 
3/10 
21.14 
1/4 
9.74 
21.44 
22.64 
18.44 
PAS 
5.94 
42.14 
2/10 
1/4 
35.54 
7.14 
16.14 
12.54 
TP+3/+4 
5.24 
5.34 
10/10 
3.24 
3.64 
3.24 
7.24 
Miscellaneous 
17.64 
31.64 
1/10 
2/4 
19.44 
14.34 
9.74 
15.74 
About 20% of the eyes had a narrow iridocorneal angle, caused by the pres-
ence of a plateau iris in open-angle glaucoma. In such cases the iris root 
inserts on the anterior part of the ciliary body and the iridai root shows a 
sharp angle at the level of the iridocorneal angle (beak shape). A shallow 
anterior chamber was found in only 9 eyes (3.0%). 
The distribution of narrow angle was fairly constant within the various 
subgroups, except in the pigment dispersion syndrome in which no narrow an-
gle occurred. 
Peripheral anterior synechiae (PAS) were mainly seen in aphakic POAG and 
secondary glaucoma. The frequencies found were significantly higher than 
those in phakic POAG (p<0.001). 
All eyes with a pigment dispersion syndrome showed marked pigmentation of 
the trabecular meshwork, while only 0 to 5.3% of the other glaucomas showed 
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such marked pigmentation. 
The abnormalities listed under Miscellaneous included - among other things 
- (local) obliteration of the angle (4.3%), shallow anterior chamber (3.0%), 
abnormal blood vessels in the angle (2.6%), trabecular meshwork not/hardly 
pigmented (1.6%), angle recession (1.6%) and an altered anatomy of the angle 
(1.3%). 
From these gonioscopic findings two variables were distilled which might 
influence ALT results: iridocorneal angle changes which might interfere with 
ALT (i.e. PAS, local obliteration of the angle and poor visualization of the 
trabecular meshwork) in aphakic POAG and secondary glaucoma, and a narrow 
iridocorneal angle due to a plateau iris in phakic POAG. 
5.7 ARGON LASER TRABECULOPIASTY 
The way in which ALT was performed in this study can be divided into three 
modifications: treatment of 360° of the trabecular meshwork in one session 
(1 * 360°), treatment of 180° of the trabecular meshwork in one session (1 * 
180°) and treatment of 360° of the trabecular meshwork in two sessions (2 * 
90 
70 
50 
30 
10-
° 2-180 
ο ΜβΟ 
о 1«Э60 
1982 1983 1984 1985 1986 
Figure 5.1. Distribution of ALT modifications by year of application. 
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180°). The distribution of these ALT modifications depended in part on the 
year in which it was performed (fig. 5.1). with increasing experience, пюге 
and more eyes were treated by 2 * 180°. 
Interpretation of ALT results should take into account that eyes treated 
by l * 180° ALT have already been selected on the basis of success. If the 
first 180" session caused no or inadequate IOP decrease, then a second ses­
sion was performed. On the other hand, a second session was often planned in 
advance without waiting for the result of the first. Figure 5.2 presents the 
cumulative frequency of the number of eyes plotted against the number of 
weeks between the first and second session in cases treated by 2 * 180° ALT. 
Up to 8 weeks (two-thirds) the eyes involved were probably eyes for which a 
second session had already been planned. The eyes with a longer interval be­
tween sessions than 8 weeks (one-third) were eyes showing no or no adequate 
response to the first session. Excluding eyes with a second session within 8 
weeks, we find that in at least 39.5% of the cases a second session, al­
though not planned, was nevertheless necessary. 
10 12 U 
time (weeks) 
Figure 5.2. Cumulative distribution of intervals (in weeks) between two ses­
sions in a 2 * 180° ALT modification. 
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Table 5.15 presents a survey of the ALT modifications used per subgroup. 
Most eyes treated by ALT over 360" were treated in two sessions. Including 
all bilateral treatments and re-treatments, 443 eyes were treated in 721 ALT 
sessions. 
Table 5.15. Distribution of ALT modifications per subgroup. 
1 * 180' 2 * 180° 1 * 360° 
PhaJtic P0ÄG 
AphaXic POAG 
PseudophaJtic P0ÍG 
Pigment Dispersion S. 
Low-tension Glaucana 
Neovascular Glaucoma 
Secondary Glaucana 
Glaucoma Suspect, DisX-
Glaucona Suspect, DisX+ 
Total 
28.8% 
42. И 
5/10 
1/10 
42. η 
2/4 
35. Λ 
17.« 
25.8% 
30.2% 
52. η 
42.П 
2/10 
5/10 
47.4% 
2/4 
45.2% 
75.0% 
64.5% 
53.1% 
18.3% 
15.8% 
3/10 
4/10 
10.5% 
19.4% 
7.1% 
9.7% 
16.7% 
Table 5.16 presents the principal ALT parameters per ALT modification. The 
standard parameters of spot size (50 цт), exposure time (0.1 sec) and mean 
power (blanching and/or bubble formation) were used in each of the three ALT 
modifications. The apparatus used was a continuous wave blue-green Argon 
laser (Coherent Radiation Model 900). 
Table 5.16. ALT parameters per type of ALT modification (Exp. time: exposure 
time in second; Mean N burns: mean number of b u m s ) . 
Exp. tine Spot size Bean power Ш Mean N bums Iris stretching corticosteroid 
1 * 180° 0.1 50 pa 1000 (800-1400) 60 (25-80) 17.0% 90.0% 
2 * 180° 0.1 50 pa 1100 (750-1500) 120 (72-190) 17.0% 94.0% 
1 * 360° 0.1 50 pa 1000 (1000-1350) 100 (45-144) 20.0% 92.0% 
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The mean number of burns corresponded with the optimum, although the range 
was wide. Deviations toward the lower limit are explained by the fact that 
it was not always possible to gain a view of the trabecular meshwork over 
the circumference desired (PAS, obliterated angle), and occasionally treat­
ment was stopped prematurely in view of serious complaints about pain. De­
viations towards the upper limit can be explained on the basis of overlap of 
treated parts of the trabecular meshwork circumference in the 2 * 180° ALT. 
The localization of the burns was the posterior trabecular meshwork in the 
first Standard Wise ALT procedures performed, and in all subsequent cases 
the anterior part. Iris stretching was done in 17.0-20.0% of the eyes, cor­
responding with the frequency of narrow and beak-shaped angles due to pla­
teau iris. Iris stretching was effected by applying about 20 burns to the 
iris using 500 \m spot size, 0.5 sec exposure time, and 200-500 mW power. 
ALT was occasionally combined with an iridotomy. In 13 eyes with phakic 
POAG this combination was regarded as an additional treatment variable. 
The standard protocol called for postoperative corticosteroid medication. 
In 63.0% of the eyes ALT was performed by two staff members with ample ex­
perience in laser techniques and gonioscopy. In the remaining 37.0% ALT was 
performed by a resident. 
5.8 CRITERIA № SUCCESS AND FAILURE 
The IOP last measured before ALT was taken as initial IOP; the finally 
measured IOP was taken as ultimate or final IOP. Neither before nor after 
ALT were several IOP values averaged because several IOP values pre-ALT were 
not always available and the interval between two measurements post-ALT of­
ten was too long. 
The need for glaucoma surgery after ALT was considered to indicate com­
plete failure of ALT. 
Changes in the use of topical medication were calculated on the basis of 
the medication score. The use of carbonic anhydrase inhibitor was coded as 
use or non-use. The resultant from changes in this medication yielded the 
possibilities of increasing, decreasing or continuing the total medication. 
If the medication score increased by a maximum of 3 points but the use of 
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carbonic anhydrase inhibitor could be discontinued, this was regarded as 'no 
change in total medication'. If systemic medication had to be started or in-
creased after ALT, however, then this was regarded as indicating complete 
failure of ALT, regardless of any changes in topical medication. An in-
creased medication score but non-use of a carbonic anhydrase inhibitor was 
likewise regarded as complete failure. 
When an eye was not regarded as one of the abovementioned complete fail-
ures, the IOP decrease had to be at least 20% and the final IOP had to be 21 
mm Hg or lower, to regard ALT as successful. 
Of the total group of 305 eyes, post-ALT visual acuity was determined in 
251, a disk score in 194 and a visual field stage in 134 eyes. These data 
could not be completed for two reasons. Firstly, 81 patients (26.6%) were 
referred back to their own ophthalmologists. Moreover, the maximum accept-
able interval between the last measurement of IOP and determination of vis-
ual acuity, disk score and visual field stage was held to be 6 months. This 
was decided in order to avoid failures to identify possible increases in 
glaucomatous damage, thus giving an unjustifiably favourable impression of 
the response to ALT. Evaluation of changes in these variables took place in 
cases in which pre-ALT as well as post-ALT values were available. 
An increase in disk score by at least two points was interpreted as sig-
nificant because it reflects an increase in cup/disk ratio. 
Pre-ALT and Post-ALT visual field stages were compared, changes being de-
fined as: - no change; 
- increased visual field defect but within the pre-ALT stage; 
- progression of visual field defect to a more advanced stage. 
The general results were determined and described for each of the sub-
groups. Specific problems were studied per subgroup concerned. For most of 
the patient, ocular and ALT variables this analysis confines itself to pha-
kic POAG because this form was regarded as most representative and constitu-
ted by far the largest subgroup. In this way disturbances by variables 
linked to a specific glaucoma type or the specific ocular condition were 
avoided. 
Independence between discrete variables were tested using the Chi-square 
test; the Wilcoxon matched-pairs test was used to test non-systematic dif-
ferences in paired observations; the Kruskal-Wallis test (one-way analysis 
225 
of variance based on ranks) was used to test differences between groups of 
unpaired observations. 
Whenever a number is less than or equal to 10, no percentage is mentioned 
but the number in question. This is done to simplify interpretation of ta­
bles by ensuring that they are less influenced by incidental large or small 
percentages of (very) small numbers. 
Evaluation of I0P changes was largely confined to success eyes for two 
reasons. To begin with, it is of importance to establish whether a variable 
of no influence on the success rate, nevertheless influences the I0P de­
crease. Secondly, eyes submitted to surgery after ALT can be included in the 
follow-up only until the operation. However, the results of post-ALT glauco­
ma surgery will be discussed on the basis of success criteria defined above. 
5.9 RESULTS 
5.9.1 Initial IOP and duration of follow-up 
Table 5.17 presents the mean initial IOP and the duration of follow-up per 
subgroup. 
Table 5.17. Mean initial IOP and mean follow-up in months per subgroup (>21 
mm Hg: initial IOP exceeding 21 mm Hg). 
I n i t i a l IOP (ив Hg) Follw-up (muis) 
Mean + SD Min - Max >21 Mean + SD Min - Max 
PhaJdcPOM 
AphaXicPOAG 
Pseudophakie FOBG 
Pigment Dispersion S. 
Low-tension Glauccna 
Neovascular Glaucoma 
Secondary Glaucona 
Glauccna Suspect, Disk-
Glaucooa Suspect, Disk+ 
Total 
25.3 + 6.7 
25.2 + 7.2 
26.1 + 4.3 
27.0 + 6.0 
16.2 + 2.1 
39.0 + 7.4 
26.3 + 7.3 
27.1 + 5.4 
25.2 + 4.3 
25.3 + 6.7 
Il-
IS -
19-
20-
12-
30-
12-
16 -
19-
11-
-60 
48 
- 32 
- 40 
- 20 
-48 
- 55 
 40 
- 36 
-60 
71.4\ 
73.6* 
8/10 
9/10 
4/4 
80.61 
85. П 
80.61 
72.0t 
28 + 13 
30 + 21 
30 + 14 
31 + 13 
32 + 14 
23+ 11 
23 + И 
28 + 11 
25 + 11 
28 + 13 
3 - 5 7 
2 - 5 6 
10 - 55 
6 - 5 3 
3 - 5 9 
13 - 36 
6 - 4 2 
2 - 4 5 
2 - 4 9 
2 - 59 
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A mean initial IOP of 25.3 mm Hg is representative for a group of eyes 
likely to be sutenitted to ALT. Initial lOPs evidently differing from the 
mean were found in low-tension glaucoma and neovascular glaucoma. 
Some 70% of all eyes had an initial IOP of 22 mm Hg or over; after exclu­
ding eyes with low-tension glaucoma this percentage rose to 76.6%. 
Eyes with relatively low initial IOP are submitted to ALT for two reasons: 
firstly in order to reduce the often maximal medication, and secondly be­
cause a relatively low initial IOP value may nevertheless be too high for a 
given individual eye. 
The mean duration of follow-up was 28 months, ranging from a minimum of 2 
months to a maximum of nearly 5 years. In cases requiring post-ALT glaucoma 
surgery, the date of operation was chosen as follow-up date. 
5.9.2 Complete failures 
Table 5.18 lists the percentages of eyes requiring secondary surgery or 
increased medication after ALT (complete failures). 
Table 5.18. Percentage of complete failures per subgroup (Surgery: eyes sub­
mitted to glaucoma surgery; Topical Med: eyes needing institu­
tion or increase of topical medication; Systemic Med: patients 
needing institution or increase of carbonic anhydrase inhibitor; 
Med. All: total percentage of eyes with increased medication; 
All Eyes: total percentage of complete failure eyes). 
Surgery Topical Med Systemic Med Med All All Eyes 
PhaXicFOAG 
AphaJcic PGAG 
PseudophaJtic POAG 
Pigment Dispersion S. 
Low-tension Glaucoaa 
Neovascular Glaucoma 
Secondary Glaucona 
Glauccna Suspect, Disk-
Glaucona Suspect, Disk* 
Total 
13. η 
15.8Î 
3/10 
1/10 
10.5* 
1/4 
45. Ά 
w.n 9.1% 
16.41 
7. К 
15. Bi 
2/10 
10.5>. 
6.5t 
3.5t 
3.2t 
7.5t 
1.3t 
5.2t 
1/4 
6.5t 
2.0t 
6.5t 
10.5t 
2/10 
10.5t 
1/4 
9.7t 
3.5t 
3.2t 
7.2t 
19.6t 
26.3t 
5/10 
1/10 
21.1t 
2/4 
54.8t 
H.3t 
12.9t 
23.6t 
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In the entire group, 72 eyes (23.6%) were ultimately classified as com­
plete failures. Some 70% of these eyes required secondary surgery, while the 
remainder required increased medication after ALT, i.e. more topical medica­
tion in 23 eyes (7.5%) and institution of systemic medication in 6 (2.0%). 
In the majority of cases (87.0%) increased medication entailed a 1-point in­
crease in medication score. 
The incidence of surgery was low in pigment dispersion syndrome, low-ten­
sion glaucoma and glaucoma suspects. Eyes with secondary glaucoma showed a 
significantly higher incidence of surgery than eyes with phaXic POAG (p< 
0.001). 
The total number of complete failures in Pseudophakie POAG and in secon­
dary glaucoma significantly exceeded that in phaXic POAG (p<0.02 and p<0.001 
respectively). The incidences in the other subgroups did not differ signifi­
cantly from that in phakic POAG. 
Table 5.19 supplies additional information on indication for surgery, in­
terval between ALT and surgery, and type of operation performed. 
In 70.0% of the cases the indication for surgery was no or an inadequate 
response to ALT; progression of the visual field defect despite an adequate 
Table 5.19. Characteristics of pressure-reducing interventions after ALT 
(PVFD: progressive visual field defect; IOPS: IOP spike: ALT-
surgery interval in weeks (w) or months (m); TE: trabeculectomy; 
CCC: cyclocryocoagulation; Molteno: Molteno implant; IE: iridec­
tomy) . 
PhaXic POAG 
Aphakic POAG 
PseudophaXic POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucana Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
Indication 
No Response 
85.0* 
3/3 
1/3 
1/1 
1/1 
64.3* 
2/3 
1/3 
70.01 
PVDF 
5.0* 
2/2 
6.01 
IOPS 
10.0% 
2/3 
35. П 
1/3 
2/3 
24.0* 
ALT-Surgery Interval 
12 + 13m (3w - Sim) 
Зш, 7m, m 
3w, 2m, 7m 
25іл 
4w, 44m 
Iw 
5 + 6m (Iw - 22ii) 
3w, 19m, 23m 
3m, 4m, 31m 
10 1 ІЗт (Iv - 51m) 
Surgical Procedures 
IE 
90.0». 
1/3 
2/3 
1/1 
2/2 
1/1 
85.7* 
2/3 
3/3 
84.0* 
CCC 
5.0* 
2/3 
7.1* 
1/3 
10.0* 
Molteno 
7.1* 
2.0* 
IE 
5.0* 
1/3 
4.0* 
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response to ALT was involved in 6.0%, and in 24.0% surgery was resorted to 
in view of an early or late I0P increase. The lastmentioned category com-
prised 12 eyes (3.9%) (5 with secondary glaucoma (4 uveitic and 1 traumatic) 
2 with Pseudophakie POAG, 2 with phakic POAG and 3 glaucoma suspects). 
The incidence in view of a post-ALT IOP spike was significantly higher in 
secondary glaucoma than in phakic POAG (p<0.001), and in the secondary glau-
coma subgroup it was higher in uveitic glaucoma (33.3%) than in the other 
forms (5.3%) (p<0.05). 
Most of the eyes requiring surgery were submitted to a trabeculectomy 
(74.0%) , while 10.0% required at least two trabeculectomies. The success 
rate of surgery was 74.0% as measured by the same criteria as those applied 
to ALT. In eyes requiring increased medication it was 36.4%. The success 
rate of surgery in view of an IOP spike (66.7%) did not differ significantly 
from that of surgery for other indications (76.3%) (p<0.50). 
5.9.3 Success rates 
Table 5.20 presents the success rates, mean initial IOP, mean final IOP 
and mean absolute and proportional IOP decrease per subgroup. The IOP para-
meters pertain to success eyes. 
After a mean follow-up of 28 months the overall success rate was 54.1% 
with a mean proportional IOP decrease of 38.8%. 
Taking phakic POAG as frame of reference, a significantly lower success 
rate was found in low-tension glaucoma (p<0.05) and in secondary glaucoma 
(p<0.02). The differences between the other subgroups and phakic POAG were 
not statistically significant. 
As compared with the final IOP in phakic POAG, that in aphakic POAG was 
significantly higher (p=0.014)l that in glaucoma suspect without optic disk 
damage was significantly higher (p=0.002)l and that in low-tension glaucoma 
was significantly lower (p=0.009). Only in low-tension glaucoma were the 
mean absolute and proportional IOP decreases significantly less marked 
(p=0.003 and p=0.005 respectively). 
Apart from the eyes which fulfilled the success criteria, 32 other eyes 
(10.5%) also derived some benefit from ALT. These 32 eyes included 15 with 
229 
Table 5.20. Success rate and Ю Р parameters per subgroup (HOP: mean initial 
IOP; FIOP: mean final IOP; IOPD mm Hg: mean absolute IOP de­
crease; PIOPD %: mean proportional IOP decrease; SD: standard 
deviation). 
Success Rate HOP + SD im Hg ПОР + SD ш Hg IOPD + SD ЯП Hg PIOPD + SD % 
PhakicPOftG 
Aphakic PCM 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
58.8% 
42.П 
4/10 
9/10 
31.6% 
2/4 
35.5% 
50.0% 
67.7% 
54.1% 
25.7 + 5. 
26.0 + 9. 
27.0 + 2. 
26.3 + 5. 
17.0 + 2. 
44.0 + 5. 
27.5 + 4.. 
27.9 + 3.' 
25.0 + 4.i 
25.9 + 5.( 
1 15.1 + 2.8 
) 16.6 + 3.3 
17.5 + 2.6 
> 15.4 + 3.1 
) 11.8 + 1.5 
/ 17.5 + 2.1 
) 14.8 + 3.1 
Г 16.9 + 2.3 
15.8 + 2.5 
15.4 + 2.9 
10.6 + 5.0 
9.4 + 9.3 
9.5+ 4.7 
10.9 + 6.5 
5.2 + 1.7 
26.5 + 7.8 
12.7 + 4.7 
11.1 + 4.3 
9.2 + 4.2 
10.5 + 5.5 
39.7 + 12.0 
32.2 + 16.2 
34.4 + 13.9 
39.3 + 16.4 
29.9+ 7.5 
59.6 + 10.0 
45.2 + 13.1 
38.6 + 11.9 
35.8 + 10.8 
38.8 + 12.6 
an initial IOP of 22 mm Hg or higher which fulfilled one of the two cri­
teria; in 5 of these eyes medication could be discontinued (carbonic anhy-
drase inhibitor stopped in 4, and topical medication stopped in 1). In addi­
tion there were 17 eyes with an initial IOP of 21 mm Hg or lower in which 
some IOP decrease was achieved (mean proportional IOP decrease: 5.0 to 
19.0%) and in 4 of which medication could be stopped. 
Having considered complete failure eyes, success eyes and eyes which de­
rive some benefit from ALT, 36 eyes (11.8%) remain that cannot be unequivo­
cally classified under any of these headings. Data on these are presented in 
table 5.21. These eyes in actual fact represent failure eyes, because they 
did not show any, or insufficient, response to ALT. However, because they 
were not operated on and medication was not increased they were not clas­
sified as complete failures. 
Twenty-two eyes (7.2%) had a final IOP which exceeded the initial IOP. In 
8 of these eyes the increase was less than 10%, and may be ascribed to other 
than ALT effects. 
In 5 of the remaining eyes with an increase by at least 10% this was due 
to postoperative reduction or discontinuation of medication. 
In the end 9 eyes (3.0%) had a final IOP at least 10% higher than the ini-
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Table 5.21. Eyes not classified as complete failures. 
Initial I0P >21 in Hg 
I0P decrease <20\, continued or less medication 9 eyes (3.K) 
I0P decrease 0Î 2 eyes (0.7>.) 
Final lOP > Initial I0P 7 eyes 12.1%) 
Initial I0P <21 m Hg 
I0P decrease 0%, continued or less nedication 3 eyes (l.Ot) 
Final lOP > initial I0P 15 eyes М.П) 
tial IOP for no discernible reason. The increase ranged from +14.3% to 
+100%. Related to initial values, this means that 7.0% of the eyes with an 
initial IOP of 21 mm Hg or lower and 1.4% of those with an initial IOP of 22 
mm Hg or higher showed an IOP increase at longer time after ALT. The differ­
ence in the incidences found was statistically significant (p<0.01). Seven 
of these 9 eyes initially showed a satisfactory IOP decrease after ALT. 
5.9.4 Success rate, initial IOP and ALT modification 
Tables 5.22 and 5.23 respectively show the distribution of success rates 
per subgroup by initial IOP (table 5.22) and by ALT modification (table 
5.23). 
In each of the subgroups except low-tension glaucoma the success rate in 
eyes with an initial IOP of at least 22 mm Hg exceeded that in eyes with an 
initial IOP of 21 mm Hg or lower. Overall, this was statistically signifi­
cant (p<0.02). 
The highest success rate was achieved with the 1 * 360° ALT, although the 
difference from 1 * 180" or 2 * 180° was not statistically significant. 
In phakic POAG, however, the difference between l * 360 е ALT and 2 * 180° 
ALT was statistically significant (p<0.02), and that between 1 * 360° ALT 
and 1 * 180° was very nearly statistically significant (p<0.10). There was 
no significant difference between 1 * 180° and 2 * 180° ALT, leaving aside 
the bias in favour of success eyes in the 1 * 180' group (see section 5.7). 
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Table 5.22. Distribution of success rate per subgroup by initial IOP, taking 
21 mm Hg as central value. 
HOP >21 DD Hg ПОР <21 mn Hg 
Phakic POAG 
AphaXic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-taision Glauecna 
Neovascular Glaucoma 
Secfflidary Glaucoma 
Glaucoma Suspect, DisX-
Glaucona Suspect, Disk* 
Total 
62. П 
42.« 
4/8 
8/9 
2/4 
36. η 
54.2t 
68.0t 
58.41 
48.8». 
2/5 
0/2 
1/1 
31.6». 
2/6 
1/4 
4/6 
43.01 
Table 5.23. Distribution of success rate per subgroup by ALT modification. 
1 * 180° 2 * 180' 1 * 360* 
Phakic POM 
Aphakic PCftG 
Pseudophakie POAG 
Pigment Dispersion s. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk* 
Total 
56.6* 
5/8 
2/5 
1/1 
1/8 
0/2 
45.5t 
2/5 
7/8 
52.a 
53. It 
3/8 
1/2 
4/5 
5/9 
2/2 
21.4>. 
57.» 
60.0t 
52.5t 
76.61 
о/з 
1/3 
4/4 
0/2 
Vi 
0/2 
2/3 
62.7t 
5.9.5 Changes in IOP in success eyes 
Tables 5.24, 5.25 and 5.26 show the changes in IOP in success eyes as a 
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function of the ALT modification used (table 5.24) and of both the initial 
IOP and the ALT modification (tables 5.25 and 5.26). 
Table 5.24. IOP parameters per subgroup by ALT modification (N: number of 
eyes; HOP: mean initial IOP; FIOP: mean final IOP; IOPD mm Hg: 
mean absolute IOP decrease; PIOPD % : mean proportional IOP de­
crease; SD: standard deviation). 
1 » 180° 
PhaJticPOAG 
AphaJcic PQAG 
Pseudophakie POAG 
Pigment Dispersion s. 
Low-tension Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk* 
Total 
2 * 180* 
PhakicTOAG 
Aphakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-taision Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
1 * 360' 
Phakic POM! 
Pseudophakie POAG 
Pigment Dispersion S. 
Secondary Glaucoma 
Glaucoma Suspect, Disk+ 
Total 
N 
25 
48 
N 
43 
12 
12 
85 
N 
22 
1 
4 
3 
2 
32 
HOP + SD nn Hg 
25.6 + 5.0 
25.2 + 3.1 
29.0 + 1.4 
40 
14 
25.2 + 4.8 
27.5 + 0.7 
24.3 + 3.2 
25.4 + 5.1 
HOP + SD im Hg 
26.9 + 5.2 
30.7 + 15.2 
24 
23.5 + 1.3 
17.6 + 2.3 
44.0 + 5.7 
32.3 + 1.3 
28.0 + 4.0 
25.7 + 4.9 
26.8 + 6.3 
HOP + SD ип Hg 
23.5 + 5.6 
26 
25.8 + 4.3 
26.7 + 1.2 
24.0 + 7.1 
24.2 + 5.1 
ПОР + SD пп Hg 
15.2 + 3.4 
17.4 + 2.2 
17.0 + 4.2 
16 
11 
15.2 + 4.1 
17.5 + 2.1 
16.7+ 1.3 
15.7 + 3.1 
FIOP + SD am Hg 
15.7 + 2.7 
15.3 + 5.0 
19 
16.3 + 1.3 
12,0+ 1.6 
17.5 + 2.1 
15.7 + 2.1 
16.8 + 2.5 
15.5 + 2.9 
15.7 + 2.7 
П О Р + SD im Hg 
13.9 + 2.2 
17 
14.5 + 4.7 
13.3 + 2.1 
14.5 + 3.5 
14.1 + 2.5 
I0PD + 
10.4 + 
5.8 + 
12.0 + 
24 
3 
10.0 + 
10.0 + 
7.6 + 
9.6 + 
IOPD + 
11.2 + 
15.3 + 
5 
7.3 + 
5.6 + 
26.5 + 
16.7 + 
11.3 + 
10.2 + 
11.2 + 
IOPD + 
9.6 + 
9 
11.3 + 
13.3 + 
9.5 + 
10.1 + 
SD on Hg 
5.1 
1.9 
5.7 
5.1 
1.4 
2.6 
5.1 
SD im Hg 
5.2 
14.3 
1.3 
1.5 
7.8 
3.5 
4.6 
4.9 
6.0 
SD ran Hg 
4.7 
5.9 
2.1 
3.5 
4.5 
PIOPD + SD \ 
39.3 + 13.9 
24.7 + 5.8 
40.9 + 17.5 
60 
21.4 
38.7 + 16.2 
36.4 + 6.1 
30.5 + 7.3 
36.4 + 13.4 
PIOPD + SD ». 
40.1 + 11.9 
44.7 + 21.8 
20.8 
30.8+ 4.7 
31.6 + 7.0 
59.6 + 10.0 
51.3 + 8.6 
39.0 + 12.7 
38.3 + 12.4 
39.6 + 12.5 
PIOPD + SD \ 
39.3 + 10.3 
34.6 
42.5 + 21.0 
50.0 + 7.7 
39.1 + 3.3 
40.6 + 11.4 
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Table 5.25. The same as 5.24, for eyes with an initial IOP <21 mm Hg. 
1 * 180' 
PhaXic POAG 
Aphakic PCRG 
Low-tension Glauccna 
Secondary Glaucoma 
Glaucoma Suspect, Disk+ 
Total 
2 * 180' 
Phakic P0ÄG 
Aphakic PffiG 
Low-taision Glaucoma 
Glaucoma Suspect, Disk-
Glaucoaa Suspect, Disk+ 
Total 
1 * 360' 
Phakic POAG 
Pigment dispersion S. 
Glaucoma Suspect, Disk+ 
Total 
N 
6 
1 
1 
2 
2 
12 
N 
5 
1 
5 
1 
1 
13 
N 
10 
1 
1 
12 
HOP + SD m 
18.8 + 1.3 
18 
14 
20.0 
20.5 + 0.7 
18.8+ 1.9 
HOP + SD en 
19.8 + 1.1 
18 
17.6 + 2.3 
20 
19 
18.8 + 1.8 
ΠΟΡ + SDra 
19.7 + 1.5 
20 
19 
19.7 + 1.4 
Hg 
Hg 
Hg 
ПОР + SD m 
12.5 + 2.4 
14 
И 
14.0 + 2.8 
16.0 
13.3 + 2.4 
ПОР + SD mi 
13.8 + 0.8 
10 
12.0 + 1.6 
16 
14 
13.0 + 1.8 
ПОР + SD ив 
13.2 + 1.5 
16 
12 
13.3 + 1.6 
Hg 
Hg 
Hg 
IOPD + SD m Hg 
6.3 + 3,1 
4 
3 
6.0 + 2.8 
4.5 + 0.7 
5.5 + 2.6 
І0ИЗ + SD m Hg 
6.0+ 1.4 
β 
5.6 + 1.5 
4 
5 
5.8 + 1.5 
IOPD + SD m Hg 
6.5 + 1.6 
4 
7 
6.3 + 1.7 
PIOPD + SD % 
33.1 + 14.7 
22.2 
21.4 
30.0 + 14.1 
21.9+ 2.7 
28.8 + 12.0 
PIOPD + SD % 
30.1 + 6.1 
44.4 
31.6 + 7.0 
20 
26.3 
30.7 + 7.5 
PIOPD + SD \ 
32.8 + 7.2 
20 
36.8 
32.1 + 7.7 
Two IOP parameters are of interest in evaluating the response to ALT: the 
final IOP achieved, and the mean proportional IOP decrease. The latter is a 
function of the initial IOP and therefore more significant than the absolute 
IOP decrease. 
Consideration on these two parameters as a function of the ALT modifica­
tion revealed that eyes treated by l * 360° ALT reached a significantly low­
er final IOP than those treated by l * 180" (p=0.008) and those treated by 2 
* 180° ALT (p=0.006), while the mean proportional IOP decrease was signifi­
cantly more marked than after 1 * 180° (p=0.05). 
When only eyes with an initial IOP of 21 mm Hg or lower were considered 
(table 5.25), the various modifications failed to show differences, either 
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Table 5.26. The same as 5.24, for eyes with an initial IOP >2l mm Hg. 
ι * leo" HOP + SD ma I ПОР + SD m Hg ІОИ) + SD ran Hg PIOPD + SD \ 
piaJcicPOÄG 
J^hakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Secondary Glaucoma 
GlauccM Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
2 * 180' 
Phakic POAG 
Aphakic POAG 
Pseuiophakic POAG 
Pigment Dispersion S. 
Neovascular Glauccna 
Secondary Glauccna 
Glaucoma Suspect, Disk-
Glauccna Suspect, Disi+ 
19 
36 
N 
38 
11 
11 
27.7 + 3.6 
24.5 + 1.3 
29.0 + 1.4 
40 
28.7 + 1.2 
27.5 + 0.7 
25.8 + 2.3 
27.6 + 3.7 
HOP + SD ms Hg 
27.8 + 4.8 
37.0 + 15.6 
24 
23.5 + 1.3 
44.0 + 5.7 
32.3 + 1.5 
28.7+ 3.3 
26.3+ 4.6 
16.0 + 3.2 
18.3+ 1.3 
17.0 + 4.2 
16 
16.0 + 5.3 
17.5 + 2.1 
17.0 + 1.4 
16.5 + 2.9 
П О Р + Я) пв Hg 
15.9 + 2.7 
18.0 + 2.8 
19 
16.3 + 1.3 
17.5 + 2.1 
15.7 + 2.1 
16.8 + 2.6 
15.6 + 3.0 
11.7 + 5.0 
6.3 + 1.9 
12.0 + 5.7 
24 
12.7 + 4.6 
10.0 + 1.4 
8.8 + 1.8 
11.0 + 5.0 
I0PD + SD ran Hg 
11.8 + 5.1 
19.0 + 18.4 
5 
7.3 + 1.3 
26.5 + 7.8 
16.7 + 3.5 
11.9+ 4.2 
10.6 + 4.9 
41.2+ 13.4 
25.3+ 6.5 
40.9 + 17.5 
60 
44.4 + 17.2 
36.4 + 6.1 
33.9 + 5.2 
39.0 + 13.0 
PIOPD + SD \ 
41.4 + 11.8 
44.9 + 30.8 
20.8 
30.8 + 4.7 
59.6 + 10.0 
51.3 + 8.6 
40.8 + 11.8 
39.4 + 12.4 
Total 72 2 8 . 3 + 5.7 16.2 + 2.6 1 2 . 1 + 6.0 
1 * ЗбО" ПОР + SD m Hg FIOP + Я) im Hg lOPD + SD im Hg 
41.2 + 12.6 
PIOPD + SD % 
Phakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Secondary Glaucoma 
Glaucoma Suspect, Disk+ 
Total 
12 
20 
26.7 + 5.7 
26 
27.7 + 2.5 
26.7+ 1.2 
29 
26.9 + 4.5 
14.5+ 2.6 
17 
14.0 + 5.6 
13.3 + 2.1 
17 
14.5 + 2.9 
12.2 + 4.9 
9 
13.7+ 4.2 
13.3 + 2.1 
12 
12.4 + 4.1 
44.8+ 9.4 
34.6 
50.0 + 18.0 
50.0 + 7.7 
41.4 
45.7 + 10.3 
in terms of final IOP or in terms of mean proportional IOP decrease. 
In eyes with an initial IOP of at least 22 mm Hg (table 5.26), however, 
the final IOP reached the lowest value after l * 360° ALT (p=0.0l5 in com­
parison with 1 * 180° ALT and p=0.024 in comparison with 2 * 180° ALT) and a 
more marked proportional IOP decrease (p=0.017 if compared with 1 * 180° 
ALT). 
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5.9.6 Changes in medication 
Table 2.27 shows the changes in use of topical medication as a function of 
the pre-ALT medication score. Eyes submitted to secondary surgery after ALT 
were not included. 
Table 5.27. Changes in use of topical medication as a function of the pre-
ALT medication score (Lower: post-ALT score lower but not 0 ) . 
Pre-ALT 
Medication Score 
0 
1 
2 
3 
4 
5 
6 
Total 
Higher 
16.7* 
10.8». 
t.1% 
3.2t 
9.0% 
Post-ALT 
Same 
83.31 
60.8* 
48.8». 
54.8* 
3/6 
1/5 
56.« 
Lorer 
32.6* 
41.9* 
3/6 
4/5 
1/1 
19.2* 
Score 0 
28.4* 
10.5* 
14.9* 
In 9.0% of the eyes a higher medication score was found after ALT, and 
these eyes were regarded as complete failures. In 56.91 of the eyes there 
was no post-ALT change in medication, and in 34.1% (37.7% of the eyes medi-
cated) , topical medication was reduced or discontinued. The chance of redu-
ced medication increased, but the chance of discontinued medication de-
creased, with an increasing medication score. The largest group able to stop 
topical medication was that of eyes with a pre-ALT score of 1, which is to 
say only one type of eyedrop. From medication score 3 on, no discontinuation 
of topical medication was possible. 
In the majority of the pertinent cases the increase in medication scores 
after ALT amounted to only 1 point (87.0%). This means addition of another 
type of eyedrop or an increase in the concentration of miotics. 
Table 5.28 lists the changes in medication after ALT for success eyes per 
subgroup. 
The mean medication score diminished in each of the subgroups (the neovas-
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Table 5.28. Post-ALT changes in medication in success eyes (Pre/Post: pre-
or post-ALT; Cont: continued; Systemic: carbonic anhydrase in­
hibitor; No Medication: percentage of eyes using no medication). 
Mean Medication Score Topical Systemic No Medicatie« 
Pre Post Cont Lower Stopped Stopped Pre Post 
Phaiic POAG 
Aphakic POAG 
PseudophaJcic POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucona Suspect, Disk+ 
Total 
2.0 4 i.i 
1.9+ 1.0 
2.0 
1.0 + 0.7 
1.2 + 0.8 
1.0 
1.2 + 0.4 
1.1 + 0.7 
1.8 + 1.4 
1.7 + 1.1 
1.4 + 1.0 
1.5 + 1.1 
2.0 
0.4 + 0.5 
0.7 + 0.5 
1.0 
0.6 + 0.5 
0.9 + 0.8 
1.3 + 1.3 
1.2+ 1.0 
59.1% 
4/7 
4/4 
3/7 
3/5 
2/2 
45.5». 
72.71 
63.2* 
59.9* 
26.71 
3/7 
1/7 
1/5 
9.« 
9.П 
15.8* 
21.7* 
14.0* 
3/7 
1/5 
45.5* 
18.2* 
21.1* 
18.4* 
84.61 
0/2 
0/1 
1/1 
54.5* 
1/1 
2/2 
67.7* 
4.4* 
1/8 
0/4 
2/9 
1/6 
0/2 
0 * 
21.4* 
9.5* 
7.9* 
17.8* 
1/8 
0/4 
5/9 
2/6 
0/2 
45.5* 
35.7* 
33.3* 
24.8* 
cular glaucoma and Pseudophakie POAG subgroups comprising respectively only 
two and four eyes). 
Topical medication could be reduced or discontinued in 40.1% of the eyes. 
The chance of stopping carbonic anhydrase inhibitors after successful ALT 
was 67.7%. Some of the patients using systemic medication, however, under­
went surgery. Of the 64 patients using carbonic anhydrase inhibitors prior 
to ALT, 31 eyes (48.4%) were classified as success eyes. In 21 of these the 
inhibitors could be discontinued; the chance of successful ALT and discon­
tinued systemic medication was therefore 32.8%. 
The rate of eyes requiring no post-ALT medication as related to the pre-
ALT situation was significantly higher in phaJcic POAG (p<0.01) and in secon­
dary glaucoma (p<0.001). 
5.9.7 Optic disk, visual acuity and visual field function 
Table 5.29 lists the mean disk scores in success eyes before as well as 
after ALT, per subgroup. 
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Table 5.29. Mean pre-ALT and post-ALT disk scores per subgroup for success 
eyes (N: number of eyes in which a score could be determined). 
N Pre-ALT Post-ALT 
PhaJcic POAG 
Aphakic POAG 
PseudophaXic POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
Total 
52 
10 
16 
105 
4.7 + 2.4 
S.3 + 1.4 
6.0 
2.0 + 2.5 
5.6 + 1.7 
0 
4.4 + 2.2 
0.0 
3.3 + 2.5 
4.0 + 2.7 
4.7 + 2.5 
6.3 + 1.4 
5.0 + 2.0 
2.0 + 2.5 
5.2 + 2.3 
0 
4.0 + 2.8 
0.0 
3.6 + 2.5 
4.0 + 2.8 
Per subgroup the mean disk score remained virtually unchanged. Of these 
105 success eyes, 7 (6.7%) showed an increase in disk score by at least 2 
points despite a good response to ALT. These included 5 with phakic POAG and 
2 with suspected glaucoma and optic disk damage. In 10 success eyes with 
suspected glaucoma without disk damage, no increase in score was observed. 
Mean visual acuity in success eyes did not change post-ALT (table 5.30). 
Table 5.30. Mean pre-ALT and post-ALT visual acuity per subgroup for success 
eyes (N: number of eyes in which visual acuity was determined). 
И Pre-ALT POSt-ALT 
74 
13 
18 
138 
0.53 + 0.31 
0.32 + 0.24 
0.45 + 0.30 
0.71 + 0.37 
0.40 + 0.19 
0.50 
0.49 + 0.39 
0.86 + 0.24 
0.68 + 0.28 
0.57 + 0.32 
0.54 + 0.29 
0.45 + 0.32 
0.25 + 0.31 
0.74 + 0.40 
0.70 + 0.20 
0.40 
0.52 + 0.47 
0.73 + 0.32 
0.68 + 0.29 
0.58 + 0.31 
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Phakic POAG 
Aphakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension Glaucona 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucooa Suspect, Disk+ 
Total 
Table 5.31 shows the changes in visual field stages as a function of the 
pre-ALT stage and as a function of the response to ALT. For eyes submitted 
to secondary surgery, the post-ALT stage immediately preceding this surgery 
was chosen in order to enable measurement of an ALT effect. 
Table 5.31. Post-ALT visual field stages as a function of the pre-ALT visual 
field stage and as a function of success and failure. 
Worsened 
Visual Field Stage No Change Sane Stage >1 Stage 
0 
1 
2 
3 
4 
5a 
ъ/с 
:ess Eyes 
ure Eyes 
ital 
94. » 
вз.з* 
52.6* 
56.01 
7/10 
33.31 
61.5t 
89.0t 
57.6t 
63.4t 
5.9t 
16.7t 
26.3t 
32.0t 
3/10 
41.7t 
20.5t 
21.1t 
27.0t 
23.9t 
21.1t 
12.0t 
25.0t 
17.9t 
9.9t 
15.9t 
12.7t 
In 63.4% of the eyes there was no deterioration in visual field stage af­
ter ALT. About 25% of the eyes did show progression of the visual field de­
fect, but within the same stage as before ALT. Progression to a more advan­
ced stage occurred in 12.7% of cases. More specifically, this progression 
was seen in the following stages: 
Stage 2 Fusion of multiple absolute defects to form a Bjerrum Scotoma. 
Stage 3 Progression to (semi(circular paracentral defects. 
Stage 5a Loss of central remnant. In 3 of 12 eyes showing this pre-ALT 
stage loss of central vision occurred despite a good response to 
ALT. These 3 eyes had all shown a transient IOP increase after 
ALT, but in only 1 eye was it possible to confirm that this was 
responsible for the progression. This could possibly have been 
prevented if the patient had presented at the appointed times for 
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Ю Р check-ups. At worst, this meant that 3 out of 305 eyes (1.0%) 
suffered a serious visual field defect as a result of ALT. 
Stages Α-C In 17.9% of the eyes showing one of these changes before ALT, a 
glaucomatous visual field defect developed. None of these eyes 
had suspected glaucoma with or without optic disk damage. Pro­
gression occurred only if an eye had been interpreted as glauco­
matous on the basis of earlier perimetric findings or findings in 
the contralateral eye. 
Thus progression to a more advanced stage occurred if an absolute defect 
was already present or if the eye was at risk. 
The differences between success eyes and failure eyes were minimal. We in­
tend to revert to this point in the Discussion (5.15). 
5.9.8 Re-treatment 
Of the total group of 305 eyes, 24 (7.9%) were submitted to re-ALT. In 16 
eyes re-ALT was performed after an initial 2 * 180°, and in 8 eyes after a 1 
* 360" ALT. The re-ALT involved treatment of 180° of the trabecular meshwork 
circumference or a 1 * 360° ALT, but in that case applying only 60 burns. 
Five eyes were submitted to a 2 * 180° re-ALT. The mean time between the in­
itial ALT and re-ALT was 19.4 + 13.9 months (range 1-50 months). 
In 13 of 24 eyes (54.2%) glaucoma surgery was after all required, and 2 
eyes (8.3%) needed increased medication. The complete failure rate was 
therefore 62.5%. The failure rate for the initial 2 * 180° ALT (10/16 eyes) 
was the same as that for the initial 1 * 360° (5/8 eyes). 
Of the remaining eyes without complete failure 7 showed adequate IOP con­
trol and the success rate after re-ALT was therefore 29.2% at a mean follow-
up period of 9.7 + 5.1 months (range 2-12 months). 
5.9.9 Bilateral ALT 
Table 5.32 lists the results of ALT in patients whose first eye had al-
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Table 5.32. Success rate and ЮР parameters in second eyes of patients 
treated bilaterally (HOP: mean initial ЮР; ПОР: mean final 
IOP; IOPD mm Hg: mean absolute IOP decrease; PIOPD %: mean pro­
portional IOP decrease; SD: standard deviation). 
Phakic P0ÄG 
AphaXic И М 
PseirtiphaXic P0ÄG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Dislt+ 
Total 
N 
66 
6 
4 
6 
12 
1 
4 
16 
13 
128 
SR 
54.5* 
1/6 
1/4 
3/6 
50.0* 
1/1 
0/4 
56.3* 
46.2* 
49.2* 
HOP + SD um Hg 
25.2 + 5.2 
20 
23 
21.0 + 4.4 
18.0 + 2.2 
28 
25.4 + 3.7 
23.0 + 3.5 
24.1 + 5.0 
Success Eves 
П О Р + SD un 
15.3 + 2.8 
14 
16 
12.3 + 3.8 
12.7 + 1.8 
16 
16.3 + 2.5 
16.0 + 2.5 
15.1 + 2.8 
Hg IOPD + SD mn Hg 
9.9 + 5.1 
6 
7 
8.7 + 3.2 
5.3 + 1.2 
12 
9.1 + 3.4 
7.0+ 2.0 
9.0+ 4.4 
PIOPD + SD * 
37.7 + 12.3 
30 
30.4 
41.4 + 14.7 
29.6 + 5.5 
42.9 
35.3+ 9.6 
30.3 + 6.7 
35.9 + 11.1 
ready been treated. 
Except in low-tension glaucoma and suspected glaucoma without optic disk 
damage, the success rate was always slightly lower than in the first eye. 
The success rate in the total group, however, did not differ statistically 
from that in the eyes treated first. The final IOP of success eyes differed 
hardly from that of the eyes first treated by ALT. 
Table 5.33 presents the results expressed as success or failure in the two 
eyes of a patient. The majority of patients proved to show a symmetrical re­
sponse. 
Table 5.34 indicates the chance of a similar response in the second as in 
the first eye. The chance of success in the second eye after a good response 
of the first is 71.8%, which is significantly higher than the expected re­
sult (54.1%) if the responses of the two eyes would be independent. There is 
a statistically significant correlation between the ALT responses of both 
eyes in a given individual (McNemar test, p<0.01). 
Although the percentages indicate that the responses of the two eyes in a 
given individual are not independent, they are of little predictive value 
because late failures are also included in these figures, and success may 
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Table 5.33. Distribution of symmetrical (bilateral success/failure) and 
asymmetrical (success-failure/failure-success) responses per 
subgroup. 
PhaJticPOAG 
Aphakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Lou-tension Glaucooa 
Neovascular Glauccna 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk* 
Total 
Bilateral success 
50.0Î 
1/4 
3/6 
33.3* 
1/1 
50.0t 
tt. г\ 
43.8* 
Bilateral Failure 
2t.0% 
2/6 
2/4 
50.0* 
2/4 
43.8* 
38.5* 
33.6* 
Success-Failure 
16.7* 
3/6 
1/4 
3/6 
2/4 
15.4* 
17.2* 
Fai lure-Success 
4.6* 
1/6 
16.7* 
6.3* 
5.5* 
5.5* 
Table 5.34. Chance of success/failure of the second eye after success/fail­
ure of the eye treated first. 
Success Failure 
Phakic POÄG 
Aphakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension Glaucooa 
Neovascular Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect, Disk-
Glaucoma Suspect, Disk+ 
75.0* 
0/3 
1/2 
3/6 
4/4 
1/1 
2/2 
8/8 
6/8 
86.4* 
2/3 
2/2 
6/8 
2/2 
7/8 
5/5 
Total 71.8* 86.0* 
have prevailed during a certain period of time. 
In this respect the need for glaucoma surgery is more revealing because 
this was often performed shortly after ALT. In the total group of bilateral-
ly treated patients, 14 first ALT eyes required secondary surgery; in 8 of 
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these 14 cases the contralateral eye was submitted to surgery (57.1%). in 
the group of first ALT eyes not operated on, only 3 second ALT eyes needed 
subsequent surgery (2.6%). 
In the phaXic POAG subgroup, 9 first ALT eyes needed surgery and in 5 of 
these the contralateral eye was operated on as well, while in 57 first ALT 
eyes not requiring surgery not a single contralateral eye needed an opera­
tion. 
5.10 VARIABLES IR FHAKC POAG 
Table 5.35 and figure 5.3 present the success rate as a function of the 
follow-up, estimated on the basis of the Kaplan-Meier technique. 
05 1.0 1.5 2.0 2.5 3.0 35 Д0 ¿5 
time post-ALT (years) 
Figure 5.3. Success rate as a function of follow-up in phakic POAG. 
The success rate readily diminished during the first few months following 
ALT. This was determined on the one hand by the secondary surgery required 
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Table 5.35. Success rate as a function of follow-up in phaJcic POAG. 
Follow-up Success rate 
1 month 83.0», 
3 months 75. г% 
Ь months П.Ь\ 
12 months 67.6* 
24 months 59.0% 
36 months 56.3». 
48 months 52.31 
shortly after ALT, and on the other by the criterion that the failure date 
was determined from a one-month follow-up on. 
Table 5.36 presents success rates and IOP parameters as a function of some 
patient variables. 
Table 5.36. Success rate and IOP parameters as a function of patient varia­
bles in phakic POAG (SR: success rate; IlOPtotai: mean initial 
IOP of the total group; FIOP: mean final IOP; IOPD mm Hg: mean 
absolute IOP decrease; PIOPD %: mean proportional IOP decrease; 
SD: standard deviation). 
Success Eyes 
Я p-value I lOPto«, HOP + SD m Hg FIOP + SD m Hg IOPD + SD m Hg PIOPD + SD* 
62.94 
53. It 
65.2t 
49.2t 
1/1 
з/з 
4/7 
45.0t 
59.2t 
54.2t 
72.0t 
0.23 
0.05 
26.4 + 7.5 
24.0 + 4.9 
26.8 + 7.1 
23.3 + 5.2 
20 
27.7 + 5.7 
26.7+ 15.1 
24.5 + 5.4 
24.7 + 4.7 
26.3 + 7.6 
25.2 + 5.7 
26.2 + 5.7 
24.8 + 4.6 
26.2 + 5.4 
24.6 + 5.2 
20 
27.7 + 5.7 
21.8 + 3.3 
24.3 + 5.7 
25.2 + 4.5 
26.9 + 6.1 
26.1 + 5.6 
15.0 + 3.1 
15.3 + 2.4 
14.8 + 2.8 
15.7 + 2.9 
12 
18.0 + 3.5 
14.3 + 2.6 
14.0+ 2.1 
15.6 + 2.9 
14.7 + 3.0 
15.3 + 2.6 
11.2+ 5.3 
9.6 + 4.5 
11.4 + 5.4 
8.9 + 3.9 
8 
9.7 + 4.0 
7.5 + 3.3 
10.3 + 4.4 
9.6 + 3.4 
12.2+ 6.6 
10.8 + 5.3 
41.2+ 12.3 
37.2 + 11.1 
42.0 + 12.0 
35.0 + 10.7 
40 
34.5 + 9.9 
33.8 + 12.0 
40.9 + 9.8 
37.6 + 9.8 
43.0 + 14.5 
39.8 + 12.7 
ODS 
Sex 
Age 
OD 
OS 
Haie 
Fatale 
20 - 29 yr 
30 - 39 yr 
40 - 49 yr 
50 - 59 yr 
60 - 69 yr 
70 - 79 yr 
80 - 89 yr 
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Neither in success rate nor in IOP parameters was a statistically signifi-
cant difference found between OD and OS. 
Men had a higher success rate than women (p<0.05); it is to be noted that 
women had a lower initial IOP. The final IOP in success eyes was lower in 
men, who showed a more marked absolute and proportional IOP decrease. 
The age distribution reveals a small proportion of eyes of patients under 
40. There was no statistically significant difference in success rate be-
tween patients over and those under 60. There were no significant differen-
ces in IOP parameters between the various age categories. 
Table 5.37 shows the effect of glaucoma variables in the response to ALT. 
The initial IOP was one of the determinants of the chance of success. Not 
one of 5 eyes with an initial IOP of 11-15 mm Hg achieved a lasting IOP de-
crease of at least 20%, whereas 2 eyes with an initial IOP of 46 mm Hg or 
higher failed to fulfil the criteria accepted. 
The success rate was 45.9% for eyes with a low initial IOP (11-20 mm Hg), 
65.0% for those with a moderately increased IOP, and 46.2% for eyes with a 
high initial IOP (>35 mm Hg). There was no statistically significant differ-
ence in success rate between eyes with a high and those with a low initial 
IOP; but eyes with a moderately increased IOP attained a significantly 
higher success rate than those with a low initial IOP (p<0.05). 
Mean absolute and proportional IOP decreases became more marked with in-
creasing initial IOP values and the differences between them were statisti-
cally significant. 
Pearson's coefficient of correlation for initial IOP-IOP decrease was 
0.85. The final IOP in eyes with a low initial IOP was significantly lower 
than that in eyes with a moderately increased initial IOP. 
Differences in success rates between eyes without or with moderate glauco-
matous optic disk damage (score 0-3), with moderate-to-severe damage (score 
4-7) and with very severe damage (score 8) were not statistically signifi-
cant; the same applies to the IOP parameters. 
The same also applies to the visual field stages. Differences in success 
rates between the different stages were not statistically significant and, 
although eyes with visual field stage 5a and 5b had a higher initial IOP, 
there was no difference in IOP decrease and final IOP. 
In terms of pre-ALT medication there were no demonstrable differences be-
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Table 5.37. The same as 5.36, for glaucoma variables (Disk Score: pre-ALT 
optic disk score; VFS: pre-ALT visual field stage; Med Score: 
pre-ALT medication score; Syst Med: pre-ALT systemic medication 
used; Miotics: pre-ALT miotics used; Not Operated: eyes not 
being submitted to previous glaucoma surgery; Trabeculectomies: 
eyes being submitted to one or more trabeculectomies; All Opera­
ted: all eyes being submitted to glaucoma surgery). 
ПОР m Hg 11-15 
16-20 
21-25 
26-30 
31-35 
36-40 
41-« 
46-50 
>50 
Disk Score 0-3 
4-7 
8 
VFS 0/A/B/C 
1-2 
3-4 
5 
Med Score 0 
1-2 
3-6 
Systeme Med Yes 
№ 
Miotics Yes 
№ 
Not operated eyes 
Trabeculectooies 
Ml operated Eyes 
SR 
0/5 
53.It 
63.01 
62.5% 
8/9 
5/9 
1/2 
0/1 
0/1 
69.4% 
57.31 
50.0% 
55.6% 
61.9% 
65.6% 
4/10 
4/9 
57.3% 
67.7% 
43.3% 
62.6% 
64.1% 
54.6% 
60.8% 
60.0% 
50.0% 
П О Р , « . , 
14.2 + 1.3 
19.0 + 1.4 
23.4 + 1.4 
28.0 + 1.5 
32.9 + 1.2 
37.1 + 1.8 
42.0 + 1.4 
48 
60 
25.3 + 5.5 
24.8 + 6.0 
29.2 + 10.3 
25.4 + 5.2 
24.3 + 5.6 
24.4 + 6.2 
27.2 + 5.9 
24.4 + 4.4 
24.7 + 6.6 
27.8 + 6.8 
27.2 + 7.6 
25.0 + 6.4 
25.5 + 6.0 
25.4 + 7.6 
25.6 + 6.9 
24.1 + 4.7 
23.8 + 4.6 
ПОР + SD па 
19.1 + 1.3 
23.4 + 1.3 
28.0 + 1.6 
32.8 + 1.2 
37.6 + 2.2 
41 
26.1 + 5,8 
25.5 + 5.0 
26.3 + 7.6 
26.7 + 5.5 
25.3 + 5.3 
24.7 + 5.2 
30.8 + 7.1 
25.3 + 2.2 
25.0 + 5.5 
27.7 + 4.9 
25.5 + 5.1 
25.7 + 5.4 
26.3 + 4.8 
24.9 + 6.3 
25.7 + 5.5 
24.8 + 4.7 
25.3 + 4.8 
Success Eves 
Hg ПОР + SD пп 
12.9 + 1.7 
14.6 + 2.6 
17.0 + 2.7 
16.0 + 2.6 
15.2 + 3.0 
16 
15.6 + 2.7 
15.0 + 2.9 
15.1 + 2.6 
15.3 + 2.7 
14.5 + 2.8 
15.0 + 3.1 
17.0 + 3.2 
15.8 + 4.0 
14.9 + 2.5 
15.7 + 3.4 
15.0 + 3.4 
15.1 + 2.8 
15.3 + 3.0 
14.7 + 2.5 
15.0 + 2.9 
14.9 + 2.4 
15.4 + 2.8 
Hg lOPD + SD пи Hg 
6.2 + 2.1 
8.8 + 2.5 
11.0 + 3.0 
16.8 + 2.6 
22.4 + 4.3 
25 
10.5 + 6.0 
10.4 + 4.5 
11.2 + 5.8 
11.3 + 5.1 
10.8 + 5.2 
9.7 + 4.7 
13.8 + 8.2 
9.5 + 2.9 
10.1 + 5.1 
12.1 + 5.1 
10.5 + 5.4 
10.6 + 5.0 
10.9 + 4.9 
10.2 + 5.5 
10.7 + 5.2 
9 .9+ 3.9 
9.9 + 3.7 
PIOPD + SD% 
32.0 + 9.8 
37.6 + 10.4 
39.3 + 9.7 
51.2 + 7.8 
59.3 + 9.3 
61 
38.2+ 13.1 
39.9 + 11.5 
40.8 + 11.4 
41.0+ 11.7 
41.3 + 12.1 
38.2 + 12.2 
42.5 + 16.9 
38.0 + 13.5 
38.8 + 11.4 
42.6 + 13.3 
39.7 + 14.4 
39.7 + 11.6 
40.5 + 11.8 
38.7 + 12.3 
40.0 + 12.3 
38.9 + 9.7 
38.3 + 9.3 
tween eyes with score 0, those with score 1-2 and those with score 3 or 
higher. Nor was there a significant difference in success rate between eyes 
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treated with miotics and those not so treated. There was an indication of a 
lower success rate in patients using a carbonic anhydrase inhibitor 
(p=0.07). There were no statistically significant differences in final IOP 
between success eyes with different medication scores, with or without 
miotics and with or without carbonic anhydrase inhibitors. 
Eyes already submitted to trabeculectomy before ALT had a similar success 
rate as those not previously operated on. These categories did not differ in 
final IOP or IOP decrease. A similar result was obtained when all surgical 
treated eyes were lunged together. 
Of 153 eyes with phakic POAG, 24 were submitted to extracapsular cataract 
extraction after ALT. The success rate in this group was 70.8%, versus 55.8% 
in eyes without cataract extraction. This difference was not statistically 
significant (p=0.17). The final IOP and the IOP decrease were the same in 
these groups. 
Table 5.38 presents results in relation to ALT variables. The respective 
success rates after iris stretching, ALT performed by a staff member and ALT 
of good quality were higher than those in the counterparts of these varia­
bles, but in none of these instances was the difference statistically sig­
nificant; nor were significant differences in final IOP or IOP decrease ob­
served. ALT combined with iridotomy gave a higher success rate than ALT 
without iridotomy, the difference not being statistically significant. 
Table 5.38. The same as 5.36, for ALT variables. 
Success Eyes 
SR ПОР»«! ПОР ί SD m Hg ПОР + SD ira Hg НИ) + SD on Hg PIOPD + Ш 
Iris Stretching Yes 68.6t 26.3 + 6.9 26.8 + 6.3 15.7 + 2.4 11.1 + 6.1 39.2 + 12.6 
No 55.9t 25.1 + 6.6 25.3 + 5.0 14.9 + 3.0 10.4 + 4.6 39.9 + 11.8 
Staff Haber 63.6t 
Résidait 50.9t 
ALT easy 58.6t 24.7 + 5.6 25.4 + 5.5 14.9 + 2.9 10.6 + 5.3 39.9 + 12.7 
laborious 41.7t 29.6 + 12.0 26.0 + 2.6 16.2 + 2.0 9.8 + 1.9 37.6 + 5.9 
ALT + Iridotomy 76.9t 28.2 + 7.9 27.4 + 5.5 16.4 + 2,3 11.0 + 4.2 39.1 + 8.6 
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5.11 VARIABLES Ш APHAKIC PQAG 
Of the eyes with aphakic POAG, 11 had undergone glaucoma surgery prior to 
ALT; 5 of these eyes responded well to ALT. Of the 8 eyes not previously 
submitted to surgery, 3 showed a good response. 
Twelve eyes showed pre-ALT gonioscopic abnormalities which might interfere 
with ALT (e.g. PAS, local obliteration of the iridocorneal angle, poor visu­
alization of the trabecular meshwork). Four of these eyes were treated suc­
cessfully. Of the remaining 7 eyes without the abovementioned abnormalities, 
4 showed a good response. 
5 . 1 2 AGE AND PIOfENT DISPERSION SYNDRCHE 
The mean age of the 10 patients with a pigment dispersion syndrome was 
41.6 + 11.1 years. Seven patients were under 50. In the group of eyes trea­
ted first, 1 eye was a complete failure. This patient was 53 years old. 
5.13 SECONDARY GLAUCOMA 
Table 5.39 presents the results in various forms of secondary glaucoma as 
so far discussed together, adding to these 4 eyes with congenital glaucoma, 
l eye with juvenile glaucoma, l eye with congenital cataract and glaucoma, 
and 1 eye of a patient with hyperthyroidism. 
The overall success rate in this group was low. Decidedly moderate results 
were obtained in uveitic glaucoma and traumatic glaucoma. Less poor results 
were obtained in glaucoma with detached retina, in glaucoma with central 
vein occlusion and in congenital glaucoma. 
Within the secondary glaucoma group 11 eyes showed extensive PAS in the 
chamber angle, while 14 eyes showed no abnormalities in the angle. Eyes with 
PAS had a success rate of 18.2%, versus 42.9% for eyes without angle abnor­
malities. 
The success rate in phakic eyes with secondary glaucoma was 40.0%, versus 
27.3% in eyes after cataract extraction. 
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Table 5.39. Success rate distribution in various forms of secondary glaucoma 
with, in addition, 4 eyes with congenital glaucoma, 1 with juve-
nile glaucoma, 1 with congenital cataract and glaucoma, and 1 
eye with hyperthyroidism. 
Number Complete Tailure Success 
Uvekic Glaucoma 
Traumatic Glaucoma 
Post Retinal Detachment 
Corticosteroid Glaucoma 
Central Vein Occlusion 
Tapetoretinal Degeneration 
Post Cataract Extraction 
Congenital Glaucoma 
Juvenile Glaucone 
Congenital Cataract 
Hyperthyroidisn 
Total 
12 
38 
10/12 
4/8 
1/5 
1/2 
1/1 
2/4 
1/1 
20/38 (52.6».) 
2/12 
2/8 
3/5 
1/2 
2/2 
1/1 
2/4 
0/1 
0/1 
13/38 (34.2*) 
5.14 SUSPECTED GLAUCOMA 
Table 5.40 once again summarizes the results of ALT in phakic POAG, sus-
pected glaucoma without glaucomatous optic disk damage, and suspected glau-
coma with optic disk damage. 
Suspected glaucoma without optic disk damage showed a higher initial IOP 
than suspected glaucoma with optic disk damage or phakic POAG. This is be-
cause the firstmentioned subgroup comprises more eyes receiving no medica-
tion (21.4%) than the two lastmentioned subgroups (12.9% and 5.9% respecti-
vely). 
In terms of two important results - success rate and final IOP - suspected 
glaucoma without optic disk damage seemed to be inferior to those in the 
other two forms. However, only the differences in final IOP were statisti-
cally significant (p=0.002 when compared with phakic POAG and p=0.04 when 
compared with suspected glaucoma with optic disk damage). The highest suc-
cess rate, lowest complete failure rate and most favourable changes in medi-
cation score were found in suspected glaucoma with optic disk damage, but 
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Table 5.40. ALT response of eyes with phakic POAG, suspected glaucoma with­
out optic disk damage and suspected glaucoma with optic disk 
damage, in terms of various parameters. 
Mean Initial I0P (m Hg) 
Mean Final I0P dm Hg) 
Mean absolute TOP decrease (ил Hg) 
Mean proportional I0P decrease Ш 
Complete Failures 
Success Rate All Eyes 
Success Rate initial I0P >21 mn Hg 
Topical Medication Less or Stopped 
Stop All Medication 
PhaticPOAG 
25.4 + 6.7 
15.1 + 2.8 
10.6 + 5.0 
39.7 + 12.0 
19.6», 
58.8% 
62. П 
40.7» 
13.4» 
Suspected 
Disk-
27.1+ 5.4 
16.9+ 2.3 
11.1+ 4.3 
38.6 + 11.9 
14.3» 
50.0» 
54.2» 
21.4» 
14.3» 
Glaucoma 
Disk+ 
25.2 + 
15.8 + 
9.2 + 
35.8 + 
12.9» 
67.7» 
68.0» 
36.8» 
23.8» 
4.3 
2.5 
4.2 
10.8 
the differences from the other two subgroups were not statistically signifi­
cant. 
5.15 DISCUSSION AND CONCLUSIONS 
Phakic POAG: 
In 153 first treated eyes with phakic POAG the success rate was 58.8% af­
ter a mean follow-up of 28 months. The mean proportional IOP decrease in the 
success group was 39.7%; the mean final IOP was 15.1 mm Hg. 
The success rate diminished with an increasing follow-up period. The fail­
ure rate during the first few months after ALT was 20%, but from 6 months 
post-ALT on (success rate at that time 72.5%) an annual maximum failure rate 
of 10% occurred, resulting in a success rate of 52.3% after a follow-up of 
48 months. The initial failures were caused on the one hand by surgery on 
non-responding eyes soon after ALT, and on the other hand because a minimum 
follow-up of 1 month was completed before an eye was interpreted as failure. 
Particularly during the period immediately after introduction of ALT, a few 
eyes were submitted to surgery shortly after ALT which today would have been 
given more time to show whether a late response to ALT might occur. 
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In 70.0% of cases needing secondary surgery, the operation was performed 
within 6 months of ALT. In 30%, however, it was a late failure of ALT that 
necessitated surgery: within a year in 3 eyes, within 2 years in l eye, 
within 4 years in 1 eye and after 4 years in 1 eye. 
Our success and failure criteria were confined to changes in IOP with un-
changed or reduced medication. Criteria relating to glaucomatous optic disk 
cupping and visual field defects were not applied. It is true of course, 
that it was not intraocular pressures that were treated, but glaucoma types; 
in that sense the non-application of the lastmentioned criteria may be re-
garded as a shortcoming. It should be borne in mind, however, that in any 
case a decrease in IOP should be regarded as one of the primary objectives 
of glaucoma therapy, hoping that the optic disk and visual field show no 
progressive increase of damage. Another reason was that in this retrospec-
tive study both the degree of optic disk cupping and the perimetry were not 
recorded in a standardized protocol in glaucoma patients treated by ALT, and 
that an analysis can consequently be performed only with great prudence. If 
only because of a time limit between perimetry and ALT, a visual field stage 
could not be assigned in a number of cases. It has already been discussed 
that this method would entail a selection based on the frequency of perimet-
ric examinations. Inclusion of a criterion relating to the perimetric find-
ings would have meant that a proportion of the population would be studied 
in a limited way, on the basis of a selection. We opted in favour of study-
ing essential changes in IOP, with glaucomatous optic disk changes and vis-
ual field defects as a result of ALT playing a subordinate role. 
The complete failure rate was 19.6%. In the majority of cases this concer-
ned eyes showing no or an inadequate response to ALT. Of the 20 eyes submit-
ted to surgery, 17 were successful (85.0%), which is consistent with glau-
coma surgery success rates reported in the literature. Two eyes had an ini-
tial IOP of 21 mm Hg or lower and even after trabeculectomy did not meet the 
criterion of a 20% IOP decrease; another eye did attain a final IOP of 21 mm 
Hg or less but showed no 20% IOP decrease. These results in eyes submitted 
to secondary surgery showed that ALT had no untoward effect on the result of 
this surgery. 
The success rate was higher in men than in women. The mean absolute and 
proportional IOP decreases were likewise significantly higher in men than in 
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women. These differences can partly be attributed to the lower initial IOP 
in women, although the final IOP in men showed a tendency to be lower than 
that in women (p=0.09). 
Age did not affect the ALT results but the number of young patients with 
phafcic POAG was too small to investigate this with sufficient power. 
The success rate correlated with the height of the initial IOP. No success 
was achieved in eyes with a decidedly low (< 15 mm Hg) or decidedly high 
(>45 mm Hg) initial IOP. 
There was no unequivocal correlation between success rate and preoperative 
optic disk score or visual field stage. There were slight differences in fi­
nal IOP, but these were not statistically significant for any of these vari­
ables. Taking into account the frequency of secondary glaucoma surgery, how­
ever, the correlation between severity of glaucoma and ALT result emerged. 
The frequency of surgery was 0% for eyes with a disk score of 0-1, 0% for 
score 2-3, 10.7% for score 4-5, 17.6% for score 6-7 and 27.8% for score 8. 
It was 0% for a visual field stage 0-1, 17.6% for stage 2-3, 21.1% for stage 
4-5, and 12.5% for stage А, В or c. 
The high initial IOP values of eyes with disk score 8 (29.2 + 10.3 mm Hg) 
and/ or visual field stage 5 (27.2 + 5.9 mm Hg) partly explain the necessity 
of an operation, but the initial IOP values of eyes with lower disk scores 
or less marked visual field defects were not different in comparison. In 
other words: the chance of success in terms of an IOP decrease was not de­
pendent on the severity of glaucoma, but the need for secondary surgery in­
creased with an increasing glaucoma severity. An eye with severe optic disk 
damage or a marked glaucomatous visual field defect was more likely to need 
secondary surgery after ALT. 
Perimetry revealed that, even in success eyes, progression of the glauco­
matous visual field defect is dependent on the loss during performance of 
the ALT. Progression to more advanced stages was observed in particular in 
eyes with absolute defects in the Bjerrum area, with Bjerrum scotomata and 
in patients with a central remnant. Another group at risk was that of eyes 
with an enlarged blind spot/baring of the blind spot, central or general de­
crease in sensitivity or combination of these, if the contralateral eye al­
ready showed unmistakable glaucomatous visual field loss. This is by no 
means to say that the lastmentioned perimetric findings should therefore be 
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regarded as early or specific signs of glaucoma, because it cannot be ex-
cluded that they are caused by concomitant lesions (cataract), or that the 
presence of glaucoma in the contralateral eye per se implies an intrinsic 
predisposition to developing a visual field defect. 
There were only minor differences in progression of visual field defects 
between success eyes and failure eyes. On the one hand because the visual 
field in eyes given secondary surgery was assessed before the operation, 
i.e. shortly after ALT, and on the other hand because the failure group also 
comprises eyes which did not fulfil the success criteria even though some 
IOP decrease occurred. Despite an insufficient IOP decrease, ALT might have 
had a favourable effect on the visual field. 
None of the glaucoma therapies given - be it topical medication, systemic 
medication or surgery - had a statistically significant effect on the suc-
cess rate, although eyes treated with carbonic anhydrase inhibitors showed 
an unmistakably lower success rate. Systemic medication was used in 64 pa-
tients (21.0%). The fact that not all used a carbonic anhydrase inhibitor is 
explained, not only by intolerance to this medication in some cases, but 
also by the position of ALT in glaucoma therapy. It seems hardly sensible 
first to give this medication for a certain time (knowing that this cannot 
be long) and then try discontinuation of this medication after ALT. The low-
er success rate in these patients confirms this. Systemic medication does 
possibly serve a purpose in protecting patients before and after ALT, as an 
aid in preventing or arresting an increase in IOP. 
What was regarded as one of the principal variables was the ALT modifica-
tion used, i.e. 1 * 180°, 2 * 180° or 1 * 360° ALT. The results of a 1 * 
360° ALT were better than those of the other modifications in terms of suc-
cess rate as well as in terms of final IOP and mean proportional IOP de-
crease. The differences between 1 * 180° ALT and 2 * 180° ALT were not sta-
tistically significant. An estimate showed that at least 39.5% of the eyes 
treated by 1 * 180° ALT required a second session; the actual success rate 
of 1 * 180° ALT in the follow-up in question was 31.6%. An additional ques-
tion is whether failure eyes after a 1 * 180° ALT, submitted to a second 
session and thereby transferred to the 2 * 180° ALT group, do not constitute 
a higher-than-expected proportion of the ultimate failure eyes in this 
group. A l * 360° ALT in one or two sessions gives a better result than a 1 
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* 180° ALT. 
Pre-ALT iris stretching in the case of a beaJc-shaped iridocorneal angle 
gives the same result as ALT alone in the absence of such an angle shape. 
A qualitatively good, easily performed ALT had a higher chance of success 
than an ALT performed with difficulty, although the difference (possibly due 
to the limited number of eyes with a cumbersome ALT: N=12) was not statisti-
cally significant. If in this context only eyes treated by one-session ALT 
are considered, then 2 of 8 eyes can ultimately be classified as success 
eyes. 
ALT combined with iridotomy if indicated (13 eyes) had a higher success 
rate, but this difference was likewise not significant. 
AphaXic and Pseudophakie POAG: 
The success rate in aphakic and Pseudophakie POAG was lower than that in 
phakic POAG, but the differences were not statistically significant. The 
subgroups were too small to permit conclusions on (possible) differences. 
Another factor which plays role in aphakic eyes is that vitreous prolapse 
into the anterior chamber as a cause of IOP increase was not represented in 
this subgroup. Only eyes with pre-existent POAG and cataract extraction were 
included. 
As in phakic eyes, pre-ALT surgery did not affect the success rate in 
aphakic POAG. An iridocorneal angle configuration unfavourable for ALT 
caused a lower success rate. 
In the event of success, the final IOP in aphakic POAG was higher than 
that in phakic POAG. 
Because post-ALT cataract extraction in phakic POAG has no significant ef-
fect on the result, and because ALT results are less good in aphakic and 
Pseudophakie POAG, the preference in cases of glaucoma and concomitant cata-
ract is for ALT followed by extracapsular cataract extraction. 
Pigment dispersion syndrome: 
The results obtained in the pigment dispersion syndrome were very good, 
both as to success rate and as to IOP decrease. Some investigators have 
found that younger patients with a pigment dispersion syndrome show better 
results than older ones, but this could not be confirmed due to the limited 
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number of eyes studied. However, the only complete failure eye in this group 
was that of a 53-year-old patient, whereas 7 eyes of patients under 50 were 
all treated successfully. After lumping unilaterally and bilaterally treated 
patients, there were still no complete failures in the group under 50. How­
ever, two second ALT eyes of patients under 50 showed a response to ALT 
which was insufficient to fulfil the success criteria. 
Low-tension glaucoma: 
Success rate, mean absolute and proportional IOP decreases in this group 
were significantly lower than the corresponding values in phakic ЮАС 
(p<0.05, p=0.003 and p=0.005 respectively). In the success eyes a low final 
IOP was achieved. Many eyes (21.1%) did show some IOP decrease, but less 
than 20%. 
The question arises whether the 20% IOP decrease criterion was not too 
high, particularly for eyes with an initial IOP of 21 mm Hg or lower. We be­
lieve that this was not the case. Particularly in patients with low-tension 
glaucoma the IOP is such that glaucomatous damage becomes manifest at rela­
tively low pressures, and a further reduction of pressure is required. How­
ever, in eyes with other glaucoma types and normal IOP values associated 
with maximum medication ALT should likewise lead to an IOP decrease if suc­
cess is to be achieved. The possibility of reducing medication can certainly 
be regarded as a benefit derived from ALT, but in the cases of maximum pre-
ALT medication in this study the chance of post-ALT IOP control without med­
ication proved to be nil. 
Another reason is that, in the end, ALT is not free from complications. In 
9 out of 305 eyes (3.0%) the final IOP exceeded the initial IOP. In 7 of 
these cases the initial response to ALT had been good, and the question 
arises whether the increase in IOP should not been ascribed to progression 
of the glaucoma in these cases. Three other eyes showed loss of central vi­
sion after ALT, and in one of them it was confirmed that this was due to a 
transient IOP increase after ALT. Proceeding from the assumption that both 
the increase in IOP and the loss of central vision in these cases resulted 
from glaucoma, the conclusion must be that in at least 1% and at most 3.9% 
of the eyes ALT led to exacerbation of glaucoma. 
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Secondary glaucoma: 
This group showed a low success rate and a high complete failure rate. 
Nearly 50% of the eyes in this group required secondary glaucoma surgery. 
One should be alert after ALT in uveitic glaucoma: 4 of the 12 eyes 
treated required secondary surgery in view of a post-ALT increase in TOP. 
Pre-ALT cataract extraction and the presence of PAS affect the success 
rate unfavourably. 
Looking at age regardless of the type of secondary glaucoma, we found a 
success rate of 40.9% in patients over 40, 47.1% in those over 50, and 63.3% 
in those over 60. The difference between patients over and under 60 was sta-
tistically significant (p<0.02). 
A reason for the higher success rate in older patients may lie in the nor-
mal ageing process of the trabecular meshwork, which shows similarities to 
the changes observed in POAG (see 2.2.2.6 and 2.2.2.7). In the senescent 
trabecular meshwork ALT may cause changes which it cannot produce in a young 
trabecular meshwork. 
Suspected glaucoma: 
Results in eyes with phakic POAG and those with suspected glaucoma with or 
without optic disk damage showed no significant differences other than a 
higher final IOP in suspected glaucoma without optic disk damage. A combina-
tion of success parameters (final IOP, success rate in eyes with an initial 
IOP of at least 22 mm Hg and changes in medication) revealed the least fa-
vourable effects in suspected glaucoma without optic disk damage and more 
favourable features (also in comparison with phakic POAG) in suspected glau-
coma with optic disk damage. 
Bearing in mind that the lastmentioned group had the highest success rate 
and lowest complete failure rate and that the complete failure rate in-
creases with the severity of phakic POAG, it would be justifiable to con-
clude that ALT should not be regarded as ultimate alternative to surgery in 
cases already showing considerable damage, but merits the consideration at a 
much earlier stage in the therapeutic approach to glaucoma. An increased IOP 
per se (suspected glaucoma without optic disk damage), however, is not the 
indication of ALT in view of the less favourable results. This is more evi-
dent in view of the fact that patients with suspected glaucoma without optic 
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disk damage had the lowest mean age and - as indicated by the success rate 
in the ALT follow-up - a grave risk of failure in the subsequent course of 
life. A re-ALT performed at that time has a low chance of success (29.2%). 
An explanation of the fact that the best results are obtained in suspected 
glaucoma with optic disk damage may be sought in the degree of degeneration 
already shown by the trabecular meshwork. Perhaps degeneration is not very 
pronounced in eyes with (still) only increased IOP, while on the other hand 
degeneration in eyes with evident glaucoma is often too advanced to warrant 
the expectation of an optimal ALT effect. 
This is not to say that ALT is of no value for eyes already showing glau-
comatous damage; it does mean, however, that the chance of stopping progres-
sion diminishes, as it also does for pressure reducing surgery. 
Bilateral ALT: 
The results in patients treated bilaterally revealed a high degree of de-
pendence between the two eyes, both in success and in failure. This was even 
more evident in cases requiring secondary surgery. The chance that after 
failure in the first eye the second eye could be successfully treated, was 
14.0%. The inevitable conclusion, therefore, is that the decision to apply 
ALT to the second eye of a patients whose first eye failed to respond, must 
be made with considerable reservations. 
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CHAPTER 6 
PROSPECTIVE STUDY 
6.1 А Ш OF THIS STUDT 
The principal aim of this study was to describe the changes in IOP (the 
IOP course) during the period immediately after ALT, because early recogni­
tion of eyes with IOP spikes after ALT is important to ensure adequate 
treatment. 
Several variables were documented in an effort to trace possible high-risk 
factors predisposing to IOP spikes following ALT. In this respect emphasis 
was placed on gonioscopic findings and on ALT parameters, but other ocular 
and patient variables were considered as well. 
The primary choice was to study the eyes treated first in patients submit­
ted to bilateral ALT, in order to exclude the bias of selection (see 5.1). 
ALT was consistently performed in two sessions, and the ocular status at 
the second session could therefore differ from that at the first. In order 
to eliminate a possible bias in this respect also, the abovementioned varia­
bles were studied with regard to their influence on IOP changes following 
the first session. The IOP course in untreated contralateral eyes was used 
as control. 
The following problem definitions were formulated: 
1. What does the IOP course after standardized ALT look like, and how do 
eyes with IOP spikes compare with those not showing these IOP spikes af­
ter ALT? 
2. Are there patient-, eye-, or ALT-related variables which correlate sta­
tistically with post-ALT spikes? 
3. Does the occurrence or non-occurrence of an IOP spike after the first ALT 
session have any predictive value for the IOP changes to be expected af­
ter the second session? 
4. Does the occurrence or non-occurrence of an IOP spike in the eye treated 
first have any predictive value for the post-ALT IOP changes to be expec­
ted in the second eye in cases of bilateral ALT? 
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Independence between discrete variables was tested using the Chi-square 
test, and interdependence between discrete variables was tested using the 
MCNemar test. 
6.2 DESIGN OF THE PROSPECTIVE STUDY AND DÏHDGRAPHIC ПАТА СИ PATIHITS 
Between 30th June 1986 and 12th October 1987, 93 eyes of 62 patients were 
treated and followed up. 
Five patients were excluded from this study for the following reasons: 
- In two patients ALT was not feasible, once because the patient collapsed 
after application of 4 burns, and once because the trabecular meshwork 
could not be visualized even after iris stretching. 
- Three patients were excluded because ALT could not be performed in a 
standardized way. In one case only 180° of the trabecular meshwork cir­
cumference was treated because before the second session this patient had 
to be hospitalized with serious pulmonary complaints related to pre-exis-
tent COLD (Chronic Obstructive Lung Disease). In one patient the trabecu­
lar meshwork was not accessible over the full 360°; 70 burns were applied 
allround in both eyes. Finally, one patient with a diabetic retinopathy 
was treated by panretinal laser coagulation after the first ALT session, 
and a second session was postponed for the time being. 
The eyes were divided into subgroups on the basis of glaucoma type and 
specific ocular status: 
Phakic POAG (N=42): 
This subgroup included eyes with an increased IOP, glaucomatous optic disk 
features and visual field defect, without other demonstrable glaucoma causes 
and without ocular details which would justify inclusion in one of the other 
subgroups. 
Eyes with an increased IOP with or without other glaucomatous features but 
with evident glaucoma of the contralateral eye, were likewise included in 
this group. 
Two eyes in this subgroup were from patients showing an IOP increase and 
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glaucomatous optic disk featured in both eyes, but without visual field de-
fect. The clinical impression and the findings at other examinations justi-
fied their inclusion in this subgroup (see also 6.6). 
Pseudophakie POAG (N=1): 
This was an eye in which glaucoma was already manifest prior to cataract 
extraction. 
Pigment dispersion syndrone (N=4): 
These four eyes showed the characteristic features of the pigment disper-
sion syndrome and glaucomatous optic disk damage, but without visual field 
defect. 
Low-tension glaucoma (N=4): 
This subgroup included eyes in which glaucoma had developed while the IOP 
remained normal (<22 mm Hg). 
Secondary glaucoma (N=2): 
One of these eyes showed features of scleritis (systemic corticosteroid 
medication), while the other showed an increased IOP following surgery for 
retinal detachment. 
Suspected glaucoma (N=2): 
Two eyes with increased IOP but without any other glaucomatous features 
were included in this subgroup. 
Thyroid disease (N=2): 
These two eyes showed an increased IOP in association with hyperthyroi-
dism. 
Table 6.1 presents demographic data on these patients and also that the 
total number of eyes treated was 87. 
With the exception of two patients whose first eye showed phakic POAG 
while the second showed Pseudophakie POAG, all patients treated bilaterally 
showed symnetrical glaucoma types. The two patients just mentioned are not 
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Table 6.1. Demographic data by subgroup (Bilat: percentage of patients trea­
ted by bilateral ALT). 
PhalicPOAG 
Pseudophakie POM 
Pigment Dispersion S. 
Low-tension Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect 
Thyroid Disease 
Total 
Pat 
42 
57 
Number 
Eyes 
64 
87 
Bilat 
52.4* 
3/4 
2/4 
2/2 
1/2 
52.61 
Aqe 
Mean SD 
65.0 + 14.3 
74 
38.3 + 9.6 
63.0 + 9.2 
74.5 + 3.5 
64.5 + 6.4 
49.0 + 33.9 
62.9 + 15.7 
Min-
22-
25 -
54-
22 -
-Max 
84 
- 47 
- 75 
84 
Male 
20 
4 
2 
1 
1 
28 
Female 
22 
29 
OD 
21 
29 
OS 
21 
3 
2 
2 
28 
included in the discussion of IOP changes in second ALT eyes. 
Despite the small numbers, this prospective study likewise revealed the 
early age at onset and the male preference of the pigment dispersion syn­
drome, as well as the female preference of low-tension glaucoma. 
6.3 DATA SAMPLING, FOLLOW-UP AND ШГСЯ П Г П Ш PROTOCOL 
The data on the 57 patients who at the end participated were recorded on 
the basis of a code book (Addendum 2). 
ALT was performed between 09.00 and 10.30 hrs. The initial IOP was meas­
ured about l hour prior to ALT. Postoperative check-ups comprised IOP meas­
urements at 6 consecutive one-hour intervals after ALT. Check-ups were like­
wise made 24 hours and 1 week after ALT. These check-ups preceded and fol­
lowed both the first and second session. 
Because 8 patients developed adenoviral keratoconjunctivitis after ALT, 
the decision was taken to perform IOP measurements with disposable Parafilm 
"M" as a barrier between the prism of the tonometer and the cornea. This 
method is practical and prevents contamination of the prism and consequently 
dissemination of bacteria and viruses. 
The effect of this Parafilm nM" on the IOP is at most 3 mm Hg, but in some 
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85% of cases the difference from the regularly measured IOP is only 1 mm Hg 
(Assia et al. 1986К1 
Postoperative Ю Р increases were not treated unless they fulfilled one or 
more of the following criteria: 
1. An IOP increase by at least 10 mm Hg from the initial IOP. 
2. An IOP increase to 30 mm Hg or higher if the preoperative IOP was less 
than 30 mm Hg. 
3. An IOP increase which endangered the eye in view of the severity of the 
glaucoma (e.g low-tension glaucoma and eyes with an end-phase visual 
field defect). 
Whenever an IOP increase fulfilled one or more of these criteria, a car­
bonic anhydrase inhibitor (250 mg Diamox) was given orally; another dose of 
250 mg Diamox was given if the IOP showed no or an inadequate response to 
the first dose, In only one instance was Diamox given intramuscularly. This 
was a functionally monocular patient with a central visual field remnant and 
a post-ALT IOP increase from 17 to 22 mm Hg (+5 mm Hg). Because this patient 
developed an attack of COLD 3 hours after ALT, he was hospitalized. Six 
hours after ALT the IOP had decreased to 15 mm Hg. One day after ALT the IOP 
was 15 mm Hg and the patient was discharged. Unfortunately, another severe 
attack of COLD occurred 2 weeks later; the patient was again hospitalized 
and no further follow-up was possible. 
6.4 EXTRAOCULAR FEATURES 
Six patients (10.5%) had diabetes mellitus (insulin-dependent in three). 
Fifteen patients (26.3%) had arterial hypertension (10 were using antihyper­
tensive medication). The mean systolic blood pressure was 132.8 + 20.8 mm Hg 
and diastolic 83.1 + 11.8 mm Hg. The lowest blood pressures were measured 
in patients with low-tension glaucoma (116.3 + 12.5 mm Hg systolic and 77.5 
+ 9.6 mm Hg diastolic). 
The incidences of diabetes mellitus and arterial hypertension exceeded 
1 Assia, E., Bartov, E., and Blmntlial, И.О.: ta. J. ОрМиІюІ. 102:397, 1986. 
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those in the retrospective study, due to the fact that in this study a gen­
eral history was part of the standard protocol. 
A non-ophthalmological operation had been performed under general anaes­
thesia in the past in 44 cases (77.2%). Eight patients (14.0%) had undergone 
at least five operations. 
Some 25% of patients were smokers and regularly dranJc alcoholic beverages 
(at least two glasses per day). 
6.5 OCULAR ANAMNESIS AND HISTORY 
Table 6.2 lists the complaints and findings from the ocular anamneses of 
the patients. 
Table 6.2. Frequencies of preoperative ocular complaints. 
Loss of vision 
Mouches volantes 
Diplopia 
Haloes 
Scotomas 
Ocular allergy 
Strabismus 
Trauma 
Epiphora 
Metarorphopsia 
Flashing light 
Shadows 
Transient ischaemic attacks 
Colour vision disorder 
Pain 
59 
19 
15 
12 
i% 
1% 
i\ 
i% 
Q\ 
3* 
b\ 
Ά 
8». 
81 
t\ 
t\ 
i\ 
i\ 
Poor vision was the most common complaint. The mean preoperative visual 
acuity was 0.67 + 0.24. In most cases the less-than-optimal vision was ex­
plained by the presence of a more or less disturbing cataract in phakic pa­
tients (78.5%). 
Seven patients (12.3%) had had haloes; 3 of them had a pigment dispersion 
syndrome, 2 had phakic POAG, 1 had Pseudophakie POAG and 1 had low-tension 
glaucoma. 
One patient with phakic POAG and one with a pigment dispersion syndrome 
had a history of a trauma of the ALT eye. In both instances conservative 
therapy had led to a complete cure. 
6.6 GLAUCOMA VARIABLES 
6.6.1 Previous therapy 
The mean medication score as determined on the basis of the medication 
scale (table 5.6) was 1.5 + 0.9. With the exception of one eye with phakic 
POAG and two with a pigment dispersion syndrome, all eyes were receiving 
topical glaucoma medication. The maximum medication score was 6. In most 
eyes the medication score was 1 or 2 (87.7%). 
Eight patients (14.0%) also used a carbonic anhydrase inhibitor. Nine eyes 
(15.8%) had already been submitted to one or several pressure-reducing in-
terventions. The distribution was as follows: 
- Phakic POAG : trabeculectomy (1), iridencleisis (1), ALT (4). 
- Pseudophakie POAG : trabeculectomy and cyclodialysis (1) 
- Pigment Dispersion S. : ALT, Scheie procedure and Elliot procedure (1). 
- Low-tension glaucoma : trabeculectomy (1). 
Four eyes with phakic POAG had previously undergone ALT in our department. 
In all cases the initial ALT was a 2 * 180° modification. 
The eye with the pigment dispersion syndrome had been submitted to ALT 
elsewhere, and the exact ALT parameters could not been traced. 
6.6.2 Anterior eye segment 
The standard protocol included a detailed examination of the anterior eye 
segment. The following abnormalities and particulars were discovered: 
- One female patient with phakic POAG showed mild rotatory nystagmus, but 
this did not impede the ALT procedure. 
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- Six eyes (10.5%) showed a Marcus Gunn pupillary reaction, indicating an 
afferent conduction defect. Two of these eyes had glaucomatous visual 
field defects, two eyes showed an enlarged blind spot and diminished sen-
sitivity, and two eyes had no perimetric abnormalities. 
- One female patient with hyperthyroidism showed minor residual infiltrates 
of the cornea after keratitis as a result of a chicken-pox infection. 
- Krukenberg spindles were observed in 4 eyes with a pigment dispersion syn-
drome. One of these eyes showed a diaphanous iris as well. 
- One eye with secondary glaucoma after retinal detachment treated by sur-
gery showed irregular pupil contours. 
- Eleven eyes (19.3%) showed pigment sprinkling of the anterior iridai sur-
face; six of these had phakic POAG. The degree of pigmentation in these 
six eyes was TP+1 (l eye), TP+2 (2 eyes) and TP+3 (3 eyes). None of these 
showed features of the pigment dispersion syndrome. 
- One eye with phakic POAG showed segmental iridai atrophy. Gonioscopy re-
vealed a wide iridocorneal angle (grade 3) and trabecular pigmentation de-
gree of TP+2. There were no peripheral anterior synechiae and there was no 
anamnestic evidence of angle closure glaucoma in the past. 
- None of these eyes showed iridai nodules, iris bombé or iridai colobomas. 
The protocol did not provide in a pre-ALT examination of the lens in 
mydriasis. After completion of the investments, however, we felt that this 
had to be done in order to look for any signs indicating a pseudo-exfolia-
tion syndrome in the patients to which this applied (i.e. phakic TOAG and 
suspected glaucoma). Of the 44 patients with phakic POAG or suspected glau-
coma, 36 were examined in mydriasis after ALT (in 8 patients this was not 
possible because of: death of patient (1), cataract extraction (1), patient 
not traceable (l) and in 5 patients this examination was not undertaken be-
cause of the presence of a (very) severe visual field defect). Of these 36 
patients, one with phakic POAG (2.8%) had evident signs of the pseudo-exfo-
liation syndrome. This patient was included in the phakic POAG group. 
Gonioscopy: 
Gonioscopy was performed immediately before ALT, and the various items 
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were classified in cooperation by the same ophthalmologist with experience 
in this field. Whenever structures could not be visualized due to a beak-
shaped angle as a result of plateau-iris, iris stretching took place first 
(7 eyes, 12.3%). 
The angle width was determined on the basis of the angle width grading 
system (Shaffer 1962; see also 3.3). An abbreviated version of this grading 
system is presented in table 6.3. 
Table 6.3. Abbreviated version of angle width grading system (see also 3.3). 
Angle Grade Angle Hidth Numerical Grade 
Wide Open Angle 45°- 35" 4 
ib°- 20° 3 
Harrow Angle 20° 2 
Narrow Angle, extraie 10' or less 1 
Narrow Angle, partial 0° 0 
or complete closure 
Table 6.4 lists the gonioscopic findings per subgroup. The distribution of 
angle widths shows that 35.1% of all eyes had a wide angle. Most eyes with a 
pigment dispersion syndrome had a wide angle, and only one eye in this sub-
group had a grade 2 angle. This eye had previously been submitted to two 
operations (Scheie procedure and Elliot procedure), with postoperative cata-
ract formation. This eye had a trabecular pigmentation degree of TP+2. The 
ophthalmological history showed that a pigment dispersion syndrome was nev-
ertheless involved. The contralateral eye of this patient likewise showed 
features of the pigment dispersion syndrome (Krukenberg spindle, trabecular 
pigmentation TP+4, and a grade 4 angle). 
A beak-shaped angle was observed in 17 eyes (29.8%). That this had impli-
cations for the angle width was apparent from the numerical angle grades of 
these eyes: 6 eyes with grade 1 and 11 eyes with grade 2 angles. Iris stret-
ching was performed on all eyes with a grade 1 angle and one eye with a 
beak-shaped grade 2 angle. 
Angle recession was observed in one eye (without any anamnestic evidence 
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Table 6.4. Pre-ALT gonioscopic findings (PDS: pigment dispersion syndrome; 
LTG: low-tension glaucoma). 
Angle Grade 0 
1 
2 
3 
4 
Beak-shaped Angle 
Recession 
Scleral Spur Visible 
Scleral Spur Moraal 
White 
Iris Processes Present 
Trab. Identification Easy 
»derate 
Laborious 
Trabecular Pi^nentation 0 
+1 
+2 
+3 
+4 
Blood in Schlenn's Canal 
Prominence of Schwalbe's Line 
Blood Vessels Circumferential 
Trabecular 
Peripheral Anterior Synechiae 
Particles in the Angle 
Phakic 
POftG 
16.1% 
47.6'. 
31.0% 
4.7» 
35.7». 
95.2?; 
95.2* 
33.3». 
52.4» 
33.3* 
14.3» 
2.4» 
21.4» 
50.0» 
26.2» 
2.4» 
47.6» 
11.9» 
2.4» 
4.8» 
Ps.Phakic 
PCIAG 
1/1 
1/1 
1/1 
1/1 
1/1 
1/1 
1/1 
PDS 
1/4 
2/4 
1/4 
3/4 
3/4 
3/4 
3/4 
1/4 
1/4 
3/4 
3/4 
1/4 
LTG 
3/4 
1/4 
1/4 
4/4 
4/4 
3/4 
3/4 
1/4 
1/4 
2/4 
1/4 
2/4 
1/4 
Secondary 
Glauc 
1/2 
1/2 
2/2 
2/2 
1/2 
1/2 
1/2 
2/2 
1/2 
Glauc 
Suspect 
2/2 
1/2 
2/2 
2/2 
1/2 
2/2 
1/2 
1/2 
1/2 
Thyroid 
Disease 
1/2 
1/2 
1/2 
2/2 
1/2 
1/2 
1/2 
1/2 
1/2 
1/2 
1/2 
1/2 
1/2 
Total 
0 » 
15.8» 
49.1» 
28.1» 
7.0» 
29.8» 
1.8» 
94.7» 
93.0» 
1.8» 
42.1» 
56.1» 
31.6» 
12.3» 
1.8» 
22.8» 
47.7» 
22.8» 
5.3» 
1.8» 
49.1» 
12.3» 
3.5» 
7.0» 
0 » 
of a trauma). 
In most eyes the scleral spur could be visualized, with or without iris 
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stretching. In 3 eyes (5.3%) the scleral spur was not seen: due to a grade 1 
angle in 2 eyes and due to excessive pigmentation in 1. The scleral spur 
showed a normal appearance in all eyes except one, which showed a decidedly 
white spur (but again without any demonstrable trauma in the anamnesis). 
Iris processes were observed in 24 eyes (42.1%). The extent ranged from a 
few small process to numerous processes distributed over the entire circum-
ference of the chamber angle. 
Trabecular pigmentation was scored according to Scheie (1957; see 3.3) and 
ranged from complete absence of pigment (TP 0) to maximum trabecular pig-
mentation (TP+4). All eyes with TP+4 in this study had a pigment dispersion 
syndrome. Because the degree of pigmentation varied within the individual 
eye (the lower two quadrants often showing more pigmentation), the entire 
angle was examined first, and then an overall score was assigned. 
Trabecular pigmentation did not correlate with the colour of the iris. Ab-
sence of pigment (TP 0) or only slight pigmentation (TP+1) occurred in 25.0% 
of blue and 27.3% of brown eyes; moderate pigmentation (TP+2) occurred in 
50.0% of blue and 48.5% of brown eyes; 25.0% of blue and 24.2% of brown eyes 
showed marked trabecular pigmentation. Not included were eyes with a pigment 
dispersion syndrome, which all had blue irides. 
Identification of the trabecular meshwork became more laborious as less 
pigmentation was present. In eyes with TP+3 and TP+4 the trabecular meshwork 
was always identified without difficulty. In 11.1% of the eyes with TP+2 and 
23.1% of those with TP+1 identification of the meshwork was difficult. In 
one eye with TP 0 it was virtually impossible to identify the trabecular 
meshwork. None of the eyes with laborious identification of the trabecular 
meshwork was scored a "good ALT" (see 6.7). 
In one eye with phakic POAG blood was seen in Schlemm's canal; no haemor-
rhage occurred during ALT in this eye. 
Schwalbe's line was described as 'normal' or 'prominent'. To establish 
this, a look through the central lens was required to see whether Schwalbe's 
line presented as a thickening in the anterior chamber. This prominence was 
observed in 49.1% of the eyes. In most cases the thickening was very slight, 
and a posterior embryotoxon as seen in some forms of iridocorneal dysgenesis 
was never observed. 
Two eyes (one with phakic POAG and one with low-tension glaucoma) showed 
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blood vessels in the chamber angle which bridged the trabecular meshwork. 
Neither eye showed signs of rubeosis iridis. 
Peripheral anterior synechiae were seen in 4 eyes (7.0%): 1 eye with Pseu-
dophakie POAG in which band- and spike-shaped synechiae extended over 5 
clock hours between iris and the anterior part of the trabecular meshwork; l 
eye with secondary glaucoma after retinal detachment treated by surgery, in 
which synechiae extended over 2 clock hours between the iris and the scleral 
spur; 1 eye with phakic POAG and previous iridencleisis in which synechiae 
extended over 1 clock hour between iris and Schwalbe's line; 1 eye with 
phakic POAG and previous trabeculectomy in which synechiae extended over 2 
clock hours between the iris and the filter. 
In 30 patients the abovementioned structures were scored bilaterally in 
the same way. The gonioscopic findings in the primarily examined eye were 
not recapitulated at examination of the second eye (at least 2 months 
later). 
Table 6.5 indicates the degree of symmetry of angle grade trabecular pig-
mentation, iris processes and prominence of Schwalbe's line in these bilat-
Table 6.5. Frequencies of symmetrical findings as to angle grade, iris pro-
cesses, trabecular pigmentation and prominence of Schwalbe's 
line. 
Angle Grade 
Iris Processes 
Trabecular Pipentation 
Proninence of Schwalbe's Line 
Bilateral Grade 1 
Bilateral Grade 2 
Bilateral Grade 3 
Bilateral Grade 4 
Total 
Bilateral Present 
Bilateral Absent 
Total 
Bilateral TP+1 
Bilateral TF42 
Bilateral TP+3 
Bilateral TP+4 
Total 
Bilateral Present 
Bilateral Absent 
Total 
3.31 
33.3». 
23.3% 
3.3? 
63.3* 
30.0* 
43.3>. 
73.31 
10.« 
30.0Í 
10. Oí 
6.7Í 
56.7Í 
43.3Í 
30. Oí 
73.3Í 
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erally examined patients. All these items showed a fair degree of symmetry. 
A difference of at least 2 points in the scores for angle grade or trabec­
ular pigmentation was observed in only 2 eyes (6.7%). 
6.6.3 Optic disk 
The optic disk was likewise described on the basis of a standard protocol. 
In 8 eyes no deta i l s were discernible: in 4 th i s was due to a corticonuclear 
cataract, and in 4 i t was caused by a combination of cataract and use of 
miotics. In 4 of these eyes a cup/disk ra t io could be estimated. 
The cup disk ra t io was estimated on the basis of the contour cup (see 
3.4.1). Table 6.6 presents the mean horizontal and vert ical cup/disk rat ios 
per subgroup. 
Table 6.6. Mean pre-ALT horizontal and vert ical cup/disk r a t i o . 
Horizontal Cup/Disk Ratio (Mean + SD) Vertical Cup/DisJt fiatio (Mean + SD) 
Phakic POAG 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Secondary Glaucone 
Glaucoma Suspect 
Thyroid Disease 
Total 0.57 + 0.21 
0.57 ι 
0.4 
У 0.20 
0.60 * 0.08 
0.83 H 
0.45 H 
0.25 н 
0.55 i 
ι- 0.06 
> 0.07 
^ 0.07 
l· 0.35 
0.63 + 
0.4 
0.70 + 
0.83 + 
0.22 
0.14 
0.06 
0.60 + 0.14 
0.3 
0.60 + 
0.63 + 
0.42 
0.22 
Most of the eyes (54.7%) showed vertically oval optic disk cupping. The 
relationship between horizontal and vertical cup/disk ratios is outlined in 
figure 6.1. The vertical cup/disk ratio exceeded the horizontal one by 0.1 
in 22 and by 0.2 in 7 eyes. Two eyes showed horizontally oval optic disk 
cupping. 
The frequencies of specific optic disk features are listed in table 6.7. 
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Figure 6 .1 . Scatter diagram of pre-ALT horizontal and vert ical cup/disk 
ra t ios . 
Table 6.7. Frequencies of preoperative glaucomatous optic disk features 
(PDS: pigment dispersion syndrome; LTG: low-tension glaucoma). 
Phakic Ps.Phakic Secondary Glauc Thyroid 
POM P0№ PDS ПГС Glauc Suspect Disease Total 
Localized Polar Notch Absent 52.\\ 
Inconplete 34.31 
Conplete 8.6% 
Peripapillary Atrophy 11.4% 
Localized Pallor of the Neural Hin 22.9». 
Overpass Cupping 2.9$ 
Displaced Blood Vessels 42.9$ 
Optic Disk Haeurrhage 2.9$ 
1/1 3/4 
1/4 
2/4 
3/4 
1/3 
2/3 
1/3 
1/3 
1/2 
1/2 
2/2 
2/2 1/2 
1/2 
1/2 
1/2 
59.2$ 
34.7$ 
6.1$ 
16.3$ 
24.5$ 
2.0$ 
44.9$ 
2.0$ 
Twenty eyes (40.8%) showed localized notching of the neural rim; three of 
these eyes showed a complete notch. The notch was localized in the supero-
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temporal quadrant in 55.0% and in the inferotemporal quadrant in 45.0%. The 
3 eyes with a complete notch showed glaucomatous visual field defects. For 1 
eye with an incomplete notch no recent perimetric findings were available. 
Of the remaining 16 eyes, 12 (75.0%) showed glaucomatous visual field de-
fects. The mean cup/disk ratio in these eyes was 0.71 + 0.14 horizontally 
and 0.80 + 0.13 vertically. 
Peripapillary atrophy was observed in 8 eyes (16.3%). all with phakic 
POAG. The atrophy occurred in eyes with a low as well as in those with high 
cup/disk ratios. 
Localized pallor of the neural rim was seen in 12 eyes (24.5%). The mean 
cup/disk ratio in these eyes was 0.71 + 0.12 horizontally and 0.81 + 0.10 
vertically. Nine (75.0%) of this 12 eyes with localized pallor also showed a 
localized notch.; of eyes without localized pallor (N=37), only 29.7% showed 
a notch. 
Overpass cupping and optic disk haemorrhage were each observed on only one 
instance. 
Unmistakable nasal displacement of blood vessels was seen in 22 eyes 
(44.9%). 
6.6.4 Perimetry 
The perimetric findings were classified in accordance with the same scale 
as in the retrospective study (table 5.8). On 3 patients (1 eye with phakic 
POAG and 2 with secondary glaucoma), no recent perimetric findings were 
available. The perimetric findings are presented in table 6.8. 
Six eyes with phakic POAG showed no visual field defect or changes (stage 
0). They were nevertheless included in this subgroup for the following rea-
sons: 2 eyes were of patients whose contralateral eye did show a glaucoma-
tous visual field defect; 2 eyes showed no abnormalities at examination for 
classification, but on a previous occasion had shown a visual field defect; 
2 patients showed no visual field defect in either eye but the other fea-
tures justified inclusion in this subgroup (female patient 053, age 41, had 
a positive family history of glaucoma, Marcus Gunn pupillary reaction and 
progressive increase in cup/disk ratio; female patient 057, age 54, had dia-
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Table 6.8. Distribution of pre-ALT visual field stage (see also 5.8). 
PliaXic POAG 
PseulophaXic POAG 
Pigment Dispersion S. 
Low-tension Glaucoœa 
Glaucoma Suspect 
Thyroid Disease 
Total 
14.6* 
m 
1/2 
14.8t 
26.8* 
1/4 
1/2 
24.η 
26.8t 
1/1 
2/4 
25.9t 
ì 4 5a 
9.Bt 4.9t 9.8t 
1/4 
9.3t 3.7t 7.4t 7.4t 3.7t 3.7t 
2.4t 
1/4 
2/2 
2.4t 
1/4 
2.4t 
1/4 
betes mellitus, arterial hypertension, Marcus Gunn pupillary reaction and 
progressive increase in cup/disk ratio with vertical ovality, nasal dis-
placement of blood vessels, and peripapillary atrophy). 
Three eyes with phakic POAG respectively showed an enlarged blind spot, 
general diminution of sensitivity and a combination of these two. Two of 
these eyes had shown glaucomatous visual field defects at an earlier exami-
nation, and 1 eye was the contralateral eye of a patient with evident glau-
comatous visual field defect. 
None of the 4 eyes with a pigment dispersion syndrome showed glaucomatous 
visual field defects. Particularly on the basis of the optic disk features, 
these patients were nevertheless submitted to ALT (patient 001: horizontal 
cup/disk ratio 0.5, vertical ratio 0.5, nasal displacement of blood vessels; 
patient 035: cup/disk ratio 0.6 horizontally and 0.7 vertically, localized 
superotemporal incomplete polar notch, localized pallor of neural rim and 
nasal displacement of blood vessels; patient 042: cup/disk ratio 0.6 hori-
zontally and 0.8 vertically, localized pallor of neural rim and nasal dis-
placement of blood vessels; patient 050: progressive increase in cup/disk 
ratio, 0.7 horizontally and 0.8 vertically). 
Two eyes of patients with suspected glaucoma showed no optic disk damage 
and no visual field defect. 
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6.7 ARGON LASER TRABECULOPLASTY 
ALT was performed always by the same staff member, over 360° of the tra-
becular meshwork circumference in two sessions, separated by a period of 4 
weeks. Per session, an attempt was made to apply 60 burns with a diameter of 
50 \m and an exposure time of 0.1 sec. The burns were applied to the anteri-
or part of the trabecular meshwork, and occurrence of pigment dispersion and 
bubble formation was accepted as criterion for a 'good burn'. The apparatus 
used was a continuous wave blue-green Argon laser (Coherent Radiation Model 
900). 
All eyes were treated with corticosteroids during one week following ALT. 
Mean power and number of burns per session are indicated in table 6.9. The 
lowest power setting was used for eyes with the pigment dispersion syndrome 
(700-1100 mW). The mean power for the two sessions was virtually the same. 
Table 6.9. Mean power setting (mW) and mean number of burns per ALT session 
PlaJricPQAC 
Pseudophakie POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Secondary Glaucoma 
Glaucoma Suspect 
Thyroid Disease 
Total 
Mean + 
First Session 
1128 + 143 
1200 
925 + 171 
1250 + 108 
1075 + 106 
1200 
1200 + 283 
1127 + 153 
SD Power m 
Second Session 
1167 + 146 
1200 
975 + 189 
1263 + 125 
1200 + 71 
1200 
1200 + 283 
1164 + 153 
Mean + SD Number of Bums 
First Session 
61 + 3 
55 
60 
61 + 1 
60 
61 + 1 
60 
61 + 3 
Second Session 
60 + 2 
60 
62 + 4 
60 
60 
61 + 1 
60 
60 + 2 
Table 6.10 shows that in the vast majority of sessions the burns could be 
applied to the anterior trabecular meshwork. In 5 sessions (4.4%) this could 
not be established with certainty. 
In 75.4% of the sessions pigment dispersion as well as bubble formation 
were seen; in 24.6% only one of these criteria was fulfilled (pigment dis-
persion being seen more often than bubble formation). 
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Table 6.10. Number of sessions during which the anterior trabecular meshwork 
was treated with certainty, and distribution of visible effects 
(both: pigment dispersion and bubble formation). 
PhaXic POAG 
PseudophaJric POAG 
Pigment Dispersion S. 
Low-tension Glaucoma 
Secondary Glaucoma 
Glaucana Suspect 
Thyroid Disease 
Total 
Localization 
Anterior 
95.2% 
2/2 
8/8 
7/8 
4/4 
4/4 
4/4 
95.6* 
Not Sure 
4.8* 
1/8 
4.4t 
Bubble 
4.8* 
1/8 
1/4 
5.3* 
Visible Effect 
Dispersion 
23.8* 
1/4 
1/4 
19.3* 
Bo til 
71.4* 
2/2 
7/8 
8/8 
2/4 
4/4 
3/4 
75.4* 
Seven eyes were submitted to iris stretching before ALT. The number of 
iris bums was 1 9 + 2 (16-22) and the power setting averaged 325 + 56 mW 
(250-400 mW), at a spot size of 500 \m and an exposure time of 0.5 sec. 
During two sessions haemorrhage from the burnt parts of the trabecular 
meshwork occurred; in both cases this was arrested simply and effectively by 
compression with the contact glass. 
The ALT quality was good in virtually 50% of the sessions, as measured by 
Table 6.11. ALT quality and patients complaints. 
P M i c POAG 
Pseudophaiic POAG 
Pigment Dispersion S. 
Lw-tension Glauccma 
Secondary Glauccma 
Glaucoma Suspect 
Thyroid Disease 
Total 
Good 
48.8* 
7/8 
2/8 
2/4 
2/4 
2/4 
49.1* 
ALT Quality 
Fairly Good 
31.0* 
1/2 
1/8 
5/8 
1/4 
2/4 
31.6* 
Moderate 
20.2* 
1/2 
1/8 
1/4 
2/4 
19.3* 
Compi 
ffinor 
77.4* 
1/2 
8/8 
4/8 
4/4 
3/4 
4/4 
78.1* 
aints 
Severe 
22.6* 
1/2 
4/8 
1/4 
21.9* 
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the good burn criteria, the localization of the burns and the patients fixa­
tion (table 6.11). A moderate ALT was usually caused by difficulty in iden­
tifying the trabecular meshwork or inadequate fixation of the patient. The 
majority of patients were not greatly inconvenienced by the ALT. 
6.8 RESULTS 
6.8.1 IOP course on the day of ALT 
Table 6.12 and figure 6.2 indicate the course of the IOP in 57 first 
treated eyes after the first and the second ALT session. They also outline 
the IOP course in untreated contralateral eyes. 
The initial IOP measured 1 hour before the first ALT session was higher in 
the eyes to be treated (24.0 + 5.7 mm Hg) than in the not-to-be-treated con­
tralateral eyes (20.0 + 5.7 mm Hg). This is explained by the fact that the 
ALT was primarily performed in the eye with the highest IOP. Moreover, in a 
number of cases the contralateral eye had a well-controlled IOP. 
The treated eyes showed an increase in mean IOP which reached a maximum 1 
hour after ALT (σ: +4.4 + 7.2 mm Hg). From 1 hour after ALT on the IOP de­
creased , and 3 hours after ALT it was lower than the initial IOP (σ: -1.0 
+ 5.2 mm Hg). This decrease continued and after 6 hours the mean IOP decrea­
se was 3.9 + 4.4 mm Hg; after 24 hours it was 7.1 + 4.6 mm Hg. That this de­
crease was consistent was evident from the fact that the initial IOP in the 
treated eyes before the second session was lower than that in the untreated 
contralateral eyes. 
A similar IOP course was observed after the second session: an increase in 
mean IOP after 1 hour (σ: +4.9 + 5.5 mm Hg), followed by a decrease. However 
the mean IOP attained a value lower than the initial IOP after the second 
session after more than 6 hours (σ: -2.4 + 3.7 mm Hg at 24 hours). 
The increase in mean IOP following both sessions was virtually the same 
(σ: +4.4 + 7.2 mm Hg and σ: +4.9 + 5.5 mm Hg), but due to the lower initial 
IOP the maximum IOP after the second session was significantly lower than 
that after the first session (22.3 + 6.0 mm Hg and 28.4 + 8.9 mm Hg respec­
tively) . 
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Ю Р (mmHg) 
2 8 -
2 4 -
20 
16 
First session 
• — · treated eyes 
о — о untreated eyes 
Г\. 
гт 
HOP 1 2 3 4 5 6 24 
time (hours) 
IOP (mmHg) 
26-
22 
1 8 -
1 4 -
Second session 
• — · treated eyes 
о — о untreated eyes 
41-1 1 1 1 1 
HOP 1 2 3 4 5 6 24 
time (hours) 
First Session Second Session 
HOP 
Ih 
2h 
3ti 
4h 
5h 
6 h 
24 h 
1 V 
Treated Eyes 
24.0 + 5.7 
28.4 + 8.9 
25.9 + 7.5 
23.0 + 5.2 
22.0 + 6.0 
20.4 + 5.7 
20.2 + 5.7 
17.0 + 3.8 
20.4 + 6.9 
Untreated Eyes 
20.0 + 5.7 
20.0 + 5.2 
18.8 + 4.5 
17.7 + 3.7 
18.5 + 5.7 
17.7 + 3.8 
18.4 + 3.8 
18.9 + 4.5 
19.7 + 4.5 
Treated Eyes 
17.4 + 3.8 
22.3 + 6.0 
20.8 + 6.7 
18.8 + 5.2 
17.5 + 4.5 
18.0 + 5.3 
17.8 + 4.4 
15.0 + 3.8 
16.7+ 4.5 
Untreated Eyes 
19,3 + 4,5 
19.5 + 4 
18.5 + 4 
18.2 + 3 
17.8 + 3 
18.0 + 3 
18.6 + 4 
19,0 + 4 
19.2 + 3 
5 
5 
7 
8 
8 
4 
5 
8 
Table 6.12 and Figure 6.2. IOP course (Mean + SD; mm Hg) until 24 hours af­
ter ALT in treated and untreated eyes after the first and second 
session (HOP: initial IOP; h:hour(s),· w:weeJc). 
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The ЮР in untreated contralateral eyes showed no change within the first 
hour after ALT, either after the first or after the second session. From the 
first hour post-ALT on, these eyes likewise showed an IOP decrease; this was 
more pronounced after the first than after the second session. Subsequently 
the IOP rose again until its initial value was attained. This transient de­
crease in IOP in the untreated contralateral eyes resulted from the fact 
that a number of patients were given Diamox in view of an IOP increase which 
had to be treated according to the criteria set (25 patients (43.9%) after 
the first and 13 (22.8%) after the second session). 
Table 6.13 and figure 6.3 illustrate this for the first ALT session. The 
IOP course in treated and in untreated contralateral eyes is shown separa­
tely for patients who did and those who did not receive Diamox after ALT. A 
fairly constant IOP was observed in contralateral eyes not treated with 
Diamox, whereas Diamox-treated eyes showed a distinct post-ALT IOP decrease. 
The mean IOP of these subgroups taken jointly revealed a decreasing tendency 
for untreated contralateral eyes. The fact that this IOP decrease was less 
pronounced after the second than after the first session (maximum decrease 
1.5 mm Hg and 2.3 mm Hg respectively) must be ascribed to the smaller number 
of patients given Diamox after the second session. 
Table 6.13 an figure 6.3 in addition show that the maximum IOP in ALT eyes 
treated with Diamox was so high (35.5 + 7.0 mm Hg one hour after ALT) that 
this temporary additional therapy was indeed indicated. 
That the decrease in mean IOP from the first postoperative hour on was an 
ALT effect rather than a Diamox effect, is evident from the IOP course in 
ALT eyes not treated with Diamox (figure 6.3). These eyes, too, showed a 
consistent IOP decrease following a mild increase. 
Table 6.14 and figure 6.4 show the IOP course in ALT eyes with phakic 
POAG, pigment dispersion syndrome and low-tension glaucoma after the first 
and the second session (the other subgroups were too small for presentation 
of the mean IOP values in this form, but the results will be discussed in a 
later section). The increase in mean IOP within l hour of ALT and the sub­
sequent IOP decrease proved to occur in each of three subgroups described 
here. 
A bilateral ALT was performed in 30 patients. The IOP course after ALT of 
the second eyes showed the expected pattern (table 6.15 and figure 6.5): 
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ЮР (mmHg)-
3« • 
30-
26 
22 
IS 
λ 
/ 
/ [/ 
\ ALT eyes 
\ 
Ί 1 
<^ ί. 
\1 
VI 
\ 
ПОР 1 2 3 ¿ 5 6 2¿ 
time (hours) 
ПОР 
1 h 
2П 
3h 
4 h 
5 h 
6)) 
24 h 
1 V 
Diamox Post-ALT 
Treated Eyes 
26.5 + 4.7 
35.5 + 7 
32.3 + 5 
26.7 + 4 
25.7 + 5 
23.8 + 5 
23.6 + 5 
18.8 + 3 
23.4 + 5 
Contralateral Eyes 
21.8 + 5.9 
22.3 + 5.8 
20.4 + 4.7 
17.6 + 4.0 
18.6 + 5.4 
17.8 + 4.0 
18.3 + 4.1 
19.6 + 4.7 
20.6 + 4.8 
No Dianox Post-ALT 
Treated Eyes 
22.1 + 4.2 
23.1 + 5.3 
20.8 + 4.0 
20.0 + 4.2 
19.2 + 4.2 
17.8 + 4.0 
17.5 + 3.4 
15.5 + 3.4 
17.9 + 6.9 
Contralateral Eyes 
18.6 + 4.1 
18.3+ 4.2 
17.5 + 4.0 
17.7 + 3.8 
18.5 + 4.8 
17.6 + 4.1 
18.4 + 4.0 
18.3 + 4.4 
19.0 + 4.5 
Table 6.13 and Figure 6.3. IOP course (Mean + SD; mm Hg) until 24 hours af­
ter ALT in treated and untreated eyes after the first session, 
separately for post-ALT Diamox treatment. 
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PhaXic POAG Pigment Dispersion S. Low-tension Glaucoma 
HOP 
I h 
2h 
3h 
4 h 
5h 
6h 
24 h 
1 ν 
1st Session 
24.3 + 4.5 
29.2 + 9 
27.0 + 7 
23.8 + 5 
22.5 + 5 
20.9 + 5 
20.6 + 5 
17.1 + 3 
20.0 + 6 
0 
2nd session 
17.6 + 3.2 
23.1 + 6.5 
21.5 + 7.0 
19.5 + 5.1 
18.0 + 5.2 
18.5 + 5.8 
18.4+ 4.4 
15.1 + 3.2 
16.9 + 3.0 
1st Session 
22.3 + 3.4 
28.5 + 8.4 
21.3 + 2.2 
19.0 + 2.6 
19.3 + 2.0 
17.3 + 1.0 
17.5 + 1.8 
13.8 + 4.4 
16.3 + 4.4 
2nd Session 
14.3 + 3.4 
21.5 + 4.2 
20.3 + 3.0 
16.8 + 3.0 
16.3 + 4.0 
15.5 + 2.6 
15.3 + 2.2 
14.8 + 3.8 
13.5 + 1.8 
1st Session 
16.5 + 3.6 
18.5 + 3.4 
17.3 + 3.4 
16.3+ 3.4 
14.5 + 3.4 
15.0 + 4.0 
12.3 + 1.8 
14.0 + 3.6 
14.3 + 2.2 
2nd Session 
13.3 + 4.8 
16.5 + 4.8 
12.0 + 0.8 
12.5 + 1.8 
12.8 + 2.0 
13.3 + 2.0 
13.8 + 1.8 
11.8 + 2.8 
12.8 + 3.0 
Table 6.14 and Figure 6.4. IOP course (Mean + SD; mm Hg) unt i l 24 hours af­
t e r ALT for treated eyes with phakic TOAG (POAG), pigment disper­
sion syndrome (PDS) and low-tension glaucoma (LTG) after the 
f i r s t and second session. 
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2д - / ^ ч . F l r s* session 
• 
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-
16-
• 
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/ \ 
1 
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\ 
I 
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Г 
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IIOP 1 2 3 4 5 6 24 
time (hou sì 
ПОР 
Ih 
2h 
31) 
4 h 
5h 
6h 
24 h 
Iw 
First Session 
Treated Eyes 
21.7 + 4.9 
25.5 + 6.6 
23.2 + 6.5 
21.7 + 5.8 
18.8 + 5.5 
18.5 + 5.5 
18.1 + 4.8 
15.6 + 3.3 
18.3 + 4.4 
Untreated Eyes 
15.1 + 3.3 
15.3 + 2.7 
14.5 + 2.7 
15.0 + 2.6 
14.1 + 3.3 
14.5 + 2.7 
14.9 + 3.2 
15.0 + 2,7 
15.0 + 2.7 
Second Session 
Treated Eyes untreated Eyes 
18.4 + 2. ' 
22.6 + 4.« 
20.8 + 5.! 
18.1 + 4. 
16.4 + 3. 
16.1 + 3. 
15.8 + 2. 
13.6 + 3. 
16.4 + 4. 
1 15.0 + 2.7 
I 16.1 + 2.2 
14.9 + 2.7 
) 15.2 + 2.7 
) 14.0 + 2.7 
I 14.3 + 2.7 
1 14.4 + 2.7 
1 14.3 + 2.7 
I 14.6 + 3.3 
Table 6.15 and Figure 6.5. IOP course (Mean + SD; mm Hg) until 24 hours af­
ter ALT in second eyes and control eyes after the first and the 
second session. 
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a brief transient TOP increase followed by a consistent decrease. In this 
context it is to be noted that the contralateral eyes described in this 
table and figure, which at the time served as control eyes, had been pre-
viously submitted to ALT. Consequently the IOP in these eyes was low. 
The mean IOP in ALT eyes showed an increase at a check-up after l week, 
both after the first and the second session. There are two reasons for as-
cribing this IOP increase to post-ALT treatment with corticosteroid eye-
drops, which in corticosteroid responders must have caused an IOP increase. 
These reasons are as following: 
- To begin with, although the mean IOP of these eyes had increased after l 
week, it subsequently fell to the value measured 24 hours after ALT, as 
evident from the initial IOP before the second session (IOP after 24 hours 
17.0 mm Hg, after 1 week 20.4 mm Hg and before the second session 17.4 mm 
Hg respectively; table 6.12). 
- Secondly, this IOP increase was not observed in the untreated contralater-
al eyes (which had not received no post-ALT corticosteroid application). 
The second eyes likewise showed an increase, but on the average there was 
no IOP decrease until the second session. However, the subgroup with phakic 
POAG did show a decreasing tendency, be it less marked than that in eyes 
treated first (IOP after 24 hours 15.9 mm Hg, after l week 19.6 mm Hg and 
before the second session 18.8 mm Hg respectively). Three second eyes with a 
pigment dispersion syndrome in particular showed no increase at the 1-week 
check-up, but the IOP thereafter increased, perhaps because no adequate res-
ponse to ALT had yet occurred. 
A second reason to assume that the group of second eyes also included cor-
ticosteroid responders derives from the differences in the standard devia-
tion from the mean IOP values after l week and before the second session. 
The smaller standard deviation from the mean IOP before the second session 
may be explained from an IOP increase in a proportion of the eyes (pigment 
dispersion syndrome) and a decrease in the eyes responding to corticoster-
oids. 
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6.8.2 Eyes with Ю Р spikes and variables in these eyes 
6.8.2.1 Eyes with IOP spikes 
An IOP spike is defined as a minimal IOP increase by at least a given num­
ber of (whole) mm Hg within 24 hours of ALT. 
This may be illustrated by the following description of a single aspect of 
the IOP pattern after ALT, separately for patients in whom the IOP increase 
did (Y) or did not (N) exceed the spike value. 
Proceeding from any increase in IOP observed - i.e. a spike value of 1 mm 
Hg or higher - one may conclude that 75.4% of the eyes showed such an in­
crease after the first session, and 86.0% after the second session. In view 
of the standard deviation of measurement error, however, it is not justifia­
ble to regard such a 'spike' as indeed a significant increase. A second rea­
son to opt in favour of a higher minimum spike value, in this study 10 mm Hg 
is its clinical relevance (it constituted an indication for Diamox treat­
ment). By way of illustration the analyses are performed also with a lower 
spike value (5 mm Hg) to indicate possible consequences of taking this value 
as a Diamox criterion. By way of example figure 6.6 presents the cumulative 
frequency distribution of all IOP spikes measured after the first and second 
session. After the first session these spikes ranges from 1 to 20 mm Hg (me­
dian 8 mm Hg), and after the second session they ranged from 1 to 22 mm Hg 
(median 7 mm Hg). 
Table 6.16 lists a number of IOP parameters for the 57 eyes treated first, 
divided into eyes with an IOP spike of at least 5 and those with a spike of 
at least 10 mm Hg. 
Some 50% of the eyes showed an IOP spike by at least 5 mm Hg after the 
first session. The maximum IOP of these eyes was 35.2 + 7.0 mm Hg, and the 
mean proportional IOP decrease 6 hours after ALT was less than that in eyes 
without an IOP spike of 5 mm Hg or more. The two groups showed a mean pro­
portional IOP decrease of the same order of magnitude 24 hours after ALT. 
An IOP spike of at least 10 mm Hg occurred in 29.8% of the eyes. These 
eyes, too, attained a high maximum IOP (37.9 + 5.0 mm Hg), while the mean 
proportional IOP decrease 6 hours after ALT was not marked. A check-up on 
IOP one day later, however, revealed an adequate decrease in IOP. 
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Figure 6.6. Cumulative frequency distribution of maximum Ю Р values after 
the first and second session. 
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Table 6.16. Frequencies of eyes with an IOP spike (IOPS) of at least 5 or 10 
mm Hg after the first and the second session, with corresponding 
initial IOP ( H O P ) , maximum IOP (ΜΆΧΙΟΡ), proportional IOP de­
crease after 6 hours and 24 hours (PIOPD 6h, 24h) (All as Mean 
+ SD). Also separately for eyes with and without post-ALT Diamox 
treatment. 
First Session ПОР m Hg НШОРипНд PIOPD 6h % PIOPD 2«i % 
I0PS >5 m Hg Yes 50.91 23.9 + 5.6 35.2 + 7.0 7.3 + 20.8 24.1 + 16.7 
N0 49.П 24.1 + 4.2 24.9 + 4.8 23.4 + 11.7 31.7 + 14.9 
IOPS >10 in Hg Yes 29.8». 23.6 + 4.0 37.9 + 5.0 4.6 + 22.1 25.3 + 16.4 
I«) 70.η 24.2 + 5.3 26.8 + 6.5 19.7+15.2 28.9 + 16.2 
Diamox Yes 43.91 26.5 + 4.7 37.6 + 4.4 9.9 + 21.0 28.0 + 14.2 
NO 56.η 22.1 + 4.2 24.3 + 4.4 19.3+15.7 27.7 + 17.8 
Second Session ПОР im Hg тХІОРшпНд PIOPD 6h % PIOPD 24h Ì 
I0PS>5 um Hg Yes 54.i% 17.3 + 4.0 27.0 + 6.5 -7.4 + 20.1 9.3 + 23.0 
No 45.6t 17.6 + 3.6 19.1 + 3.2 0.1 + 19.6 14.9 + 15.9 
I0PS >10 m Hg Yes 21.Ц 18.4 + 4.3 32.5 + 6.1 -16.5 + 20.7 11.5 + 25.2 
No 78.9t 17.2 + 3.7 21.0 + 4.1 - 0.9 + 18.8 11.9 + 18.9 
Diaeox Yes 22.8t 19.5 + 4.5 32.9 + 5.5 -14.3 + 18.5 10.5 + 22.8 
N0 77.2t 16.8 + 3.4 20.6 + 3.6 -1.1 + 19.7 12.2+19.5 
In 43.9% of the eyes, Diamox was required after the first ALT session in 
view of an IOP spike which fulfilled the criteria for additional treatment. 
The frequency of occurrence of IOP spikes after the second ALT session did 
not differ markedly from that after the first session. Because the initial 
IOP before the second session was unmistakably lower, however, lower maximum 
IOP values were attained. This was also evident from the smaller proportion 
of eyes requiring Diamox after the second session (22.8%, versus 43.9% after 
the first session; p<0.01). 
Contrary to the IOP course following the first session, a mean proportio­
nal IOP increase was observed б hours after the second session; 24 hours af­
ter ALT, however, these eyes also showed a mean proportional IOP decrease. 
The mean interval after which a maximum IOP spike occurred was 1.4 + 0.8 
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hours (>5 mm Hg) and 1.4 + 0.6 (>10 mm Hg) after the first session, and 1.4 
+ 0 . 5 (>5 mm Hg) and 1.9 + 1.7 hours (>10 mm Hg) after the second. 
The time at which Diamox was indicated is of greater clinical importance. 
This was 1.5 + 0.8 hours after the first, and 1.5 + 0.5 hours after the sec-
ond session. In most cases requiring Diamox this was given within 2 hours of 
ALT (68.0% 1 and 28.0% 2 hours after the first session; 69.2% l and 23.1% 2 
hours after the second session). 
In only one eye was an IOP decrease observed first, followed by a spike 
which necessitated Diamox treatment 4 hours after ALT. 
Of 25 eyes requiring Diamox after the first session, 15 (60.0%) received 
250 mg, 9 (36.0%) 500 mg and 1 (4.0%) 750 mg before the IOP tended to de-
crease. After the second session 9 eyes (69.2%) received 250 mg, and 4 
(30.8%) 500 mg. 
Table 6.17 lists the frequencies of IOP spikes after the first and second 
session per subgroup. The subgroups were often too small to reveal inter-
subgroup differences. The pigment dispersion syndrome tended to show high 
IOP spikes. Alertness is imperative also in low-tension glaucoma. 
Table 6.17. Frequencies of IOP spikes of at least 5 or 10 mm Hg after the 
first and the second session, per subgroup. 
PhaJcicPOÄG 
PseudophaXic POftG 
Pigment Dispersion S. 
Low-tension Glaucona 
Secondary Glaucona 
Glaucona Suspect 
Thyroid Disease 
Total 
First Session 
>5miHg 
57.« 
-
2/4 
1/4 
-
-
2/2 
50.« 
HOmHg 
33.3». 
-
2/4 
-
-
-
1/2 
29.8% 
Second Session 
>5 m H g 
57. η 
-
4/4 
1/4 
1/2 
1/2 
-
54.« 
>10 MiHg 
23.8% 
-
1/4 
-
1/2 
-
-
21.« 
Figure 6.7 shows the distribution of eyes with an IOP spike of at least 5 
or 10 nm Hg as a function of the post-ALT check-up time after the first and 
second session. 
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Figure 6.7. Frequencies of eyes with an TOP spike of at least 5 or 10 mm Hg 
after the first and the second session as a function of the time 
of post-ALT check-up. 
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After the first session the highest frequency of these two IOP spikes was 
measured 1 hour after ALT; subsequently the number of eyes with an IOP spike 
diminished consistently, similar findings were obtained after the second 
session: highest frequency of IOP spikes after l hour, with a subsequent de­
crease in frequency. After neither session did eyes show a spike of at least 
5 mm Hg 24 hours after ALT. 
6.8.2.2 Variables in eyes with IOP spikes 
In order to reach a conclusion about high-risk factors correlating with 
post-ALT IOP spikes, the occurrence of these spikes was submitted to an ex­
ploratory analysis in correlation with the values of several variables. This 
analysis was: 
1. confined to IOP spikes of at least 5 or 10 mm Hg; 
2. confined to IOP spikes observed after the first session; 
3. applied both to the entire population (N=57) and separately to the eyes 
with phakic POAG. 
The variables and the corresponding frequencies of IOP spikes are presen­
ted in table 6.18. 
Table 6.18. Frequencies of IOP spikes of at least 5 or 10 mm Hg after the 
first session in all eyes and in eyes with phakic POAG as a 
function of patient, ocular, gonioscopic and ALT variables. 
I0PS Ml Eyes IQPS PhaXic POBG 
Patient Variables >5 m Hg >10 mn Hg >5 mn Hg >10 лп Hg 
Age <60 yr 41.2* 17.6* 4/10 1/10 
>60 yr 55.8* 35.0* 62.5* 40.6* 
Male 60.7* 39.3* 70.0* 40.0* 
Fanale 41.4* 20.7* 45.5* 27.3* 
(contimed) 
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Table 6.18 continued 
Ocular/Glaucona Variables 
OD 
OS 
Brown E y e s 
Blue Eyes 
Hypermetropia 
Myopia 
ПОР <20 m Hg 
>20mHg 
<25imHg 
>25 nnHg 
Miotics 
Other tcf>ical medication 
Diaaox рте-АЬТ Yes 
№ 
Previous Surgery 
Previous ALT 
No Previous Surgery 
lOPSAll 
>5nnHg 
44.81 
57. Ц 
70.0Î 
40.5% 
41.7t 
56.01 
64.3t 
66.7t 
51.4t 
50.0t 
50.0t 
50.0t 
5/8 
49.0t 
1/5 
2/4 
54.2t 
Eyes 
HO ип Hg 
27.6t 
32.1t 
35.0t 
27.0t 
20.8t 
32.0t 
35.7t 
27.4t 
35.1t 
20.0t 
35.7t 
25.0t 
3/8 
28.6t 
1/5 
1/4 
31.2t 
IOPS Phakic POAG 
>5 mmHg 
57.1t 
57.1t 
72.2t 
45. St 
52.9t 
55.6t 
6/8 
52.9t 
57.1t 
57.1t 
58.3t 
58.6t 
3/4 
55.3t 
1/2 
2/4 
58.3t 
MOrniHg 
33.3t 
33.3t 
38.9t 
29.2t 
29.4t 
27.8t 
3/8 
32.4t 
39.3t 
21.4t 
41.7t 
31.0t 
2/4 
31.6t 
1/2 
1/4 
33.3t 
Gonioscopic Variables 
Angle Grade 1-2 
Grade 3-4 
Beak-shaped Angle Absent 
Present 
Iris Processes Absent 
Present 
Trabecular Pignentation TP 0 
ТР+Э 
-TP+2 
-TP+4 
Proainence of Sclwalbe's line Absent 
Present 
Peripheral Anterior Synechiae Absent 
Present 
51.4t 
50.0t 
52.5t 
47.1t 
39.4t 
66.7t 
41.5t 
75.0t 
48.3t 
53.6t 
52.8t 
1/4 
27.0t 
35.0t 
37.5t 
11.8t 
24.2t 
37.5t 
22.0t 
50.0t 
27.6t 
32.1t 
30.2t 
1/4 
63.0t 
46.7t 
59.3Î 
53.3t 
42.9t 
85.7t 
48.4t 
81.8t 
54.5t 
60.0t 
57.5t 
1/2 
37.0t 
26.7t 
44.4t 
13.3t 
25.0t 
50.0t 
29.0t 
45.5t 
31.8t 
35.0t 
32.5t 
1/2 
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(continued) 
Table 6.1β continued 
ALT Variables 
Bubble or Dispersion 
Bubble and Dispersion 
Power <1000 вй 
ПОООиИ 
Iris Stretching Performed 
Not Perforaed 
ALT Quality (fairly) Good 
Moderate 
Patient Complaints Moderate 
Severe 
I0PS All Eves 
>5inHg 
50.0% 
51.2* 
49.0* 
3/7 
52.0t 
54.5* 
3β.5* 
50.0* 
5/9 
ПОЮ Hg 
IB. β* 
34.1* 
4/6 
25.9* 
0/7 
34.0* 
34.1* 
15.4* 
27.1* 
4/9 
lOPS PhaJcic POAG 
>5 im Hg 
53.8* 
58.6* 
2/4 
57.9* 
3/7 
60.0* 
60.6* 
4/9 
55.9* 
5/8 
>10 mo Hg 
23.1* 
37.9* 
2/4 
31.6* 
0/7 
40.0* 
36.4* 
2/9 
29.4* 
4/8 
The number of eyes with the following variables was too small for a suffi­
ciently powerful analysis: 
- pre-ALT Diamox treatment, 
- pre-ALT glaucoma surgery, 
- presence of peripheral anterior synechiae, 
- ALT with a power setting <1000 mW, 
- severe post-ALT complaints. 
A significantly high frequency of IOP spikes of at least 5 mm Hg was found 
in eyes with brown irides, eyes with iris processes and eyes with trabecular 
pigmentation degree TP+3 and TP+4 (p<0.05 respectively). 
A significantly lower frequency of IOP spikes of at least 10 mm Hg was 
found in eyes with a beak-shaped iridocorneal angle and those submitted to 
iris stretching prior to ALT (p<0.05 respectively). 
The low frequencies of IOP spikes in eyes with a beak-shaped angle and 
eyes submitted to iris stretching were not independent findings because iris 
stretching was performed only in eyes with a beak-shaped angle. This type of 
angle existed in 15 eyes with phakic POAG, and 7 of these were submitted to 
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iris stretching. None of the latter eyes showed an IOP spike of at least 10 
mm Hg, which was found in 2 of the 8 eyes not submitted to iris stretching. 
A high trabecular pigmentation degree (TP+3 and TP+4) was associated with 
more IOP spikes. This also explained why 4 of the 6 eyes with a first ALT 
session at less than 1000 mW power setting showed an IOP spike of at least 
10 mm Hg: two of these had TP+3, and two had TP+4. 
An analysis confined to eyes with phakic POAG revealed no correlation be­
tween ALT power setting and the occurrence of IOP spikes (frequency of 
spikes of at least 5 mm Hg: 58.8% at power setting <1100 mW, 56.0% at power 
setting >1100 mW, 52.2% at power setting <1200 mW and 63.2% at power setting 
>1200 mW). 
Brown irides were associated with more IOP spikes than blue ones. Because 
the two iris colours did not differ in degree of trabecular pigmentation, 
this could not be a consequence of differences in degree of pigmentation. 
ALTs described as (fairly) good were associated with more IOP spikes than 
moderate ALTs. This is explained by the fact that most good ALTs caused pig­
ment dispersion as well as bubble formation, and this combination produced 
more IOP spikes than either criterion alone. 
6.8.3 First and second session IOP spikes 
Table 6.19 lists first and/or second session IOP spikes of at least 5 or 
10 mm Hg, both for the entire group and for phakic POAG eyes. 
Table 6.19. Frequencies of eyes with an IOP spike of at least 5 or 10 mm Hg 
after no, one or both session(s) for all eyes and for eyes with 
phakic POAG. 
M I Eyes Phakic POIVG 
>5 MI Hg >10 ira Hg >5 мл Hg >10 m Hg 
29. i\ 10.5% 35. П U.ìi 
21.Ц 19.3% 21.4% 19.0% 
24.6% 10.5% 21.4% 11.9% 
24.6% 59.6% 21.4% 54.8% 
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Both Sessions 
First Session Only 
Second session Only 
None of Both Session 
On the basis of the data in table 6.19 the distribution of eyes with a 
second session IOP spike can be outlined as a function of the occurrence or 
non-occurrence of a first session IOP spike. This is done in table 6.20. 
Table 6.20. Frequencies of IOP spikes (IOPS) of at least 5 or 10 mm Hg after 
the second session as a function of the response to the first 
session, for all eyes and for eyes with phakic POAG. 
Second Session IOPS No second Session IOPS 
First Session IOPS >5 am Hg All Eyes 58.61 41.« 
Phakic POAG 62.S% 37.5* 
First Sessi«) No IOPS >5 on Hg All Eyes 50.0% 50.01 
Phakic PCM 50.Oí 50.0% 
First Session IOPS >10 ran Hg All Eyes 35.5>. 64.7% 
Phakic POAG 42.9% 57.1% 
First Session No IOPS >10 m Hg All Eyes 15.0% 85.0% 
Phakic PCftG 17.9% 82.1% 
For each of the two sessions the chance of an IOP spike at least 5 mm Hg 
was about 50%, the events occurring independently. The chance of an IOP 
spike of at least 10 mm Hg was virtually 30% after the first and 20% after 
the second session. These IOP spikes, too, occurred independently. 
6.8.4 First and second eye IOP spikes 
All other things being equal, the analysis applied to first and second 
session spikes may also be carried out for patients treated bilaterally. 
Table 6.21 shows the distribution of IOP spikes after the first session in 
bilaterally treated patients. 
Table 6.22 presents the distribution of eyes with an IOP spike after the 
first session of the second eye, as a function of the reaction after the 
first session of the first eye. 
A small number of patients showed an IOP spike after the first session of 
the second eye although it had not occurred after the first session of the 
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Table 6.21. Frequencies of Ю Р spikes (lOPS) of at least 5 or 10 mm Hg after 
the first session in no, one or both eye(s). 
All Eyes PhaXic PCftG 
>5 on Hg >10 m Hg >5 un Hg >10 mn Hg 
Botheyes 36.6* 20.0t 45.0t 30.Oí 
First Eye Only 26.74 23.34 25.04 15.04 
Second Eye Only 6.74 3.34 5.04 5.04 
None Of Both Eyes 30.04 53.34 25.04 50.04 
Table 6.22. Frequencies of IOP spikes of at least 5 or 10 mm Hg after the 
first session in the second eye as a function of the response of 
the first eye to the first session. 
First Eye I0PS >5 m Hg M l Eyes 
PhaXic И М 
First Eye No I0PS >5 mn Hg All Eyes 
PhaJtic POM 
First Eye MPS >10 m Hg All Eyes 
PhaXicPOAG 
First Eye No I0PS >10 m Hg All Eyes 
PhakicPCRG 
Second Eye I0PS 
57.94 
64.34 
18.24 
1/6 
42.24 
66.74 
5.94 
9.14 
Second Eye No I0PS 
42.14 
35.74 
81.84 
5/6 
53.84 
33.34 
94.14 
90.94 
the first eye. As expected, therefore, there is a statistical indication 
(p<0.l0) of a correlation between occurrence of spikes after first sessions 
of ALT in both eyes of the same individual. 
A related, and clinically more important, finding is that whenever the 
first eye shows no IOP spike of at least 10 mm Hg after either session, no 
IOP spike of at least 10 mm Hg is seen in the second eye in 93.3% of all and 
88.9% of the phakic POAG eyes. If on the other hand an IOP spike of at least 
10 mm Hg occurs in the first eye after one of the two sessions, then a simi­
lar spike is observed after at least one session in 53.3% of all and in 
72.7% of the phakic POAG second eyes. 
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There is a statistically significant (p<0.05) interdependence in occurren­
ce of IOP spikes of at least 10 mm Hg in the two eyes of an individual. 
6.8.5 Success rate and visual field function 
Table 6.23 shows the results of ALT in the various subgroups. One patient 
with phakic POAG dropped out and was not considered in the compilation of 
these results. Success was defined as a proportional IOP decrease of a least 
20% and a final IOP of 21 mm Hg or lower. 
Table 6.23. ALT results per subgroup (CFR: complete failure rate; SR: suc­
cess rate; H O P : initial IOP; FIOP: final IOP; IOPD: absolute 
IOP decrease; PIOPD: proportional IOP decrease (All as Mean+ 
SD) FU: follow-up ). 
CFR 
Success Eyes 
SR HOP m Hg ПОР ив Hg IOPD пи Hg PIOPD % FU (mths) 
Phakic EWG 
Pseudophaïic POÄG 
Pigment Dispersion S. 
Low-tension Glaucona 
Secondary Glaucoma 
Glaucoma Suspect 
Thyroid Disease 
7.3* 
1/4 
75.61 
1/1 
3/4 
1/4 
1/2 
2/2 
0/2 
Total 
25.7 + 5.4 14.7 + 3.1 11.0 + 6.3 40.9 + 15.2 7.0+3.9 
19 15 4 21.1 5.8 
25.0 + 4.4 13.3 + 0.6 11.7 + 4.2 45.6+ 9.6 7.0+3.1 
14 10 4 28.6 10.5 + 3.1 
32 16 16 50.0 8.9 + 1.9 
29.0 + 5.7 19.5 + 4.0 9.5 + 4.9 36.1 + 17.0 4.3 + 0.5 
8.9* 69.6* 25.5 + 5.6 14.7 + 3.1 10.8 + 6.0 40.2 + 14.6 7.3 + 3.7 
After a mean follow-up of 7 months the success rate in phakic POAG was 
75.6%, which is in accordance with expectations based on the estimated Kap-
lan-Meier survival curve in the retrospectively studied patient population 
(table 5.35, figure 5.3). 
These eyes again showed differences in success rate as a function of the 
initial IOP: eyes with an initial IOP of at least 22 mm Hg had a success 
rate of 88.9%, versus one of only 50.0% in eyes with an initial IOP below 22 
mm Hg (p<0.01). 
Three eyes with phakic POAG were evaluated as complete failures (7.3%); 
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two required increased medication and the third was treated by trabeculec-
tomy after ALT. This eye had previously been submitted to ALT in our depart-
ment, and after the re-ALT it showed IOP spikes of +2 mm Hg after the first 
and +8 mm Hg after the second session. The last IOP spike was arrested with 
Diamox. Because no adequate IOP decrease occurred in spite of additional 
Diamox (initial IOP 30 mm Hg, IOP 3 weeks after the second session 28 mm 
Hg), a trabeculectomy was performed. 
The relationship between IOP spikes and success rate in eyes with phakic 
POAG was as follows. Occurrence of an IOP spike of at least 5 or 10 mm Hg 
after at least one session correlated with a success rate of 78.1% or 89.5% 
respectively. On the other hand, an IOP spike of at least 10 mm Hg was ob-
served in 54.8% of the success eyes, versus only 20.0% of the failure eyes 
(p<0.l0). If no IOP spike of at least 5 or 10 mm Hg occurred after either 
session, then the respective success rates were 66.7% and 63.6%. Even the 
occurrence of an IOP spike of at least 5 or 10 mm Hg after both sessions did 
not result in a lower success rate (IOP spike >5 mm Hg: success rate 88.2%; 
IOP spike >10 mm Hg: success in 5 out of 6 eyes). 
In view of the small numbers in the other subgroups it would make little 
sense to present a detailed discussion of the results in these subgroups. 
However, the trends were similar to those seen in the retrospective study: 
good responses in eyes with a pigment dispersion syndrome and moderate re-
sults in low-tension glaucoma). 
An eye with the features of scleritis and requiring systemic corticoster-
oids showed a good response to ALT. Two eyes of patients with hyperthyroi-
dism showed no response to ALT. 
In none of the eyes visual acuity was reduced by more than 2 lines. 
Post-ALT perimetric findings were available on 46 eyes, the mean interval 
between ALT and perimetry being 4.2 + 2.5 months. Three of these 46 eyes 
(6.5%) showed progression of visual field defects to the next higher stage; 
6 eyes (13.0%) showed deterioration, but within the same stage, and 37 eyes 
(80.4%) showed no change. 
Six of the eyes with visual field deterioration had shown a good IOP de-
crease and all had shown an IOP spike of at least 5 mm Hg (3 one of at least 
10 mm Hg) after at least one session. Two of these eyes showed progression 
to the next higher visual field stage. 
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To summarize: the visual field defect had progressed to the next higher 
stage in 2 out of 32 eyes (6.3%) with an IOP spike of at least 5 mm Hg after 
at least one session and a good response to ALT. Eleven eyes without an IOP 
spike of at least 5 mm Hg and with an adequate response to ALT showed no 
progression of visual field defects to the next higher stage. This differ-
ence was not statistically significant (p<0.50). 
6.9 DISCUSSIMI AND CONCLUSIONS 
IOP course on the day of ALT: 
The mean IOP of eyes treated by ALT showed an increase during the immedi-
ate post-ALT phase. This increase was transient, because from the third hour 
after the first session on the IOP was lower than the initial IOP. After the 
second session it took more than 6 hours before the IOP was lower than the 
initial IOP; this may be explained by the fact that the post-ALT IOP de-
crease correlates with the initial IOP level. Because the increase in mean 
IOP was the same after the first and after the second session but a higher 
maximum IOP was attained after the first, an IOP decrease after the first 
session was more likely to result in an IOP lower than the initial IOP. 
That the IOP increases and decreases measured were predominantly an effect 
of ALT may be concluded from the course of the IOP in untreated contralater-
al eyes: excluding eyes temporarily showing a Diamox effect, this course 
showed no significant changes in IOP. 
An increase in mean IOP was observed after first as well after second ses-
sions, in first and in second eyes, and in the three major subgroups phakic 
POAG, pigment dispersion syndrome and low-tension glaucoma. 
The mean IOP measured 4 weeks after the first session (17.4 + 3.8 mm Hg) 
equalled the IOP recorded 24 hours after the first session (17.0 + 3.8 mm 
Hg). Apart from a transient IOP increase during the first week after ALT 
which should be ascribed to post-ALT corticosteroid medication, there was no 
essential change in IOP after the first 24 postoperative hours. The maximum 
IOP decrease was attained within 24 hours of the first session (mean propor-
tional IOP decrease 27.8 + 16.2%). The mean proportional IOP decrease re-
corded 24 hours after the second session was 11.9 + 20.0%. 
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This ready Ю Р decrease after the first session can be considered in the 
discussion about the mechanism of action of ALT. The fact that the IOP de­
crease became manifest within a few hours of ALT is indicative of a mechan­
ical action. This is consistent with the tightening effect described by 
Wise: shrinking of the collagenous core of the trabeculae is an immediate 
laser effect. The contraction of the iris in iris stretching could be regar­
ded as an analogous process. 
Biochemical changes in the trabecular meshwork also occur fairly soon af­
ter ALT (see 4.14), but they attain a maximum only a few days later. Yet 
cellular and biochemical changes must also play a role, but possibly in 
maintaining the IOP decrease after ALT. Organization of the laser burns and 
reorganization of the trabecular meshwork are processes not observed until a 
few weeks after ALT. 
A plausible mechanism might thus comprise a mechanical factor (responsible 
for the ready IOP decrease after ALT), and secondary biochemical and cellu­
lar factors which maintain the decrease in IOP. The occurrence of so-called 
late failures is not at odds with this concept because in these eyes the 
ready IOP decrease has occurred (as evident from the initially good respon­
se) , but the secondary changes are insufficient. 
Eyes with IOP spikes and variables in these eyes: 
In some 50% of all eyes an IOP spike of at least 5 mm Hg occurred, and IOP 
spikes of at least 10 mm Hg were seen in virtually 1 out of 4 eyes. The max­
imum IOP increase was on average found 1.5 hours after an ALT session. On 
the basis of our criteria Diamox was indicated for 43.9% of the eyes after 
the first and 22.8% after the second session. At least 500 mg Diamox was re­
quired after the first session in 40.0% and after the second session in 
30.8%. 
A check-up on the IOP 1 and 2 hours after ALT would have adequately iden­
tified 96.0% of the eyes requiring Diamox after the first, and 92.3% of 
those requiring it after the second session. 
These results emphasize a point already discussed in chapter 4: IOP check­
ups 1 and 2 hours after ALT should be part of the standard ALT protocol. 
Whenever an IOP spike is found to fulfill certain criteria (e.g. 10 mm Hg) 
and additional medication is indicated, these eyes should be followed up and 
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treated until an adequate IOP decrease is achieved. 
Given this strategy, only one eye out of 114 sessions (0.9%) in this study 
would not have been selected as requiring Diamox. In one other eye an IOP 
spike was visible after l and after 2 hours, but the decision to give Diamox 
was not made until 3 hours after ALT. 
On the basis of the variables studied, eyes with the following features 
seemed to run a graver risk of developing an IOP spike after ALT: eyes with 
brown irides, those with iris processes and those with a high degree of tra-
becular pigmentation (TP+3 or TP+4). 
In particular the high frequency of IOP spikes in eyes with iris processes 
and those with a high degree of pigmentation provides an indication of the 
pathogenetic mechanism underlying these IOP spikes. ALT applied to such eyes 
will lead to release of pigment and debris which is trapped between the 
trabeculae, reducing the facility of outflow and thus causing an increase in 
IOP. The fact that most IOP spikes are of short duration also argues in fa-
vour of a mechanical obstruction. The tightening effect of ALT will soon 
cause an increase in intertrabecular space and thus a clearing of the ob-
structing material. 
A disruption of the blood-aqueous barrier may also play a role in this re-
spect, although this cannot be a decisive role. Virtually all eyes submitted 
to ALT subsequently showed increased congestion of conjunctival vessels. Un-
mistakable signs of iritis (aqueous flare and cells in the anterior chamber) 
were observed in 41.2% of the eyes with an IOP spike of at least 5 mm Hg; in 
58.8% of these eyes, however, there was only a mild flare or no visible 
signs at all. Distinct evidence of iritis was found in 15.9% of the eyes 
without IOP spikes. The higher incidence of signs of iritis in eyes with an 
IOP spike was statistically significant but their occurrence was not suffi-
ciently consistent to warrant the conclusion that iritis was the sole cause 
of these IOP spikes. 
Another finding in this study which indicates a mechanical pathogenesis 
was the fact that no eye submitted to iris stretching subsequently showed an 
IOP spike of 10 mm Hg or higher. If disruption of the blood-aqueous barrier 
really played an essential role, then it would be precisely after iris 
stretching that a high frequency of IOP spikes might be expected. After all, 
the iris is a prostaglandin depository par excellence, and a release of 
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these prostaglandins would have lead to disruption of the blood-aqueous bar­
rier. However, the opposite seemed more likely: eyes with a beak-shaped 
chamber angle showed an IOP spike of at least 10 mm Hg in 2 out of 8 cases 
without preceding iris stretching. The effect of iris stretching might be 
based on traction upon the trabecular meshwork, producing an additional 
tightening effect. From a clinical point of view, iris stretching is indi­
cated for eyes with a beak-shaped chamber angle. 
ALTs of good quality by our criteria produced slightly more IOP spikes 
than ALTs of moderate quality. This difference cannot be ascribed to a dif­
ference in power setting, because no correlation was found between power 
setting and occurrence of IOP spikes in phakic POAG. On the contrary: a pow­
er setting of less than 1000 mW caused an IOP spike of at least 10 mm Hg in 
4 out of 6 eyes. In a highly pigmented trabecular meshwork pigment disper­
sion and bubble formation will become visible at a lower power setting, and 
the high frequency of IOP spikes at a power setting of less than 1000 mW and 
after ALTs of good quality can be traced to' a high degree of pigmentation. 
Predictive value of first session or first eye IOP spikes: 
The risk of occurrence of an IOP spike of at least 5 mm Hg after the sec­
ond session was not higher when such an IOP spike had been observed after 
the first session. An IOP spike of at least 10 mm Hg after the second ses­
sion was more frequently seen when a similar spike had occurred after the 
first; even then, however, the spikes occurred independently. About 1 eye 
out of б showed an IOP spike of at least 10 mm Hg after the second session 
although no such spike had occurred after the first. 
The conclusion should therefore be that the occurrence of a first session 
IOP spike has little predictive value for the reaction after the second ses­
sion. 
The occurrence of IOP spikes in bilaterally treated patients, however, 
showed a different pattern. 
Assuming that an IOP spike of at least 10 mm Hg should be regarded as 
clinically most relevant (68.0% of the eyes requiring Diamox after the 
first, and 84.8% of those requiring Diamox after the second session), the 
risk that second eyes would show such an IOP spike after at least one ses­
sion after occurrence of the spike after at least one session in the first 
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eye, proved to be 53.3% for all eyes and 72.7% for eyes with phakic POAG. 
If the first eye showed no IOP spike of at least 10 mm Hg after either 
session, then the chance that the same would apply to the second eye was 
93.3% for all eyes and 88.9% for eyes with phakic POAG. 
This symmetry in occurrence of IOP spikes is not surprising in view of the 
fact that there was a fair symmetry of gonioscopic findings and the ALT was 
always performed in a standardized way. The findings would seem to warrant 
the conclusion that an IOP spike of at least 10 mm Hg after one of the two 
sessions implies a high risk that the contralateral eye will show a similar 
spike after ALT. 
IOP spikes, success rate and visual field function: 
The success rate was not negatively affected by the occurrence of IOP 
spikes in phakic POAG. On the contrary: there was a statistical indication 
of a difference in frequency of IOP spikes of at least 10 mm Hg between suc-
cess eyes (54.8%) and failure eyes (20.0%). 
If there was a positive correlation between occurrence of IOP spikes and 
success rate, then this should be traceable to factors which on the one hand 
predispose to developing an IOP spike and on the other hand exert a favour-
able influence on ALT results. One of these factors is probably the degree 
of pigmentation. This study revealed that a high degree of trabecular pig-
mentation was associated with more IOP spikes. Confining analysis to eyes 
with phakic POAG (in order to eliminate a disturbing effect of other varia-
bles) , we found the success rate of eyes with trabecular pigmentation TP 0 
or TP+1 was 60.0%, versus 81.3% for eyes with TP+2 or TP+3. Although this 
difference was not statistically significant, it provided an indication to 
why eyes with an IOP spike showed a higher success rate than those without 
an IOP spike. 
Two out of 32 phakic POAG eyes with an IOP spike of at least 5 mm Hg and a 
good ALT result showed progression of visual field defects to the next 
higher stage. In one of these eyes, however, an exudative diabetic retino-
pathy had become manifest. 
The extent to which the IOP spikes were responsible for this visual field 
deterioration cannot be established with certainty. On the one hand, a 
causal relationship is conceivable - which would imply that 6.3% of the suc-
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cessfully treated eyes showed progression of visual field defect as a result 
of an IOP spike. On the other hand, at least one of these eyes with progres-
sion was also subject to another complicating factor, and the interval be-
tween ALT and perimetry (4.2 months on the average) was too long to permit 
definite demonstration of a causal relationship. 
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SUMMARY 
This thesis describes an investigation into the effects of Argon Laser 
Trabeculoplasty (ALT). Its aim was to evaluate the results of ALT (retro-
spective study) and to study the course of the intraocular pressure (IOP) 
during the period immediately after ALT (prospective study). 
The thesis is divided into two parts. The first part (chapters 1, 2 and 3) 
discusses a number of aspects of glaucoma considered to be of relevance to 
this study. The second part (chapters 4, 5 and 6) presents a review of the 
literature on ALT and describes the results of the retrospective and pros-
pective study. 
Chapter l describes how the glaucoma concept developed through the ages. 
Until well into the Middle Ages glaucoma was regarded as a disease of the 
lens, but numerous new theories were introduced between 1750 and 1850. 
Albrecht von Graefe was the first to describe increased IOP not as a compli-
cation but as a cause of glaucoma. 
Chapter 2 describes the functional anatomy, physiology and pathology of 
the angle of the anterior chamber and the trabecular meshwork. Embryological 
development and macroscopic anatomy are discussed. 
The microscopic structure of the uveal trabeculae (and to a lesser degree 
that of the corneoscleral trabeculae) shows that these contribute little to 
the resistance to aqueous outflow required to produce IOP. The major resis-
tance is provided by the trabecular wall of Schlemm's canal. 
Perfusion studies and other research have shown that the transport of 
aqueous humour to the lumen of Schlemm's canal takes place via a system of 
dynamic vacuolation. Prostaglandins and proteoglycans possibly contribute to 
maintenance of the resistance to outflow. 
The ageing process of the trabecular meshwork results in hyalinization, 
plaque formation, a decrease in cellularity, a decrease in number and size 
of vacuoles in the endothelium and constriction of the lumen of Schlemm's 
canal. Similar changes are observed in glaucoma. Besides quantitative dif-
ferences from the normal ageing process, however, qualitative differences 
play a role. Morphological findings indicate that some plaques occur in 
glaucoma but are not observed in ageing; and enzyme-resistant glycosamino-
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glycans are found only in glaucomatous eyes. 
This chapter closes with a section on the optic nerve. Today there are in-
dications that the vascularity of the anterior part of the optic nerve has a 
mechanism of autoregulation. Disturbed autoregulation possibly plays a role 
in the pathogenesis of glaucomatous optic disk damage. There are two theo-
ries on the pathogenesis of glaucomatous lesions of the optic nerve: a vaso-
genic and a mechanical concept. Indications in favour of both concepts are 
discussed. 
Chapter 3 describes the ocular findings which suggest the possibility of 
glaucoma. Biophysical and clinical aspects of tonometry and findings at 
gonioscopy are discussed. Various aspects of glaucomatous optic disk cupping 
are described with special reference to their correlation with visual field 
defects. 
Early glaucomatous visual field defects may manifest themselves as para-
central scotoma, a wedge-shaped defect or a nasal step (isolated or other-
wise). Classification of visual field defects may be based on the visual 
field stages defined by Aulhorn. The fact that adequate therapy cannot al-
ways prevent progression of the visual field defect is discussed. 
Tonography as well as most provocation tests can be described as having 
fair-to-good sensitivity but low specificity, so that they have a low pre-
dictive value as to possible visual field defects in patients with suspected 
glaucoma. 
Chapter 4 outlines the results of ALT as reported in the literature. Both 
the original Wise ALT and the various modifications of this technique give 
good results in primary open-angle glaucoma, pseudo-exfoliation glaucoma and 
the pigment dispersion syndrome. Results are less good in low-tension glau-
coma, and only moderate results are obtained in various forms of secondary 
glaucoma as well as after cataract extraction. 
ALT applied as primary therapy gives better results than secondary ALT. 
The success rate diminishes as the follow-up increases, and 6 years after 
ALT it is still about 50%. 
The degree of the decrease in IOP correlates with the level of the initial 
IOP. The degree of pigmentation of the trabecular meshwork may also play a 
role in this respect. The success rate is unfavourably influenced by an 
early age and moderate trabecular pigmentation, and may be lower in patients 
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of the negroid race. 
Most modifications of the original Wise technique give good results, ex-
cept one session ALT treating only 90° of the trabecular meshwork circumfer-
ence, or a power setting below 500 mW. 
A transient increase in IOP (IOP spike) is the principal complication ob-
served after ALT. Its incidence largely depends on the time of measurement 
and on the lower limit set, and ranges from 0% to 70%. These IOP spikes may 
lead to visual field defects. Treatment of only 180° of the trabecular mesh-
work per session and application of burns to the anterior part of the mesh-
work reduces the incidence and height of IOP spikes. Corticosteroids and 
prostaglandin synthetase inhibitors exert no significant influence. 
Re-ALT has a lower success rate and, dependent on the modification used, 
produces more IOP spikes. ALT does not unfavourably affect the results of 
ocular hypotensive surgery. 
The mechanism of action of ALT seems to involve mechanical, cellular and 
biochemical changes. 
Chapter 5 describes a retrospective study of the results of ALT performed 
on 433 eyes of 305 patients between 15th June 1982 and 24th June 1986. For 
methodological reasons, however, only the eyes treated first were considered 
in the evaluation. 
In 16.4% of cases ALT was followed by glaucoma surgery, indicated in 25% 
of these cases by an increase in IOP. More medication was required in 7.5% 
of cases. Eyes with secondary glaucoma required post-ALT surgery in 45.2% of 
cases. 
A decrease in IOP by at least 20% and a final IOP of 21 mm Hg or lower was 
observed in 54.1% of the eyes treated. The mean decrease in IOP in these 
eyes was 10.5 mm Hg (38.8%). 
Once the IOP was controlled, topical medication could be reduced or dis-
continued in 40.1% of cases, while systemic medication could be stopped in 
67.7%. 
In eyes with an adequate response to ALT there was no further glaucomatous 
damage to the optic disk in 93.3%, and 69.0% showed stabilization of the 
visual field defect. 
Moderate results were obtained in eyes with low-tension glaucoma and those 
with secondary glaucoma. Good results were obtained in the pigment disper-
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sion syndrome and in suspected glaucoma with damage to the optic disk. Apha-
kic and Pseudophakie eyes showed less good results than phakic eyes. 
Progression of glaucoma as a result of ALT was observed in 1% of the eyes. 
The results in bilaterally treated patients showed a high degree of similar-
ity between the two eyes of an individual. 
The success rate for phakic eyes with primary open-angle glaucoma was 
higher in males than in females (due to the lower initial IOP in females), 
related to the initial IOP level and lower in the case of pre-ALT Diamox 
medication. The coefficient of correlation between initial IOP and decrease 
in IOP was 0.85. Due to the limited number of young patients in this study, 
no correlation between age and success rate was established. 
Treatment of 360° of the trabecular meshwork circumference in one session 
gives a significantly lower final IOP. One session ALT treating 180° has a 
lower success rate. 
A chamber angle configuration unfavourably for ALT caused a lower success 
rate in aphakic eyes or eyes with secondary glaucoma; the results in the 
latter group were age dependent. 
In view of these findings the preferable sequence in the treatment of 
glaucoma with concomitant cataract is: ALT followed by extracapsular cata-
ract extraction. 
The position of ALT in the treatment of glaucoma is discussed on the basis 
of the results obtained in primary open-angle glaucoma and in suspected 
glaucoma. 
Chapter 6 describes a prospective study of the changes in IOP in the 
period immediately after ALT in 57 patients. 
Alt was performed in a standardized way, treating 360° of the trabecular 
meshwork circumference in two sessions separated by an interval of 4 weeks, 
applying a total of 120 burns of 50 \m diameter at an exposure time of 0.1 
second. The bums were applied to the anterior part of the trabecular mesh-
work and the power was titrated on the basis of visible pigment dispersion 
and bubble formation. Corticosteroid eyedrops were given after ALT. This 
technique is now the standard procedure used in our department. 
The IOP was measured 1 hour before ALT, every hour for 6 hours after ALT, 
and 24 hours after ALT. 
One hour after ALT a transient increase in mean IOP was observed, both af-
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ter the first and after the second session, in the first as well as in the 
second eyes treated and in the three major subgroups, within 3 hours of the 
first ALT session an IOP value was found which averaged lower than the ini-
tial IOP. After the second session this took at least 6 hours. 
In 50.9% of the eyes an increase in IOP of at least 5 mm Hg was seen after 
the first session, and in 29.8% of the eyes the increase was at least 10 mm 
Hg. The incidences after the second session were not strikingly different 
from those after the first. The height of the increases in IOP ranged from l 
to 22 mm Hg. 
Additional medication in view of an IOP spike which met the criteria ac-
cepted was required after the first session in 43.9% of cases and after the 
second in 22.8%. 
A significantly higher incidence of IOP spikes of at least 5 mm Hg was 
found in eyes with brown irides, eyes with iris processes, and eyes with a 
high degree of trabecular pigmentation. A significantly lower incidence of 
IOP spikes of at least 10 mm Hg was found in eyes with a beak-shaped angle 
of the anterior chamber and eyes submitted to iris stretching (these two 
variables of course correlate). 
IOP spikes after the first and after the second session occurred indepen-
dently. 
There was a statistically significant dependence of occurrence of an IOP 
spike of at least 10 mm Hg in both eyes of the same individual. 
The success rate after a mean follow-up of 7 months was 75.6% in phakic 
eyes with primary open-angle glaucoma. There is a statistical indication 
that IOP spikes of at least 10 mm Hg occur more frequently in these eyes 
than in eyes in which no adequate control of IOP is achieved. 
Two eyes with an IOP spike of at least 5 mm Hg and adequate IOP control 
showed progression of the visual field defect. The discussion considers the 
(un)likelihood of a causal relationship. 
On the basis of the changes in IOP after ALT and in view of the correla-
tion between certain gonioscopic findings and the occurrence of IOP spikes, 
the discussion considers a mechanical explanation of the decrease in IOP as 
well as the transient increase in IOP after ALT. 
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SAMENVATTING 
Dit proefschrift beschrijft een onderzoek naar de effecten van Argon Laser 
Trabeculoplasty (ALT). Het doel van dit onderzoek is het evalueren van het 
resultaat van ALT (retrospectief onderzoek) en het verloop van de intraocu-
laire druk (IOD) in de onmiddellijke periode na ALT (prospectief onderzoek). 
Het proefschrift bestaat uit twee delen. In het eerste deel (hoofdstukken 
1,2 en 3) wordt ingegaan op een aantal aspecten van glaucoom, voor zover 
deze relevant zijn voor het onderzoek. Het tweede deel (hoofdstukken 4, 5 en 
6) bestaat uit een literatuuroverzicht van ALT en uit een beschrijving van 
de resultaten van het onderzoek. 
Hoofdstuk 1 beschrijft hoe het ziektebeeld glaucoom door de eeuwen heen 
vorm kreeg. Tot ver in de middeleeuwen wordt het glaucoom gezien als een 
ziekte van de lens, maar tussen 1750 en 1850 treden tal van nieuwe theorieën 
naar voren. Albrecht von Graefe beschreef als eerste dat de verhoogde IOD 
geen complicatie, maar de oorzaak van glaucoom is. 
Hoofdstuk 2 beschrijft de functionele anatomie, fysiologie en pathologie 
van de voorste oogkamerhoek en het trabeculum. De embryologisehe ontwikke-
ling en de macroscopische anatomie worden besproken. 
De microscopische bouw van het trabeculum uveale en, in mindere mate van 
het trabeculum comeosclerale, laat zien dat deze slechts weinig bijdraagt 
aan de weerstand die het oogkamervocht dient te ondervinden om IOD op te 
bouwen. De grootste weerstand wordt gevormd door de trabeculaire wand van 
het kanaal van Schlemm. 
Uit onder andere perfusieonderzoek blijkt dat het transport van oogkamer-
vocht naar het lumen van het kanaal van Schlemm via een systeem van dynami-
sche vacuolisatie verloopt. Mogelijk dragen Prostaglandinen en proteoglyca-
nen bij aan het handhaven van de weerstand. 
Het verouderingsproces van het trabeculum resulteert in hyalinisatie, 
plaquesvorming, afname in cellulariteit, afname van het aantal en de grootte 
van de vacuolen in het endotheel en vernauwing van het lumen van het kanaal 
van Schlemm. Deze veranderingen worden ook gezien bij glaucoom. Naast kwan-
titatieve verschillen met het normale verouderingsproces echter, spelen ook 
kwalitatieve verschillen een rol. Morfologisch lijken sommige plaques wel 
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bij glaucoom, maar niet bij veroudering gezien te worden. Ook enzymresisten-
te glycosaminoglycanen komen slechts voor in glaucomateuze ogen. 
Dit hoofdstuk wordt afgesloten met een paragraaf over de nervus opticus. 
Er zijn thans aanwijzingen dat de vasculariteit van het anteriore deel van 
de nervus opticus een autoregulatiemechanisme heeft. Een gestoorde autoregu-
latie speelt mogelijk een rol in het ontstaan van glaucomateuze papilbescha-
diging. Omtrent het ontstaan van glaucomateuze beschadiging van de nervus 
opticus bestaan 2 theorieën: een vasogeen versus een mechanisch concept. 
Aanwijzingen voor beide concepten worden besproken. 
Hoofdstuk 3 beschrijft de bevindingen bij het oogheelkundig onderzoek die 
in de richting van glaucoom wijzen. Biofysische en klinische aspecten van 
tonometrie komen aan de orde evenals de bevindingen bij gonioscopie. 
Diverse aspecten van de glaucomateuze papilexcavatie worden beschreven, 
met name in hun relatie tot gezichtsvelduitval. 
Vroege glaucomateuze gezichtsvelduitval kan zich manifesteren als een pa-
racentraal scotoom, een wigvormig defect en een al dan niet geïsoleerde 'na-
sal step'. Het classificeren van de mate van uitval kan gebeuren aan de hand 
van de stadia die door Aulhorn werden beschreven. Dat adequate therapie de 
progressie van gezichtsvelduitval niet steeds kan voorkomen wordt besproken. 
Zowel ten aanzien van de tonografie als van de meeste provocatietesten 
geldt dat ze een redelijke tot goede sensitiviteit, maar een lage specifici-
teit en dus een lage predictieve waarde hebben ten aanzien van het voorspel-
len van gezichtsvelduitval in glaucoom suspecte patiënten. 
Hoofdstuk 4 schetst de resultaten van ALT zoals deze in de literatuur be-
schreven worden. 
Zowel de oorspronkelijke Wise ALT, als ook diverse modificaties van deze 
techniek geven goede resultaten in het primair open kamerhoek glaucoom, het 
pseudo-exfoliatieve glaucoom en het pigment dispersie syndroom. Minder goede 
resultaten worden behaald in het low-tension glaucoom en matige resultaten 
in diverse vormen van secundair glaucoom en na cataractextractie. 
ALT toegepast als primaire therapie geeft betere resultaten dan wanneer 
deze als secundaire therapie wordt toegepast. Met het vorderen van de fol-
low-up daalt de succes rate en 6 jaar na ALT bedraagt deze nog ongeveer 50%. 
De mate van IOD daling is sterk gecorreleerd aan de hoogte van de initiële 
IOD. Ook de pigmentatiegraad speelt hierbij mogelijk een rol. De succes rate 
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wordt nadelig beïnvloed door een jonge leeftijd, een matig gepigmenteerd 
trabeculum en is mogelijk lager in patiënten van het negroïde ras. 
Het merendeel van de modificaties van de originele Wise techniek geeft 
goede resultaten, behoudens het eenmalig behandelen van slechts 90° van het 
trabeculum en een vermogen van minder dan 500 mW. 
De belangrijkste complicatie na ALT bestaat uit een tijdelijke stijging 
van de IOD. De incidentie is sterk afhankelijk van het tijdstip van meten en 
van de ondergrens die men aan een stijging toekent, en varieert van 0% tot 
70%. Deze IOD stijgingen kunnen tot gezichtsvelduitval leiden. 
Het behandelen van slechts 180* van het trabeculum per sessie, als ook het 
plaatsen van de coagulaten op het anteriore deel van het trabeculum geeft 
een lagere incidentie en hoogte van drukstijgingen. Corticosteroiden en 
prostaglandinesynthetase-remmers hebben geen significante invloed. 
Hernieuwde ALT geeft een geringere kans op succes en, afhankelijk van de 
modificatie, meer IOD stijgingen. ALT heeft geen nadelige invloed op het re-
sultaat van een drukverlagende operatie. 
Ten aanzien van het werkingsmechanisme van ALT lijken mechanische, cellu-
laire en biochemische veranderingen een rol te spelen. 
Hoofdstuk 5 beschrijft een retrospectief onderzoek naar de resultaten van 
ALT, die verricht werd bij 433 ogen van 305 patiënten in de periode van 15 
juni 1982 tot en met 24 juni 1986. Om methodologische redenen echter werden 
slechts de eerst behandelde ogen in de evaluatie betrokken. 
In 16.4% van de ogen werd na ALT een drukverlagende operatie verricht, 
waarvan in een kwart vanwege een IOD stijging. Meer medicatie was in 7.5% 
van de ogen nodig. Ogen met secundair glaucoom werden in 45.2% van de geval-
len geopereerd. 
In 54.1% van de ogen trad een IOD daling van tenminste 20% op en werd een 
uiteindelijke IOD van 21 mm Hg of lager bereikt. De gemiddelde daling in 
deze ogen bedroeg 10.5 mm Hg (38.8%). 
Na drukregulering was het in 40.1% mogelijk lokale medicatie te verminde-
ren of stoppen en in 67.7% mogelijk systemische medicatie te stoppen. 
In ogen met een goede IOD regulering werd in 93.3% van de gevallen geen 
verdere glaucomateuze papilbeschadiging en in 69.0% een stabilisering van de 
gezichtsvelduitval gezien. 
Matige resultaten werden bereikt in ogen met low-tension glaucoom en in 
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ogen met secundair glaucoom; goede resultaten in ogen met het pigment dis-
persie syndroom en in glaucoom suspecte ogen met papilbeschadiging. AphaJce 
en pseudophake ogen lieten minder goede resultaten zien dan phake ogen. Een 
progressie van het glaucoom door ALT werd in 1% gevonden. 
De uitkomsten in bilateraal behandelde patiënten lieten een hoge mate van 
samenhang zien tussen de resultaten in beide ogen van een individu. 
Voor phake ogen met primair open kamerhoek glaucoom was de succes rate ho-
ger voor mannen dan voor vrouwen (hetgeen te wijten is aan de lagere ini-
tiële IOD die voor vrouwen bestond), gerelateerd aan de hoogte van de ini-
tiële IOD en lager wanneer voor ALT Diamox werd gebruikt. De correlatie-
coëfficiënt tussen initiële IOD en drukdaling bedroeg 0.85. 
In dit onderzoek werd, tengevolge van het gering aantal jonge patiënten, 
geen correlatie tussen leeftijd en succes rate gevonden. 
Een eenmalige behandeling van 360° van het trabeculum gaf een significant-
lagere uiteindelijke IOD. Een eenmalige behandeling van 180° geeft een la-
gere succes rate. 
Een voor ALT ongunstige configuratie van de kamerhoek in aphake ogen of in 
ogen met secundair glaucoom gaf een lagere succes rate. De uitkomst in deze 
laatste groep was leeftijdsafhankelijk. 
In geval van glaucoom en concomiterend cataract dient op basis van deze 
bevindingen de voorkeur gegeven te worden aan eerst ALT en dan extracapsu-
laire cataractextractie. 
Aan de hand van de resultaten in ogen met primair open kamerhoek glaucoom 
en in glaucoom suspecte ogen wordt over de plaats van ALT binnen het behan-
delingsschema van glaucoom gediscussieerd. 
Hoofdstuk 6 beschrijft een prospectief onderzoek naar het IOD verloop in 
de periode onmiddellijk na ALT bij 57 patiënten. 
ALT werd op een gestandaardiseerde wijze verricht: behandeling van 360° 
van het trabeculum in 2 sessies, gescheiden door een periode van 4 weken, 
met in totaal 120 coagulaten van 50 \m diameter en een exposure tijd van 0.1 
seconde. De coagulaten werden geplaatst op het anteriore deel van het trabe-
culum en het vermogen werd getitreerd op een zichtbare pigmentdispersie en 
luchtbelvorming. Nabehandeling vond plaats met corticosteroiden druppels. 
Deze techniek is thans de standaardwijze om een ALT te verrichten in onze 
kliniek. De IOD werd onder andere 1 uur voor, op 6 achtereenvolgende en 24 
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uur na ALT gemeten. 
Één uur na ALT werd een tijdelijke stijging van de gemiddelde IOD gezien. 
Dit werd zowel na de eerste als tweede sessie, in het eerste als tweede oog 
en in de 3 grootste subgroepen gevonden. Na de eerste sessie werd reeds 3 
uur na ALT een druk gevonden die gemiddeld lager was dan de initiële IOD. Na 
de tweede sessie duurde dit langer dan 6 uur. 
In 50.9% van de ogen trad een IOD stijging van tenminste 5 mm Hg en in 
29.8% van tenminste 10 mm Hg op na de eerste sessie. De frequenties na de 
tweede sessie waren niet opvallend verschillend van die na de eerste sessie. 
De spreiding van de hoogte van de drukstijgingen was 1 tot 22 mm Hg. 
Additionele medicamenteuze therapie in verband met een IOD stijging die 
aan vastgestelde criteria voldeed was in 43.9% na de eerste en in 22.8% na 
de tweede sessie noodzakelijk. 
Een significant hogere frequentie van drukstijgingen van tenminste 5 mm Hg 
werd gevonden in ogen met bruine irides, in ogen met iris processi en in 
ogen met een hoge trabeculaire pigmentâtiegraad. Een significant lagere fre-
quentie van IOD stijgingen van tenminste 10 mm Hg in ogen met een snavelbek-
vormige kamerhoek en in ogen waarin iris stretching werd verricht. Deze 
beide laatste variabelen zijn uiteraard gecorreleerd. 
IOD stijgingen na de eerste en tweede sessie traden onafhankelijk van el-
kaar op, maar er was een statistisch significante afhankelijkheid tussen het 
optreden van IOD stijgingen van tenminste 10 mm Hg in beide ogen van een in-
dividu. 
Voor phake ogen met primair open kamerhoek glaucoom werd een succes rate 
van 75.6% gevonden, bij een gemiddelde follow-up van 7 maanden. Er bestaat 
een statistische aanwijzing dat IOD stijgingen van tenminste 10 mm Hg in 
deze ogen frequenter optreden dan in ogen waarin geen goede drukregulering 
wordt bereikt. 
In twee ogen met een IOD stijging van tenminste 5 mm Hg en een goede druk-
regulering werd een progressie van de gezichtsvelduitval gevonden. In de 
discussie wordt ingegaan op een al dan niet causaal verband. 
Aan de hand van het IOD verloop na ALT en op basis van de correlatie tus-
sen zekere gonioscopische bevindingen en het optreden van IOD stijgingen, 
wordt in de discussie ingegaan op een mechanische verklaring van zowel druk-
daling als tijdelijke drukstijging na ALT. 
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ADDENDUM 1 
Patient number 
Date of birth 
Sex 
Treated by 
Glaucoma type 
Date of previous cataract extraction 
Complaints 
Duration of glaucoma 
Previous topical therapy: score 
Carbonic anhydrase inhibitor use: yes/no 
Previous glaucoma surgery: number and type(s) 
General medical history 
Ocular history 
Visual acuity ь refraction 
General ocular examination 
Gonioscopy 
Optic disk: score 
Visual field: stage 
ALT indication 
Argon Laser Trabeculoplasty: Right/left eye 
Nasal/temporal 
І О ЗбО" 
Power (mW) 
Number of coagulates 
Iris stretching: yes/no 
Corticosteroids: yes/no 
Specifications 
Post-ALT surgery or re-ALT: Secondary glaucoma surgery: number and type(s) 
Re-treatment: parameters as in initial ALT 
Cataract extraction 
Miscellaneous 
Post-ALT IOP records: Date 
IOP 
Specifications 
Final ocular examination: Date 
IOP 
Topical medication: score 
Carbonic anhydrase use: yes/no 
Visual acuity 
Optic Disk: score 
Visual field: stage 
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Demographic data: 
Glaucoma: 
Previous therapy: 
Medical history: 
Ocular examination: 
ADDENDUM 2 
Demographic data: Patient number 
Date of birth 
Sex 
Race 
Previous therapy: 
Glaucoma: Glaucoma type 
Date of cataract extraction 
Complaints 
Year of diagnosis 
Time (months) not treated 
Compliance 
Previous topical therapy: score 
Carbonic anhydrase inhibitor use: yes/no 
Previous glaucoma surgery: number and type 
Allergic reactions to medical therapy 
Postoperative complications 
General examination and history: Blood pressure 
Special child diseases 
Diabetes mellitus 
Arterial hypertension 
Ischaemic heart disease 
Transient ischaemic attacks 
Thyroid disease 
Migraine 
Number of operations (general anaesthesia) 
Medication 
Intoxication 
Allergies 
Ocular history: Loss of vision 
Diplopia 
Mouches volantes 
Haloes 
Scotomas 
Metamorphopsia 
Shadows 
Flashing light 
Mi с rops i a/mac rops i a 
Transient ischaemic attacks 
Colour vision disorder 
Nyctalopia 
Congenital disorders 
Pain 
Uveitis 
Ocular traumata 
Ocular surgery 
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Ocular examination 
Gonioscopy iris: Colour 
Pupillary contours 
Pigment dispersion 
Atrophy 
Nodules 
Iridodonesis 
Colobomas 
Gonioscopy iridocorneal angle: Angle grade 
Plateau iris 
Recession 
Scleral spur visibility 
Scleral spur aspect 
Iris processi 
Trabecular identification 
Trabecular pigmentation 
Blood in Schlemm's canal 
Prominence of schwalbe's line 
Blood vessels 
Peripheral anterior synechiae 
Optic disk: 
Preoperative visual field stage 
Argon Laser Trabeculoplasty: 
Horizontal cup/disk ratio 
Vertical cup/disk ratio 
Localized polar notching 
Localized pallor of the neural rim 
Overpass cupping 
Peripapillary atrophy 
Displaced blood vessels 
Optic disk haemorrhage 
Papilloedema 
Date 
Right/left eye 
Nasal/temporal 
Visible effect 
Power 
Number of coagulates 
Anterior localization 
Iris stretching 
Power 
Number of coagulates 
Haemorrhage 
Postoperative corticosteroids 
Quality 
Patient complaints 
IOP 1 hour preoperative 
IOP 1-6 hours postoperative 
Diamox postoperative 
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Conjunctival injection 
Anterior chamber reaction 
Post-ALT IOP records: 
Regular out-patient check-ups 
Final ocular examination: 
IOP (day 1 and day 7) 
Conjunctival injection (day 1 and day 7) 
Anterior chamber reaction (day 1 and day 7) 
Date 
IOP 
Topical medication score 
Carbonic anhydrase inhibitor use: yes/no 
Visual acuity 
Visual field stage 
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DANKWOORD 
Vanaf deze plaats wil ik mijn waardering uitspreken voor allen die bijge-
dragen hebben aan de totstandXoming van dit proefschrift. 
Helaas verbieden reglementen mij de personen te bedanken, die hun vertrou-
wen in mij gesteld hebben en zonder wiens hulp dit proefschrift niet ge-
schreven zou zijn. Anderen mogen wel genoemd worden: 
Stafleden, assistenten en overige medewerkers van de afdeling oogheelkunde 
van het St. Radboud Ziekenhuis te Nijmegen (Hoofd: Prof. Dr. A.F. Deutman) 
dank ik voor de getoonde interesse en blijken van waardering. 
Yolanda Hennink, beheersfunctionaris van bovengenoemde afdeling, bedank ik 
voor haar hulp bij het oplossen van een aantal problemen, die niets met het 
onderzoek, maar alles met de promotie te maken hadden. 
Dhr. Th. van Winsen dank ik voor de voortreffelijke vertaling van het ma-
nuscript en de zeer plezierige correspondentie. 
Drs. W.H. Doesburg en dhr. W.A.J.G. Lemmens van de Mathematisch-Statisti-
sche Adviesafdeling dank ik voor de statistische verwerking van de data. Wim 
1 en Wim 2: zonder jullie kennis en ideeën (en de 466,7 meter computeruit-
draai) was het mij niet gelukt. 
Dhr. A.T. van Uden van de Medische Tekenkamer dank ik voor het verzorgen 
van de illustraties behorende bij de hoofdstukken 5 en 6. 
Niet in de laatste plaats wil ik mijn echtgenote Marianne bedanken voor de 
steun en relativerende opmerkingen over dit proefschrift. Ook onze zoon 
Casper verdient een woord van waardering daar hij, slechts enkele maanden 
oud, begreep dat rust in huize Webers gewenst was. 
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CURRICULUM VITAE 
Carroll Webers werd geboren op 5 maart 1960 te Conrad (U.S.A.). Na het be-
halen van het diploma Atheneum-B aan de Albert Schweitzer Scholengemeenschap 
te Geleen, werd in 1978 begonnen met de studie geneeskunde aan de Katholieke 
Universiteit te Nijmegen. Het artsexamen werd behaald in mei 1985. 
De basis van het in dit proefschrift beschreven onderzoek werd gelegd tij-
dens een keuzestage oogheelkunde als onderdeel van de postdoctorale studie 
geneeskunde in de kliniek voor Oogheelkunde van het St. Radboud Ziekenhuis 
te Nijmegen (Hoofd: Prof. Dr. A.F. Deutman). Het onderzoek werd begeleid 
door Dr. F. Hendrikse. 
Naast de researchactiviteiten werd in de periode van 9 juli 1985 tot 1 
maart 1987 de militaire dienstplicht vervuld als reserve-officier-arts bij 
het 473 Regionaal Geneeskundig Detachement (GCKL). 
Sinds 1983 is hij getrouwd met Marianne Zaicsek en sinds oktober 1987 heb-
ben ze een zoon, Casper. 

STELLINGEN 
behorende bij het proefschrift 
ARGON LASER TRABECULOPLASTY 
-a retrospective and prospective study-
C.A.B . WEBERS 
I 
De kans op secundaire glaucoomchirurgie na ALT is evenredig met de reeds 
bestaande glaucomateuze schade. 
Dit proefschrift. 
II 
Zowel ten aanzien van het resultaat als ten aanzien van mtraoculaire 
drukstijgingen na ALT bestaat een grote mate van afhankelijkheid tussen 
beide ogen van een individu. 
Dit proefsctirift. 
III 
Bij patiënten met een verhoogde intraoculaire druk, zonder andere glau-
coomkenmerken, dient niet zonder meer ALT uitgevoerd te worden. 
Dit proefsctinft. 
IV 
De relatie tussen mtraoculaire drukstijgingen na ALT en het aspect van 
de voorste oogkamerhoek maakt een mechanische verklaring waarschijnlijk. 
Dit proefschrift. 
V 
De conclusie van Rouhiainen et al. dat de trabeculaire pigmentatiegraad 
geen rol speelt bij het optreden van intraoculaire drukstijgingen na 
ALT is niet juist. 
Rouhiainen, H.J. et al., Arch. Ophüialnol. 105:1352, 1987. 
VI 
De slechte resultaten van Wishart et al. met betrekking tot de combina-
tie van ALT en iris stretching berusten op een onjuiste indicatiestel-
ling en onjuiste techniek van zowel ALT als iris stretching. 
Wishart, P.R. et al., Eye 1:567, 1987. 
VII 
Het plaatsen van een achterste oogkamerkunstlens is niet gecontramdi-
ceerd bij glaucoom. 
Vili 
Als algemene regel kan gesteld worden dat voor elke significantietoets 
geldt dat deze niet valide is wanneer de 'sample size' groter is dan het 
aantal individuen in een onderzoek. 
Newerabe, R.G., and Duff, G.R., Br. J. OphÜialirol. 71:645, 1987. 
IX 
In sommige geva l len kan een spontane l i n k s z i j d i g e pneumothorax zonder 
medische hulpmiddelen gediagnost iseerd worden. 
Eigen waarneming. 
X 
Toenemende bezuinigingen leiden ook in figuurlijke zin tot een verarming 
van de gezondheidszorg. 
XI 
Door laakbaar gedrag van fokkers en houders is de pit-bull terrier thans 
de gebeten hond. 
Nijmegen, 30 september 1988 



